{"id":"qld:sl-2021-0140","name":"Medicines and Poisons (Medicines) Regulation 2021","slug":"medicines-and-poisons-medicines-regulation-2021","collection":"regulation","jurisdiction":"qld","status":"in_force","isInForce":true,"actNumber":"140 of 2021","makingDate":null,"administeringDepartment":null,"currentVersion":{"id":173942,"registerId":"qld-sl-2021-0140-current","compilationNumber":null,"startDate":"2026-04-05","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"ch.1-pt.1","sectionType":"part","heading":"Preliminary","content":"# Preliminary","sortOrder":0},{"sectionNumber":"sec.1","sectionType":"section","heading":"Short title","content":"### sec.1 Short title\n\nThis regulation may be cited as the Medicines and Poisons (Medicines) Regulation 2021 .","sortOrder":1},{"sectionNumber":"sec.2","sectionType":"section","heading":"Commencement","content":"### sec.2 Commencement\n\nThis regulation commences on 27 September 2021.","sortOrder":2},{"sectionNumber":"sec.3","sectionType":"section","heading":"Application of regulation","content":"### sec.3 Application of regulation\n\nThis regulation applies in relation to a regulated activity that is a dealing with a medicine.\nSee the Medicines and Poisons (Poisons and Prohibited Substances) Regulation 2021 in relation to particular dealings with poisons and prohibited substances.\nSee the Medicines and Poisons (Pest Management Activities) Regulation 2021 in relation to pest management activities.\n- 1 See the Medicines and Poisons (Poisons and Prohibited Substances) Regulation 2021 in relation to particular dealings with poisons and prohibited substances.\n- 2 See the Medicines and Poisons (Pest Management Activities) Regulation 2021 in relation to pest management activities.","sortOrder":3},{"sectionNumber":"ch.1-pt.2","sectionType":"part","heading":"Interpretation","content":"# Interpretation","sortOrder":4},{"sectionNumber":"sec.4","sectionType":"section","heading":"Definitions","content":"### sec.4 Definitions\n\nThe dictionary in schedule 22 defines particular words used in this regulation.","sortOrder":5},{"sectionNumber":"sec.5","sectionType":"section","heading":"References to registration under Health Practitioner Regulation National Law","content":"### sec.5 References to registration under Health Practitioner Regulation National Law\n\nA provision of this regulation referring to a person registered under the Health Practitioner Regulation National Law to practise in a profession—\nincludes a person with provisional registration or limited registration for the profession; but\ndoes not include a person registered to practise in the profession only as a student or for training purposes.\nSee schedule 12 , part 7 and schedule 11 , part 3 in relation to trainees.\nHowever, subsection (1) does not apply in relation to the enrolled nurses division of the nursing profession or the pharmacy profession.\nSee schedule 7 , parts 4 to 6 in relation to enrolled nursing professions.\nSee schedule 9 in relation to pharmaceutical professions.\n(sec.5-ssec.1) A provision of this regulation referring to a person registered under the Health Practitioner Regulation National Law to practise in a profession— includes a person with provisional registration or limited registration for the profession; but does not include a person registered to practise in the profession only as a student or for training purposes. See schedule 12 , part 7 and schedule 11 , part 3 in relation to trainees.\n(sec.5-ssec.2) However, subsection (1) does not apply in relation to the enrolled nurses division of the nursing profession or the pharmacy profession. See schedule 7 , parts 4 to 6 in relation to enrolled nursing professions. See schedule 9 in relation to pharmaceutical professions.\n- (a) includes a person with provisional registration or limited registration for the profession; but\n- (b) does not include a person registered to practise in the profession only as a student or for training purposes. Note— See schedule 12 , part 7 and schedule 11 , part 3 in relation to trainees.\n- 1 See schedule 7 , parts 4 to 6 in relation to enrolled nursing professions.\n- 2 See schedule 9 in relation to pharmaceutical professions.","sortOrder":6},{"sectionNumber":"ch.1-pt.3","sectionType":"part","heading":"Exemptions","content":"# Exemptions","sortOrder":7},{"sectionNumber":"sec.6","sectionType":"section","heading":"Exemption for national blood supply arrangements— Act , s 7","content":"### sec.6 Exemption for national blood supply arrangements— Act , s 7\n\nFor section 7 (1) of the Act , each of the following activities with the following substances is prescribed—\nbuying a listed blood product using the national blood tracking system;\npossessing a listed blood product obtained using the national blood tracking system;\nsupplying, by wholesale, stock of a listed blood product using the national blood tracking system;\ndispensing a listed blood product on a prescription made in the national blood tracking system;\ngiving a treatment dose of a listed blood product on a prescription made in the national blood tracking system;\nprescribing a listed blood product using the national blood tracking system;\nadministering a listed blood product on a prescription made in the national blood tracking system.\nHowever, the activity is prescribed only to the extent—\nthe activity is carried out by a person performing a function under the national blood supply arrangements; and\nfor subsection (1) (d) or (e) —the listed blood product is labelled in compliance with—\nthe labelling requirements stated in the Poisons Standard, Appendix L; or\nif the listed blood product has been granted a labelling exemption by an appropriate authority under the Poisons Standard, section 39 —any labelling requirements imposed by the appropriate authority for the product.\nIn this section—\nlisted blood product means an S4 medicine that is an immunoglobulin blood product mentioned on the national product price list.\nNational Blood Agreement see the National Blood Authority Act 2003 (Cwlth) , section 3 .\nnational blood supply arrangements means the arrangements made under the National Blood Agreement.\nnational blood tracking system means the system for ordering, or authorising orders for, blood or blood-related products, established for facilitating the national blood supply arrangements.\nnational product price list means the price list for blood products or blood-related products supplied under the National Blood Agreement, approved by the Ministerial Council under that agreement.\ns 6 amd 2023 SL No. 170 s 4\n(sec.6-ssec.1) For section 7 (1) of the Act , each of the following activities with the following substances is prescribed— buying a listed blood product using the national blood tracking system; possessing a listed blood product obtained using the national blood tracking system; supplying, by wholesale, stock of a listed blood product using the national blood tracking system; dispensing a listed blood product on a prescription made in the national blood tracking system; giving a treatment dose of a listed blood product on a prescription made in the national blood tracking system; prescribing a listed blood product using the national blood tracking system; administering a listed blood product on a prescription made in the national blood tracking system.\n(sec.6-ssec.2) However, the activity is prescribed only to the extent— the activity is carried out by a person performing a function under the national blood supply arrangements; and for subsection (1) (d) or (e) —the listed blood product is labelled in compliance with— the labelling requirements stated in the Poisons Standard, Appendix L; or if the listed blood product has been granted a labelling exemption by an appropriate authority under the Poisons Standard, section 39 —any labelling requirements imposed by the appropriate authority for the product.\n(sec.6-ssec.3) In this section— listed blood product means an S4 medicine that is an immunoglobulin blood product mentioned on the national product price list. National Blood Agreement see the National Blood Authority Act 2003 (Cwlth) , section 3 . national blood supply arrangements means the arrangements made under the National Blood Agreement. national blood tracking system means the system for ordering, or authorising orders for, blood or blood-related products, established for facilitating the national blood supply arrangements. national product price list means the price list for blood products or blood-related products supplied under the National Blood Agreement, approved by the Ministerial Council under that agreement.\n- (a) buying a listed blood product using the national blood tracking system;\n- (b) possessing a listed blood product obtained using the national blood tracking system;\n- (c) supplying, by wholesale, stock of a listed blood product using the national blood tracking system;\n- (d) dispensing a listed blood product on a prescription made in the national blood tracking system;\n- (e) giving a treatment dose of a listed blood product on a prescription made in the national blood tracking system;\n- (f) prescribing a listed blood product using the national blood tracking system;\n- (g) administering a listed blood product on a prescription made in the national blood tracking system.\n- (a) the activity is carried out by a person performing a function under the national blood supply arrangements; and\n- (b) for subsection (1) (d) or (e) —the listed blood product is labelled in compliance with— (i) the labelling requirements stated in the Poisons Standard, Appendix L; or (ii) if the listed blood product has been granted a labelling exemption by an appropriate authority under the Poisons Standard, section 39 —any labelling requirements imposed by the appropriate authority for the product.\n- (i) the labelling requirements stated in the Poisons Standard, Appendix L; or\n- (ii) if the listed blood product has been granted a labelling exemption by an appropriate authority under the Poisons Standard, section 39 —any labelling requirements imposed by the appropriate authority for the product.\n- (i) the labelling requirements stated in the Poisons Standard, Appendix L; or\n- (ii) if the listed blood product has been granted a labelling exemption by an appropriate authority under the Poisons Standard, section 39 —any labelling requirements imposed by the appropriate authority for the product.","sortOrder":8},{"sectionNumber":"sec.6A","sectionType":"section","heading":"Exemption for S3 naloxone treatment programs— Act , s 7","content":"### sec.6A Exemption for S3 naloxone treatment programs— Act , s 7\n\nFor section 7 (1) of the Act , each of the following activities with the following substances is prescribed—\nsupplying, by wholesale, stock of S3 naloxone for a naloxone treatment program;\ngiving 1 or more doses of S3 naloxone obtained under a naloxone treatment program to a person;\nadministering S3 naloxone obtained under a naloxone treatment program to a person.\nHowever, subsection (3) applies to an activity mentioned in subsection (1) (b) carried out by a person performing a function under a naloxone treatment program.\nThe activity is prescribed only to the extent—\nthe person is appropriately qualified; and\nthe person, when carrying out the activity, gives instructions about—\nhow to recognise signs and symptoms of suspected opioid overdose; and\nhow to administer the S3 naloxone.\nIn this section—\nnaloxone treatment program means a program set up by an entity of the State or Commonwealth to make S3 naloxone widely available for treating opioid overdose.\nS3 naloxone means naloxone in a manufacturer’s pack for the treatment of opioid overdose, other than naloxone that is an S4 medicine.\ns 6A ins 2023 SL No. 51 s 4\n(sec.6A-ssec.1) For section 7 (1) of the Act , each of the following activities with the following substances is prescribed— supplying, by wholesale, stock of S3 naloxone for a naloxone treatment program; giving 1 or more doses of S3 naloxone obtained under a naloxone treatment program to a person; administering S3 naloxone obtained under a naloxone treatment program to a person.\n(sec.6A-ssec.2) However, subsection (3) applies to an activity mentioned in subsection (1) (b) carried out by a person performing a function under a naloxone treatment program.\n(sec.6A-ssec.3) The activity is prescribed only to the extent— the person is appropriately qualified; and the person, when carrying out the activity, gives instructions about— how to recognise signs and symptoms of suspected opioid overdose; and how to administer the S3 naloxone.\n(sec.6A-ssec.4) In this section— naloxone treatment program means a program set up by an entity of the State or Commonwealth to make S3 naloxone widely available for treating opioid overdose. S3 naloxone means naloxone in a manufacturer’s pack for the treatment of opioid overdose, other than naloxone that is an S4 medicine.\n- (a) supplying, by wholesale, stock of S3 naloxone for a naloxone treatment program;\n- (b) giving 1 or more doses of S3 naloxone obtained under a naloxone treatment program to a person;\n- (c) administering S3 naloxone obtained under a naloxone treatment program to a person.\n- (a) the person is appropriately qualified; and\n- (b) the person, when carrying out the activity, gives instructions about— (i) how to recognise signs and symptoms of suspected opioid overdose; and (ii) how to administer the S3 naloxone.\n- (i) how to recognise signs and symptoms of suspected opioid overdose; and\n- (ii) how to administer the S3 naloxone.\n- (i) how to recognise signs and symptoms of suspected opioid overdose; and\n- (ii) how to administer the S3 naloxone.","sortOrder":9},{"sectionNumber":"sec.6B","sectionType":"section","heading":"Exemption for buying or supplying stock of national stockpile medicines— Act , s 7","content":"### sec.6B Exemption for buying or supplying stock of national stockpile medicines— Act , s 7\n\nFor section 7 (1) of the Act , the activities prescribed are buying or supplying stock of a national stockpile medicine.\nHowever, each activity is prescribed only to the extent it is carried out by—\na responsible government entity; or\na person acting under a direction given by a responsible government entity.\nIn this section—\nCommonwealth health secretary means the secretary of the department of the Commonwealth in which the National Health Security Act 2007 (Cwlth) is administered.\nnational stockpile medicine means a medicine supplied in the first instance from a reserve of stock of medicines held by the Commonwealth health secretary in stockpile for a health emergency.\nresponsible government entity means an entity of the State or Commonwealth responsible for managing the distribution of stock of national stockpile medicines.\ns 6B ins 2024 SL No. 102 s 4\n(sec.6B-ssec.1) For section 7 (1) of the Act , the activities prescribed are buying or supplying stock of a national stockpile medicine.\n(sec.6B-ssec.2) However, each activity is prescribed only to the extent it is carried out by— a responsible government entity; or a person acting under a direction given by a responsible government entity.\n(sec.6B-ssec.3) In this section— Commonwealth health secretary means the secretary of the department of the Commonwealth in which the National Health Security Act 2007 (Cwlth) is administered. national stockpile medicine means a medicine supplied in the first instance from a reserve of stock of medicines held by the Commonwealth health secretary in stockpile for a health emergency. responsible government entity means an entity of the State or Commonwealth responsible for managing the distribution of stock of national stockpile medicines.\n- (a) a responsible government entity; or\n- (b) a person acting under a direction given by a responsible government entity.","sortOrder":10},{"sectionNumber":"sec.6C","sectionType":"section","heading":"Exemption for buying, supplying or possessing stock of immunisation medicines— Act , s 7","content":"### sec.6C Exemption for buying, supplying or possessing stock of immunisation medicines— Act , s 7\n\nFor section 7 (1) of the Act , the activities prescribed are buying, supplying or possessing stock of an immunisation medicine.\nHowever, each activity is prescribed only to the extent—\nthe stock is originally supplied to a registered immunisation service provider by the department; and\nthe activity is for transferring stock from 1 registered immunisation service provider to another registered immunisation service provider; and\nif the activity is supplying the stock—the registered immunisation service provider supplying the stock notifies the chief executive of the supply as soon as practicable after the supply happens.\ns 6C ins 2025 SL No. 19 s 4\n(sec.6C-ssec.1) For section 7 (1) of the Act , the activities prescribed are buying, supplying or possessing stock of an immunisation medicine.\n(sec.6C-ssec.2) However, each activity is prescribed only to the extent— the stock is originally supplied to a registered immunisation service provider by the department; and the activity is for transferring stock from 1 registered immunisation service provider to another registered immunisation service provider; and if the activity is supplying the stock—the registered immunisation service provider supplying the stock notifies the chief executive of the supply as soon as practicable after the supply happens.\n- (a) the stock is originally supplied to a registered immunisation service provider by the department; and\n- (b) the activity is for transferring stock from 1 registered immunisation service provider to another registered immunisation service provider; and\n- (c) if the activity is supplying the stock—the registered immunisation service provider supplying the stock notifies the chief executive of the supply as soon as practicable after the supply happens.","sortOrder":11},{"sectionNumber":"ch.1-pt.4","sectionType":"part","heading":"Approval of documents","content":"# Approval of documents","sortOrder":12},{"sectionNumber":"sec.7","sectionType":"section","heading":"Extended practice authorities— Act , s 232","content":"### sec.7 Extended practice authorities— Act , s 232\n\nFor section 232 (4) of the Act , each extended practice authority mentioned in schedule 1 , part 1 is approved.\nSee section 232 (4) of the Act for when an extended practice authority takes effect.\nA reference in this regulation to an extended practice authority by its name is a reference to the extended practice authority mentioned in schedule 1 , part 1 —\nwith that name; and\nwith the version number mentioned opposite that name.\n(sec.7-ssec.1) For section 232 (4) of the Act , each extended practice authority mentioned in schedule 1 , part 1 is approved. See section 232 (4) of the Act for when an extended practice authority takes effect.\n(sec.7-ssec.2) A reference in this regulation to an extended practice authority by its name is a reference to the extended practice authority mentioned in schedule 1 , part 1 — with that name; and with the version number mentioned opposite that name.\n- (a) with that name; and\n- (b) with the version number mentioned opposite that name.","sortOrder":13},{"sectionNumber":"sec.8","sectionType":"section","heading":"Departmental standards— Act , s 233","content":"### sec.8 Departmental standards— Act , s 233\n\nFor section 233 (4) of the Act , each departmental standard mentioned in schedule 1 , part 2 is approved.\nSee section 233 (4) of the Act for when a departmental standard takes effect.\nA reference in this regulation to a departmental standard by its name is a reference to the standard mentioned in schedule 1 , part 2 —\nwith that name; and\nwith the version number mentioned opposite that name.\n(sec.8-ssec.1) For section 233 (4) of the Act , each departmental standard mentioned in schedule 1 , part 2 is approved. See section 233 (4) of the Act for when a departmental standard takes effect.\n(sec.8-ssec.2) A reference in this regulation to a departmental standard by its name is a reference to the standard mentioned in schedule 1 , part 2 — with that name; and with the version number mentioned opposite that name.\n- (a) with that name; and\n- (b) with the version number mentioned opposite that name.","sortOrder":14},{"sectionNumber":"ch.1-pt.5","sectionType":"part","heading":"Categories of medicines","content":"# Categories of medicines","sortOrder":15},{"sectionNumber":"sec.9","sectionType":"section","heading":"Restricted medicines","content":"### sec.9 Restricted medicines\n\nA medicine mentioned in schedule 2 , part 1 is a restricted medicine .","sortOrder":16},{"sectionNumber":"sec.10","sectionType":"section","heading":"High-risk medicines— Act , s 40","content":"### sec.10 High-risk medicines— Act , s 40\n\nFor section 40 (3) of the Act , definition high-risk medicine , a medicine mentioned in schedule 2 , part 2 is prescribed to be a high-risk medicine.","sortOrder":17},{"sectionNumber":"sec.11","sectionType":"section","heading":"Diversion-risk medicines— Act , sch 1","content":"### sec.11 Diversion-risk medicines— Act , sch 1\n\nFor schedule 1 of the Act , definition diversion-risk medicine , a medicine mentioned in schedule 2 , part 3 is prescribed to be a diversion-risk medicine.","sortOrder":18},{"sectionNumber":"sec.12","sectionType":"section","heading":"Monitored medicines— Act , sch 1","content":"### sec.12 Monitored medicines— Act , sch 1\n\nFor schedule 1 of the Act , definition monitored medicine , a medicine mentioned in schedule 2 , part 4 is prescribed to be a monitored medicine.","sortOrder":19},{"sectionNumber":"ch.2-pt.1","sectionType":"part","heading":"Approved persons","content":"# Approved persons","sortOrder":20},{"sectionNumber":"sec.13","sectionType":"section","heading":"Approved persons— Act , s 54","content":"### sec.13 Approved persons— Act , s 54\n\nFor section 54 (1) of the Act , a class of persons stated in a relevant schedule is prescribed for the dealing with the medicine stated in the table in the schedule for the class of persons to the extent the dealing is carried out by a person acting—\nas a member of the class of persons; and\nwithin the scope for the dealing, if any.\nA pharmacist is prescribed for a dealing with a medicine stated in the table in schedule 9 , section 2 to the extent the pharmacist is practising the pharmacy profession and acting within the scope of the dealing stated in column 3 of the table.\nA principal of a school is prescribed for a dealing with a medicine stated in the table in schedule 13 , section 9 to the extent of acting as the principal for the school within the scope stated for the dealing in column 3 of the table.\nIn this section—\nrelevant schedule means any of schedules 3 to 15 .\nscope , for a dealing with a medicine, means a circumstance, purpose, extended practice authority or other matter stated in a table in a relevant schedule for the dealing.\n(sec.13-ssec.1) For section 54 (1) of the Act , a class of persons stated in a relevant schedule is prescribed for the dealing with the medicine stated in the table in the schedule for the class of persons to the extent the dealing is carried out by a person acting— as a member of the class of persons; and within the scope for the dealing, if any. A pharmacist is prescribed for a dealing with a medicine stated in the table in schedule 9 , section 2 to the extent the pharmacist is practising the pharmacy profession and acting within the scope of the dealing stated in column 3 of the table. A principal of a school is prescribed for a dealing with a medicine stated in the table in schedule 13 , section 9 to the extent of acting as the principal for the school within the scope stated for the dealing in column 3 of the table.\n(sec.13-ssec.2) In this section— relevant schedule means any of schedules 3 to 15 . scope , for a dealing with a medicine, means a circumstance, purpose, extended practice authority or other matter stated in a table in a relevant schedule for the dealing.\n- (a) as a member of the class of persons; and\n- (b) within the scope for the dealing, if any.\n- 1 A pharmacist is prescribed for a dealing with a medicine stated in the table in schedule 9 , section 2 to the extent the pharmacist is practising the pharmacy profession and acting within the scope of the dealing stated in column 3 of the table.\n- 2 A principal of a school is prescribed for a dealing with a medicine stated in the table in schedule 13 , section 9 to the extent of acting as the principal for the school within the scope stated for the dealing in column 3 of the table.","sortOrder":21},{"sectionNumber":"ch.2-pt.2","sectionType":"part","heading":"Prescribed classes of general approvals","content":"# Prescribed classes of general approvals","sortOrder":22},{"sectionNumber":"sec.14","sectionType":"section","heading":"Classes of general approvals— Act , s 68","content":"### sec.14 Classes of general approvals— Act , s 68\n\nFor section 68 (2) of the Act , this part prescribes classes of general approvals.","sortOrder":23},{"sectionNumber":"sec.15","sectionType":"section","heading":"Acute health conditions at isolated sites","content":"### sec.15 Acute health conditions at isolated sites\n\nA general approval (acute health conditions at isolated sites) is prescribed for the classes of persons mentioned in column 1 of the table in schedule 16 , section 2 for carrying out the dealings with the medicines mentioned opposite in column 2, for the purpose of treating acute health conditions.","sortOrder":24},{"sectionNumber":"sec.16","sectionType":"section","heading":"Emergency first aid","content":"### sec.16 Emergency first aid\n\nA general approval (emergency first aid) is prescribed for the classes of persons mentioned in column 1 of the table in schedule 16 , section 4 for carrying out the dealings with the medicines mentioned opposite in column 2, for the purpose of providing first aid in an emergency.","sortOrder":25},{"sectionNumber":"sec.17","sectionType":"section","heading":"Emergency management of animals","content":"### sec.17 Emergency management of animals\n\nA general approval (emergency management of animals) is prescribed for the classes of persons mentioned in column 1 of the table in schedule 16 , section 6 for carrying out the dealings with the medicines mentioned opposite in column 2, for the purpose of the emergency care and treatment of sick, injured or orphaned animals.","sortOrder":26},{"sectionNumber":"ch.3-pt.1","sectionType":"part","heading":"Preliminary","content":"# Preliminary","sortOrder":27},{"sectionNumber":"sec.18","sectionType":"section","heading":"Application of chapter— Act , s 70","content":"### sec.18 Application of chapter— Act , s 70\n\nFor section 70 (1) (a) of the Act , this chapter prescribes standard conditions applying in relation to substance authorities authorising dealings with medicines.\nSee also chapters 4 and 5 about requirements prescribed under section 91 (1) of the Act .","sortOrder":28},{"sectionNumber":"ch.3-pt.2","sectionType":"part","heading":"Manufacturing licences","content":"# Manufacturing licences","sortOrder":29},{"sectionNumber":"ch.3-pt.2-div.1","sectionType":"division","heading":"Conditions for all manufacturers","content":"## Conditions for all manufacturers","sortOrder":30},{"sectionNumber":"sec.19","sectionType":"section","heading":"Application of division","content":"### sec.19 Application of division\n\nThis division applies in relation to a manufacturing licence authorising the manufacture of a medicine.","sortOrder":31},{"sectionNumber":"sec.20","sectionType":"section","heading":"Manufacturing must be supervised","content":"### sec.20 Manufacturing must be supervised\n\nThe holder of a manufacturing licence must appoint an appropriately qualified person to supervise manufacturing under the licence.\nThe holder must take all reasonable steps to ensure the medicine is manufactured under the supervision of the person mentioned in subsection (1) .\n(sec.20-ssec.1) The holder of a manufacturing licence must appoint an appropriately qualified person to supervise manufacturing under the licence.\n(sec.20-ssec.2) The holder must take all reasonable steps to ensure the medicine is manufactured under the supervision of the person mentioned in subsection (1) .","sortOrder":32},{"sectionNumber":"sec.21","sectionType":"section","heading":"Quality control","content":"### sec.21 Quality control\n\nThe holder of a manufacturing licence must take all reasonable steps to ensure a medicine manufactured under the licence is fit for its intended use and free from contamination.\nThe holder is taken to comply with subsection (1) if the holder complies with a code, guideline, standard or quality assurance scheme that is recognised for promoting best practice in the industry for the type of manufacturing authorised under the licence.\n(sec.21-ssec.1) The holder of a manufacturing licence must take all reasonable steps to ensure a medicine manufactured under the licence is fit for its intended use and free from contamination.\n(sec.21-ssec.2) The holder is taken to comply with subsection (1) if the holder complies with a code, guideline, standard or quality assurance scheme that is recognised for promoting best practice in the industry for the type of manufacturing authorised under the licence.","sortOrder":33},{"sectionNumber":"sec.22","sectionType":"section","heading":"Open for inspection","content":"### sec.22 Open for inspection\n\nThe holder of a manufacturing licence must keep an authorised place stated in the licence open for inspection during the times the place is open for carrying on business or otherwise open for entry.","sortOrder":34},{"sectionNumber":"ch.3-pt.2-div.2","sectionType":"division","heading":"Particular conditions for manufacturers of medicated feed","content":"## Particular conditions for manufacturers of medicated feed","sortOrder":35},{"sectionNumber":"sec.23","sectionType":"section","heading":"Application of division","content":"### sec.23 Application of division\n\nThis division applies in relation to a manufacturing licence authorising the supply of medicated feed to a person who is a farmer of a group of animals.","sortOrder":36},{"sectionNumber":"sec.24","sectionType":"section","heading":"Supply on prescriptions","content":"### sec.24 Supply on prescriptions\n\nThe holder of a manufacturing licence must not supply medicated feed to a farmer of a group of animals unless the farmer has a written prescription for the feed from a veterinary surgeon.","sortOrder":37},{"sectionNumber":"sec.25","sectionType":"section","heading":"Manufacturer must give and keep supply records","content":"### sec.25 Manufacturer must give and keep supply records\n\nWhen supplying medicated feed to a farmer of a group of animals, the holder of a manufacturing licence must give the farmer a document stating the following information—\na unique identifier for the document;\nthe date of the supply;\nthe name and address of the farmer;\nthe unique identifier on the prescription held by the farmer;\ndetails about the form, strength and amount of the feed supplied.\nIf the medicated feed is to be delivered to the farmer, the address mentioned in subsection (1) (c) must be the street address for delivery of the feed.\nThe holder must—\nkeep a copy of the document or a record of the details contained in the document; and\nSee section 224 about keeping records.\ngive a copy of the document to the veterinary surgeon who prescribed the feed, if asked to do so by the veterinary surgeon.\n(sec.25-ssec.1) When supplying medicated feed to a farmer of a group of animals, the holder of a manufacturing licence must give the farmer a document stating the following information— a unique identifier for the document; the date of the supply; the name and address of the farmer; the unique identifier on the prescription held by the farmer; details about the form, strength and amount of the feed supplied.\n(sec.25-ssec.2) If the medicated feed is to be delivered to the farmer, the address mentioned in subsection (1) (c) must be the street address for delivery of the feed.\n(sec.25-ssec.3) The holder must— keep a copy of the document or a record of the details contained in the document; and See section 224 about keeping records. give a copy of the document to the veterinary surgeon who prescribed the feed, if asked to do so by the veterinary surgeon.\n- (a) a unique identifier for the document;\n- (b) the date of the supply;\n- (c) the name and address of the farmer;\n- (d) the unique identifier on the prescription held by the farmer;\n- (e) details about the form, strength and amount of the feed supplied.\n- (a) keep a copy of the document or a record of the details contained in the document; and Note— See section 224 about keeping records.\n- (b) give a copy of the document to the veterinary surgeon who prescribed the feed, if asked to do so by the veterinary surgeon.","sortOrder":38},{"sectionNumber":"sec.26","sectionType":"section","heading":"Delivery of medicated feed","content":"### sec.26 Delivery of medicated feed\n\nThis section applies if the holder of a manufacturing licence delivers, or arranges for delivery of, medicated feed to a farmer of a group of animals.\nThe holder must ensure a notice stating the name of the farmer and the street address for delivery—\nis attached to the medicated feed; or\nif it is not reasonably practicable to attach the notice to the feed—accompanies the medicated feed.\na notice is sent in a truck carrying medicated feed supplied in bulk for delivery directly to a silo\n(sec.26-ssec.1) This section applies if the holder of a manufacturing licence delivers, or arranges for delivery of, medicated feed to a farmer of a group of animals.\n(sec.26-ssec.2) The holder must ensure a notice stating the name of the farmer and the street address for delivery— is attached to the medicated feed; or if it is not reasonably practicable to attach the notice to the feed—accompanies the medicated feed. a notice is sent in a truck carrying medicated feed supplied in bulk for delivery directly to a silo\n- (a) is attached to the medicated feed; or\n- (b) if it is not reasonably practicable to attach the notice to the feed—accompanies the medicated feed. Example for paragraph (b) — a notice is sent in a truck carrying medicated feed supplied in bulk for delivery directly to a silo","sortOrder":39},{"sectionNumber":"ch.3-pt.3","sectionType":"part","heading":"Retail licences","content":"# Retail licences","sortOrder":40},{"sectionNumber":"sec.27","sectionType":"section","heading":"Selling within 25km from pharmacy","content":"### sec.27 Selling within 25km from pharmacy\n\nThe holder of an S2 retail licence must not sell an S2 medicine under the licence within 25km in a direct route from a pharmacy.\nHowever, subsection (3) applies if, during the term of the S2 retail licence, a new pharmacy opens within 25km in a direct route from an authorised place stated in the licence.\nFor a period of up to 6 months from the day the pharmacy opens, the holder may sell any S2 medicines bought under the licence before the pharmacy opened.\nIn this section—\ndirect route , in relation to 2 places, means the most direct route between the places, calculated using the distance of the roads on the route between the places.\n(sec.27-ssec.1) The holder of an S2 retail licence must not sell an S2 medicine under the licence within 25km in a direct route from a pharmacy.\n(sec.27-ssec.2) However, subsection (3) applies if, during the term of the S2 retail licence, a new pharmacy opens within 25km in a direct route from an authorised place stated in the licence.\n(sec.27-ssec.3) For a period of up to 6 months from the day the pharmacy opens, the holder may sell any S2 medicines bought under the licence before the pharmacy opened.\n(sec.27-ssec.4) In this section— direct route , in relation to 2 places, means the most direct route between the places, calculated using the distance of the roads on the route between the places.","sortOrder":41},{"sectionNumber":"sec.28","sectionType":"section","heading":"Selling S2 medicines in manufacturer’s pack","content":"### sec.28 Selling S2 medicines in manufacturer’s pack\n\nThe holder of an S2 retail licence must not sell an S2 medicine other than in a manufacturer’s pack.","sortOrder":42},{"sectionNumber":"sec.29","sectionType":"section","heading":"Open for inspection","content":"### sec.29 Open for inspection\n\nThe holder of an S2 retail licence must keep an authorised place stated in the licence open for inspection during the times the place is open for carrying on business or otherwise open for entry.","sortOrder":43},{"sectionNumber":"ch.3-pt.4","sectionType":"part","heading":"Prescribing approvals for approved opioids","content":"# Prescribing approvals for approved opioids","sortOrder":44},{"sectionNumber":"sec.30","sectionType":"section","heading":"Application of part","content":"### sec.30 Application of part\n\nThis part applies in relation to a prescribing approval authorising a dealing with an approved opioid under an opioid treatment program.\nSee also the requirements for prescribing medicines under chapter 4 , part 6 .","sortOrder":45},{"sectionNumber":"sec.31","sectionType":"section","heading":"Notification when starting and stopping treatment","content":"### sec.31 Notification when starting and stopping treatment\n\nIf the holder of a prescribing approval starts treating a patient under an opioid treatment program, the holder must ensure notice is given to the chief executive in the approved form.\nThe notice must be given to the chief executive as soon as practicable, but no later than the end of the next business day, after the treatment starts.\nIf the holder stops treating the patient, the holder must ensure notice is given to the chief executive in the approved form as soon as practicable, but no later than 3 business days, after the treatment stops.\n(sec.31-ssec.1) If the holder of a prescribing approval starts treating a patient under an opioid treatment program, the holder must ensure notice is given to the chief executive in the approved form.\n(sec.31-ssec.2) The notice must be given to the chief executive as soon as practicable, but no later than the end of the next business day, after the treatment starts.\n(sec.31-ssec.3) If the holder stops treating the patient, the holder must ensure notice is given to the chief executive in the approved form as soon as practicable, but no later than 3 business days, after the treatment stops.","sortOrder":46},{"sectionNumber":"ch.3-pt.5","sectionType":"part","heading":"General approvals","content":"# General approvals","sortOrder":47},{"sectionNumber":"ch.3-pt.5-div.1","sectionType":"division","heading":"Acute health conditions at isolated sites","content":"## Acute health conditions at isolated sites","sortOrder":48},{"sectionNumber":"sec.32","sectionType":"section","heading":"Appropriately qualified practitioners","content":"### sec.32 Appropriately qualified practitioners\n\nThe holder of a general approval (acute health conditions at isolated sites) must appoint a medical practitioner or nurse practitioner who is appropriately qualified to oversee the dealings authorised under the approval.","sortOrder":49},{"sectionNumber":"sec.33","sectionType":"section","heading":"Practitioners must be contactable","content":"### sec.33 Practitioners must be contactable\n\nThe holder of a general approval (acute health conditions at isolated sites) must take all reasonable steps to ensure a medical practitioner or nurse practitioner is available to be contacted when a dealing is carried out under the approval.","sortOrder":50},{"sectionNumber":"ch.3-pt.5-div.2","sectionType":"division","heading":"Emergency first aid","content":"## Emergency first aid","sortOrder":51},{"sectionNumber":"sec.34","sectionType":"section","heading":"Appropriately qualified practitioners","content":"### sec.34 Appropriately qualified practitioners\n\nThe holder of a general approval (emergency first aid) must appoint a medical practitioner or nurse practitioner who is appropriately qualified to oversee the dealings authorised under the approval.","sortOrder":52},{"sectionNumber":"sec.35","sectionType":"section","heading":"Notification about events","content":"### sec.35 Notification about events\n\nThe holder of a general approval (emergency first aid) must give notice to the chief executive if a registered nurse, first aid provider or paramedic intends to attend an event under the approval.\nThe notice must be given in the approved form no less than 2 business days before the event happens.\n(sec.35-ssec.1) The holder of a general approval (emergency first aid) must give notice to the chief executive if a registered nurse, first aid provider or paramedic intends to attend an event under the approval.\n(sec.35-ssec.2) The notice must be given in the approved form no less than 2 business days before the event happens.","sortOrder":53},{"sectionNumber":"sec.36","sectionType":"section","heading":"Practitioners must be contactable","content":"### sec.36 Practitioners must be contactable\n\nThe holder of a general approval (emergency first aid) must take all reasonable steps to ensure a medical practitioner or nurse practitioner is available to be contacted when a registered nurse, first aid provider or paramedic is attending an event or site under the approval.","sortOrder":54},{"sectionNumber":"ch.3-pt.5-div.3","sectionType":"division","heading":"Emergency management of animals","content":"## Emergency management of animals","sortOrder":55},{"sectionNumber":"sec.37","sectionType":"section","heading":"Appropriately qualified veterinary surgeons","content":"### sec.37 Appropriately qualified veterinary surgeons\n\nThe holder of a general approval (emergency management of animals) must appoint a veterinary surgeon who is appropriately qualified to oversee the dealings authorised under the approval.","sortOrder":56},{"sectionNumber":"sec.38","sectionType":"section","heading":"Veterinary surgeons must be contactable","content":"### sec.38 Veterinary surgeons must be contactable\n\nThe holder of a general approval (emergency management of animals) must take all reasonable steps to ensure a veterinary surgeon is available to be contacted when a person is likely to be caring for or treating sick, injured or orphaned animals under the approval.","sortOrder":57},{"sectionNumber":"ch.3-pt.6","sectionType":"part","heading":"All substance authorities","content":"# All substance authorities","sortOrder":58},{"sectionNumber":"sec.39","sectionType":"section","heading":"Application of part","content":"### sec.39 Application of part\n\nThis part applies in relation to all substance authorities authorising dealings with medicines.","sortOrder":59},{"sectionNumber":"sec.40","sectionType":"section","heading":"Keeping invoices","content":"### sec.40 Keeping invoices\n\nThe holder of a substance authority must keep any invoice received for any medicine supplied to the holder for a dealing under the authority.","sortOrder":60},{"sectionNumber":"sec.41","sectionType":"section","heading":"Availability of records for inspection","content":"### sec.41 Availability of records for inspection\n\nThe holder of a substance authority must ensure any records required to be kept under the Act in relation to an authorised place stated in the authority are available for inspection at the place.\nHowever, if the records are kept electronically, the holder must ensure the records for each authorised place stated in the authority are available for inspection from the primary place of business of the holder.\n(sec.41-ssec.1) The holder of a substance authority must ensure any records required to be kept under the Act in relation to an authorised place stated in the authority are available for inspection at the place.\n(sec.41-ssec.2) However, if the records are kept electronically, the holder must ensure the records for each authorised place stated in the authority are available for inspection from the primary place of business of the holder.","sortOrder":61},{"sectionNumber":"sec.42","sectionType":"section","heading":"Notification of particular changes affecting authority","content":"### sec.42 Notification of particular changes affecting authority\n\nThe holder of a substance authority must give notice to the chief executive in the approved form if any of the following changes are proposed by the holder—\na change to an authorised place stated in the authority;\na change to a relevant person stated in the authority;\nif the substance authority is a manufacturing licence—a change to the person who is appointed to supervise manufacturing under the licence;\nanother change to the holder’s circumstances that substantially affects the holder’s ability to comply with a condition of the authority.\na fire at an authorised place stated in a wholesale licence damages stock of medicines and the security system at the place\nThe notice must be given as soon as practicable, but no later than 5 business days, after the change of circumstances happens.\n(sec.42-ssec.1) The holder of a substance authority must give notice to the chief executive in the approved form if any of the following changes are proposed by the holder— a change to an authorised place stated in the authority; a change to a relevant person stated in the authority; if the substance authority is a manufacturing licence—a change to the person who is appointed to supervise manufacturing under the licence; another change to the holder’s circumstances that substantially affects the holder’s ability to comply with a condition of the authority. a fire at an authorised place stated in a wholesale licence damages stock of medicines and the security system at the place\n(sec.42-ssec.2) The notice must be given as soon as practicable, but no later than 5 business days, after the change of circumstances happens.\n- (a) a change to an authorised place stated in the authority;\n- (b) a change to a relevant person stated in the authority;\n- (c) if the substance authority is a manufacturing licence—a change to the person who is appointed to supervise manufacturing under the licence;\n- (d) another change to the holder’s circumstances that substantially affects the holder’s ability to comply with a condition of the authority. Example for paragraph (d) — a fire at an authorised place stated in a wholesale licence damages stock of medicines and the security system at the place","sortOrder":62},{"sectionNumber":"sec.43","sectionType":"section","heading":"Stopping dealing","content":"### sec.43 Stopping dealing\n\nThis section applies if a holder of a substance authority proposes to stop carrying out a dealing with a medicine under the substance authority.\nThe holder must give the chief executive a notice in the approved form stating the following information—\nthe day the dealing is proposed to stop;\nthe amount of medicine that is likely to be unused on the day mentioned in paragraph (a) , if any;\nhow the holder proposes to deal with any unused medicine.\n(sec.43-ssec.1) This section applies if a holder of a substance authority proposes to stop carrying out a dealing with a medicine under the substance authority.\n(sec.43-ssec.2) The holder must give the chief executive a notice in the approved form stating the following information— the day the dealing is proposed to stop; the amount of medicine that is likely to be unused on the day mentioned in paragraph (a) , if any; how the holder proposes to deal with any unused medicine.\n- (a) the day the dealing is proposed to stop;\n- (b) the amount of medicine that is likely to be unused on the day mentioned in paragraph (a) , if any;\n- (c) how the holder proposes to deal with any unused medicine.","sortOrder":63},{"sectionNumber":"ch.4-pt.1","sectionType":"part","heading":"Preliminary","content":"# Preliminary","sortOrder":64},{"sectionNumber":"sec.44","sectionType":"section","heading":"Application of chapter— Act , s 91","content":"### sec.44 Application of chapter— Act , s 91\n\nFor section 91 (1) of the Act , this chapter prescribes requirements, for a person authorised under section 54 (4) or 62 of the Act to deal with a medicine, in relation to carrying out the dealing.\nThis chapter applies to the person in addition to chapter 5 , unless otherwise stated.\nSee section 91 (3) of the Act in relation to the matters to which the requirements under this chapter are subject.\nThis chapter does not apply in relation to persons authorised to deal with a medicine under section 57 of the Act which relates to emergency orders.\n(sec.44-ssec.1) For section 91 (1) of the Act , this chapter prescribes requirements, for a person authorised under section 54 (4) or 62 of the Act to deal with a medicine, in relation to carrying out the dealing.\n(sec.44-ssec.2) This chapter applies to the person in addition to chapter 5 , unless otherwise stated.\n- 1 See section 91 (3) of the Act in relation to the matters to which the requirements under this chapter are subject.\n- 2 This chapter does not apply in relation to persons authorised to deal with a medicine under section 57 of the Act which relates to emergency orders.","sortOrder":65},{"sectionNumber":"ch.4-pt.2","sectionType":"part","heading":"Manufacturing by compounding","content":"# Manufacturing by compounding","sortOrder":66},{"sectionNumber":"sec.45","sectionType":"section","heading":"Application of part","content":"### sec.45 Application of part\n\nThis part applies to a person who is authorised to manufacture a medicine by compounding it.","sortOrder":67},{"sectionNumber":"sec.46","sectionType":"section","heading":"Compounded medicine fit for use","content":"### sec.46 Compounded medicine fit for use\n\nA person compounding a medicine must take all reasonable steps to ensure the medicine is fit for its intended use and free from contamination.","sortOrder":68},{"sectionNumber":"sec.47","sectionType":"section","heading":"Compounding for patients under departmental standard","content":"### sec.47 Compounding for patients under departmental standard\n\nA person compounding a medicine for a patient must compound the medicine in accordance with the departmental standard called ‘Compounding’.","sortOrder":69},{"sectionNumber":"ch.4-pt.3","sectionType":"part","heading":"Buying by giving purchase orders","content":"# Buying by giving purchase orders","sortOrder":70},{"sectionNumber":"sec.48","sectionType":"section","heading":"Application of part","content":"### sec.48 Application of part\n\nThis part applies to a person (a buyer ) who is authorised to give a purchase order for stock of an S4 or S8 medicine.\nSee also section 34 of the Act in relation to exclusions for buying particular S4 and S8 medicines.\nSee part 4 for requirements about supplying stock.\nSee also chapter 8 , part 4 about recording and keeping information.\n- 1 See also section 34 of the Act in relation to exclusions for buying particular S4 and S8 medicines.\n- 2 See part 4 for requirements about supplying stock.\n- 3 See also chapter 8 , part 4 about recording and keeping information.","sortOrder":71},{"sectionNumber":"sec.49","sectionType":"section","heading":"Definitions for part","content":"### sec.49 Definitions for part\n\nbuyer see section 48 .\nsupplier means a person authorised under the Act , or permitted under a corresponding law or another law, to supply stock of an S4 or S8 medicine.","sortOrder":72},{"sectionNumber":"sec.50","sectionType":"section","heading":"When purchase order must be given","content":"### sec.50 When purchase order must be given\n\nA buyer must give a supplier of an S4 or S8 medicine a purchase order before or at the time of supply of the stock.","sortOrder":73},{"sectionNumber":"sec.51","sectionType":"section","heading":"Nature of purchase order","content":"### sec.51 Nature of purchase order\n\nA buyer must make a written purchase order for stock of an S4 or S8 medicine and send it to the supplier in a way that is reasonably likely to—\nminimise fraud or tampering; and\nif sent electronically—be transmitted securely.\nthe white space on the purchase order is marked with hatching to prevent additional information being added\nthe purchase order is sent using an electronic system which locks when not in use by a person with a unique identifier\nThe buyer must sign the purchase order or use the buyer’s unique identifier in the purchase order.\nthe buyer has a unique username or account number that is shown on the purchase order when the buyer uses a secure ordering website\nThe buyer must not amend the purchase order once it is made without clearly showing the amendments in the purchase order.\nthe buyer changes the brand name for a medicine stated in the purchase order and initials the order next to the change\n(sec.51-ssec.1) A buyer must make a written purchase order for stock of an S4 or S8 medicine and send it to the supplier in a way that is reasonably likely to— minimise fraud or tampering; and if sent electronically—be transmitted securely. the white space on the purchase order is marked with hatching to prevent additional information being added the purchase order is sent using an electronic system which locks when not in use by a person with a unique identifier\n(sec.51-ssec.2) The buyer must sign the purchase order or use the buyer’s unique identifier in the purchase order. the buyer has a unique username or account number that is shown on the purchase order when the buyer uses a secure ordering website\n(sec.51-ssec.3) The buyer must not amend the purchase order once it is made without clearly showing the amendments in the purchase order. the buyer changes the brand name for a medicine stated in the purchase order and initials the order next to the change\n- (a) minimise fraud or tampering; and\n- (b) if sent electronically—be transmitted securely.\n- • the white space on the purchase order is marked with hatching to prevent additional information being added\n- • the purchase order is sent using an electronic system which locks when not in use by a person with a unique identifier","sortOrder":74},{"sectionNumber":"sec.52","sectionType":"section","heading":"Information for inclusion in purchase order","content":"### sec.52 Information for inclusion in purchase order\n\nA buyer must state the following information in a purchase order for stock of an S4 or S8 medicine—\na unique identifier for the purchase order;\nthe date the purchase order is made;\nthe name and address of the buyer;\nif the stock is to be delivered—\nthe street address of the buyer; or\nan authorised place at which the buyer is authorised to possess the stock; or\nif the stock is to be delivered to a hospital—the name of the hospital;\nthe details of the buyer’s authorisation to give the purchase order;\nthe name, form and strength of the stock sought;\nthe amount of the stock sought.\n- (a) a unique identifier for the purchase order;\n- (b) the date the purchase order is made;\n- (c) the name and address of the buyer;\n- (d) if the stock is to be delivered— (i) the street address of the buyer; or (ii) an authorised place at which the buyer is authorised to possess the stock; or (iii) if the stock is to be delivered to a hospital—the name of the hospital;\n- (i) the street address of the buyer; or\n- (ii) an authorised place at which the buyer is authorised to possess the stock; or\n- (iii) if the stock is to be delivered to a hospital—the name of the hospital;\n- (e) the details of the buyer’s authorisation to give the purchase order;\n- (f) the name, form and strength of the stock sought;\n- (g) the amount of the stock sought.\n- (i) the street address of the buyer; or\n- (ii) an authorised place at which the buyer is authorised to possess the stock; or\n- (iii) if the stock is to be delivered to a hospital—the name of the hospital;","sortOrder":75},{"sectionNumber":"sec.53","sectionType":"section","heading":"Buyer acknowledging receipt of stock of S8 medicine","content":"### sec.53 Buyer acknowledging receipt of stock of S8 medicine\n\nThis section applies in relation to stock of an S8 medicine.\nOn the day a buyer receives the stock, the buyer must—\nsign the purchase order for the stock or another notice to confirm the buyer has received all of the stock; or\nif the stock is delivered to the buyer—ensure a signed notice is sent to the supplier to confirm the buyer has received all of the stock.\nIf the stock is bought for a pharmacy, a pharmacist from the pharmacy must sign the purchase order or notice confirming receipt of the stock.\nThe buyer must keep a copy of a notice sent to the supplier under subsection (2) (b) .\nSee section 224 about keeping records.\nSee also chapter 8 , part 2 , division 3 about recording stock received in a medicine register.\n(sec.53-ssec.1) This section applies in relation to stock of an S8 medicine.\n(sec.53-ssec.2) On the day a buyer receives the stock, the buyer must— sign the purchase order for the stock or another notice to confirm the buyer has received all of the stock; or if the stock is delivered to the buyer—ensure a signed notice is sent to the supplier to confirm the buyer has received all of the stock.\n(sec.53-ssec.3) If the stock is bought for a pharmacy, a pharmacist from the pharmacy must sign the purchase order or notice confirming receipt of the stock.\n(sec.53-ssec.4) The buyer must keep a copy of a notice sent to the supplier under subsection (2) (b) .\n- (a) sign the purchase order for the stock or another notice to confirm the buyer has received all of the stock; or\n- (b) if the stock is delivered to the buyer—ensure a signed notice is sent to the supplier to confirm the buyer has received all of the stock.\n- 1 See section 224 about keeping records.\n- 2 See also chapter 8 , part 2 , division 3 about recording stock received in a medicine register.","sortOrder":76},{"sectionNumber":"ch.4-pt.4","sectionType":"part","heading":"Supplying stock","content":"# Supplying stock","sortOrder":77},{"sectionNumber":"ch.4-pt.4-div.1","sectionType":"division","heading":"Preliminary","content":"## Preliminary","sortOrder":78},{"sectionNumber":"sec.54","sectionType":"section","heading":"Application of part","content":"### sec.54 Application of part\n\nThis part applies to a person who is authorised (a supplier ) to supply stock of a medicine.\nThis part applies in relation to the supply of stock of a medicine for—\nretail on-sale; or\nuse by, or in connection with, carrying on a business, industry, profession or trade.\nsupply to a midwife for a birthing kit\nsupply to the principal of a school for stocking the school\nHowever, this part does not apply in relation to the supply of medicated feed to a farmer of a group of animals.\nSee chapter 3 , part 2 , division 2 about holders of manufacturing licences supplying medicated feed.\nSee also chapter 8 , part 4 about recording and keeping information.\n(sec.54-ssec.1) This part applies to a person who is authorised (a supplier ) to supply stock of a medicine.\n(sec.54-ssec.2) This part applies in relation to the supply of stock of a medicine for— retail on-sale; or use by, or in connection with, carrying on a business, industry, profession or trade. supply to a midwife for a birthing kit supply to the principal of a school for stocking the school\n(sec.54-ssec.3) However, this part does not apply in relation to the supply of medicated feed to a farmer of a group of animals.\n- (a) retail on-sale; or\n- (b) use by, or in connection with, carrying on a business, industry, profession or trade. Examples for paragraph (b) — • supply to a midwife for a birthing kit • supply to the principal of a school for stocking the school\n- • supply to a midwife for a birthing kit\n- • supply to the principal of a school for stocking the school\n- • supply to a midwife for a birthing kit\n- • supply to the principal of a school for stocking the school\n- 1 See chapter 3 , part 2 , division 2 about holders of manufacturing licences supplying medicated feed.\n- 2 See also chapter 8 , part 4 about recording and keeping information.","sortOrder":79},{"sectionNumber":"sec.55","sectionType":"section","heading":"Definitions for part","content":"### sec.55 Definitions for part\n\nIn this part—\nbuyer means a person buying stock.\nsupplier see section 54 .","sortOrder":80},{"sectionNumber":"ch.4-pt.4-div.2","sectionType":"division","heading":"Supplying in appropriate circumstances","content":"## Supplying in appropriate circumstances","sortOrder":81},{"sectionNumber":"sec.56","sectionType":"section","heading":"Supply of S4 or S8 medicine","content":"### sec.56 Supply of S4 or S8 medicine\n\nThis section applies in relation to stock of an S4 or S8 medicine.\nA supplier must not supply the stock to a buyer unless—\nthe supplier reasonably believes that the buyer—\nis authorised under the Act to give a purchase order or otherwise buy the stock; or\nis permitted under a corresponding law or another law to obtain the stock; and\nthe supplier obtains a compliant purchase order for the stock from the buyer.\nIf the buyer is the master of a ship mentioned in schedule 13 , section 19 , the supplier must not supply the stock unless the purchase order is also signed by a medical practitioner.\nSubsection (3) does not apply if the stock is required to be kept on the ship under another law.\nIn this section—\ncompliant purchase order means—\na purchase order given in compliance with sections 51 and 52 ; or\nan eligible order under the National Health (Remote Area Aboriginal Health Services Program) Special Arrangement 2017 (PB 107 of 2017) (Cwlth) ; or\nan order complying with the National Health (Pharmaceutical Benefits) Regulations 2017 (Cwlth) , section 33 .\nThe National Health (Pharmaceutical Benefits) Regulations 2017 (Cwlth) , section 33 allows particular pharmaceutical benefits to be supplied by pharmacists to particular health practitioners using an order complying with that section.\n(sec.56-ssec.1) This section applies in relation to stock of an S4 or S8 medicine.\n(sec.56-ssec.2) A supplier must not supply the stock to a buyer unless— the supplier reasonably believes that the buyer— is authorised under the Act to give a purchase order or otherwise buy the stock; or is permitted under a corresponding law or another law to obtain the stock; and the supplier obtains a compliant purchase order for the stock from the buyer.\n(sec.56-ssec.3) If the buyer is the master of a ship mentioned in schedule 13 , section 19 , the supplier must not supply the stock unless the purchase order is also signed by a medical practitioner.\n(sec.56-ssec.4) Subsection (3) does not apply if the stock is required to be kept on the ship under another law.\n(sec.56-ssec.5) In this section— compliant purchase order means— a purchase order given in compliance with sections 51 and 52 ; or an eligible order under the National Health (Remote Area Aboriginal Health Services Program) Special Arrangement 2017 (PB 107 of 2017) (Cwlth) ; or an order complying with the National Health (Pharmaceutical Benefits) Regulations 2017 (Cwlth) , section 33 . The National Health (Pharmaceutical Benefits) Regulations 2017 (Cwlth) , section 33 allows particular pharmaceutical benefits to be supplied by pharmacists to particular health practitioners using an order complying with that section.\n- (a) the supplier reasonably believes that the buyer— (i) is authorised under the Act to give a purchase order or otherwise buy the stock; or (ii) is permitted under a corresponding law or another law to obtain the stock; and\n- (i) is authorised under the Act to give a purchase order or otherwise buy the stock; or\n- (ii) is permitted under a corresponding law or another law to obtain the stock; and\n- (b) the supplier obtains a compliant purchase order for the stock from the buyer.\n- (i) is authorised under the Act to give a purchase order or otherwise buy the stock; or\n- (ii) is permitted under a corresponding law or another law to obtain the stock; and\n- (a) a purchase order given in compliance with sections 51 and 52 ; or\n- (b) an eligible order under the National Health (Remote Area Aboriginal Health Services Program) Special Arrangement 2017 (PB 107 of 2017) (Cwlth) ; or\n- (c) an order complying with the National Health (Pharmaceutical Benefits) Regulations 2017 (Cwlth) , section 33 . Note— The National Health (Pharmaceutical Benefits) Regulations 2017 (Cwlth) , section 33 allows particular pharmaceutical benefits to be supplied by pharmacists to particular health practitioners using an order complying with that section.","sortOrder":82},{"sectionNumber":"sec.57","sectionType":"section","heading":"Supply of S2 or S3 medicine for authorised facility","content":"### sec.57 Supply of S2 or S3 medicine for authorised facility\n\nThis section applies in relation to stock of an S2 or S3 medicine sought by a buyer for an authorised facility.\nA supplier must not supply the stock to the buyer unless—\nthe supplier reasonably believes the buyer is permitted by the buyer’s employer to buy the stock for the authorised facility; and\nthe supplier reasonably believes the buyer has a reasonable need for the stock, and the amount of stock sought, for the facility; and\nthe supplier receives a purchase order for the stock signed by the buyer; and\nif the stock is to be delivered—the supplier obtains a street address for delivery of the stock.\nIn this section—\nauthorised facility means—\na community pharmacy; or\na specified place.\n(sec.57-ssec.1) This section applies in relation to stock of an S2 or S3 medicine sought by a buyer for an authorised facility.\n(sec.57-ssec.2) A supplier must not supply the stock to the buyer unless— the supplier reasonably believes the buyer is permitted by the buyer’s employer to buy the stock for the authorised facility; and the supplier reasonably believes the buyer has a reasonable need for the stock, and the amount of stock sought, for the facility; and the supplier receives a purchase order for the stock signed by the buyer; and if the stock is to be delivered—the supplier obtains a street address for delivery of the stock.\n(sec.57-ssec.3) In this section— authorised facility means— a community pharmacy; or a specified place.\n- (a) the supplier reasonably believes the buyer is permitted by the buyer’s employer to buy the stock for the authorised facility; and\n- (b) the supplier reasonably believes the buyer has a reasonable need for the stock, and the amount of stock sought, for the facility; and\n- (c) the supplier receives a purchase order for the stock signed by the buyer; and\n- (d) if the stock is to be delivered—the supplier obtains a street address for delivery of the stock.\n- (a) a community pharmacy; or\n- (b) a specified place.","sortOrder":83},{"sectionNumber":"sec.58","sectionType":"section","heading":"Supply of S2 or S3 medicine for professional practice","content":"### sec.58 Supply of S2 or S3 medicine for professional practice\n\nThis section applies in relation to stock of an S2 or S3 medicine sought by a buyer for practising a buyer’s profession, other than at an authorised facility under section 57 .\nA supplier must not supply the stock to a buyer unless—\nthe supplier reasonably believes the buyer is authorised under the Act , or permitted under a corresponding law or another law, to administer the medicine without a prescription; and\nthe supplier reasonably believes the buyer has a reasonable need for the stock and the amount of stock sought; and\nthe supplier receives a purchase order for the stock signed by the buyer; and\nif the stock is to be delivered—the supplier obtains a street address for delivery of the stock.\n(sec.58-ssec.1) This section applies in relation to stock of an S2 or S3 medicine sought by a buyer for practising a buyer’s profession, other than at an authorised facility under section 57 .\n(sec.58-ssec.2) A supplier must not supply the stock to a buyer unless— the supplier reasonably believes the buyer is authorised under the Act , or permitted under a corresponding law or another law, to administer the medicine without a prescription; and the supplier reasonably believes the buyer has a reasonable need for the stock and the amount of stock sought; and the supplier receives a purchase order for the stock signed by the buyer; and if the stock is to be delivered—the supplier obtains a street address for delivery of the stock.\n- (a) the supplier reasonably believes the buyer is authorised under the Act , or permitted under a corresponding law or another law, to administer the medicine without a prescription; and\n- (b) the supplier reasonably believes the buyer has a reasonable need for the stock and the amount of stock sought; and\n- (c) the supplier receives a purchase order for the stock signed by the buyer; and\n- (d) if the stock is to be delivered—the supplier obtains a street address for delivery of the stock.","sortOrder":84},{"sectionNumber":"sec.59","sectionType":"section","heading":"Supply of S2 and S3 medicines to manufacturers, wholesalers or retailers","content":"### sec.59 Supply of S2 and S3 medicines to manufacturers, wholesalers or retailers\n\nThis section applies in relation to stock of an S2 or S3 medicine sought by a buyer for manufacture or on-sale, other than at an authorised facility under section 57 .\nA supplier must not supply the stock to a buyer unless—\nthe supplier reasonably believes the buyer is authorised under the Act , or permitted under a corresponding law or another law, to manufacture or sell the medicine; and\nthe supplier receives a purchase order for the stock signed by the buyer; and\nif the stock is to be delivered—the supplier obtains a street address for delivery of the stock.\n(sec.59-ssec.1) This section applies in relation to stock of an S2 or S3 medicine sought by a buyer for manufacture or on-sale, other than at an authorised facility under section 57 .\n(sec.59-ssec.2) A supplier must not supply the stock to a buyer unless— the supplier reasonably believes the buyer is authorised under the Act , or permitted under a corresponding law or another law, to manufacture or sell the medicine; and the supplier receives a purchase order for the stock signed by the buyer; and if the stock is to be delivered—the supplier obtains a street address for delivery of the stock.\n- (a) the supplier reasonably believes the buyer is authorised under the Act , or permitted under a corresponding law or another law, to manufacture or sell the medicine; and\n- (b) the supplier receives a purchase order for the stock signed by the buyer; and\n- (c) if the stock is to be delivered—the supplier obtains a street address for delivery of the stock.","sortOrder":85},{"sectionNumber":"sec.60","sectionType":"section","heading":"When supply is not otherwise permitted","content":"### sec.60 When supply is not otherwise permitted\n\nThis section applies in relation to stock of any medicine.\nA supplier must not supply stock of a medicine to a buyer if the supplier reasonably suspects—\nthe purchase order for the stock has been unlawfully obtained or made; or\nthe purchase order for the stock has been fulfilled or cancelled.\nAlso, the supplier must not supply the stock if the date stated on the purchase order is more than 1 year before the day on which the stock is proposed to be supplied.\n(sec.60-ssec.1) This section applies in relation to stock of any medicine.\n(sec.60-ssec.2) A supplier must not supply stock of a medicine to a buyer if the supplier reasonably suspects— the purchase order for the stock has been unlawfully obtained or made; or the purchase order for the stock has been fulfilled or cancelled.\n(sec.60-ssec.3) Also, the supplier must not supply the stock if the date stated on the purchase order is more than 1 year before the day on which the stock is proposed to be supplied.\n- (a) the purchase order for the stock has been unlawfully obtained or made; or\n- (b) the purchase order for the stock has been fulfilled or cancelled.","sortOrder":86},{"sectionNumber":"ch.4-pt.4-div.3","sectionType":"division","heading":"Documentation for supply","content":"## Documentation for supply","sortOrder":87},{"sectionNumber":"sec.61","sectionType":"section","heading":"Supplier to give invoice or other notice","content":"### sec.61 Supplier to give invoice or other notice\n\nOn the supply of stock of a medicine to a buyer, a supplier must give the buyer an invoice or other notice (a notice ) stating the following information—\na unique identifier for the notice;\nthe date of the supply;\nthe name and address of the buyer;\nif the stock is delivered—the place to which the stock is delivered;\nthe details of the buyer’s authorisation or permission to buy the stock;\nthe name, form and strength of the medicine supplied;\nthe amount of stock of the medicine supplied.\nThe supplier must keep a copy of the notice or a record of the details contained in the notice.\nSee section 224 about keeping records.\n(sec.61-ssec.1) On the supply of stock of a medicine to a buyer, a supplier must give the buyer an invoice or other notice (a notice ) stating the following information— a unique identifier for the notice; the date of the supply; the name and address of the buyer; if the stock is delivered—the place to which the stock is delivered; the details of the buyer’s authorisation or permission to buy the stock; the name, form and strength of the medicine supplied; the amount of stock of the medicine supplied.\n(sec.61-ssec.2) The supplier must keep a copy of the notice or a record of the details contained in the notice. See section 224 about keeping records.\n- (a) a unique identifier for the notice;\n- (b) the date of the supply;\n- (c) the name and address of the buyer;\n- (d) if the stock is delivered—the place to which the stock is delivered;\n- (e) the details of the buyer’s authorisation or permission to buy the stock;\n- (f) the name, form and strength of the medicine supplied;\n- (g) the amount of stock of the medicine supplied.","sortOrder":88},{"sectionNumber":"sec.62","sectionType":"section","heading":"Completing and keeping purchase orders","content":"### sec.62 Completing and keeping purchase orders\n\nWhen supplying stock of a medicine, a supplier must—\nmark the purchase order for the stock in a way that shows the order has been supplied and, if applicable, delivered; and\nkeep a copy of the marked purchase order.\n- (a) mark the purchase order for the stock in a way that shows the order has been supplied and, if applicable, delivered; and\n- (b) keep a copy of the marked purchase order.","sortOrder":89},{"sectionNumber":"ch.4-pt.4-div.4","sectionType":"division","heading":"Delivery of supplied stock","content":"## Delivery of supplied stock","sortOrder":90},{"sectionNumber":"sec.63","sectionType":"section","heading":"Application of division","content":"### sec.63 Application of division\n\nThis division applies if a supplier delivers, or arranges delivery of, stock of a medicine to a buyer.","sortOrder":91},{"sectionNumber":"sec.64","sectionType":"section","heading":"Secure packaging for all medicines","content":"### sec.64 Secure packaging for all medicines\n\nA supplier must ensure stock of a medicine is—\nsealed in a securely closed package that is likely to show if the package breaks or anyone tampers with it; and\nclearly labelled with the name of the buyer of the medicine and street address for delivery stated on the purchase order for the stock or otherwise obtained by the supplier.\n- (a) sealed in a securely closed package that is likely to show if the package breaks or anyone tampers with it; and\n- (b) clearly labelled with the name of the buyer of the medicine and street address for delivery stated on the purchase order for the stock or otherwise obtained by the supplier.","sortOrder":92},{"sectionNumber":"sec.65","sectionType":"section","heading":"Additional requirements for packaging S8 medicines","content":"### sec.65 Additional requirements for packaging S8 medicines\n\nThis section applies in relation to stock that includes an S8 medicine.\nA supplier must ensure the stock is packaged for delivery in a way that does not—\nmix the S8 medicine with anything other than other S8 medicines; or\nlabel or mark the packaging with a statement indicating it contains an S8 medicine.\n(sec.65-ssec.1) This section applies in relation to stock that includes an S8 medicine.\n(sec.65-ssec.2) A supplier must ensure the stock is packaged for delivery in a way that does not— mix the S8 medicine with anything other than other S8 medicines; or label or mark the packaging with a statement indicating it contains an S8 medicine.\n- (a) mix the S8 medicine with anything other than other S8 medicines; or\n- (b) label or mark the packaging with a statement indicating it contains an S8 medicine.","sortOrder":93},{"sectionNumber":"sec.66","sectionType":"section","heading":"Engaging carrier","content":"### sec.66 Engaging carrier\n\nA supplier must not engage a carrier to deliver stock of a medicine unless the supplier reasonably considers the carrier is capable of complying with—\nfor stock of an S4 or S8 medicine—the requirements in part 5 ; or\nfor stock of an S2 or S3 medicine— section 220 .\nBefore arranging with the carrier to deliver the stock, the supplier must notify the carrier of the temperature limits for the stock that are recommended by the manufacturer of the medicine.\nSee section 76 about carriers storing medicines within notified temperature limits.\n(sec.66-ssec.1) A supplier must not engage a carrier to deliver stock of a medicine unless the supplier reasonably considers the carrier is capable of complying with— for stock of an S4 or S8 medicine—the requirements in part 5 ; or for stock of an S2 or S3 medicine— section 220 .\n(sec.66-ssec.2) Before arranging with the carrier to deliver the stock, the supplier must notify the carrier of the temperature limits for the stock that are recommended by the manufacturer of the medicine. See section 76 about carriers storing medicines within notified temperature limits.\n- (a) for stock of an S4 or S8 medicine—the requirements in part 5 ; or\n- (b) for stock of an S2 or S3 medicine— section 220 .","sortOrder":94},{"sectionNumber":"sec.67","sectionType":"section","heading":"Delivery to street address","content":"### sec.67 Delivery to street address\n\nA supplier must deliver, or arrange delivery of, stock of a medicine to the street address stated on the purchase order for the stock or otherwise obtained by the supplier.\nUnder sections 57 to 59 , the supplier must obtain the street address for delivery of stock of S2 and S3 medicines.\nUnder section 52 , the street address for delivery of stock must be stated on the purchase order.\n- 1 Under sections 57 to 59 , the supplier must obtain the street address for delivery of stock of S2 and S3 medicines.\n- 2 Under section 52 , the street address for delivery of stock must be stated on the purchase order.","sortOrder":95},{"sectionNumber":"sec.68","sectionType":"section","heading":"Supplier to obtain receipt for stock of S8 medicines","content":"### sec.68 Supplier to obtain receipt for stock of S8 medicines\n\nThis section applies in relation to stock that includes an S8 medicine.\nA supplier must obtain a signed notice acknowledging receipt of the delivery of the stock from the buyer of the stock, or from an adult acting, or purportedly acting, on behalf of the buyer at the buyer’s street address.\nThe supplier must keep the notice.\nSee section 224 about keeping records.\n(sec.68-ssec.1) This section applies in relation to stock that includes an S8 medicine.\n(sec.68-ssec.2) A supplier must obtain a signed notice acknowledging receipt of the delivery of the stock from the buyer of the stock, or from an adult acting, or purportedly acting, on behalf of the buyer at the buyer’s street address.\n(sec.68-ssec.3) The supplier must keep the notice. See section 224 about keeping records.","sortOrder":96},{"sectionNumber":"sec.69","sectionType":"section","heading":"Supplier to notify chief executive if no receipt provided","content":"### sec.69 Supplier to notify chief executive if no receipt provided\n\nThis section applies if a supplier has not received from a buyer a notice of receipt mentioned in section 53 within 5 business days after the date of delivery of stock of a medicine.\nThe supplier must give a notice to the chief executive in the approved form about the buyer’s failure to confirm receipt.\n(sec.69-ssec.1) This section applies if a supplier has not received from a buyer a notice of receipt mentioned in section 53 within 5 business days after the date of delivery of stock of a medicine.\n(sec.69-ssec.2) The supplier must give a notice to the chief executive in the approved form about the buyer’s failure to confirm receipt.","sortOrder":97},{"sectionNumber":"ch.4-pt.4-div.5","sectionType":"division","heading":"Other requirements","content":"## Other requirements","sortOrder":98},{"sectionNumber":"sec.70","sectionType":"section","heading":"Responsibilities for employees and representatives","content":"### sec.70 Responsibilities for employees and representatives\n\nA supplier must take all reasonable steps to—\nensure stock of a medicine is handled for the supplier only by an appropriately qualified adult employed by the supplier; and\nmake and keep records showing the details of any stock given to a wholesale representative of the supplier; and\nSee section 224 about keeping records.\nensure each wholesale representative of the supplier is aware of requirements under the Act applying to the supplier and representative.\nThis section does not apply to a pharmacist or pharmacy employee dealing with stock at a pharmacy.\nSee chapter 5 , parts 2 and 3 for requirements that apply to pharmacists and pharmacy employees.\n(sec.70-ssec.1) A supplier must take all reasonable steps to— ensure stock of a medicine is handled for the supplier only by an appropriately qualified adult employed by the supplier; and make and keep records showing the details of any stock given to a wholesale representative of the supplier; and See section 224 about keeping records. ensure each wholesale representative of the supplier is aware of requirements under the Act applying to the supplier and representative.\n(sec.70-ssec.2) This section does not apply to a pharmacist or pharmacy employee dealing with stock at a pharmacy. See chapter 5 , parts 2 and 3 for requirements that apply to pharmacists and pharmacy employees.\n- (a) ensure stock of a medicine is handled for the supplier only by an appropriately qualified adult employed by the supplier; and\n- (b) make and keep records showing the details of any stock given to a wholesale representative of the supplier; and Note— See section 224 about keeping records.\n- (c) ensure each wholesale representative of the supplier is aware of requirements under the Act applying to the supplier and representative.","sortOrder":99},{"sectionNumber":"sec.71","sectionType":"section","heading":"Compliance with code","content":"### sec.71 Compliance with code\n\nA supplier must comply with, and take all reasonable steps to ensure a person employed by the supplier complies with, the document called the ‘Australian code of good wholesaling practice for medicines in schedules 2, 3, 4 and 8 ’ that—\nwas made on 1 April 2011 by the former Commonwealth entity known as the National Coordinating Committee on Therapeutic Goods; and\nis published by the Therapeutic Goods Administration.\n- (a) was made on 1 April 2011 by the former Commonwealth entity known as the National Coordinating Committee on Therapeutic Goods; and\n- (b) is published by the Therapeutic Goods Administration.","sortOrder":100},{"sectionNumber":"sec.72","sectionType":"section","heading":"Supplying medicine in manufacturer’s pack","content":"### sec.72 Supplying medicine in manufacturer’s pack\n\nA supplier must not supply stock of medicine other than in a manufacturer’s pack, unless the supplier is authorised to repackage the medicine.","sortOrder":101},{"sectionNumber":"sec.73","sectionType":"section","heading":"Labels and containers must comply with Poisons Standard or approved alternatives","content":"### sec.73 Labels and containers must comply with Poisons Standard or approved alternatives\n\nA supplier must not supply stock of a medicine to a buyer unless the labelling on the medicine complies with—\nthe labelling requirements for the medicine stated in the Poisons Standard, part 2 , division 2 ; or\nif an alternative way for labelling the medicine is approved, or taken to be approved, under section 237 —the alternative way.\nA supplier must not supply stock of a medicine to a buyer unless the container of the medicine complies with—\nthe requirements for containers for the medicine stated in the Poisons Standard, part 2 , division 3 ; or\nif an alternative way for packaging the medicine is approved, or taken to be approved, under section 237 —the alternative way.\nTo remove any doubt, it is declared that subsections (1) (a) and (2) (a) do not apply to the supplier to the extent an exemption mentioned in the Poisons Standard applies to the labelling or packaging for the medicine.\ns 73 amd 2023 SL No. 170 s 5\n(sec.73-ssec.1) A supplier must not supply stock of a medicine to a buyer unless the labelling on the medicine complies with— the labelling requirements for the medicine stated in the Poisons Standard, part 2 , division 2 ; or if an alternative way for labelling the medicine is approved, or taken to be approved, under section 237 —the alternative way.\n(sec.73-ssec.2) A supplier must not supply stock of a medicine to a buyer unless the container of the medicine complies with— the requirements for containers for the medicine stated in the Poisons Standard, part 2 , division 3 ; or if an alternative way for packaging the medicine is approved, or taken to be approved, under section 237 —the alternative way.\n(sec.73-ssec.3) To remove any doubt, it is declared that subsections (1) (a) and (2) (a) do not apply to the supplier to the extent an exemption mentioned in the Poisons Standard applies to the labelling or packaging for the medicine.\n- (a) the labelling requirements for the medicine stated in the Poisons Standard, part 2 , division 2 ; or\n- (b) if an alternative way for labelling the medicine is approved, or taken to be approved, under section 237 —the alternative way.\n- (a) the requirements for containers for the medicine stated in the Poisons Standard, part 2 , division 3 ; or\n- (b) if an alternative way for packaging the medicine is approved, or taken to be approved, under section 237 —the alternative way.","sortOrder":102},{"sectionNumber":"sec.74","sectionType":"section","heading":"Open for inspection","content":"### sec.74 Open for inspection\n\nA supplier must keep an authorised place where the stock is kept open for inspection during the times the place is open for carrying on business or otherwise open for entry.","sortOrder":103},{"sectionNumber":"ch.4-pt.5","sectionType":"part","heading":"Possessing stock for delivery","content":"# Possessing stock for delivery","sortOrder":104},{"sectionNumber":"sec.75","sectionType":"section","heading":"Application of part","content":"### sec.75 Application of part\n\nThis part applies to a carrier who is authorised to possess an S4 or S8 medicine for the purposes of delivery.\nThis part applies in relation to the delivery of stock of an S4 or S8 medicine other than medicated feed.\nSee section 220 in relation to carriers delivering stock of S2 and S3 medicines.\n(sec.75-ssec.1) This part applies to a carrier who is authorised to possess an S4 or S8 medicine for the purposes of delivery.\n(sec.75-ssec.2) This part applies in relation to the delivery of stock of an S4 or S8 medicine other than medicated feed. See section 220 in relation to carriers delivering stock of S2 and S3 medicines.","sortOrder":105},{"sectionNumber":"sec.76","sectionType":"section","heading":"Storing stock within notified temperature limits","content":"### sec.76 Storing stock within notified temperature limits\n\nA carrier must take all reasonable steps to keep stock of an S4 or S8 medicine being delivered by the carrier within any temperature limits for the stock notified to the carrier by the person who engaged the carrier to deliver the stock.","sortOrder":106},{"sectionNumber":"sec.77","sectionType":"section","heading":"Stock not to be left unattended","content":"### sec.77 Stock not to be left unattended\n\nA carrier must not leave stock of an S4 or S8 medicine unattended, other than in a secure area.","sortOrder":107},{"sectionNumber":"sec.78","sectionType":"section","heading":"Delivery to person at street address","content":"### sec.78 Delivery to person at street address\n\nA carrier must deliver stock of an S4 or S8 medicine to the street address stated on the packaging for the stock.\nThe carrier must not leave the stock at the street address unless the carrier obtains a written receipt for the delivery of the stock from—\nthe person named on the package for the stock; or\nan adult at the address acting, or purportedly acting, on behalf of the person mentioned in paragraph (a) .\n(sec.78-ssec.1) A carrier must deliver stock of an S4 or S8 medicine to the street address stated on the packaging for the stock.\n(sec.78-ssec.2) The carrier must not leave the stock at the street address unless the carrier obtains a written receipt for the delivery of the stock from— the person named on the package for the stock; or an adult at the address acting, or purportedly acting, on behalf of the person mentioned in paragraph (a) .\n- (a) the person named on the package for the stock; or\n- (b) an adult at the address acting, or purportedly acting, on behalf of the person mentioned in paragraph (a) .","sortOrder":108},{"sectionNumber":"ch.4-pt.6","sectionType":"part","heading":"Prescribing medicines","content":"# Prescribing medicines","sortOrder":109},{"sectionNumber":"ch.4-pt.6-div.1","sectionType":"division","heading":"Preliminary","content":"## Preliminary","sortOrder":110},{"sectionNumber":"sec.79","sectionType":"section","heading":"Application of part","content":"### sec.79 Application of part\n\nThis part applies to a person (a prescriber ) who is authorised to prescribe a medicine.\nHowever, this part does not apply in relation to prescribing an S4 medicine or medicated feed for administration to a group of animals by a farmer of the animals.\nSee chapter 5 , part 4 about veterinary surgeons prescribing S4 medicine and medicated feed.\nSee also chapter 8 , part 4 about recording and keeping information.\n(sec.79-ssec.1) This part applies to a person (a prescriber ) who is authorised to prescribe a medicine.\n(sec.79-ssec.2) However, this part does not apply in relation to prescribing an S4 medicine or medicated feed for administration to a group of animals by a farmer of the animals. See chapter 5 , part 4 about veterinary surgeons prescribing S4 medicine and medicated feed. See also chapter 8 , part 4 about recording and keeping information.\n- 1 See chapter 5 , part 4 about veterinary surgeons prescribing S4 medicine and medicated feed.\n- 2 See also chapter 8 , part 4 about recording and keeping information.","sortOrder":111},{"sectionNumber":"sec.80","sectionType":"section","heading":"Definitions for part","content":"### sec.80 Definitions for part\n\nIn this part—\nmedication chart prescription means—\na prescription contained in a record for a patient or an animal that is kept at a place where a medicine is prescribed for the patient or animal and is not given to the patient or owner or custodian of the animal; or\na medication chart or clinical record at a relevant institution or a patient record kept by a prescriber\na national medication chart prescription.\nnational medication chart prescription means a medication chart prescription under the National Health (Pharmaceutical Benefits) Regulations 2017 (Cwlth) , section 41 (1) .\n- (a) a prescription contained in a record for a patient or an animal that is kept at a place where a medicine is prescribed for the patient or animal and is not given to the patient or owner or custodian of the animal; or Examples— a medication chart or clinical record at a relevant institution or a patient record kept by a prescriber\n- (b) a national medication chart prescription.","sortOrder":112},{"sectionNumber":"ch.4-pt.6-div.2","sectionType":"division","heading":"Prescribing generally","content":"## Prescribing generally","sortOrder":113},{"sectionNumber":"sec.81","sectionType":"section","heading":"Reasonable necessity for therapeutic treatment","content":"### sec.81 Reasonable necessity for therapeutic treatment\n\nA prescriber must not prescribe a medicine for a patient or an animal unless the prescriber assesses the medicine to be reasonably necessary for the therapeutic treatment of the patient or animal.","sortOrder":114},{"sectionNumber":"ch.4-pt.6-div.3","sectionType":"division","heading":"Prescribing for dispensing or giving treatment doses","content":"## Prescribing for dispensing or giving treatment doses","sortOrder":115},{"sectionNumber":"sec.82","sectionType":"section","heading":"Application of subdivision","content":"### sec.82 Application of subdivision\n\nThis subdivision applies if a prescriber makes a written prescription for dispensing or giving a treatment dose of a medicine for a patient or an animal.\nSee division 4 about prescribing for administration.\nSee section 92 about oral prescriptions for dispensing or giving treatment doses of S4 and S8 medicines.\n- 1 See division 4 about prescribing for administration.\n- 2 See section 92 about oral prescriptions for dispensing or giving treatment doses of S4 and S8 medicines.","sortOrder":116},{"sectionNumber":"sec.83","sectionType":"section","heading":"Electronic prescription","content":"### sec.83 Electronic prescription\n\nA prescriber must not make an electronic prescription except by using an electronic prescription management system.\nSee chapter 8 , part 1 about electronic prescription management systems.","sortOrder":117},{"sectionNumber":"sec.84","sectionType":"section","heading":"Sending prescription electronically","content":"### sec.84 Sending prescription electronically\n\nA prescriber must not send a prescription for a medicine to another person using electronic communication except by—\nusing an electronic prescription management system in accordance with any requirements for using the system; or\nsending a digital copy of a paper prescription to a person the prescriber reasonably believes is authorised to dispense or give a treatment dose of the medicine.\nSubsections (3) and (4) apply if the prescriber is sending a digital copy of a paper prescription to a person.\nIf the medicine is a diversion-risk medicine, the prescriber must take all reasonable steps, before sending the digital copy, to ensure the following details are written on the paper prescription—\nthe way in which the digital copy is being sent;\nthe place to which the digital copy is being sent;\nthe date on which the digital copy is being sent.\nA prescriber writes the words ‘emailed to Hypothetical Pharmacy, Brisbane on 1 January 2022’ on a paper prescription.\nAfter sending the digital copy, the prescriber must send the paper prescription to the person as soon as practicable, but no later than—\nif the prescription is for an S8 medicine—the end of the next business day after the digital copy was sent; or\notherwise—7 days after the digital copy was sent.\ns 84 amd 2022 SL No. 77 s 4\n(sec.84-ssec.1) A prescriber must not send a prescription for a medicine to another person using electronic communication except by— using an electronic prescription management system in accordance with any requirements for using the system; or sending a digital copy of a paper prescription to a person the prescriber reasonably believes is authorised to dispense or give a treatment dose of the medicine.\n(sec.84-ssec.2) Subsections (3) and (4) apply if the prescriber is sending a digital copy of a paper prescription to a person.\n(sec.84-ssec.3) If the medicine is a diversion-risk medicine, the prescriber must take all reasonable steps, before sending the digital copy, to ensure the following details are written on the paper prescription— the way in which the digital copy is being sent; the place to which the digital copy is being sent; the date on which the digital copy is being sent. A prescriber writes the words ‘emailed to Hypothetical Pharmacy, Brisbane on 1 January 2022’ on a paper prescription.\n(sec.84-ssec.4) After sending the digital copy, the prescriber must send the paper prescription to the person as soon as practicable, but no later than— if the prescription is for an S8 medicine—the end of the next business day after the digital copy was sent; or otherwise—7 days after the digital copy was sent.\n- (a) using an electronic prescription management system in accordance with any requirements for using the system; or\n- (b) sending a digital copy of a paper prescription to a person the prescriber reasonably believes is authorised to dispense or give a treatment dose of the medicine.\n- (a) the way in which the digital copy is being sent;\n- (b) the place to which the digital copy is being sent;\n- (c) the date on which the digital copy is being sent.\n- (a) if the prescription is for an S8 medicine—the end of the next business day after the digital copy was sent; or\n- (b) otherwise—7 days after the digital copy was sent.","sortOrder":118},{"sectionNumber":"sec.85","sectionType":"section","heading":"Generation of paper prescription using computer","content":"### sec.85 Generation of paper prescription using computer\n\nThis section applies if a prescriber uses a computer to generate a paper prescription.\nHowever, this section does not apply if a prescribing approval held by the prescriber states another way to use a computer to generate a paper prescription.\nThe prescriber must ensure the following things are included on the paper prescription—\na unique identifier that allows the prescription to be matched to a record kept by the prescriber for the patient or animal for which the medicine is prescribed;\na space for the prescriber to include a handwritten signature other than a signature printed by the computer;\neither—\nthe total number of medicines prescribed; or\nscoring or hatching of any blank space below or above the space for the prescriber’s handwritten signature.\n(sec.85-ssec.1) This section applies if a prescriber uses a computer to generate a paper prescription.\n(sec.85-ssec.2) However, this section does not apply if a prescribing approval held by the prescriber states another way to use a computer to generate a paper prescription.\n(sec.85-ssec.3) The prescriber must ensure the following things are included on the paper prescription— a unique identifier that allows the prescription to be matched to a record kept by the prescriber for the patient or animal for which the medicine is prescribed; a space for the prescriber to include a handwritten signature other than a signature printed by the computer; either— the total number of medicines prescribed; or scoring or hatching of any blank space below or above the space for the prescriber’s handwritten signature.\n- (a) a unique identifier that allows the prescription to be matched to a record kept by the prescriber for the patient or animal for which the medicine is prescribed;\n- (b) a space for the prescriber to include a handwritten signature other than a signature printed by the computer;\n- (c) either— (i) the total number of medicines prescribed; or (ii) scoring or hatching of any blank space below or above the space for the prescriber’s handwritten signature.\n- (i) the total number of medicines prescribed; or\n- (ii) scoring or hatching of any blank space below or above the space for the prescriber’s handwritten signature.\n- (i) the total number of medicines prescribed; or\n- (ii) scoring or hatching of any blank space below or above the space for the prescriber’s handwritten signature.","sortOrder":119},{"sectionNumber":"sec.86","sectionType":"section","heading":"Content of written prescription","content":"### sec.86 Content of written prescription\n\nA prescriber must state the following information on a prescription for a medicine—\nthe prescriber’s name or a unique identifier for the prescriber;\nthe place where the prescriber usually practices;\nthe prescriber’s phone number or pager number;\nthe prescriber’s qualifications;\nthe date of the prescription;\nif the medicine is for a patient—\nthe patient’s name and address; and\nfor a monitored medicine—the patient’s date of birth;\nif the medicine is for an animal—\nthe species of the animal; and\nthe name of the animal or another description that identifies the animal; and\nthe name and address of the owner or custodian of the animal; and\na statement that the medicine is for animal treatment only;\nthe name of the medicine;\nthe approved name or brand name of the medicine\na description of the medicine to be compounded\nthe form and strength of the medicine;\nhow much of the medicine may be dispensed or given, including the number of repeats for the medicine, if any;\ninstructions about using the medicine;\nthe date for dispensing or giving the medicine, if applicable;\nif the medicine is a restricted medicine—the details of the prescriber’s authorisation to prescribe the restricted medicine.\nthe identifying number of the prescribing approval held by the prescriber\nthe qualifications of the prescriber\nSubsection (1) (b) , (c) and (d) do not apply if the prescription is a medication chart prescription.\nThe prescriber is taken to comply with this section if the prescription is a national medication chart prescription.\ns 86 amd 2025 SL No. 148 s 4\n(sec.86-ssec.1) A prescriber must state the following information on a prescription for a medicine— the prescriber’s name or a unique identifier for the prescriber; the place where the prescriber usually practices; the prescriber’s phone number or pager number; the prescriber’s qualifications; the date of the prescription; if the medicine is for a patient— the patient’s name and address; and for a monitored medicine—the patient’s date of birth; if the medicine is for an animal— the species of the animal; and the name of the animal or another description that identifies the animal; and the name and address of the owner or custodian of the animal; and a statement that the medicine is for animal treatment only; the name of the medicine; the approved name or brand name of the medicine a description of the medicine to be compounded the form and strength of the medicine; how much of the medicine may be dispensed or given, including the number of repeats for the medicine, if any; instructions about using the medicine; the date for dispensing or giving the medicine, if applicable; if the medicine is a restricted medicine—the details of the prescriber’s authorisation to prescribe the restricted medicine. the identifying number of the prescribing approval held by the prescriber the qualifications of the prescriber\n(sec.86-ssec.2) Subsection (1) (b) , (c) and (d) do not apply if the prescription is a medication chart prescription.\n(sec.86-ssec.3) The prescriber is taken to comply with this section if the prescription is a national medication chart prescription.\n- (a) the prescriber’s name or a unique identifier for the prescriber;\n- (b) the place where the prescriber usually practices;\n- (c) the prescriber’s phone number or pager number;\n- (d) the prescriber’s qualifications;\n- (e) the date of the prescription;\n- (f) if the medicine is for a patient— (i) the patient’s name and address; and (ii) for a monitored medicine—the patient’s date of birth;\n- (i) the patient’s name and address; and\n- (ii) for a monitored medicine—the patient’s date of birth;\n- (g) if the medicine is for an animal— (i) the species of the animal; and (ii) the name of the animal or another description that identifies the animal; and (iii) the name and address of the owner or custodian of the animal; and (iv) a statement that the medicine is for animal treatment only;\n- (i) the species of the animal; and\n- (ii) the name of the animal or another description that identifies the animal; and\n- (iii) the name and address of the owner or custodian of the animal; and\n- (iv) a statement that the medicine is for animal treatment only;\n- (h) the name of the medicine; Examples— • the approved name or brand name of the medicine • a description of the medicine to be compounded\n- • the approved name or brand name of the medicine\n- • a description of the medicine to be compounded\n- (i) the form and strength of the medicine;\n- (j) how much of the medicine may be dispensed or given, including the number of repeats for the medicine, if any;\n- (k) instructions about using the medicine;\n- (l) the date for dispensing or giving the medicine, if applicable;\n- (m) if the medicine is a restricted medicine—the details of the prescriber’s authorisation to prescribe the restricted medicine. Examples for paragraph (m) — • the identifying number of the prescribing approval held by the prescriber • the qualifications of the prescriber\n- • the identifying number of the prescribing approval held by the prescriber\n- • the qualifications of the prescriber\n- (i) the patient’s name and address; and\n- (ii) for a monitored medicine—the patient’s date of birth;\n- (i) the species of the animal; and\n- (ii) the name of the animal or another description that identifies the animal; and\n- (iii) the name and address of the owner or custodian of the animal; and\n- (iv) a statement that the medicine is for animal treatment only;\n- • the approved name or brand name of the medicine\n- • a description of the medicine to be compounded\n- • the identifying number of the prescribing approval held by the prescriber\n- • the qualifications of the prescriber","sortOrder":120},{"sectionNumber":"sec.87","sectionType":"section","heading":"Additional content of written prescription for S8 medicine","content":"### sec.87 Additional content of written prescription for S8 medicine\n\nThis section applies, in addition to section 86 , in relation to a written prescription for an S8 medicine.\nA prescriber must also state the following information on the prescription—\nif the prescription is a paper prescription—both words and numbers to describe how much of the medicine may be dispensed or given;\nthe minimum number of days, of at least 1 day, before the medicine may be further dispensed or given on any repeats on the prescription;\nif the S8 medicine is a psychostimulant medicine—\nwords to indicate the condition being treated; or\nthe words ‘specified condition’ if the medicine is for the treatment of a specified condition.\nThe prescriber is taken to comply with subsection (2) if the prescription is a national medication chart prescription.\nSubsection (5) applies if the prescriber is prescribing an approved opioid, other than on a medication chart prescription.\nThe prescriber must also state the following information on the prescription—\nif the prescriber holds a prescribing approval for prescribing the opioid—the identifying number of the prescribing approval;\nthe name of the place where the approved opioid is to be dispensed or given;\ninstructions for how 1 or more doses of the medicine are to be dispensed or given, including the circumstances (if any) in which the patient may be given a dose;\nthe start and end dates for when 1 or more doses of the opioid are to be dispensed or given.\nThe prescriber may state different forms of a particular type of S8 medicine on the prescription but must not state more than 1 type of S8 medicine.\nIn this section—\nspecified condition means—\nADHD; or\nbrain injury; or\nnarcolepsy.\nSee section 95 about the content of prescriptions for administration by authorised persons.\ns 87 amd 2022 SL No. 77 s 5 ; 2025 SL No. 148 s 5\n(sec.87-ssec.1) This section applies, in addition to section 86 , in relation to a written prescription for an S8 medicine.\n(sec.87-ssec.2) A prescriber must also state the following information on the prescription— if the prescription is a paper prescription—both words and numbers to describe how much of the medicine may be dispensed or given; the minimum number of days, of at least 1 day, before the medicine may be further dispensed or given on any repeats on the prescription; if the S8 medicine is a psychostimulant medicine— words to indicate the condition being treated; or the words ‘specified condition’ if the medicine is for the treatment of a specified condition.\n(sec.87-ssec.3) The prescriber is taken to comply with subsection (2) if the prescription is a national medication chart prescription.\n(sec.87-ssec.4) Subsection (5) applies if the prescriber is prescribing an approved opioid, other than on a medication chart prescription.\n(sec.87-ssec.5) The prescriber must also state the following information on the prescription— if the prescriber holds a prescribing approval for prescribing the opioid—the identifying number of the prescribing approval; the name of the place where the approved opioid is to be dispensed or given; instructions for how 1 or more doses of the medicine are to be dispensed or given, including the circumstances (if any) in which the patient may be given a dose; the start and end dates for when 1 or more doses of the opioid are to be dispensed or given.\n(sec.87-ssec.6) The prescriber may state different forms of a particular type of S8 medicine on the prescription but must not state more than 1 type of S8 medicine.\n(sec.87-ssec.7) In this section— specified condition means— ADHD; or brain injury; or narcolepsy.\n- (a) if the prescription is a paper prescription—both words and numbers to describe how much of the medicine may be dispensed or given;\n- (b) the minimum number of days, of at least 1 day, before the medicine may be further dispensed or given on any repeats on the prescription;\n- (c) if the S8 medicine is a psychostimulant medicine— (i) words to indicate the condition being treated; or (ii) the words ‘specified condition’ if the medicine is for the treatment of a specified condition.\n- (i) words to indicate the condition being treated; or\n- (ii) the words ‘specified condition’ if the medicine is for the treatment of a specified condition.\n- (i) words to indicate the condition being treated; or\n- (ii) the words ‘specified condition’ if the medicine is for the treatment of a specified condition.\n- (a) if the prescriber holds a prescribing approval for prescribing the opioid—the identifying number of the prescribing approval;\n- (b) the name of the place where the approved opioid is to be dispensed or given;\n- (c) instructions for how 1 or more doses of the medicine are to be dispensed or given, including the circumstances (if any) in which the patient may be given a dose;\n- (d) the start and end dates for when 1 or more doses of the opioid are to be dispensed or given.\n- (a) ADHD; or\n- (b) brain injury; or\n- (c) narcolepsy.","sortOrder":121},{"sectionNumber":"sec.88","sectionType":"section","heading":"Signing written prescription","content":"### sec.88 Signing written prescription\n\nA prescriber must sign a prescription.\nSee section 89 (2) (d) about signing the prescription when using printed labels.","sortOrder":122},{"sectionNumber":"sec.89","sectionType":"section","heading":"Using printed label on prescription","content":"### sec.89 Using printed label on prescription\n\nThis section applies if a prescriber uses a printed label to record any information required under section 86 or 87 on a paper prescription.\nThe prescriber must—\nuse a printed label that is legible; and\nattach the label to the prescription in a way that it can not be easily removed; and\nplace the label in a way that clearly connects the information to the patient or animal; and\nsign the label in a way that does not obscure the information on the printed label.\n(sec.89-ssec.1) This section applies if a prescriber uses a printed label to record any information required under section 86 or 87 on a paper prescription.\n(sec.89-ssec.2) The prescriber must— use a printed label that is legible; and attach the label to the prescription in a way that it can not be easily removed; and place the label in a way that clearly connects the information to the patient or animal; and sign the label in a way that does not obscure the information on the printed label.\n- (a) use a printed label that is legible; and\n- (b) attach the label to the prescription in a way that it can not be easily removed; and\n- (c) place the label in a way that clearly connects the information to the patient or animal; and\n- (d) sign the label in a way that does not obscure the information on the printed label.","sortOrder":123},{"sectionNumber":"sec.90","sectionType":"section","heading":"Amending written prescription","content":"### sec.90 Amending written prescription\n\nA prescriber must not amend a prescription (the original prescription ) unless the prescriber made the prescription in the first instance.\nThe prescriber must—\nsign and date the amendment handwritten on the original prescription; and\nensure the amendment is made in a way that does not obscure the content of the original prescription.\nIf the original prescription was printed from a computer, the prescription must be amended on a computer and printed again.\nIf the original prescription was contained in an electronic prescription management system, the prescription must be cancelled in the system and remade if it needs amendment.\n(sec.90-ssec.1) A prescriber must not amend a prescription (the original prescription ) unless the prescriber made the prescription in the first instance.\n(sec.90-ssec.2) The prescriber must— sign and date the amendment handwritten on the original prescription; and ensure the amendment is made in a way that does not obscure the content of the original prescription.\n(sec.90-ssec.3) If the original prescription was printed from a computer, the prescription must be amended on a computer and printed again.\n(sec.90-ssec.4) If the original prescription was contained in an electronic prescription management system, the prescription must be cancelled in the system and remade if it needs amendment.\n- (a) sign and date the amendment handwritten on the original prescription; and\n- (b) ensure the amendment is made in a way that does not obscure the content of the original prescription.","sortOrder":124},{"sectionNumber":"sec.91","sectionType":"section","heading":"Application of subdivision","content":"### sec.91 Application of subdivision\n\nThis subdivision applies if a prescriber prescribes a medicine for dispensing or giving a treatment dose for a patient.\nSee subdivision 1 about written prescriptions for dispensing or giving treatment doses for patients and animals.\nSee division 4 about prescribing for administration.\n- 1 See subdivision 1 about written prescriptions for dispensing or giving treatment doses for patients and animals.\n- 2 See division 4 about prescribing for administration.","sortOrder":125},{"sectionNumber":"sec.92","sectionType":"section","heading":"Oral prescription for S4 or S8 medicine","content":"### sec.92 Oral prescription for S4 or S8 medicine\n\nThis section applies in relation to an S4 or S8 medicine.\nA prescriber must not give an oral prescription for the medicine except to a person whom the prescriber reasonably believes is authorised to dispense or give a treatment dose of the medicine.\nIf the person dispenses or gives the medicine on the oral prescription, the prescriber must give the person a written prescription that confirms the oral prescription.\nThe prescriber must give the written prescription to the person—\nfor an S4 medicine—7 days after the oral prescription was given; or\nfor an S8 medicine—as soon as practicable, but no later than the end of the next business day, after the oral prescription was given.\nThis section does not apply if the medicine being prescribed is from an RFDS medicine chest kept by the Royal Flying Doctor Service of Australia.\n(sec.92-ssec.1) This section applies in relation to an S4 or S8 medicine.\n(sec.92-ssec.2) A prescriber must not give an oral prescription for the medicine except to a person whom the prescriber reasonably believes is authorised to dispense or give a treatment dose of the medicine.\n(sec.92-ssec.3) If the person dispenses or gives the medicine on the oral prescription, the prescriber must give the person a written prescription that confirms the oral prescription.\n(sec.92-ssec.4) The prescriber must give the written prescription to the person— for an S4 medicine—7 days after the oral prescription was given; or for an S8 medicine—as soon as practicable, but no later than the end of the next business day, after the oral prescription was given.\n(sec.92-ssec.5) This section does not apply if the medicine being prescribed is from an RFDS medicine chest kept by the Royal Flying Doctor Service of Australia.\n- (a) for an S4 medicine—7 days after the oral prescription was given; or\n- (b) for an S8 medicine—as soon as practicable, but no later than the end of the next business day, after the oral prescription was given.","sortOrder":126},{"sectionNumber":"sec.93","sectionType":"section","heading":"Compliance with monitored medicines standard","content":"### sec.93 Compliance with monitored medicines standard\n\nThis section applies if a prescriber prescribes a monitored medicine, whether orally or by written prescription.\nThe prescriber must prescribe the medicine in accordance with the departmental standard called ‘Monitored medicines’.\n(sec.93-ssec.1) This section applies if a prescriber prescribes a monitored medicine, whether orally or by written prescription.\n(sec.93-ssec.2) The prescriber must prescribe the medicine in accordance with the departmental standard called ‘Monitored medicines’.","sortOrder":127},{"sectionNumber":"ch.4-pt.6-div.4","sectionType":"division","heading":"Prescribing for administration by authorised persons","content":"## Prescribing for administration by authorised persons","sortOrder":128},{"sectionNumber":"sec.94","sectionType":"section","heading":"Application of subdivision","content":"### sec.94 Application of subdivision\n\nThis subdivision applies if a prescriber makes a written prescription for administration of a medicine by another person to a patient or an animal.\nSee subdivision 2 about oral prescriptions for administration to patients and animals.\nSee division 3 about prescribing for dispensing or giving treatment doses for patients and animals.\n- 1 See subdivision 2 about oral prescriptions for administration to patients and animals.\n- 2 See division 3 about prescribing for dispensing or giving treatment doses for patients and animals.","sortOrder":129},{"sectionNumber":"sec.95","sectionType":"section","heading":"Content of written prescription","content":"### sec.95 Content of written prescription\n\nA prescriber must state the following information on a prescription for a medicine—\nthe prescriber’s name or a unique identifier for the prescriber;\nthe date of the prescription;\nif the medicine is to be administered to a patient—\nthe patient’s name and address; and\nfor a monitored medicine—the patient’s date of birth;\nif the medicine is to be administered to an animal—\nthe species of the animal; and\nthe name of the animal or another description that identifies the animal; and\nthe name and address of the owner or custodian of the animal;\nthe name of the medicine;\nthe approved name or brand name of the medicine\na description of the medicine to be compounded\nthe form and strength of the medicine;\nhow much of the medicine may be administered;\ninstructions about using the medicine.\n- (a) the prescriber’s name or a unique identifier for the prescriber;\n- (b) the date of the prescription;\n- (c) if the medicine is to be administered to a patient— (i) the patient’s name and address; and (ii) for a monitored medicine—the patient’s date of birth;\n- (i) the patient’s name and address; and\n- (ii) for a monitored medicine—the patient’s date of birth;\n- (d) if the medicine is to be administered to an animal— (i) the species of the animal; and (ii) the name of the animal or another description that identifies the animal; and (iii) the name and address of the owner or custodian of the animal;\n- (i) the species of the animal; and\n- (ii) the name of the animal or another description that identifies the animal; and\n- (iii) the name and address of the owner or custodian of the animal;\n- (e) the name of the medicine; Examples— • the approved name or brand name of the medicine • a description of the medicine to be compounded\n- • the approved name or brand name of the medicine\n- • a description of the medicine to be compounded\n- (f) the form and strength of the medicine;\n- (g) how much of the medicine may be administered;\n- (h) instructions about using the medicine.\n- (i) the patient’s name and address; and\n- (ii) for a monitored medicine—the patient’s date of birth;\n- (i) the species of the animal; and\n- (ii) the name of the animal or another description that identifies the animal; and\n- (iii) the name and address of the owner or custodian of the animal;\n- • the approved name or brand name of the medicine\n- • a description of the medicine to be compounded","sortOrder":130},{"sectionNumber":"sec.96","sectionType":"section","heading":"Additional content of written prescription for approved opioid","content":"### sec.96 Additional content of written prescription for approved opioid\n\nThis section applies, in addition to section 95 , if—\na prescriber is the holder of a prescribing approval; and\nthe prescriber is making a written prescription for the administration of an approved opioid, other than a medication chart prescription.\nThe prescriber must also state the following information on the prescription—\nthe identifying number of the prescribing approval, if any;\nthe name of the place where the approved opioid is to be administered;\ninstructions for how 1 or more doses of the opioid are to be administered;\nthe start and end dates for when 1 or more doses of the opioid are to be administered.\nSee sections 86 and 87 for requirements about prescriptions for dispensing or giving treatment doses.\n(sec.96-ssec.1) This section applies, in addition to section 95 , if— a prescriber is the holder of a prescribing approval; and the prescriber is making a written prescription for the administration of an approved opioid, other than a medication chart prescription.\n(sec.96-ssec.2) The prescriber must also state the following information on the prescription— the identifying number of the prescribing approval, if any; the name of the place where the approved opioid is to be administered; instructions for how 1 or more doses of the opioid are to be administered; the start and end dates for when 1 or more doses of the opioid are to be administered. See sections 86 and 87 for requirements about prescriptions for dispensing or giving treatment doses.\n- (a) a prescriber is the holder of a prescribing approval; and\n- (b) the prescriber is making a written prescription for the administration of an approved opioid, other than a medication chart prescription.\n- (a) the identifying number of the prescribing approval, if any;\n- (b) the name of the place where the approved opioid is to be administered;\n- (c) instructions for how 1 or more doses of the opioid are to be administered;\n- (d) the start and end dates for when 1 or more doses of the opioid are to be administered.","sortOrder":131},{"sectionNumber":"sec.97","sectionType":"section","heading":"Signing written prescription","content":"### sec.97 Signing written prescription\n\nA prescriber must sign a prescription.\nSee section 98 (2) (d) about signing the prescription when using printed labels.","sortOrder":132},{"sectionNumber":"sec.98","sectionType":"section","heading":"Using printed label","content":"### sec.98 Using printed label\n\nThis section applies if a prescriber uses a printed label to record any information required under section 95 or 96 on paper prescription.\nThe prescriber must—\nuse a printed label that is legible; and\nattach the label to the prescription in a way that it can not be easily removed; and\nplace the label in a way that clearly connects the information to the patient or animal; and\nsign the label in a way that does not obscure the information on the printed label.\n(sec.98-ssec.1) This section applies if a prescriber uses a printed label to record any information required under section 95 or 96 on paper prescription.\n(sec.98-ssec.2) The prescriber must— use a printed label that is legible; and attach the label to the prescription in a way that it can not be easily removed; and place the label in a way that clearly connects the information to the patient or animal; and sign the label in a way that does not obscure the information on the printed label.\n- (a) use a printed label that is legible; and\n- (b) attach the label to the prescription in a way that it can not be easily removed; and\n- (c) place the label in a way that clearly connects the information to the patient or animal; and\n- (d) sign the label in a way that does not obscure the information on the printed label.","sortOrder":133},{"sectionNumber":"sec.99","sectionType":"section","heading":"Application of subdivision","content":"### sec.99 Application of subdivision\n\nThis subdivision applies if a prescriber orally prescribes a medicine for administration to a patient or an animal.\nSee subdivision 1 about written prescriptions for administration to patients and animals.\nSee division 3 about prescribing for dispensing or giving treatment doses.\n- 1 See subdivision 1 about written prescriptions for administration to patients and animals.\n- 2 See division 3 about prescribing for dispensing or giving treatment doses.","sortOrder":134},{"sectionNumber":"sec.100","sectionType":"section","heading":"Oral prescription","content":"### sec.100 Oral prescription\n\nA prescriber must not give an oral prescription for a medicine except to a person whom the prescriber reasonably believes is authorised to administer the medicine.\nIf the medicine is an S8 medicine and the person administers the S8 medicine on the oral prescription, the prescriber must—\ngive the person a written prescription that confirms the oral prescription; or\nsign another record made by the person at the time of the administration on the oral prescription.\nThe written prescription must be given, or the signature made, as soon as practicable, but no later than the end of the next business day, after the medicine was administered.\nThis section does not apply if the medicine being prescribed is from an RFDS medicine chest kept by the Royal Flying Doctor Service of Australia.\n(sec.100-ssec.1) A prescriber must not give an oral prescription for a medicine except to a person whom the prescriber reasonably believes is authorised to administer the medicine.\n(sec.100-ssec.2) If the medicine is an S8 medicine and the person administers the S8 medicine on the oral prescription, the prescriber must— give the person a written prescription that confirms the oral prescription; or sign another record made by the person at the time of the administration on the oral prescription.\n(sec.100-ssec.3) The written prescription must be given, or the signature made, as soon as practicable, but no later than the end of the next business day, after the medicine was administered.\n(sec.100-ssec.4) This section does not apply if the medicine being prescribed is from an RFDS medicine chest kept by the Royal Flying Doctor Service of Australia.\n- (a) give the person a written prescription that confirms the oral prescription; or\n- (b) sign another record made by the person at the time of the administration on the oral prescription.","sortOrder":135},{"sectionNumber":"ch.4-pt.7","sectionType":"part","heading":"Making standing orders","content":"# Making standing orders","sortOrder":136},{"sectionNumber":"ch.4-pt.7-div.1","sectionType":"division","heading":"Preliminary","content":"## Preliminary","sortOrder":137},{"sectionNumber":"sec.101","sectionType":"section","heading":"Meaning of clinical protocol","content":"### sec.101 Meaning of clinical protocol\n\nA clinical protocol is a standing order applying in relation to an approved person performing a procedure or diagnostic test at a place for practising any of the following professions—\nclinical perfusion;\northoptics;\nnuclear medicine technology;\nrespiratory science;\nspeech pathology.\n- (a) clinical perfusion;\n- (b) orthoptics;\n- (c) nuclear medicine technology;\n- (d) respiratory science;\n- (e) speech pathology.","sortOrder":138},{"sectionNumber":"ch.4-pt.7-div.2","sectionType":"division","heading":"Standing orders","content":"## Standing orders","sortOrder":139},{"sectionNumber":"sec.102","sectionType":"section","heading":"Application of division","content":"### sec.102 Application of division\n\nThis division applies to a person (a prescriber ) who is authorised to make a standing order.\nHowever, this division does not apply in relation to a standing order that is a clinical protocol.\n(sec.102-ssec.1) This division applies to a person (a prescriber ) who is authorised to make a standing order.\n(sec.102-ssec.2) However, this division does not apply in relation to a standing order that is a clinical protocol.","sortOrder":140},{"sectionNumber":"sec.103","sectionType":"section","heading":"Making standing order for relevant institution","content":"### sec.103 Making standing order for relevant institution\n\nA prescriber must not make a standing order for a relevant institution unless—\na medicines and therapeutics committee of the institution has approved the making of the order; and\nthe order is signed by a member of the committee who is a prescriber authorised to make standing orders.\nIn this section—\nmedicines and therapeutics committee , of a relevant institution, means a committee—\nestablished by the institution to approve standing orders for the administration or giving of treatment doses of medicines to patients at the institution; and\nwhose members include 1 medical practitioner, 1 registered nurse and 1 pharmacist.\n(sec.103-ssec.1) A prescriber must not make a standing order for a relevant institution unless— a medicines and therapeutics committee of the institution has approved the making of the order; and the order is signed by a member of the committee who is a prescriber authorised to make standing orders.\n(sec.103-ssec.2) In this section— medicines and therapeutics committee , of a relevant institution, means a committee— established by the institution to approve standing orders for the administration or giving of treatment doses of medicines to patients at the institution; and whose members include 1 medical practitioner, 1 registered nurse and 1 pharmacist.\n- (a) a medicines and therapeutics committee of the institution has approved the making of the order; and\n- (b) the order is signed by a member of the committee who is a prescriber authorised to make standing orders.\n- (a) established by the institution to approve standing orders for the administration or giving of treatment doses of medicines to patients at the institution; and\n- (b) whose members include 1 medical practitioner, 1 registered nurse and 1 pharmacist.","sortOrder":141},{"sectionNumber":"sec.104","sectionType":"section","heading":"Making other standing orders","content":"### sec.104 Making other standing orders\n\nThis section applies in relation to a standing order that is not for a relevant institution.\nA prescriber must not make the standing order unless the order relates to—\na place used by an Aboriginal or Torres Strait Islander health service; or\na place or circumstance authorised under—\na general approval (emergency first aid); or\na general approval (emergency management of animals); or\na place or circumstance otherwise approved by the chief executive.\ns 104 amd 2023 SL No. 6 s 4\n(sec.104-ssec.1) This section applies in relation to a standing order that is not for a relevant institution.\n(sec.104-ssec.2) A prescriber must not make the standing order unless the order relates to— a place used by an Aboriginal or Torres Strait Islander health service; or a place or circumstance authorised under— a general approval (emergency first aid); or a general approval (emergency management of animals); or a place or circumstance otherwise approved by the chief executive.\n- (a) a place used by an Aboriginal or Torres Strait Islander health service; or\n- (b) a place or circumstance authorised under— (i) a general approval (emergency first aid); or (ii) a general approval (emergency management of animals); or\n- (i) a general approval (emergency first aid); or\n- (ii) a general approval (emergency management of animals); or\n- (c) a place or circumstance otherwise approved by the chief executive.\n- (i) a general approval (emergency first aid); or\n- (ii) a general approval (emergency management of animals); or","sortOrder":142},{"sectionNumber":"sec.105","sectionType":"section","heading":"Safe circumstances for making standing order","content":"### sec.105 Safe circumstances for making standing order\n\nA prescriber must not make a standing order unless the prescriber is reasonably satisfied that—\nthe order would not allow a person to administer or give a treatment dose of a medicine in a way that exceeds the person’s authorisation or training; and\naction taken under the order would be likely to improve the timeliness of treatment and access to care by patients or animals.\nThe prescriber must ensure the standing order does not apply in relation to—\nmore than 1 medicine; or\ngiving a treatment dose of a monitored medicine.\n(sec.105-ssec.1) A prescriber must not make a standing order unless the prescriber is reasonably satisfied that— the order would not allow a person to administer or give a treatment dose of a medicine in a way that exceeds the person’s authorisation or training; and action taken under the order would be likely to improve the timeliness of treatment and access to care by patients or animals.\n(sec.105-ssec.2) The prescriber must ensure the standing order does not apply in relation to— more than 1 medicine; or giving a treatment dose of a monitored medicine.\n- (a) the order would not allow a person to administer or give a treatment dose of a medicine in a way that exceeds the person’s authorisation or training; and\n- (b) action taken under the order would be likely to improve the timeliness of treatment and access to care by patients or animals.\n- (a) more than 1 medicine; or\n- (b) giving a treatment dose of a monitored medicine.","sortOrder":143},{"sectionNumber":"sec.106","sectionType":"section","heading":"Content of standing order","content":"### sec.106 Content of standing order\n\nA prescriber must make a standing order in writing and sign the standing order.\nThe prescriber must state the following information on the standing order—\nthe name of the prescriber;\nthe date the standing order is made;\nthe date, no later than 2 years after the standing order is made, on which the standing order expires;\nthe single medicine to which the order applies;\nthe class of persons who may administer or give a treatment dose of the medicine under the order;\nthe medical conditions to which the order applies;\nif the order applies to administration—the way the medicine may be administered under the order;\nif the order applies to giving a treatment dose—the maximum amount of the medicine that may be given under the order;\nthe maximum duration for which treatment of a patient under the order is authorised;\nin what circumstances the medicine may be administered or given as a treatment dose, and the recommended dose or dose range for the circumstances;\nthe circumstances in which the medicine should not be administered or given as a treatment dose;\nthe reference charts for dose calculation, if required, the monitoring requirements, if required, and the type of equipment and management procedures required for management of an emergency associated with the use of the medicine;\nthe day, no later than 2 years after the order is made, by which the order must be reviewed.\n(sec.106-ssec.1) A prescriber must make a standing order in writing and sign the standing order.\n(sec.106-ssec.2) The prescriber must state the following information on the standing order— the name of the prescriber; the date the standing order is made; the date, no later than 2 years after the standing order is made, on which the standing order expires; the single medicine to which the order applies; the class of persons who may administer or give a treatment dose of the medicine under the order; the medical conditions to which the order applies; if the order applies to administration—the way the medicine may be administered under the order; if the order applies to giving a treatment dose—the maximum amount of the medicine that may be given under the order; the maximum duration for which treatment of a patient under the order is authorised; in what circumstances the medicine may be administered or given as a treatment dose, and the recommended dose or dose range for the circumstances; the circumstances in which the medicine should not be administered or given as a treatment dose; the reference charts for dose calculation, if required, the monitoring requirements, if required, and the type of equipment and management procedures required for management of an emergency associated with the use of the medicine; the day, no later than 2 years after the order is made, by which the order must be reviewed.\n- (a) the name of the prescriber;\n- (b) the date the standing order is made;\n- (c) the date, no later than 2 years after the standing order is made, on which the standing order expires;\n- (d) the single medicine to which the order applies;\n- (e) the class of persons who may administer or give a treatment dose of the medicine under the order;\n- (f) the medical conditions to which the order applies;\n- (g) if the order applies to administration—the way the medicine may be administered under the order;\n- (h) if the order applies to giving a treatment dose—the maximum amount of the medicine that may be given under the order;\n- (i) the maximum duration for which treatment of a patient under the order is authorised;\n- (j) in what circumstances the medicine may be administered or given as a treatment dose, and the recommended dose or dose range for the circumstances;\n- (k) the circumstances in which the medicine should not be administered or given as a treatment dose;\n- (l) the reference charts for dose calculation, if required, the monitoring requirements, if required, and the type of equipment and management procedures required for management of an emergency associated with the use of the medicine;\n- (m) the day, no later than 2 years after the order is made, by which the order must be reviewed.","sortOrder":144},{"sectionNumber":"sec.107","sectionType":"section","heading":"Additional content of standing order under general approval","content":"### sec.107 Additional content of standing order under general approval\n\nThis section applies if a standing order is made by a prescriber in relation to—\na general approval (emergency first aid); or\na general approval (emergency management of animals).\nThe prescriber must state in the standing order that a person proposing to administer, or give a treatment dose of, a medicine under the order must first attempt to contact the prescriber or another person authorised to prescribe the medicine, before administering or giving the treatment dose.\nHowever, the prescriber must also state in the standing order that the requirement stated in the standing order under subsection (2) does not apply in relation to—\nadministration in urgent situations requiring immediate treatment of a patient or an animal; or\nadministration of 1 of the following medicines—\nadrenaline (epinephrine);\nglyceryl trinitrate;\nglucagon;\nnaloxone;\nnitrous oxide;\nmethoxyflurane;\nsalbutamol.\n(sec.107-ssec.1) This section applies if a standing order is made by a prescriber in relation to— a general approval (emergency first aid); or a general approval (emergency management of animals).\n(sec.107-ssec.2) The prescriber must state in the standing order that a person proposing to administer, or give a treatment dose of, a medicine under the order must first attempt to contact the prescriber or another person authorised to prescribe the medicine, before administering or giving the treatment dose.\n(sec.107-ssec.3) However, the prescriber must also state in the standing order that the requirement stated in the standing order under subsection (2) does not apply in relation to— administration in urgent situations requiring immediate treatment of a patient or an animal; or administration of 1 of the following medicines— adrenaline (epinephrine); glyceryl trinitrate; glucagon; naloxone; nitrous oxide; methoxyflurane; salbutamol.\n- (a) a general approval (emergency first aid); or\n- (b) a general approval (emergency management of animals).\n- (a) administration in urgent situations requiring immediate treatment of a patient or an animal; or\n- (b) administration of 1 of the following medicines— (i) adrenaline (epinephrine); (ii) glyceryl trinitrate; (iii) glucagon; (iv) naloxone; (v) nitrous oxide; (vi) methoxyflurane; (vii) salbutamol.\n- (i) adrenaline (epinephrine);\n- (ii) glyceryl trinitrate;\n- (iii) glucagon;\n- (iv) naloxone;\n- (v) nitrous oxide;\n- (vi) methoxyflurane;\n- (vii) salbutamol.\n- (i) adrenaline (epinephrine);\n- (ii) glyceryl trinitrate;\n- (iii) glucagon;\n- (iv) naloxone;\n- (v) nitrous oxide;\n- (vi) methoxyflurane;\n- (vii) salbutamol.","sortOrder":145},{"sectionNumber":"sec.108","sectionType":"section","heading":"Standing order available for inspection","content":"### sec.108 Standing order available for inspection\n\nA prescriber must take all reasonable steps to ensure a standing order made by the prescriber is available for inspection at a place to which the order relates by—\nany person who may administer or give a treatment dose of a medicine under the order; and\nthe prescriber’s employer; and\nthe chief executive; and\nan inspector; and\na health ombudsman official.\n- (a) any person who may administer or give a treatment dose of a medicine under the order; and\n- (b) the prescriber’s employer; and\n- (c) the chief executive; and\n- (d) an inspector; and\n- (e) a health ombudsman official.","sortOrder":146},{"sectionNumber":"ch.4-pt.7-div.3","sectionType":"division","heading":"Clinical protocols","content":"## Clinical protocols","sortOrder":147},{"sectionNumber":"sec.109","sectionType":"section","heading":"Application of division","content":"### sec.109 Application of division\n\nThis division applies to a person (a prescriber ) who is authorised to make a clinical protocol.","sortOrder":148},{"sectionNumber":"sec.110","sectionType":"section","heading":"Contents of clinical protocol","content":"### sec.110 Contents of clinical protocol\n\nA prescriber must make a clinical protocol in writing and state the following information—\nthe name of the prescriber;\nthe place to which it relates;\nthe class of persons who may administer a medicine under the protocol;\nthe circumstances in which the protocol applies;\n1 or more medicines to which the protocol applies;\nthe way each medicine may be administered;\nthe day, no later than 2 years after the protocol is made, by which the protocol must be reviewed.\n- (a) the name of the prescriber;\n- (b) the place to which it relates;\n- (c) the class of persons who may administer a medicine under the protocol;\n- (d) the circumstances in which the protocol applies;\n- (e) 1 or more medicines to which the protocol applies;\n- (f) the way each medicine may be administered;\n- (g) the day, no later than 2 years after the protocol is made, by which the protocol must be reviewed.","sortOrder":149},{"sectionNumber":"sec.111","sectionType":"section","heading":"Protocol available for inspection","content":"### sec.111 Protocol available for inspection\n\nA prescriber must take all reasonable steps to ensure a clinical protocol made by the prescriber is readily available for inspection at the place to which it relates by—\nany person who may administer a medicine under the protocol; and\nthe chief executive; and\nan inspector; and\na health ombudsman official.\n- (a) any person who may administer a medicine under the protocol; and\n- (b) the chief executive; and\n- (c) an inspector; and\n- (d) a health ombudsman official.","sortOrder":150},{"sectionNumber":"ch.4-pt.8","sectionType":"part","heading":"Dispensing medicines","content":"# Dispensing medicines","sortOrder":151},{"sectionNumber":"ch.4-pt.8-div.1","sectionType":"division","heading":"Patients and animals","content":"## Patients and animals","sortOrder":152},{"sectionNumber":"sec.112","sectionType":"section","heading":"Application of division","content":"### sec.112 Application of division\n\nThis division applies to a person (a dispenser ) who is authorised to dispense a medicine on a prescription for a patient or an animal.","sortOrder":153},{"sectionNumber":"sec.113","sectionType":"section","heading":"Dispensing on compliant written prescription","content":"### sec.113 Dispensing on compliant written prescription\n\nThis section applies in relation to a written prescription for a medicine.\nA dispenser must not dispense the medicine unless—\nthe prescription contains the information mentioned in sections 86 to 88 , to the extent the information is required under the sections for the medicine; and\nif the prescription is amended by a person other than the dispenser—it is amended in a way that complies with section 90 .\n(sec.113-ssec.1) This section applies in relation to a written prescription for a medicine.\n(sec.113-ssec.2) A dispenser must not dispense the medicine unless— the prescription contains the information mentioned in sections 86 to 88 , to the extent the information is required under the sections for the medicine; and if the prescription is amended by a person other than the dispenser—it is amended in a way that complies with section 90 .\n- (a) the prescription contains the information mentioned in sections 86 to 88 , to the extent the information is required under the sections for the medicine; and\n- (b) if the prescription is amended by a person other than the dispenser—it is amended in a way that complies with section 90 .","sortOrder":154},{"sectionNumber":"sec.114","sectionType":"section","heading":"Dispensing on electronic prescription","content":"### sec.114 Dispensing on electronic prescription\n\nThis section applies in relation to an electronic prescription for a medicine.\nA dispenser must use an electronic prescription management system to record the dispensing of the medicine.\n(sec.114-ssec.1) This section applies in relation to an electronic prescription for a medicine.\n(sec.114-ssec.2) A dispenser must use an electronic prescription management system to record the dispensing of the medicine.","sortOrder":155},{"sectionNumber":"sec.115","sectionType":"section","heading":"Dispensing on digital copy of paper prescription","content":"### sec.115 Dispensing on digital copy of paper prescription\n\nThis section applies in relation to a digital copy of a paper prescription for a medicine.\nA dispenser must not dispense the medicine unless the digital copy is from a prescriber or another dispenser.\n(sec.115-ssec.1) This section applies in relation to a digital copy of a paper prescription for a medicine.\n(sec.115-ssec.2) A dispenser must not dispense the medicine unless the digital copy is from a prescriber or another dispenser.","sortOrder":156},{"sectionNumber":"sec.116","sectionType":"section","heading":"Digital copy of paper prescription for diversion-risk medicine between dispensers","content":"### sec.116 Digital copy of paper prescription for diversion-risk medicine between dispensers\n\nThis section applies in relation to a paper prescription for a diversion-risk medicine.\nA dispenser (the sender ) must not send a digital copy of the paper prescription to another person other than a person the sender reasonably believes is another dispenser (the receiver ) authorised to dispense the diversion-risk medicine.\nBefore dispensing on the prescription, the receiver must make reasonable attempts to contact the sender and check whether the diversion-risk medicine has already been dispensed.\nSubsection (5) applies if the diversion-risk medicine is also a monitored medicine.\nThe dispenser is taken to comply with subsection (3) if the dispenser checks the monitored medicines database and information in the database indicates the medicine has not been dispensed on the same prescription or the same repeat of the prescription.\nThe sender must give the paper prescription to the receiver—\nif the prescription is for an S8 medicine—the next business day after the digital copy was sent; or\notherwise—7 days after the digital copy was sent.\n(sec.116-ssec.1) This section applies in relation to a paper prescription for a diversion-risk medicine.\n(sec.116-ssec.2) A dispenser (the sender ) must not send a digital copy of the paper prescription to another person other than a person the sender reasonably believes is another dispenser (the receiver ) authorised to dispense the diversion-risk medicine.\n(sec.116-ssec.3) Before dispensing on the prescription, the receiver must make reasonable attempts to contact the sender and check whether the diversion-risk medicine has already been dispensed.\n(sec.116-ssec.4) Subsection (5) applies if the diversion-risk medicine is also a monitored medicine.\n(sec.116-ssec.5) The dispenser is taken to comply with subsection (3) if the dispenser checks the monitored medicines database and information in the database indicates the medicine has not been dispensed on the same prescription or the same repeat of the prescription.\n(sec.116-ssec.6) The sender must give the paper prescription to the receiver— if the prescription is for an S8 medicine—the next business day after the digital copy was sent; or otherwise—7 days after the digital copy was sent.\n- (a) if the prescription is for an S8 medicine—the next business day after the digital copy was sent; or\n- (b) otherwise—7 days after the digital copy was sent.","sortOrder":157},{"sectionNumber":"sec.117","sectionType":"section","heading":"Restrictions on amending written prescriptions","content":"### sec.117 Restrictions on amending written prescriptions\n\nA dispenser must not amend a written prescription for a medicine other than in accordance with this subdivision or section 229 .\nSection 229 relates to marking non-compliant paper prescriptions.\ns 117 amd 2023 SL No. 170 s 14\nsub 2025 SL No. 60 s 5","sortOrder":158},{"sectionNumber":"sec.117A","sectionType":"section","heading":"Clarifying prescriber’s direction","content":"### sec.117A Clarifying prescriber’s direction\n\nA dispenser may amend a written prescription for a medicine before dispensing the medicine by adding additional information to the prescription to clarify the direction of the prescriber who made the prescription.\nBefore amending the prescription, the dispenser must—\nobtain consent to the amendment from the person obtaining the medicine; and\nhave agreement to the amendment from the prescriber.\nThe dispenser must make the amendment—\nin the way agreed by the prescriber; and\nby signing and dating the amendment; and\nin a way that does not obscure the information originally stated on the prescription before the amendment.\nSee section 124 (1) (m) about records of amendments required to be kept by dispensers.\ns 117A ins 2025 SL No. 60 s 5\n(sec.117A-ssec.1) A dispenser may amend a written prescription for a medicine before dispensing the medicine by adding additional information to the prescription to clarify the direction of the prescriber who made the prescription.\n(sec.117A-ssec.2) Before amending the prescription, the dispenser must— obtain consent to the amendment from the person obtaining the medicine; and have agreement to the amendment from the prescriber.\n(sec.117A-ssec.3) The dispenser must make the amendment— in the way agreed by the prescriber; and by signing and dating the amendment; and in a way that does not obscure the information originally stated on the prescription before the amendment. See section 124 (1) (m) about records of amendments required to be kept by dispensers.\n- (a) obtain consent to the amendment from the person obtaining the medicine; and\n- (b) have agreement to the amendment from the prescriber.\n- (a) in the way agreed by the prescriber; and\n- (b) by signing and dating the amendment; and\n- (c) in a way that does not obscure the information originally stated on the prescription before the amendment. Note— See section 124 (1) (m) about records of amendments required to be kept by dispensers.","sortOrder":159},{"sectionNumber":"sec.117B","sectionType":"section","heading":"Dispensing an equivalent medicine","content":"### sec.117B Dispensing an equivalent medicine\n\nThis section applies to a dispenser if—\nthe dispenser is a pharmacist; and\nthe dispenser is dispensing a medicine for a patient, other than a restricted medicine or diversion-risk medicine, on a written prescription; and\nthe dispenser proposes to dispense an equivalent medicine as a substitute to the medicine stated on the prescription (the original medicine ).\nThe dispenser may amend the prescription to dispense the equivalent medicine if the dispenser assesses the amendment to be reasonably necessary for the therapeutic treatment of the patient.\nBefore amending the prescription, the dispenser must obtain consent to the amendment from the person obtaining the medicine.\nThe dispenser must make the amendment—\nby recording the following details on the prescription—\nthe name of the dispenser;\nthe place where the dispenser usually practices;\nthe dispenser’s phone number;\nthe dispenser’s qualifications;\nthe details of the change made to the original medicine; and\nby signing and dating the amendment; and\nin a way that does not obscure the information originally stated on the prescription before the amendment.\nSee section 124 (1) (m) about records of amendments required to be kept by dispensers.\nThe dispenser must take all reasonable steps to ensure the prescriber who made the prescription is—\nadvised of the details recorded on the prescription under subsection (4) (a) ; and\ngiven a brief description of why the dispenser amended the prescription.\nIn this section—\nequivalent medicine , to the original medicine, means a medicine that—\nis listed on the register under the Therapeutic Goods Act 1989 (Cwlth) for the same indication as the original medicine; and\nis able to be dispensed in a dose and for a duration that is intended to have a therapeutic effect equivalent to the therapeutic effect of the original medicine; and\nhas the same or similar chemical composition or pharmacological means of action as the original medicine.\nindication means an indication within the meaning of the Therapeutic Goods Act 1989 (Cwlth) .\ns 117B ins 2025 SL No. 60 s 5\n(sec.117B-ssec.1) This section applies to a dispenser if— the dispenser is a pharmacist; and the dispenser is dispensing a medicine for a patient, other than a restricted medicine or diversion-risk medicine, on a written prescription; and the dispenser proposes to dispense an equivalent medicine as a substitute to the medicine stated on the prescription (the original medicine ).\n(sec.117B-ssec.2) The dispenser may amend the prescription to dispense the equivalent medicine if the dispenser assesses the amendment to be reasonably necessary for the therapeutic treatment of the patient.\n(sec.117B-ssec.3) Before amending the prescription, the dispenser must obtain consent to the amendment from the person obtaining the medicine.\n(sec.117B-ssec.4) The dispenser must make the amendment— by recording the following details on the prescription— the name of the dispenser; the place where the dispenser usually practices; the dispenser’s phone number; the dispenser’s qualifications; the details of the change made to the original medicine; and by signing and dating the amendment; and in a way that does not obscure the information originally stated on the prescription before the amendment. See section 124 (1) (m) about records of amendments required to be kept by dispensers.\n(sec.117B-ssec.5) The dispenser must take all reasonable steps to ensure the prescriber who made the prescription is— advised of the details recorded on the prescription under subsection (4) (a) ; and given a brief description of why the dispenser amended the prescription.\n(sec.117B-ssec.6) In this section— equivalent medicine , to the original medicine, means a medicine that— is listed on the register under the Therapeutic Goods Act 1989 (Cwlth) for the same indication as the original medicine; and is able to be dispensed in a dose and for a duration that is intended to have a therapeutic effect equivalent to the therapeutic effect of the original medicine; and has the same or similar chemical composition or pharmacological means of action as the original medicine. indication means an indication within the meaning of the Therapeutic Goods Act 1989 (Cwlth) .\n- (a) the dispenser is a pharmacist; and\n- (b) the dispenser is dispensing a medicine for a patient, other than a restricted medicine or diversion-risk medicine, on a written prescription; and\n- (c) the dispenser proposes to dispense an equivalent medicine as a substitute to the medicine stated on the prescription (the original medicine ).\n- (a) by recording the following details on the prescription— (i) the name of the dispenser; (ii) the place where the dispenser usually practices; (iii) the dispenser’s phone number; (iv) the dispenser’s qualifications; (v) the details of the change made to the original medicine; and\n- (i) the name of the dispenser;\n- (ii) the place where the dispenser usually practices;\n- (iii) the dispenser’s phone number;\n- (iv) the dispenser’s qualifications;\n- (v) the details of the change made to the original medicine; and\n- (b) by signing and dating the amendment; and\n- (c) in a way that does not obscure the information originally stated on the prescription before the amendment. Note— See section 124 (1) (m) about records of amendments required to be kept by dispensers.\n- (i) the name of the dispenser;\n- (ii) the place where the dispenser usually practices;\n- (iii) the dispenser’s phone number;\n- (iv) the dispenser’s qualifications;\n- (v) the details of the change made to the original medicine; and\n- (a) advised of the details recorded on the prescription under subsection (4) (a) ; and\n- (b) given a brief description of why the dispenser amended the prescription.\n- (a) is listed on the register under the Therapeutic Goods Act 1989 (Cwlth) for the same indication as the original medicine; and\n- (b) is able to be dispensed in a dose and for a duration that is intended to have a therapeutic effect equivalent to the therapeutic effect of the original medicine; and\n- (c) has the same or similar chemical composition or pharmacological means of action as the original medicine.","sortOrder":160},{"sectionNumber":"sec.118","sectionType":"section","heading":"Labelling dispensed medicine","content":"### sec.118 Labelling dispensed medicine\n\nA dispenser must not dispense a medicine unless the labelling on the medicine complies with the labelling requirements for the medicine under the Poisons Standard, Appendix L and, if applicable to the medicine, Appendix K.","sortOrder":161},{"sectionNumber":"sec.119","sectionType":"section","heading":"Expired medicine","content":"### sec.119 Expired medicine\n\nA dispenser must not dispense a medicine on a day that is after the expiry date stated on the container or label of the medicine.","sortOrder":162},{"sectionNumber":"sec.120","sectionType":"section","heading":"When dispensing is not otherwise permitted","content":"### sec.120 When dispensing is not otherwise permitted\n\nA dispenser must not dispense a medicine on a written prescription if—\ninformation on or with the prescription shows it has been fulfilled or cancelled; or\nfor a digital copy of a paper prescription for a diversion-risk medicine—the prescription states it has been sent to another place; or\nthe dispenser reasonably suspects—\nthe prescription is a document that has been unlawfully prepared or obtained; or\nthe prescription has been made by a person who is not authorised under the Act , or permitted under a corresponding law or another law, to prescribe the medicine; or\nthe prescription does not otherwise comply with the Act .\n- (a) information on or with the prescription shows it has been fulfilled or cancelled; or\n- (b) for a digital copy of a paper prescription for a diversion-risk medicine—the prescription states it has been sent to another place; or\n- (c) the dispenser reasonably suspects— (i) the prescription is a document that has been unlawfully prepared or obtained; or (ii) the prescription has been made by a person who is not authorised under the Act , or permitted under a corresponding law or another law, to prescribe the medicine; or (iii) the prescription does not otherwise comply with the Act .\n- (i) the prescription is a document that has been unlawfully prepared or obtained; or\n- (ii) the prescription has been made by a person who is not authorised under the Act , or permitted under a corresponding law or another law, to prescribe the medicine; or\n- (iii) the prescription does not otherwise comply with the Act .\n- (i) the prescription is a document that has been unlawfully prepared or obtained; or\n- (ii) the prescription has been made by a person who is not authorised under the Act , or permitted under a corresponding law or another law, to prescribe the medicine; or\n- (iii) the prescription does not otherwise comply with the Act .","sortOrder":163},{"sectionNumber":"sec.121","sectionType":"section","heading":"Expired written prescription","content":"### sec.121 Expired written prescription\n\nA dispenser must not dispense a medicine on a written prescription if—\nfor an S2, S3 or S4 medicine—the prescription was made more than 1 year before the day the medicine is to be dispensed; or\nfor an S8 medicine—the prescription was made more than 6 months before the day the medicine is to be dispensed.\n- (a) for an S2, S3 or S4 medicine—the prescription was made more than 1 year before the day the medicine is to be dispensed; or\n- (b) for an S8 medicine—the prescription was made more than 6 months before the day the medicine is to be dispensed.","sortOrder":164},{"sectionNumber":"sec.122","sectionType":"section","heading":"Dispensing information on or with written prescription","content":"### sec.122 Dispensing information on or with written prescription\n\nWhen dispensing a medicine on a written prescription, a dispenser must record the following information on or with the prescription—\nthe date the medicine is dispensed;\nthe dispensary where the medicine is dispensed;\nif the medicine is dispensed on a repeat—the number of the repeat dispensed;\nthe dispenser’s signature.\nIf the medicine is an S8 medicine, the dispenser must record the cancellation of the prescription on or with the prescription after dispensing—\nif the prescription is for a single supply of the medicine—the single supply; or\nif the prescription is a national medication chart prescription—the last supply of the medicine; or\notherwise—the final repeat for the medicine.\n(sec.122-ssec.1) When dispensing a medicine on a written prescription, a dispenser must record the following information on or with the prescription— the date the medicine is dispensed; the dispensary where the medicine is dispensed; if the medicine is dispensed on a repeat—the number of the repeat dispensed; the dispenser’s signature.\n(sec.122-ssec.2) If the medicine is an S8 medicine, the dispenser must record the cancellation of the prescription on or with the prescription after dispensing— if the prescription is for a single supply of the medicine—the single supply; or if the prescription is a national medication chart prescription—the last supply of the medicine; or otherwise—the final repeat for the medicine.\n- (a) the date the medicine is dispensed;\n- (b) the dispensary where the medicine is dispensed;\n- (c) if the medicine is dispensed on a repeat—the number of the repeat dispensed;\n- (d) the dispenser’s signature.\n- (a) if the prescription is for a single supply of the medicine—the single supply; or\n- (b) if the prescription is a national medication chart prescription—the last supply of the medicine; or\n- (c) otherwise—the final repeat for the medicine.","sortOrder":165},{"sectionNumber":"sec.123","sectionType":"section","heading":"Keeping fulfilled paper prescription","content":"### sec.123 Keeping fulfilled paper prescription\n\nThis section applies in relation to a paper prescription for a medicine.\nA dispenser must keep the paper prescription, or a copy of the prescription, after the dispenser—\nhas fulfilled the entire prescription for a single supply of the medicine; or\nhas dispensed the final repeat of the medicine.\n(sec.123-ssec.1) This section applies in relation to a paper prescription for a medicine.\n(sec.123-ssec.2) A dispenser must keep the paper prescription, or a copy of the prescription, after the dispenser— has fulfilled the entire prescription for a single supply of the medicine; or has dispensed the final repeat of the medicine.\n- (a) has fulfilled the entire prescription for a single supply of the medicine; or\n- (b) has dispensed the final repeat of the medicine.","sortOrder":166},{"sectionNumber":"sec.124","sectionType":"section","heading":"Dispensing record for dispensed medicine","content":"### sec.124 Dispensing record for dispensed medicine\n\nAs soon as practicable after dispensing a medicine, a dispenser must make and keep a record of the following information—\nthe name of the dispenser;\nthe dispensary where the medicine was dispensed;\nthe date the medicine was dispensed;\nif the medicine was dispensed for a patient—\nthe name and address of the patient; and\nfor a monitored medicine—the date of birth of the patient;\nif the medicine was dispensed for an animal—\nthe species of the animal; and\nthe name of the animal or another description to identify the animal; and\nthe name and address of the owner or custodian of the animal;\nthe name of the medicine or other sufficient information to accurately identify the medicine;\nthe approved name or brand name of the medicine\na description of the medicine compounded\nthe form, strength and amount of the medicine;\nthe name of the prescriber of the medicine;\nthe date of the prescription for the medicine;\na unique identifier given to the prescription by the dispenser;\nif instructions for use of the medicine are stated in the prescription—the instructions;\nif the medicine was dispensed on a repeat—the number of the repeat dispensed;\nif the prescription was amended by the dispenser in accordance with subdivision 2A —\nfor an amendment mentioned in section 117A —the details of the amendment and the agreement with the prescriber; or\nfor an amendment mentioned in section 117B —the details of the amendment and a brief description of why the dispenser made the amendment.\nA record made under subsection (1) is a dispensing record .\nSee section 123 about keeping fulfilled paper prescriptions.\nSee section 224 about keeping records.\ns 124 amd 2023 SL No. 170 s 15 ; 2025 SL No. 60 s 6\n(sec.124-ssec.1) As soon as practicable after dispensing a medicine, a dispenser must make and keep a record of the following information— the name of the dispenser; the dispensary where the medicine was dispensed; the date the medicine was dispensed; if the medicine was dispensed for a patient— the name and address of the patient; and for a monitored medicine—the date of birth of the patient; if the medicine was dispensed for an animal— the species of the animal; and the name of the animal or another description to identify the animal; and the name and address of the owner or custodian of the animal; the name of the medicine or other sufficient information to accurately identify the medicine; the approved name or brand name of the medicine a description of the medicine compounded the form, strength and amount of the medicine; the name of the prescriber of the medicine; the date of the prescription for the medicine; a unique identifier given to the prescription by the dispenser; if instructions for use of the medicine are stated in the prescription—the instructions; if the medicine was dispensed on a repeat—the number of the repeat dispensed; if the prescription was amended by the dispenser in accordance with subdivision 2A — for an amendment mentioned in section 117A —the details of the amendment and the agreement with the prescriber; or for an amendment mentioned in section 117B —the details of the amendment and a brief description of why the dispenser made the amendment.\n(sec.124-ssec.2) A record made under subsection (1) is a dispensing record . See section 123 about keeping fulfilled paper prescriptions. See section 224 about keeping records.\n- (a) the name of the dispenser;\n- (b) the dispensary where the medicine was dispensed;\n- (c) the date the medicine was dispensed;\n- (d) if the medicine was dispensed for a patient— (i) the name and address of the patient; and (ii) for a monitored medicine—the date of birth of the patient;\n- (i) the name and address of the patient; and\n- (ii) for a monitored medicine—the date of birth of the patient;\n- (e) if the medicine was dispensed for an animal— (i) the species of the animal; and (ii) the name of the animal or another description to identify the animal; and (iii) the name and address of the owner or custodian of the animal;\n- (i) the species of the animal; and\n- (ii) the name of the animal or another description to identify the animal; and\n- (iii) the name and address of the owner or custodian of the animal;\n- (f) the name of the medicine or other sufficient information to accurately identify the medicine; Examples— • the approved name or brand name of the medicine • a description of the medicine compounded\n- • the approved name or brand name of the medicine\n- • a description of the medicine compounded\n- (g) the form, strength and amount of the medicine;\n- (h) the name of the prescriber of the medicine;\n- (i) the date of the prescription for the medicine;\n- (j) a unique identifier given to the prescription by the dispenser;\n- (k) if instructions for use of the medicine are stated in the prescription—the instructions;\n- (l) if the medicine was dispensed on a repeat—the number of the repeat dispensed;\n- (m) if the prescription was amended by the dispenser in accordance with subdivision 2A — (i) for an amendment mentioned in section 117A —the details of the amendment and the agreement with the prescriber; or (ii) for an amendment mentioned in section 117B —the details of the amendment and a brief description of why the dispenser made the amendment.\n- (i) for an amendment mentioned in section 117A —the details of the amendment and the agreement with the prescriber; or\n- (ii) for an amendment mentioned in section 117B —the details of the amendment and a brief description of why the dispenser made the amendment.\n- (i) the name and address of the patient; and\n- (ii) for a monitored medicine—the date of birth of the patient;\n- (i) the species of the animal; and\n- (ii) the name of the animal or another description to identify the animal; and\n- (iii) the name and address of the owner or custodian of the animal;\n- • the approved name or brand name of the medicine\n- • a description of the medicine compounded\n- (i) for an amendment mentioned in section 117A —the details of the amendment and the agreement with the prescriber; or\n- (ii) for an amendment mentioned in section 117B —the details of the amendment and a brief description of why the dispenser made the amendment.\n- 1 See section 123 about keeping fulfilled paper prescriptions.\n- 2 See section 224 about keeping records.","sortOrder":167},{"sectionNumber":"ch.4-pt.8-div.2","sectionType":"division","heading":"Patients only","content":"## Patients only","sortOrder":168},{"sectionNumber":"sec.125","sectionType":"section","heading":"Application of division","content":"### sec.125 Application of division\n\nThis division applies to a person (a dispenser ) who is authorised to dispense a medicine for a patient.","sortOrder":169},{"sectionNumber":"sec.126","sectionType":"section","heading":"Compliance with monitored medicines standard","content":"### sec.126 Compliance with monitored medicines standard\n\nA dispenser must dispense a monitored medicine in accordance with the departmental standard called ‘Monitored medicines’.","sortOrder":170},{"sectionNumber":"sec.127","sectionType":"section","heading":"Dispensing diversion-risk medicine","content":"### sec.127 Dispensing diversion-risk medicine\n\nThis section applies in relation to a written prescription for a diversion-risk medicine.\nA dispenser must take all reasonable steps to ensure the named prescriber on the prescription is genuinely the prescriber of the diversion-risk medicine.\nThe dispenser is taken to comply with subsection (2) if—\nthe dispenser is familiar with information on the prescription identifying the named prescriber to the dispenser; or\nthe dispenser contacts the named prescriber and confirms the prescription was made by the named prescriber.\nSubsection (5) applies if the diversion-risk medicine is also a monitored medicine.\nThe dispenser is taken to comply with subsection (2) if the dispenser checks the monitored medicines database and information in the database indicates the medicine was prescribed by the named prescriber.\nIn this section—\nnamed prescriber , on a prescription, means the person named as prescribing the medicine on the prescription.\n(sec.127-ssec.1) This section applies in relation to a written prescription for a diversion-risk medicine.\n(sec.127-ssec.2) A dispenser must take all reasonable steps to ensure the named prescriber on the prescription is genuinely the prescriber of the diversion-risk medicine.\n(sec.127-ssec.3) The dispenser is taken to comply with subsection (2) if— the dispenser is familiar with information on the prescription identifying the named prescriber to the dispenser; or the dispenser contacts the named prescriber and confirms the prescription was made by the named prescriber.\n(sec.127-ssec.4) Subsection (5) applies if the diversion-risk medicine is also a monitored medicine.\n(sec.127-ssec.5) The dispenser is taken to comply with subsection (2) if the dispenser checks the monitored medicines database and information in the database indicates the medicine was prescribed by the named prescriber.\n(sec.127-ssec.6) In this section— named prescriber , on a prescription, means the person named as prescribing the medicine on the prescription.\n- (a) the dispenser is familiar with information on the prescription identifying the named prescriber to the dispenser; or\n- (b) the dispenser contacts the named prescriber and confirms the prescription was made by the named prescriber.","sortOrder":171},{"sectionNumber":"sec.128","sectionType":"section","heading":"Dispensing generic medicine","content":"### sec.128 Dispensing generic medicine\n\nThis section applies if a medicine (the prescribed medicine ) is prescribed for a patient using an approved name or brand name but the medicine (the generic medicine ) is also available under another brand name or without a brand name.\nA dispenser must not dispense the generic medicine for the patient instead of the prescribed medicine unless—\nthe generic medicine is, in the reasonable opinion of the dispenser, physiologically equivalent to the prescribed medicine in its clinical effect and has the same active ingredients; and\na medicine approved by the Therapeutic Goods Administration for sale as a generic medicine to substitute for a brand name medicine\na medicine flagged in the ‘Schedule of pharmaceutical benefits’ as biosimilar or equivalent to another medicine\nthe prescriber of the prescribed medicine did not specifically state that only the prescribed medicine is to be dispensed; and\nthe patient asks for, or agrees to, the dispensing of the generic medicine instead of the prescribed medicine.\nSubsection (2) (b) and (c) does not apply if the medicine is dispensed to the patient at a public sector hospital.\nSee also the Therapeutic Goods Act 1989 (Cwlth) , sections 30EK and 30EL about pharmacists dispensing scarce medicines.\n(sec.128-ssec.1) This section applies if a medicine (the prescribed medicine ) is prescribed for a patient using an approved name or brand name but the medicine (the generic medicine ) is also available under another brand name or without a brand name.\n(sec.128-ssec.2) A dispenser must not dispense the generic medicine for the patient instead of the prescribed medicine unless— the generic medicine is, in the reasonable opinion of the dispenser, physiologically equivalent to the prescribed medicine in its clinical effect and has the same active ingredients; and a medicine approved by the Therapeutic Goods Administration for sale as a generic medicine to substitute for a brand name medicine a medicine flagged in the ‘Schedule of pharmaceutical benefits’ as biosimilar or equivalent to another medicine the prescriber of the prescribed medicine did not specifically state that only the prescribed medicine is to be dispensed; and the patient asks for, or agrees to, the dispensing of the generic medicine instead of the prescribed medicine.\n(sec.128-ssec.3) Subsection (2) (b) and (c) does not apply if the medicine is dispensed to the patient at a public sector hospital.\n- (a) the generic medicine is, in the reasonable opinion of the dispenser, physiologically equivalent to the prescribed medicine in its clinical effect and has the same active ingredients; and Examples of medicines that may be physiologically equivalent— • a medicine approved by the Therapeutic Goods Administration for sale as a generic medicine to substitute for a brand name medicine • a medicine flagged in the ‘Schedule of pharmaceutical benefits’ as biosimilar or equivalent to another medicine\n- • a medicine approved by the Therapeutic Goods Administration for sale as a generic medicine to substitute for a brand name medicine\n- • a medicine flagged in the ‘Schedule of pharmaceutical benefits’ as biosimilar or equivalent to another medicine\n- (b) the prescriber of the prescribed medicine did not specifically state that only the prescribed medicine is to be dispensed; and\n- (c) the patient asks for, or agrees to, the dispensing of the generic medicine instead of the prescribed medicine.\n- • a medicine approved by the Therapeutic Goods Administration for sale as a generic medicine to substitute for a brand name medicine\n- • a medicine flagged in the ‘Schedule of pharmaceutical benefits’ as biosimilar or equivalent to another medicine","sortOrder":172},{"sectionNumber":"ch.4-pt.9","sectionType":"part","heading":"Giving treatment doses of medicines","content":"# Giving treatment doses of medicines","sortOrder":173},{"sectionNumber":"ch.4-pt.9-div.1","sectionType":"division","heading":"Preliminary","content":"## Preliminary","sortOrder":174},{"sectionNumber":"sec.129","sectionType":"section","heading":"Application of part","content":"### sec.129 Application of part\n\nThis part applies to a person (an authorised person ) who is authorised to give a treatment dose of a medicine for a patient or an animal.","sortOrder":175},{"sectionNumber":"ch.4-pt.9-div.2","sectionType":"division","heading":"Giving treatment doses generally","content":"## Giving treatment doses generally","sortOrder":176},{"sectionNumber":"sec.130","sectionType":"section","heading":"Reasonable necessity for therapeutic treatment","content":"### sec.130 Reasonable necessity for therapeutic treatment\n\nThis section applies to an authorised person who is authorised to give a treatment dose of a medicine without a prescription for a patient or an animal.\nThe authorised person must not give the treatment dose unless the person assesses the medicine to be reasonably necessary for the therapeutic treatment of the patient or animal.\n(sec.130-ssec.1) This section applies to an authorised person who is authorised to give a treatment dose of a medicine without a prescription for a patient or an animal.\n(sec.130-ssec.2) The authorised person must not give the treatment dose unless the person assesses the medicine to be reasonably necessary for the therapeutic treatment of the patient or animal.","sortOrder":177},{"sectionNumber":"sec.131","sectionType":"section","heading":"Giving medicine in manufacturer’s pack","content":"### sec.131 Giving medicine in manufacturer’s pack\n\nAn authorised person must not give a treatment dose of a medicine other than in a manufacturer’s pack, unless the person is authorised to repackage the medicine.","sortOrder":178},{"sectionNumber":"sec.132","sectionType":"section","heading":"Giving diversion-risk medicine","content":"### sec.132 Giving diversion-risk medicine\n\nThis section applies in relation to a diversion-risk medicine for a patient being given on a written prescription.\nAn authorised person must take all reasonable steps to ensure the named prescriber on the prescription is genuinely the prescriber of the diversion-risk medicine.\nThe authorised person is taken to comply with subsection (2) if—\nthe person is familiar with information on the prescription identifying the named prescriber to the person; or\nthe person contacts the named prescriber and confirms the prescription was given by the named prescriber.\nSubsection (5) applies if the diversion-risk medicine is also a monitored medicine.\nThe authorised person is taken to comply with subsection (2) if the person checks the monitored medicines database and information in the database indicates the medicine was prescribed by the named prescriber.\nIn this section—\nnamed prescriber , on a prescription, means the person named as prescribing the medicine on the prescription.\n(sec.132-ssec.1) This section applies in relation to a diversion-risk medicine for a patient being given on a written prescription.\n(sec.132-ssec.2) An authorised person must take all reasonable steps to ensure the named prescriber on the prescription is genuinely the prescriber of the diversion-risk medicine.\n(sec.132-ssec.3) The authorised person is taken to comply with subsection (2) if— the person is familiar with information on the prescription identifying the named prescriber to the person; or the person contacts the named prescriber and confirms the prescription was given by the named prescriber.\n(sec.132-ssec.4) Subsection (5) applies if the diversion-risk medicine is also a monitored medicine.\n(sec.132-ssec.5) The authorised person is taken to comply with subsection (2) if the person checks the monitored medicines database and information in the database indicates the medicine was prescribed by the named prescriber.\n(sec.132-ssec.6) In this section— named prescriber , on a prescription, means the person named as prescribing the medicine on the prescription.\n- (a) the person is familiar with information on the prescription identifying the named prescriber to the person; or\n- (b) the person contacts the named prescriber and confirms the prescription was given by the named prescriber.","sortOrder":179},{"sectionNumber":"sec.133","sectionType":"section","heading":"When giving treatment dose is not otherwise permitted","content":"### sec.133 When giving treatment dose is not otherwise permitted\n\nAn authorised person must not give a treatment dose of a medicine on a written prescription if—\ninformation on or with the prescription shows it has been fulfilled or cancelled; or\nthe authorised person reasonably suspects—\nthe prescription is a document that has been unlawfully prepared or obtained; or\nthe prescription has been made by a person who is not authorised under the Act , or permitted under a corresponding law or another law, to prescribe the medicine; or\nthe prescription does not otherwise comply with the Act .\n- (a) information on or with the prescription shows it has been fulfilled or cancelled; or\n- (b) the authorised person reasonably suspects— (i) the prescription is a document that has been unlawfully prepared or obtained; or (ii) the prescription has been made by a person who is not authorised under the Act , or permitted under a corresponding law or another law, to prescribe the medicine; or (iii) the prescription does not otherwise comply with the Act .\n- (i) the prescription is a document that has been unlawfully prepared or obtained; or\n- (ii) the prescription has been made by a person who is not authorised under the Act , or permitted under a corresponding law or another law, to prescribe the medicine; or\n- (iii) the prescription does not otherwise comply with the Act .\n- (i) the prescription is a document that has been unlawfully prepared or obtained; or\n- (ii) the prescription has been made by a person who is not authorised under the Act , or permitted under a corresponding law or another law, to prescribe the medicine; or\n- (iii) the prescription does not otherwise comply with the Act .","sortOrder":180},{"sectionNumber":"ch.4-pt.9-div.3","sectionType":"division","heading":"Labelling and records","content":"## Labelling and records","sortOrder":181},{"sectionNumber":"sec.134","sectionType":"section","heading":"Labelling treatment dose of medicine","content":"### sec.134 Labelling treatment dose of medicine\n\nAn authorised person must not give a treatment dose of a medicine unless the labelling on the medicine complies with the labelling requirements for the medicine under the Poisons Standard, Appendix L and, if applicable to the medicine, Appendix K.\nHowever, subsection (1) does not apply in relation to an S2 or S3 medicine given in a manufacturer’s pack.\n(sec.134-ssec.1) An authorised person must not give a treatment dose of a medicine unless the labelling on the medicine complies with the labelling requirements for the medicine under the Poisons Standard, Appendix L and, if applicable to the medicine, Appendix K.\n(sec.134-ssec.2) However, subsection (1) does not apply in relation to an S2 or S3 medicine given in a manufacturer’s pack.","sortOrder":182},{"sectionNumber":"sec.135","sectionType":"section","heading":"Information on or with prescription","content":"### sec.135 Information on or with prescription\n\nWhen giving a treatment dose of a medicine on a written prescription, an authorised person must record the following information on or with the prescription—\nthe date the treatment dose is given;\nthe authorised person’s name and signature;\nthat the prescription has been fulfilled or cancelled.\nHowever, if the prescription is a medication chart prescription, the authorised person must record only the following information on the prescription—\nthe date the medicine is given;\nthe amount of the medicine given;\nthe authorised person’s signature.\n(sec.135-ssec.1) When giving a treatment dose of a medicine on a written prescription, an authorised person must record the following information on or with the prescription— the date the treatment dose is given; the authorised person’s name and signature; that the prescription has been fulfilled or cancelled.\n(sec.135-ssec.2) However, if the prescription is a medication chart prescription, the authorised person must record only the following information on the prescription— the date the medicine is given; the amount of the medicine given; the authorised person’s signature.\n- (a) the date the treatment dose is given;\n- (b) the authorised person’s name and signature;\n- (c) that the prescription has been fulfilled or cancelled.\n- (a) the date the medicine is given;\n- (b) the amount of the medicine given;\n- (c) the authorised person’s signature.","sortOrder":183},{"sectionNumber":"sec.136","sectionType":"section","heading":"Treatment dose record","content":"### sec.136 Treatment dose record\n\nThis section applies to an authorised person giving a treatment dose of a medicine that is—\nan S3 medicine containing pseudoephedrine; or\nan S4 or S8 medicine.\nAs soon as practicable after giving the treatment dose, the authorised person must make and keep a record of the following information—\nthe name of the authorised person;\nthe date the medicine was given;\nif the medicine was given for a patient—\nthe name and address of the patient; and\nfor a monitored medicine—the date of birth of the patient;\nif the medicine was given for an animal—the name and address of the owner or custodian of the animal;\nthe name of the medicine or other sufficient information to accurately identify the medicine;\nthe approved name or brand name of the medicine\na description of the medicine compounded\nthe form, strength and amount of the medicine;\nif the treatment dose was given on a prescription—the name of the prescriber who prescribed the medicine.\nSee section 224 about keeping records.\nSee chapter 5 , part 2 , division 3 for additional requirements that apply to pharmacists selling medicines without a prescription.\nThis section does not apply in relation to a treatment dose given—\non a medication chart prescription; or\nfrom an RFDS medicine chest kept by the Royal Flying Doctor Service of Australia.\n(sec.136-ssec.1) This section applies to an authorised person giving a treatment dose of a medicine that is— an S3 medicine containing pseudoephedrine; or an S4 or S8 medicine.\n(sec.136-ssec.2) As soon as practicable after giving the treatment dose, the authorised person must make and keep a record of the following information— the name of the authorised person; the date the medicine was given; if the medicine was given for a patient— the name and address of the patient; and for a monitored medicine—the date of birth of the patient; if the medicine was given for an animal—the name and address of the owner or custodian of the animal; the name of the medicine or other sufficient information to accurately identify the medicine; the approved name or brand name of the medicine a description of the medicine compounded the form, strength and amount of the medicine; if the treatment dose was given on a prescription—the name of the prescriber who prescribed the medicine. See section 224 about keeping records. See chapter 5 , part 2 , division 3 for additional requirements that apply to pharmacists selling medicines without a prescription.\n(sec.136-ssec.3) This section does not apply in relation to a treatment dose given— on a medication chart prescription; or from an RFDS medicine chest kept by the Royal Flying Doctor Service of Australia.\n- (a) an S3 medicine containing pseudoephedrine; or\n- (b) an S4 or S8 medicine.\n- (a) the name of the authorised person;\n- (b) the date the medicine was given;\n- (c) if the medicine was given for a patient— (i) the name and address of the patient; and (ii) for a monitored medicine—the date of birth of the patient;\n- (i) the name and address of the patient; and\n- (ii) for a monitored medicine—the date of birth of the patient;\n- (d) if the medicine was given for an animal—the name and address of the owner or custodian of the animal;\n- (e) the name of the medicine or other sufficient information to accurately identify the medicine; Examples— • the approved name or brand name of the medicine • a description of the medicine compounded\n- • the approved name or brand name of the medicine\n- • a description of the medicine compounded\n- (f) the form, strength and amount of the medicine;\n- (g) if the treatment dose was given on a prescription—the name of the prescriber who prescribed the medicine.\n- (i) the name and address of the patient; and\n- (ii) for a monitored medicine—the date of birth of the patient;\n- • the approved name or brand name of the medicine\n- • a description of the medicine compounded\n- 1 See section 224 about keeping records.\n- 2 See chapter 5 , part 2 , division 3 for additional requirements that apply to pharmacists selling medicines without a prescription.\n- (a) on a medication chart prescription; or\n- (b) from an RFDS medicine chest kept by the Royal Flying Doctor Service of Australia.","sortOrder":184},{"sectionNumber":"ch.4-pt.9-div.4","sectionType":"division","heading":"Expired prescriptions and medicines","content":"## Expired prescriptions and medicines","sortOrder":185},{"sectionNumber":"sec.137","sectionType":"section","heading":"Expired written prescription","content":"### sec.137 Expired written prescription\n\nAn authorised person must not give a treatment dose of a medicine on a written prescription if—\nfor an S2, S3 or S4 medicine—the prescription was made more than 1 year before the day the medicine is to be given; or\nfor an S8 medicine—the prescription was made more than 6 months before the day the medicine is to be given.\n- (a) for an S2, S3 or S4 medicine—the prescription was made more than 1 year before the day the medicine is to be given; or\n- (b) for an S8 medicine—the prescription was made more than 6 months before the day the medicine is to be given.","sortOrder":186},{"sectionNumber":"sec.138","sectionType":"section","heading":"Expired medicine","content":"### sec.138 Expired medicine\n\nAn authorised person must not give a treatment dose of a medicine on a day that is after the expiry date stated on the container or label of the medicine.","sortOrder":187},{"sectionNumber":"ch.4-pt.10","sectionType":"part","heading":"Administering medicines","content":"# Administering medicines","sortOrder":188},{"sectionNumber":"sec.139","sectionType":"section","heading":"Application of part","content":"### sec.139 Application of part\n\nThis part applies to a person (an authorised person ) who is authorised to administer a medicine to a patient or an animal.","sortOrder":189},{"sectionNumber":"sec.140","sectionType":"section","heading":"Reasonable necessity for therapeutic treatment","content":"### sec.140 Reasonable necessity for therapeutic treatment\n\nThis section applies to an authorised person who is authorised to administer a medicine to a patient or an animal without a prescription.\nThe authorised person must not administer the medicine unless the person assesses the medicine to be reasonably necessary for the therapeutic treatment of the patient or animal.\n(sec.140-ssec.1) This section applies to an authorised person who is authorised to administer a medicine to a patient or an animal without a prescription.\n(sec.140-ssec.2) The authorised person must not administer the medicine unless the person assesses the medicine to be reasonably necessary for the therapeutic treatment of the patient or animal.","sortOrder":190},{"sectionNumber":"sec.141","sectionType":"section","heading":"Record for administering on standing order","content":"### sec.141 Record for administering on standing order\n\nThis section applies to an authorised person who is authorised to administer a medicine on a standing order.\nAs soon as practicable after administering the medicine, the authorised person must make and keep a record of the following information—\nthe name of the authorised person;\nthe date the medicine was administered;\nif the medicine was administered to a patient—\nthe name and address of the patient; and\nfor a monitored medicine—the date of birth of the patient;\nif the medicine was administered to an animal—the name and address of the owner or custodian of the animal;\nthe name of the medicine or other sufficient information to accurately identify the medicine;\nthe approved name or brand name of the medicine\na description of the medicine compounded\nthe form, strength and amount of the medicine;\nthe name of the prescriber who made the standing order.\nSee section 224 about keeping records.\n(sec.141-ssec.1) This section applies to an authorised person who is authorised to administer a medicine on a standing order.\n(sec.141-ssec.2) As soon as practicable after administering the medicine, the authorised person must make and keep a record of the following information— the name of the authorised person; the date the medicine was administered; if the medicine was administered to a patient— the name and address of the patient; and for a monitored medicine—the date of birth of the patient; if the medicine was administered to an animal—the name and address of the owner or custodian of the animal; the name of the medicine or other sufficient information to accurately identify the medicine; the approved name or brand name of the medicine a description of the medicine compounded the form, strength and amount of the medicine; the name of the prescriber who made the standing order.\n- (a) the name of the authorised person;\n- (b) the date the medicine was administered;\n- (c) if the medicine was administered to a patient— (i) the name and address of the patient; and (ii) for a monitored medicine—the date of birth of the patient;\n- (i) the name and address of the patient; and\n- (ii) for a monitored medicine—the date of birth of the patient;\n- (d) if the medicine was administered to an animal—the name and address of the owner or custodian of the animal;\n- (e) the name of the medicine or other sufficient information to accurately identify the medicine; Examples— • the approved name or brand name of the medicine • a description of the medicine compounded\n- • the approved name or brand name of the medicine\n- • a description of the medicine compounded\n- (f) the form, strength and amount of the medicine;\n- (g) the name of the prescriber who made the standing order.\n- (i) the name and address of the patient; and\n- (ii) for a monitored medicine—the date of birth of the patient;\n- • the approved name or brand name of the medicine\n- • a description of the medicine compounded","sortOrder":191},{"sectionNumber":"sec.142","sectionType":"section","heading":"Expired written prescription","content":"### sec.142 Expired written prescription\n\nAn authorised person must not administer a medicine on a written prescription if—\nfor an S2, S3 or S4 medicine—the prescription was made more than 1 year before the day the medicine is to be administered; or\nfor an S8 medicine—the prescription was made more than 6 months before the day the medicine is to be administered.\n- (a) for an S2, S3 or S4 medicine—the prescription was made more than 1 year before the day the medicine is to be administered; or\n- (b) for an S8 medicine—the prescription was made more than 6 months before the day the medicine is to be administered.","sortOrder":192},{"sectionNumber":"ch.4-pt.11","sectionType":"part","heading":"Disposing of waste from diversion-risk medicines","content":"# Disposing of waste from diversion-risk medicines","sortOrder":193},{"sectionNumber":"ch.4-pt.11-div.1","sectionType":"division","heading":"Preliminary","content":"## Preliminary","sortOrder":194},{"sectionNumber":"sec.143","sectionType":"section","heading":"Application of part","content":"### sec.143 Application of part\n\nThis part applies to a person (an approved disposer ) who is authorised to dispose of waste from a diversion-risk medicine.\nHowever, this part does not apply in relation to waste that is—\nresidue from a diversion-risk medicine in the form of—\nan unused portion of a tablet; or\nthe unused partial contents of a previously sterile ampoule or container; or\na used transdermal patch; and\ndestroyed immediately after the medicine is no longer required for administration.\nAlso, this part does not apply in relation to waste from a diversion-risk medicine from an RFDS medicine chest kept by the Royal Flying Doctor Service of Australia under a general approval for the service.\n(sec.143-ssec.1) This part applies to a person (an approved disposer ) who is authorised to dispose of waste from a diversion-risk medicine.\n(sec.143-ssec.2) However, this part does not apply in relation to waste that is— residue from a diversion-risk medicine in the form of— an unused portion of a tablet; or the unused partial contents of a previously sterile ampoule or container; or a used transdermal patch; and destroyed immediately after the medicine is no longer required for administration.\n(sec.143-ssec.3) Also, this part does not apply in relation to waste from a diversion-risk medicine from an RFDS medicine chest kept by the Royal Flying Doctor Service of Australia under a general approval for the service.\n- (a) residue from a diversion-risk medicine in the form of— (i) an unused portion of a tablet; or (ii) the unused partial contents of a previously sterile ampoule or container; or (iii) a used transdermal patch; and\n- (i) an unused portion of a tablet; or\n- (ii) the unused partial contents of a previously sterile ampoule or container; or\n- (iii) a used transdermal patch; and\n- (b) destroyed immediately after the medicine is no longer required for administration.\n- (i) an unused portion of a tablet; or\n- (ii) the unused partial contents of a previously sterile ampoule or container; or\n- (iii) a used transdermal patch; and","sortOrder":195},{"sectionNumber":"ch.4-pt.11-div.2","sectionType":"division","heading":"S8 diversion-risk medicine waste","content":"## S8 diversion-risk medicine waste","sortOrder":196},{"sectionNumber":"sec.144","sectionType":"section","heading":"Application of division","content":"### sec.144 Application of division\n\nThis division applies in relation to waste ( S8 waste ) from a diversion-risk medicine that is an S8 medicine.","sortOrder":197},{"sectionNumber":"sec.145","sectionType":"section","heading":"Separation of waste","content":"### sec.145 Separation of waste\n\nAn approved disposer must ensure S8 waste is—\nplaced in an S8 safe; and\nseparated from other medicines in the safe; and\nclearly marked for destruction.\n- (a) placed in an S8 safe; and\n- (b) separated from other medicines in the safe; and\n- (c) clearly marked for destruction.","sortOrder":198},{"sectionNumber":"sec.146","sectionType":"section","heading":"Transfer of waste for destruction","content":"### sec.146 Transfer of waste for destruction\n\nAn approved disposer (a giver ) must not transfer S8 waste for destruction other than to another person (a receiver ) who the disposer reasonably believes is an approved disposer authorised to destroy the S8 waste.\nThe receiver must acknowledge receipt of the S8 waste by—\nsigning an entry for the transfer of the waste in the medicine register for the S8 safe in which the waste was kept before the transfer; or\nSee also chapter 8 , part 2 , division 3 about recording dealings in a medicine register.\nsigning a separate notice for the giver.\nThe giver must keep a notice provided to the giver under subsection (2) (b) .\nSee section 224 about keeping records.\n(sec.146-ssec.1) An approved disposer (a giver ) must not transfer S8 waste for destruction other than to another person (a receiver ) who the disposer reasonably believes is an approved disposer authorised to destroy the S8 waste.\n(sec.146-ssec.2) The receiver must acknowledge receipt of the S8 waste by— signing an entry for the transfer of the waste in the medicine register for the S8 safe in which the waste was kept before the transfer; or See also chapter 8 , part 2 , division 3 about recording dealings in a medicine register. signing a separate notice for the giver.\n(sec.146-ssec.3) The giver must keep a notice provided to the giver under subsection (2) (b) . See section 224 about keeping records.\n- (a) signing an entry for the transfer of the waste in the medicine register for the S8 safe in which the waste was kept before the transfer; or Note— See also chapter 8 , part 2 , division 3 about recording dealings in a medicine register.\n- (b) signing a separate notice for the giver.","sortOrder":199},{"sectionNumber":"sec.147","sectionType":"section","heading":"Destruction of waste","content":"### sec.147 Destruction of waste\n\nAn approved disposer must not destroy S8 waste unless the approved disposer is—\nany of the following persons in charge of disposal at a place—\nambulance officer;\ndentist;\nmedical practitioner;\nnurse practitioner, midwife, registered nurse or enrolled nurse;\npharmacist;\npodiatrist or podiatric surgeon;\nveterinary surgeon; or\nspecifically authorised to supervise the destruction of the waste under a substance authority.\nThe approved disposer must not destroy the S8 waste unless the destruction is witnessed by a person not related or married to, or in a de facto relationship with, the approved disposer who is—\na member of a class of persons mentioned in subsection (1) ; or\nan inspector; or\na police officer.\n(sec.147-ssec.1) An approved disposer must not destroy S8 waste unless the approved disposer is— any of the following persons in charge of disposal at a place— ambulance officer; dentist; medical practitioner; nurse practitioner, midwife, registered nurse or enrolled nurse; pharmacist; podiatrist or podiatric surgeon; veterinary surgeon; or specifically authorised to supervise the destruction of the waste under a substance authority.\n(sec.147-ssec.2) The approved disposer must not destroy the S8 waste unless the destruction is witnessed by a person not related or married to, or in a de facto relationship with, the approved disposer who is— a member of a class of persons mentioned in subsection (1) ; or an inspector; or a police officer.\n- (a) any of the following persons in charge of disposal at a place— (i) ambulance officer; (ii) dentist; (iii) medical practitioner; (iv) nurse practitioner, midwife, registered nurse or enrolled nurse; (v) pharmacist; (vi) podiatrist or podiatric surgeon; (vii) veterinary surgeon; or\n- (i) ambulance officer;\n- (ii) dentist;\n- (iii) medical practitioner;\n- (iv) nurse practitioner, midwife, registered nurse or enrolled nurse;\n- (v) pharmacist;\n- (vi) podiatrist or podiatric surgeon;\n- (vii) veterinary surgeon; or\n- (b) specifically authorised to supervise the destruction of the waste under a substance authority.\n- (i) ambulance officer;\n- (ii) dentist;\n- (iii) medical practitioner;\n- (iv) nurse practitioner, midwife, registered nurse or enrolled nurse;\n- (v) pharmacist;\n- (vi) podiatrist or podiatric surgeon;\n- (vii) veterinary surgeon; or\n- (a) a member of a class of persons mentioned in subsection (1) ; or\n- (b) an inspector; or\n- (c) a police officer.","sortOrder":200},{"sectionNumber":"ch.4-pt.11-div.3","sectionType":"division","heading":"Other diversion-risk medicine waste","content":"## Other diversion-risk medicine waste","sortOrder":201},{"sectionNumber":"sec.148","sectionType":"section","heading":"Preventing public access to waste","content":"### sec.148 Preventing public access to waste\n\nThis section applies in relation to waste from a diversion-risk medicine other than an S8 medicine.\nAn approved disposer must not leave the waste unattended in a location unless the disposer reasonably believes—\na member of the public could not access the waste without being seen; and\nthe waste is likely to be taken for destruction as soon as practicable.\n(sec.148-ssec.1) This section applies in relation to waste from a diversion-risk medicine other than an S8 medicine.\n(sec.148-ssec.2) An approved disposer must not leave the waste unattended in a location unless the disposer reasonably believes— a member of the public could not access the waste without being seen; and the waste is likely to be taken for destruction as soon as practicable.\n- (a) a member of the public could not access the waste without being seen; and\n- (b) the waste is likely to be taken for destruction as soon as practicable.","sortOrder":202},{"sectionNumber":"ch.5-pt.1","sectionType":"part","heading":"Preliminary","content":"# Preliminary","sortOrder":203},{"sectionNumber":"sec.149","sectionType":"section","heading":"Application of chapter— Act , s 91","content":"### sec.149 Application of chapter— Act , s 91\n\nFor section 91 (1) of the Act , this chapter prescribes requirements for a person authorised under section 54 (4) of the Act to deal with a medicine, in relation to carrying out the dealing.\nThis part applies in addition to chapter 4 , unless otherwise stated.\nSee section 91 (3) of the Act about the relationship between requirements prescribed under section 91 and other provisions of the Act .\nSee also section 31 of the Act for when a person deals with a medicine in the authorised way.\n(sec.149-ssec.1) For section 91 (1) of the Act , this chapter prescribes requirements for a person authorised under section 54 (4) of the Act to deal with a medicine, in relation to carrying out the dealing.\n(sec.149-ssec.2) This part applies in addition to chapter 4 , unless otherwise stated.\n- 1 See section 91 (3) of the Act about the relationship between requirements prescribed under section 91 and other provisions of the Act .\n- 2 See also section 31 of the Act for when a person deals with a medicine in the authorised way.","sortOrder":204},{"sectionNumber":"ch.5-pt.2","sectionType":"part","heading":"Pharmacists","content":"# Pharmacists","sortOrder":205},{"sectionNumber":"ch.5-pt.2-div.1","sectionType":"division","heading":"Preliminary","content":"## Preliminary","sortOrder":206},{"sectionNumber":"sec.150","sectionType":"section","heading":"Application of part","content":"### sec.150 Application of part\n\nThis part applies to a pharmacist who is authorised to deal with a medicine, in relation to carrying out the dealing at a pharmacy.","sortOrder":207},{"sectionNumber":"ch.5-pt.2-div.2","sectionType":"division","heading":"Supplying stock","content":"## Supplying stock","sortOrder":208},{"sectionNumber":"sec.151","sectionType":"section","heading":"Supply for filling another pharmacy client order","content":"### sec.151 Supply for filling another pharmacy client order\n\nThis section applies in relation to supplying stock of a medicine to fill an order made by a client of another pharmacist.\nThe pharmacist supplying the stock must—\nbe reasonably satisfied the request is for satisfying the client’s order; and\nsupply the minimum amount of stock necessary to satisfy the client’s order; and\nobtain a signed, written request for the stock from the other pharmacist.\n(sec.151-ssec.1) This section applies in relation to supplying stock of a medicine to fill an order made by a client of another pharmacist.\n(sec.151-ssec.2) The pharmacist supplying the stock must— be reasonably satisfied the request is for satisfying the client’s order; and supply the minimum amount of stock necessary to satisfy the client’s order; and obtain a signed, written request for the stock from the other pharmacist.\n- (a) be reasonably satisfied the request is for satisfying the client’s order; and\n- (b) supply the minimum amount of stock necessary to satisfy the client’s order; and\n- (c) obtain a signed, written request for the stock from the other pharmacist.","sortOrder":209},{"sectionNumber":"sec.152","sectionType":"section","heading":"Records when supplying to another pharmacist","content":"### sec.152 Records when supplying to another pharmacist\n\nThis section applies in relation to supplying stock of a medicine to another pharmacist.\nThe pharmacist supplying the stock must make and keep a record of the following information—\nthe signed, written request for the stock;\nthe date on which the stock was supplied;\nthe type of stock supplied;\nthe amount of stock supplied.\nSee section 224 about keeping records.\n(sec.152-ssec.1) This section applies in relation to supplying stock of a medicine to another pharmacist.\n(sec.152-ssec.2) The pharmacist supplying the stock must make and keep a record of the following information— the signed, written request for the stock; the date on which the stock was supplied; the type of stock supplied; the amount of stock supplied. See section 224 about keeping records.\n- (a) the signed, written request for the stock;\n- (b) the date on which the stock was supplied;\n- (c) the type of stock supplied;\n- (d) the amount of stock supplied.","sortOrder":210},{"sectionNumber":"ch.5-pt.2-div.3","sectionType":"division","heading":"Selling medicines without prescriptions","content":"## Selling medicines without prescriptions","sortOrder":211},{"sectionNumber":"sec.153","sectionType":"section","heading":"Application of division","content":"### sec.153 Application of division\n\nThis division applies in relation to selling a medicine without a prescription.\nHowever, subsection (3) applies if the medicine is sold under a Continued Dispensing Determination or an extended practice authority.\nIf a provision of this division is inconsistent with a document mentioned in subsection (2) , the document prevails to the extent of any inconsistency.\nSee also schedule 9 , part 1 about pharmacists repackaging medicines.\ns 153 amd 2025 SL No. 60 s 7\n(sec.153-ssec.1) This division applies in relation to selling a medicine without a prescription.\n(sec.153-ssec.2) However, subsection (3) applies if the medicine is sold under a Continued Dispensing Determination or an extended practice authority.\n(sec.153-ssec.3) If a provision of this division is inconsistent with a document mentioned in subsection (2) , the document prevails to the extent of any inconsistency.","sortOrder":212},{"sectionNumber":"sec.154","sectionType":"section","heading":"Labelling sold medicine","content":"### sec.154 Labelling sold medicine\n\nThis section does not apply in relation to an S2 medicine in a manufacturer’s pack.\nA pharmacist must not sell a medicine unless the labelling on the medicine complies with the labelling requirements for the medicine under the Poisons Standard, Appendix L and, if applicable to the medicine, Appendix K.\nHowever, if the medicine is an S3 medicine in a manufacturer’s pack, the pharmacist must instead attach a label to the medicine stating the following information—\nthe date the medicine is sold;\nthe name of the patient;\nthe name of the medicine;\nif the medicine is mentioned in the Poisons Standard, Appendix K—the warning statement mentioned in Appendix K for the medicine.\n(sec.154-ssec.1) This section does not apply in relation to an S2 medicine in a manufacturer’s pack.\n(sec.154-ssec.2) A pharmacist must not sell a medicine unless the labelling on the medicine complies with the labelling requirements for the medicine under the Poisons Standard, Appendix L and, if applicable to the medicine, Appendix K.\n(sec.154-ssec.3) However, if the medicine is an S3 medicine in a manufacturer’s pack, the pharmacist must instead attach a label to the medicine stating the following information— the date the medicine is sold; the name of the patient; the name of the medicine; if the medicine is mentioned in the Poisons Standard, Appendix K—the warning statement mentioned in Appendix K for the medicine.\n- (a) the date the medicine is sold;\n- (b) the name of the patient;\n- (c) the name of the medicine;\n- (d) if the medicine is mentioned in the Poisons Standard, Appendix K—the warning statement mentioned in Appendix K for the medicine.","sortOrder":213},{"sectionNumber":"sec.155","sectionType":"section","heading":"Definitions for subdivision","content":"### sec.155 Definitions for subdivision\n\nIn this subdivision—\noral hormonal contraceptive means an oral preparation of a medicine for preventing pregnancy by interrupting ovulation.\npre-packed , in relation to a medicine, means the medicine is a pre-packed liquid, cream, ointment or aerosol.\ns 155 def pre-packed ins 2025 SL No. 60 s 8 (2)\ns 155 amd 2025 SL No. 60 s 8(1)","sortOrder":214},{"sectionNumber":"sec.156","sectionType":"section","heading":"Selling S4 oral hormonal contraceptive","content":"### sec.156 Selling S4 oral hormonal contraceptive\n\nThis section applies in relation to an S4 medicine that is an oral hormonal contraceptive for a patient.\nA pharmacist must not sell the medicine unless the pharmacist reasonably believes—\nthe patient has been treated by a prescriber with the medicine for a continuous period of a reasonable length; and\nit is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine; and\nthe patient has not, in the year before seeking the medicine from the pharmacist, been sold the medicine without a prescription from the pharmacy at which the medicine is sought.\nA pharmacist must not sell an amount of the medicine that is more than a manufacturer’s pack of the medicine.\ns 156 amd 2025 SL No. 60 s 9\n(sec.156-ssec.1) This section applies in relation to an S4 medicine that is an oral hormonal contraceptive for a patient.\n(sec.156-ssec.2) A pharmacist must not sell the medicine unless the pharmacist reasonably believes— the patient has been treated by a prescriber with the medicine for a continuous period of a reasonable length; and it is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine; and the patient has not, in the year before seeking the medicine from the pharmacist, been sold the medicine without a prescription from the pharmacy at which the medicine is sought.\n(sec.156-ssec.3) A pharmacist must not sell an amount of the medicine that is more than a manufacturer’s pack of the medicine.\n- (a) the patient has been treated by a prescriber with the medicine for a continuous period of a reasonable length; and\n- (b) it is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine; and\n- (c) the patient has not, in the year before seeking the medicine from the pharmacist, been sold the medicine without a prescription from the pharmacy at which the medicine is sought.","sortOrder":215},{"sectionNumber":"sec.157","sectionType":"section","heading":"Selling S4 diversion-risk medicine","content":"### sec.157 Selling S4 diversion-risk medicine\n\nThis section applies in relation to an S4 medicine that is a diversion-risk medicine for a patient.\nA pharmacist must not sell the medicine unless the pharmacist reasonably believes—\nthe medicine has been previously prescribed to the patient; and\nfailure to sell the medicine could be life-threatening for the patient; and\nit is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine.\nA pharmacist must not sell an amount of the medicine that is—\nif the medicine is pre-packed—more than the smallest available size of a manufacturer’s pack of the medicine; or\notherwise—more than 3 days’ supply of the medicine.\ns 157 amd 2025 SL No. 60 s 10\n(sec.157-ssec.1) This section applies in relation to an S4 medicine that is a diversion-risk medicine for a patient.\n(sec.157-ssec.2) A pharmacist must not sell the medicine unless the pharmacist reasonably believes— the medicine has been previously prescribed to the patient; and failure to sell the medicine could be life-threatening for the patient; and it is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine.\n(sec.157-ssec.3) A pharmacist must not sell an amount of the medicine that is— if the medicine is pre-packed—more than the smallest available size of a manufacturer’s pack of the medicine; or otherwise—more than 3 days’ supply of the medicine.\n- (a) the medicine has been previously prescribed to the patient; and\n- (b) failure to sell the medicine could be life-threatening for the patient; and\n- (c) it is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine.\n- (a) if the medicine is pre-packed—more than the smallest available size of a manufacturer’s pack of the medicine; or\n- (b) otherwise—more than 3 days’ supply of the medicine.","sortOrder":216},{"sectionNumber":"sec.158","sectionType":"section","heading":"Selling S4 restricted medicine","content":"### sec.158 Selling S4 restricted medicine\n\nThis section applies in relation to an S4 medicine that is a restricted medicine for a patient.\nA pharmacist must not sell the medicine unless the pharmacist reasonably believes—\nthe medicine has been previously prescribed to the patient; and\ncontinuing the patient’s treatment with the medicine is urgent and essential for the patient’s wellbeing; and\nit is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine.\nA pharmacist must not sell an amount of the medicine that is—\nif the medicine is pre-packed—more than the smallest available size of a manufacturer’s pack of the medicine; or\notherwise—more than 3 days’ supply of the medicine.\ns 158 sub 2025 SL No. 60 s 11\n(sec.158-ssec.1) This section applies in relation to an S4 medicine that is a restricted medicine for a patient.\n(sec.158-ssec.2) A pharmacist must not sell the medicine unless the pharmacist reasonably believes— the medicine has been previously prescribed to the patient; and continuing the patient’s treatment with the medicine is urgent and essential for the patient’s wellbeing; and it is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine.\n(sec.158-ssec.3) A pharmacist must not sell an amount of the medicine that is— if the medicine is pre-packed—more than the smallest available size of a manufacturer’s pack of the medicine; or otherwise—more than 3 days’ supply of the medicine.\n- (a) the medicine has been previously prescribed to the patient; and\n- (b) continuing the patient’s treatment with the medicine is urgent and essential for the patient’s wellbeing; and\n- (c) it is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine.\n- (a) if the medicine is pre-packed—more than the smallest available size of a manufacturer’s pack of the medicine; or\n- (b) otherwise—more than 3 days’ supply of the medicine.","sortOrder":217},{"sectionNumber":"sec.159","sectionType":"section","heading":"Selling other S4 medicines","content":"### sec.159 Selling other S4 medicines\n\nThis section applies in relation to an S4 medicine for a patient, other than a medicine otherwise mentioned in this subdivision.\nA pharmacist must not sell the medicine unless the pharmacist reasonably believes—\nthe patient has not, in the year before seeking the medicine from the pharmacist, been sold the medicine without a prescription from the pharmacy at which the medicine is sought; and\nthe medicine has been lawfully supplied to the patient in the 6 months before being sought from the pharmacist; and\ncontinuing the patient’s treatment with the medicine is urgent and essential for the patient’s wellbeing; and\nit is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine.\nA pharmacist must not sell an amount of the medicine that is more than the smallest available size of a manufacturer’s pack of the medicine.\ns 159 amd 2022 SL No. 77 s 6 ; 2023 SL No. 170 s 16\nsub 2025 SL No. 60 s 11\n(sec.159-ssec.1) This section applies in relation to an S4 medicine for a patient, other than a medicine otherwise mentioned in this subdivision.\n(sec.159-ssec.2) A pharmacist must not sell the medicine unless the pharmacist reasonably believes— the patient has not, in the year before seeking the medicine from the pharmacist, been sold the medicine without a prescription from the pharmacy at which the medicine is sought; and the medicine has been lawfully supplied to the patient in the 6 months before being sought from the pharmacist; and continuing the patient’s treatment with the medicine is urgent and essential for the patient’s wellbeing; and it is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine.\n(sec.159-ssec.3) A pharmacist must not sell an amount of the medicine that is more than the smallest available size of a manufacturer’s pack of the medicine.\n- (a) the patient has not, in the year before seeking the medicine from the pharmacist, been sold the medicine without a prescription from the pharmacy at which the medicine is sought; and\n- (b) the medicine has been lawfully supplied to the patient in the 6 months before being sought from the pharmacist; and\n- (c) continuing the patient’s treatment with the medicine is urgent and essential for the patient’s wellbeing; and\n- (d) it is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine.","sortOrder":218},{"sectionNumber":"sec.160","sectionType":"section","heading":"Record when selling S4 medicine","content":"### sec.160 Record when selling S4 medicine\n\nAs soon as practicable after selling an S4 medicine for a patient, a pharmacist must make and keep a record of the following information—\nthe name of the pharmacist;\nthe date the medicine is sold;\nthe name and address of the patient;\nfor a monitored medicine—the date of birth of the patient;\nthe name of the medicine or other sufficient information to accurately identify the medicine;\nthe approved name or brand name of the medicine\na description of the medicine compounded\nthe form, strength and amount of the medicine sold;\nthe instructions given for the use of the medicine;\nthe name of the prescriber who last prescribed the medicine to the person, if known;\na brief description of why the pharmacist is selling the medicine.\nSee section 224 about keeping records.\ns 160 amd 2025 SL No. 60 s 12\n- (a) the name of the pharmacist;\n- (b) the date the medicine is sold;\n- (c) the name and address of the patient;\n- (d) for a monitored medicine—the date of birth of the patient;\n- (e) the name of the medicine or other sufficient information to accurately identify the medicine; Examples— • the approved name or brand name of the medicine • a description of the medicine compounded\n- • the approved name or brand name of the medicine\n- • a description of the medicine compounded\n- (f) the form, strength and amount of the medicine sold;\n- (g) the instructions given for the use of the medicine;\n- (h) the name of the prescriber who last prescribed the medicine to the person, if known;\n- (i) a brief description of why the pharmacist is selling the medicine.\n- • the approved name or brand name of the medicine\n- • a description of the medicine compounded","sortOrder":219},{"sectionNumber":"sec.161","sectionType":"section","heading":"Selling S3 medicine with instructions for use","content":"### sec.161 Selling S3 medicine with instructions for use\n\nA pharmacist must not sell an S3 medicine for a patient unless the pharmacist reasonably believes the patient has a therapeutic need for the medicine.\nA pharmacist must not sell an S3 medicine for an animal except to a person the pharmacist reasonably believes is the owner or custodian of the animal.\nThe pharmacist must give instructions about the appropriate way to use the S3 medicine to the person buying the medicine.\nA pharmacist instructs a patient’s carer about how to use an adrenaline (epinephrine) device to treat an anaphylactic reaction.\ns 161 amd 2023 SL No. 51 s 5 ; 2025 SL No. 148 s 6\n(sec.161-ssec.1) A pharmacist must not sell an S3 medicine for a patient unless the pharmacist reasonably believes the patient has a therapeutic need for the medicine.\n(sec.161-ssec.2) A pharmacist must not sell an S3 medicine for an animal except to a person the pharmacist reasonably believes is the owner or custodian of the animal.\n(sec.161-ssec.3) The pharmacist must give instructions about the appropriate way to use the S3 medicine to the person buying the medicine. A pharmacist instructs a patient’s carer about how to use an adrenaline (epinephrine) device to treat an anaphylactic reaction.","sortOrder":220},{"sectionNumber":"sec.162","sectionType":"section","heading":"Record keeping for pseudoephedrine","content":"### sec.162 Record keeping for pseudoephedrine\n\nThis section applies in relation to an S3 medicine containing pseudoephedrine.\nAs soon as practicable after selling the medicine, a pharmacist must make and keep a record of the following information—\nthe date of the sale;\nthe name of the medicine;\nthe amount of the medicine sold;\nthe name and address of the person who bought the medicine;\nthe type of document used to identify the person who bought the medicine and an identifier for the document, if applicable.\ndriver licence number, passport number\nThe record must be kept electronically in a way that complies with the departmental standard called ‘Pseudoephedrine recording’.\n(sec.162-ssec.1) This section applies in relation to an S3 medicine containing pseudoephedrine.\n(sec.162-ssec.2) As soon as practicable after selling the medicine, a pharmacist must make and keep a record of the following information— the date of the sale; the name of the medicine; the amount of the medicine sold; the name and address of the person who bought the medicine; the type of document used to identify the person who bought the medicine and an identifier for the document, if applicable. driver licence number, passport number\n(sec.162-ssec.3) The record must be kept electronically in a way that complies with the departmental standard called ‘Pseudoephedrine recording’.\n- (a) the date of the sale;\n- (b) the name of the medicine;\n- (c) the amount of the medicine sold;\n- (d) the name and address of the person who bought the medicine;\n- (e) the type of document used to identify the person who bought the medicine and an identifier for the document, if applicable. Examples for paragraph (e) — driver licence number, passport number","sortOrder":221},{"sectionNumber":"ch.5-pt.3","sectionType":"part","heading":"Pharmacy employees","content":"# Pharmacy employees","sortOrder":222},{"sectionNumber":"sec.163","sectionType":"section","heading":"Application of part","content":"### sec.163 Application of part\n\nThis part applies to a pharmacy employee who is authorised to deal with a medicine, in relation to dealing with the medicine at a pharmacy.","sortOrder":223},{"sectionNumber":"sec.164","sectionType":"section","heading":"Notifying pharmacist of discrepancy","content":"### sec.164 Notifying pharmacist of discrepancy\n\nThis section applies in relation to stock of S8 medicines received from a wholesale supplier for a pharmacy.\nA pharmacy employee in possession of the stock must immediately check the amount of stock received against the amount of stock listed on the invoice from the wholesale supplier.\nThe pharmacy employee must notify a pharmacist at the pharmacy of any discrepancy between the invoice and stock received.\n(sec.164-ssec.1) This section applies in relation to stock of S8 medicines received from a wholesale supplier for a pharmacy.\n(sec.164-ssec.2) A pharmacy employee in possession of the stock must immediately check the amount of stock received against the amount of stock listed on the invoice from the wholesale supplier.\n(sec.164-ssec.3) The pharmacy employee must notify a pharmacist at the pharmacy of any discrepancy between the invoice and stock received.","sortOrder":224},{"sectionNumber":"sec.165","sectionType":"section","heading":"Selling S2 medicine in manufacturer’s pack","content":"### sec.165 Selling S2 medicine in manufacturer’s pack\n\nA pharmacy employee must not sell an S2 medicine other than in a manufacturer’s pack.","sortOrder":225},{"sectionNumber":"ch.5-pt.4","sectionType":"part","heading":"Veterinary professions","content":"# Veterinary professions","sortOrder":226},{"sectionNumber":"ch.5-pt.4-div.1","sectionType":"division","heading":"Veterinary surgeons prescribing S4 medicines and medicated feed","content":"## Veterinary surgeons prescribing S4 medicines and medicated feed","sortOrder":227},{"sectionNumber":"sec.166","sectionType":"section","heading":"Application of division","content":"### sec.166 Application of division\n\nThis division applies to a veterinary surgeon who is authorised to prescribe a medicine for an animal if the medicine—\nis an S4 medicine or medicated feed; and\nis to be mixed with food for administration to a group of animals by a farmer of the animals.\n- (a) is an S4 medicine or medicated feed; and\n- (b) is to be mixed with food for administration to a group of animals by a farmer of the animals.","sortOrder":228},{"sectionNumber":"sec.167","sectionType":"section","heading":"Instructions for administration to food producing animals","content":"### sec.167 Instructions for administration to food producing animals\n\nThis section applies in relation to food producing animals.\nA veterinary surgeon must give instructions to the farmer of the food producing animals about how to—\nmeasure and combine an S4 medicine or medicated feed with food to administer to the animals; and\nclean any residue from the medicine or feed from any equipment used to administer it to the animals.\nThis section does not apply if the veterinary surgeon has previously given the farmer the relevant instructions.\n(sec.167-ssec.1) This section applies in relation to food producing animals.\n(sec.167-ssec.2) A veterinary surgeon must give instructions to the farmer of the food producing animals about how to— measure and combine an S4 medicine or medicated feed with food to administer to the animals; and clean any residue from the medicine or feed from any equipment used to administer it to the animals.\n(sec.167-ssec.3) This section does not apply if the veterinary surgeon has previously given the farmer the relevant instructions.\n- (a) measure and combine an S4 medicine or medicated feed with food to administer to the animals; and\n- (b) clean any residue from the medicine or feed from any equipment used to administer it to the animals.","sortOrder":229},{"sectionNumber":"sec.168","sectionType":"section","heading":"Written prescription for medicine and medicated feed","content":"### sec.168 Written prescription for medicine and medicated feed\n\nA veterinary surgeon must make a written prescription for an S4 medicine or medicated feed for a group of animals that states the following information—\na unique identifier for the prescription;\nthe name of the veterinary surgeon;\nthe address of the veterinary premises of the veterinary surgeon;\nthe qualifications of the veterinary surgeon;\nthe date of the prescription;\nthe name and address of the farmer of the animals;\nthe date, no later than 6 months after the date the prescription is given, when the prescription expires;\nthe species of the animals;\nany other details necessary to identify the animals, including, for example, the age, breed or sex of the animals;\na statement that the medicine or feed is for animal treatment only;\nfor a medicine—\nthe name of the medicine; and\nthe form and strength of the medicine; and\nthe final concentration of the medicine to be in the food administered to the animals;\nfor medicated feed—\nthe name of the medicine mixed, or to be mixed, into the feed; and\nthe form and strength of the medicine mixed, or to be mixed, into the feed; and\nthe name and address of the manufacturer to supply the feed; and\nthe final concentration of the medicine to be mixed into the feed supplied by the manufacturer; and\nhow much feed may be supplied by the manufacturer;\nthe instructions mentioned in section 167 for administering the medicine or feed to the animals, if any.\nSee also the Chemical Usage (Agricultural and Veterinary) Control Act 1988 , section 12M for additional requirements in relation to prescriptions for medicated feed.\nThe veterinary surgeon must sign, and keep a copy of, the written prescription.\nSee section 224 about keeping records.\n(sec.168-ssec.1) A veterinary surgeon must make a written prescription for an S4 medicine or medicated feed for a group of animals that states the following information— a unique identifier for the prescription; the name of the veterinary surgeon; the address of the veterinary premises of the veterinary surgeon; the qualifications of the veterinary surgeon; the date of the prescription; the name and address of the farmer of the animals; the date, no later than 6 months after the date the prescription is given, when the prescription expires; the species of the animals; any other details necessary to identify the animals, including, for example, the age, breed or sex of the animals; a statement that the medicine or feed is for animal treatment only; for a medicine— the name of the medicine; and the form and strength of the medicine; and the final concentration of the medicine to be in the food administered to the animals; for medicated feed— the name of the medicine mixed, or to be mixed, into the feed; and the form and strength of the medicine mixed, or to be mixed, into the feed; and the name and address of the manufacturer to supply the feed; and the final concentration of the medicine to be mixed into the feed supplied by the manufacturer; and how much feed may be supplied by the manufacturer; the instructions mentioned in section 167 for administering the medicine or feed to the animals, if any. See also the Chemical Usage (Agricultural and Veterinary) Control Act 1988 , section 12M for additional requirements in relation to prescriptions for medicated feed.\n(sec.168-ssec.2) The veterinary surgeon must sign, and keep a copy of, the written prescription. See section 224 about keeping records.\n- (a) a unique identifier for the prescription;\n- (b) the name of the veterinary surgeon;\n- (c) the address of the veterinary premises of the veterinary surgeon;\n- (d) the qualifications of the veterinary surgeon;\n- (e) the date of the prescription;\n- (f) the name and address of the farmer of the animals;\n- (g) the date, no later than 6 months after the date the prescription is given, when the prescription expires;\n- (h) the species of the animals;\n- (i) any other details necessary to identify the animals, including, for example, the age, breed or sex of the animals;\n- (j) a statement that the medicine or feed is for animal treatment only;\n- (k) for a medicine— (i) the name of the medicine; and (ii) the form and strength of the medicine; and (iii) the final concentration of the medicine to be in the food administered to the animals;\n- (i) the name of the medicine; and\n- (ii) the form and strength of the medicine; and\n- (iii) the final concentration of the medicine to be in the food administered to the animals;\n- (l) for medicated feed— (i) the name of the medicine mixed, or to be mixed, into the feed; and (ii) the form and strength of the medicine mixed, or to be mixed, into the feed; and (iii) the name and address of the manufacturer to supply the feed; and (iv) the final concentration of the medicine to be mixed into the feed supplied by the manufacturer; and (v) how much feed may be supplied by the manufacturer;\n- (i) the name of the medicine mixed, or to be mixed, into the feed; and\n- (ii) the form and strength of the medicine mixed, or to be mixed, into the feed; and\n- (iii) the name and address of the manufacturer to supply the feed; and\n- (iv) the final concentration of the medicine to be mixed into the feed supplied by the manufacturer; and\n- (v) how much feed may be supplied by the manufacturer;\n- (m) the instructions mentioned in section 167 for administering the medicine or feed to the animals, if any.\n- (i) the name of the medicine; and\n- (ii) the form and strength of the medicine; and\n- (iii) the final concentration of the medicine to be in the food administered to the animals;\n- (i) the name of the medicine mixed, or to be mixed, into the feed; and\n- (ii) the form and strength of the medicine mixed, or to be mixed, into the feed; and\n- (iii) the name and address of the manufacturer to supply the feed; and\n- (iv) the final concentration of the medicine to be mixed into the feed supplied by the manufacturer; and\n- (v) how much feed may be supplied by the manufacturer;","sortOrder":230},{"sectionNumber":"sec.169","sectionType":"section","heading":"Sending written prescription","content":"### sec.169 Sending written prescription\n\nThis section applies if a veterinary surgeon sends a written prescription for medicated feed to the holder of a manufacturing licence for the feed.\nThe written prescription must be made and sent to the holder in a way that is reasonably likely to—\nminimise fraud or tampering; and\nallow the prescription to be amended only by the veterinary surgeon; and\nif sent electronically—be transmitted securely.\n(sec.169-ssec.1) This section applies if a veterinary surgeon sends a written prescription for medicated feed to the holder of a manufacturing licence for the feed.\n(sec.169-ssec.2) The written prescription must be made and sent to the holder in a way that is reasonably likely to— minimise fraud or tampering; and allow the prescription to be amended only by the veterinary surgeon; and if sent electronically—be transmitted securely.\n- (a) minimise fraud or tampering; and\n- (b) allow the prescription to be amended only by the veterinary surgeon; and\n- (c) if sent electronically—be transmitted securely.","sortOrder":231},{"sectionNumber":"ch.5-pt.4-div.2","sectionType":"division","heading":"Veterinary nurses","content":"## Veterinary nurses","sortOrder":232},{"sectionNumber":"sec.170","sectionType":"section","heading":"Record for veterinary nurse administering on oral prescription","content":"### sec.170 Record for veterinary nurse administering on oral prescription\n\nThis section applies to a veterinary nurse who is authorised to administer a medicine to an animal, if the medicine is administered on an oral prescription.\nThe veterinary nurse must make and keep a record of—\nthe oral prescription; and\nthe name of the veterinary surgeon who prescribed the medicine; and\nthe date and time the medicine is administered; and\nthe amount of medicine administered.\nSee section 224 about keeping records.\n(sec.170-ssec.1) This section applies to a veterinary nurse who is authorised to administer a medicine to an animal, if the medicine is administered on an oral prescription.\n(sec.170-ssec.2) The veterinary nurse must make and keep a record of— the oral prescription; and the name of the veterinary surgeon who prescribed the medicine; and the date and time the medicine is administered; and the amount of medicine administered. See section 224 about keeping records.\n- (a) the oral prescription; and\n- (b) the name of the veterinary surgeon who prescribed the medicine; and\n- (c) the date and time the medicine is administered; and\n- (d) the amount of medicine administered.","sortOrder":233},{"sectionNumber":"ch.5-pt.5","sectionType":"part","heading":"Wholesale representatives","content":"# Wholesale representatives","sortOrder":234},{"sectionNumber":"sec.171","sectionType":"section","heading":"Disposal of unused starter packs","content":"### sec.171 Disposal of unused starter packs\n\nThis section applies to a wholesale representative who is authorised to dispose of waste from a diversion-risk medicine.\nA wholesale representative must return to the representative’s employer any starter pack of a diversion-risk medicine that is unwanted, expired or otherwise unused.\nIn this section—\nemployer , of a wholesale representative, means the wholesaler who employs the representative.\nSee also section 232 requiring wholesale representatives to complete returns of transactions.\n(sec.171-ssec.1) This section applies to a wholesale representative who is authorised to dispose of waste from a diversion-risk medicine.\n(sec.171-ssec.2) A wholesale representative must return to the representative’s employer any starter pack of a diversion-risk medicine that is unwanted, expired or otherwise unused.\n(sec.171-ssec.3) In this section— employer , of a wholesale representative, means the wholesaler who employs the representative.","sortOrder":235},{"sectionNumber":"ch.7-pt.1","sectionType":"part","heading":"Preliminary","content":"# Preliminary","sortOrder":236},{"sectionNumber":"sec.175","sectionType":"section","heading":"Application to information from other States","content":"### sec.175 Application to information from other States\n\nThis chapter applies in relation to information recorded in another State to the extent the information relates to—\na health practitioner ordinarily practising in Queensland; or\na patient ordinarily residing in Queensland; or\na prescription made in Queensland; or\na medicine dispensed or given in Queensland.\nFor applying subsection (1) , a reference in this chapter to a type of information recorded under the Act is taken to include a reference to the equivalent type of information recorded under a corresponding law, to the extent the context permits.\n(sec.175-ssec.1) This chapter applies in relation to information recorded in another State to the extent the information relates to— a health practitioner ordinarily practising in Queensland; or a patient ordinarily residing in Queensland; or a prescription made in Queensland; or a medicine dispensed or given in Queensland.\n(sec.175-ssec.2) For applying subsection (1) , a reference in this chapter to a type of information recorded under the Act is taken to include a reference to the equivalent type of information recorded under a corresponding law, to the extent the context permits.\n- (a) a health practitioner ordinarily practising in Queensland; or\n- (b) a patient ordinarily residing in Queensland; or\n- (c) a prescription made in Queensland; or\n- (d) a medicine dispensed or given in Queensland.","sortOrder":237},{"sectionNumber":"sec.176","sectionType":"section","heading":"Definitions for chapter","content":"### sec.176 Definitions for chapter\n\nIn this chapter—\ndata source entity means any of the following entities—\nFred IT Group Pty Ltd ABN 68 109 546 901;\nMedication Knowledge Pty Ltd ABN 47 622 493 967;\nthe Australian Health Practitioner Regulation Agency;\na government entity in another State responsible for the administration of an equivalent database;\nan entity that is a data source entity under a corresponding law;\nanother entity that provides a prescription exchange system to a health practitioner.\nequivalent database means a database kept under a corresponding law that is the same as, or substantially similar to, the monitored medicines database.\nprescription exchange system means an electronic system for recording or transmitting prescriptions, or information in prescriptions, for dispensing to patients.\n- (a) Fred IT Group Pty Ltd ABN 68 109 546 901;\n- (b) Medication Knowledge Pty Ltd ABN 47 622 493 967;\n- (c) the Australian Health Practitioner Regulation Agency;\n- (d) a government entity in another State responsible for the administration of an equivalent database;\n- (e) an entity that is a data source entity under a corresponding law;\n- (f) another entity that provides a prescription exchange system to a health practitioner.","sortOrder":238},{"sectionNumber":"sec.177","sectionType":"section","heading":"Additional purposes— Act , s 224","content":"### sec.177 Additional purposes— Act , s 224\n\nFor section 224 (2) (g) of the Act , the following purposes are prescribed—\nto manage the operation of the database;\nto exercise a power, or perform another function, under the Act in relation to a monitored medicine.\n- (a) to manage the operation of the database;\n- (b) to exercise a power, or perform another function, under the Act in relation to a monitored medicine.","sortOrder":239},{"sectionNumber":"ch.7-pt.2","sectionType":"part","heading":"Requirement to check database","content":"# Requirement to check database","sortOrder":240},{"sectionNumber":"sec.178","sectionType":"section","heading":"Relevant practitioners— Act , s 41","content":"### sec.178 Relevant practitioners— Act , s 41\n\nFor section 41 (4) of the Act , definition relevant practitioner , each health practitioner stated in schedule 18 , part 1 is prescribed to be a relevant practitioner.","sortOrder":241},{"sectionNumber":"sec.178A","sectionType":"section","heading":"Exempt circumstances— Act , s 41","content":"### sec.178A Exempt circumstances— Act , s 41\n\nFor section 41 (3) (a) of the Act , a relevant practitioner proposing to carry out a dealing stated in column 1 of the table in schedule 18 , part 1A is prescribed to be exempt from section 41 (2) of the Act in the circumstances for the dealing stated opposite in column 2 of the table.\ns 178A ins 2024 SL No. 44 s 5","sortOrder":242},{"sectionNumber":"ch.7-pt.3","sectionType":"part","heading":"Information for database","content":"# Information for database","sortOrder":243},{"sectionNumber":"sec.179","sectionType":"section","heading":"Information recorded in database— Act , s 225","content":"### sec.179 Information recorded in database— Act , s 225\n\nFor section 225 (1) of the Act , the following information is prescribed—\ninformation given to the chief executive under section 226 of the Act ;\ninformation in relation to a patient’s treatment stated in a prescribing approval for a monitored medicine;\nthe registration details from time to time, under the Health Practitioner Regulation National Law , of a health practitioner given to, or held by, the chief executive;\ninformation about any other qualification of a health practitioner for treating a patient with a monitored medicine given to, or held by, the chief executive;\npersonal information to identify a health practitioner for accessing or using the monitored medicines database given to, or held by, the chief executive;\ninformation about a health practitioner provided for the purpose of accessing or using the database.\n- (a) information given to the chief executive under section 226 of the Act ;\n- (b) information in relation to a patient’s treatment stated in a prescribing approval for a monitored medicine;\n- (c) the registration details from time to time, under the Health Practitioner Regulation National Law , of a health practitioner given to, or held by, the chief executive;\n- (d) information about any other qualification of a health practitioner for treating a patient with a monitored medicine given to, or held by, the chief executive;\n- (e) personal information to identify a health practitioner for accessing or using the monitored medicines database given to, or held by, the chief executive;\n- (f) information about a health practitioner provided for the purpose of accessing or using the database.","sortOrder":244},{"sectionNumber":"sec.180","sectionType":"section","heading":"Information providers and relevant information— Act , s 226","content":"### sec.180 Information providers and relevant information— Act , s 226\n\nFor section 226 (2) of the Act , definition information provider , each entity stated in column 1 of the table in schedule 18 , part 2 is prescribed to be an information provider.\nFor section 226 (2) of the Act , definition relevant information , the information mentioned in column 2 of the table in schedule 18 , part 2 is prescribed to be the relevant information for the information provider mentioned opposite in column 1.\n(sec.180-ssec.1) For section 226 (2) of the Act , definition information provider , each entity stated in column 1 of the table in schedule 18 , part 2 is prescribed to be an information provider.\n(sec.180-ssec.2) For section 226 (2) of the Act , definition relevant information , the information mentioned in column 2 of the table in schedule 18 , part 2 is prescribed to be the relevant information for the information provider mentioned opposite in column 1.","sortOrder":245},{"sectionNumber":"sec.181","sectionType":"section","heading":"Method for data source entities giving information— Act , s 226","content":"### sec.181 Method for data source entities giving information— Act , s 226\n\nThis section applies in relation to an information provider that is a data source entity.\nFor section 226 (1) of the Act —\nthe way prescribed is by sending an electronic copy of the relevant information to the monitored medicines database; and\nthe time prescribed is when the relevant information is received by the information provider.\n(sec.181-ssec.1) This section applies in relation to an information provider that is a data source entity.\n(sec.181-ssec.2) For section 226 (1) of the Act — the way prescribed is by sending an electronic copy of the relevant information to the monitored medicines database; and the time prescribed is when the relevant information is received by the information provider.\n- (a) the way prescribed is by sending an electronic copy of the relevant information to the monitored medicines database; and\n- (b) the time prescribed is when the relevant information is received by the information provider.","sortOrder":246},{"sectionNumber":"sec.182","sectionType":"section","heading":"Method for dispensers giving information— Act , s 226","content":"### sec.182 Method for dispensers giving information— Act , s 226\n\nThis section applies in relation to an information provider who is a dispenser.\nFor section 226 (1) of the Act —\nthe way prescribed is by using a prescription exchange system; and\nthe time prescribed is when the information provider is recording the information in the system.\n(sec.182-ssec.1) This section applies in relation to an information provider who is a dispenser.\n(sec.182-ssec.2) For section 226 (1) of the Act — the way prescribed is by using a prescription exchange system; and the time prescribed is when the information provider is recording the information in the system.\n- (a) the way prescribed is by using a prescription exchange system; and\n- (b) the time prescribed is when the information provider is recording the information in the system.","sortOrder":247},{"sectionNumber":"ch.7-pt.4","sectionType":"part","heading":"Disclosure","content":"# Disclosure","sortOrder":248},{"sectionNumber":"sec.183","sectionType":"section","heading":"Users— Act , s 227","content":"### sec.183 Users— Act , s 227\n\nFor section 227 (4) of the Act , definition user , each entity stated in column 1 of the table in schedule 18 , part 3 is prescribed to be a user.\nFor section 227 (2) of the Act , each purpose stated in column 2 of the table in schedule 18 , part 3 is prescribed to be a purpose for the user opposite in column 1.\n(sec.183-ssec.1) For section 227 (4) of the Act , definition user , each entity stated in column 1 of the table in schedule 18 , part 3 is prescribed to be a user.\n(sec.183-ssec.2) For section 227 (2) of the Act , each purpose stated in column 2 of the table in schedule 18 , part 3 is prescribed to be a purpose for the user opposite in column 1.","sortOrder":249},{"sectionNumber":"ch.8-pt.1","sectionType":"part","heading":"Electronic prescription management systems","content":"# Electronic prescription management systems","sortOrder":250},{"sectionNumber":"ch.8-pt.1-div.1","sectionType":"division","heading":"Preliminary","content":"## Preliminary","sortOrder":251},{"sectionNumber":"sec.184","sectionType":"section","heading":"Application of part","content":"### sec.184 Application of part\n\nThis part applies in relation to an entity that establishes or uses an electronic system for—\nmaking or transmitting prescriptions for dispensing medicines; or\nretrieving prescriptions for dispensing medicines, including recording information relating to the dispensing of the medicines.\nAn electronic system mentioned in subsection (1) is an electronic prescription management system .\nTo remove any doubt, it is declared that the monitored medicines database is not an electronic prescription management system.\n(sec.184-ssec.1) This part applies in relation to an entity that establishes or uses an electronic system for— making or transmitting prescriptions for dispensing medicines; or retrieving prescriptions for dispensing medicines, including recording information relating to the dispensing of the medicines.\n(sec.184-ssec.2) An electronic system mentioned in subsection (1) is an electronic prescription management system .\n(sec.184-ssec.3) To remove any doubt, it is declared that the monitored medicines database is not an electronic prescription management system.\n- (a) making or transmitting prescriptions for dispensing medicines; or\n- (b) retrieving prescriptions for dispensing medicines, including recording information relating to the dispensing of the medicines.","sortOrder":252},{"sectionNumber":"ch.8-pt.1-div.2","sectionType":"division","heading":"Key appointments","content":"## Key appointments","sortOrder":253},{"sectionNumber":"sec.185","sectionType":"section","heading":"Appointments for managing system","content":"### sec.185 Appointments for managing system\n\nThe person in charge of an entity to which this part applies must appoint, in writing, an appropriately qualified person (a system manager ) to be responsible for the establishment and operation of the entity’s electronic prescription management system, unless the person has a reasonable excuse.\nMaximum penalty—80 penalty units.\nThe system manager of an entity’s electronic prescription management system must appoint, in writing, 1 or more appropriately qualified persons (each a system administrator ) to be responsible for the administration and technical maintenance of the system, unless the manager has a reasonable excuse.\nMaximum penalty—80 penalty units.\nThe system manager must record and keep the name and contact details for each person appointed under subsection (2) , unless the manager has a reasonable excuse.\nMaximum penalty—80 penalty units.\nSee section 224 about keeping records.\nThe person in charge of the entity must take all reasonable steps to ensure that each person appointed under subsection (1) or (2) is advised, in writing, of the provisions applying to the person under this part.\nMaximum penalty—80 penalty units.\n(sec.185-ssec.1) The person in charge of an entity to which this part applies must appoint, in writing, an appropriately qualified person (a system manager ) to be responsible for the establishment and operation of the entity’s electronic prescription management system, unless the person has a reasonable excuse. Maximum penalty—80 penalty units.\n(sec.185-ssec.2) The system manager of an entity’s electronic prescription management system must appoint, in writing, 1 or more appropriately qualified persons (each a system administrator ) to be responsible for the administration and technical maintenance of the system, unless the manager has a reasonable excuse. Maximum penalty—80 penalty units.\n(sec.185-ssec.3) The system manager must record and keep the name and contact details for each person appointed under subsection (2) , unless the manager has a reasonable excuse. Maximum penalty—80 penalty units. See section 224 about keeping records.\n(sec.185-ssec.4) The person in charge of the entity must take all reasonable steps to ensure that each person appointed under subsection (1) or (2) is advised, in writing, of the provisions applying to the person under this part. Maximum penalty—80 penalty units.","sortOrder":254},{"sectionNumber":"ch.8-pt.1-div.3","sectionType":"division","heading":"System managers","content":"## System managers","sortOrder":255},{"sectionNumber":"sec.186","sectionType":"section","heading":"System must comply with departmental standard","content":"### sec.186 System must comply with departmental standard\n\nThe system manager of an entity’s electronic prescription management system must take all reasonable steps to ensure the system complies with the departmental standard called ‘Requirements for an electronic prescription management system’.\nMaximum penalty—80 penalty units.","sortOrder":256},{"sectionNumber":"sec.187","sectionType":"section","heading":"Security measures required for system","content":"### sec.187 Security measures required for system\n\nThe system manager of an entity’s electronic prescription management system must take all reasonable steps to ensure security measures are embedded in the system to—\nprevent a person who is not approved to use the system from accessing or using the system; and\nmonitor any breaches of the system or events affecting the integrity of the system; and\nkeep each record made in the system for at least 2 years after the record is created.\nMaximum penalty—80 penalty units.\n- (a) prevent a person who is not approved to use the system from accessing or using the system; and\n- (b) monitor any breaches of the system or events affecting the integrity of the system; and\n- (c) keep each record made in the system for at least 2 years after the record is created.","sortOrder":257},{"sectionNumber":"ch.8-pt.1-div.4","sectionType":"division","heading":"System administrators","content":"## System administrators","sortOrder":258},{"sectionNumber":"sec.188","sectionType":"section","heading":"Giving access to the system","content":"### sec.188 Giving access to the system\n\nA system administrator of an entity’s electronic prescription management system must not give a person access to the system unless the administrator reasonably believes—\nthe person works for the entity; and\nthe access given is limited to the extent required for the person to perform the person’s role or function for the entity; and\nthe person has appropriate authorisation under the Act to use the system to perform the person’s role or function for the entity.\nMaximum penalty—80 penalty units.\nA prescriber working for the entity is given access to view information and record prescriptions about the entity’s patients.\nA dispenser working for the entity is given access to retrieve prescriptions and record information when dispensing medicines for the entity’s patients.\nAn information technology technician working for the entity is given access to perform administrative or technical tasks to maintain the security of the electronic prescription management system.\nA person given access to an entity’s electronic prescription management system under subsection (1) is an approved user of the system.\nThe system administrator must give each approved user only 1 secure system identifier for the electronic prescription management system.\nMaximum penalty—80 penalty units.\n(sec.188-ssec.1) A system administrator of an entity’s electronic prescription management system must not give a person access to the system unless the administrator reasonably believes— the person works for the entity; and the access given is limited to the extent required for the person to perform the person’s role or function for the entity; and the person has appropriate authorisation under the Act to use the system to perform the person’s role or function for the entity. Maximum penalty—80 penalty units. A prescriber working for the entity is given access to view information and record prescriptions about the entity’s patients. A dispenser working for the entity is given access to retrieve prescriptions and record information when dispensing medicines for the entity’s patients. An information technology technician working for the entity is given access to perform administrative or technical tasks to maintain the security of the electronic prescription management system.\n(sec.188-ssec.2) A person given access to an entity’s electronic prescription management system under subsection (1) is an approved user of the system.\n(sec.188-ssec.3) The system administrator must give each approved user only 1 secure system identifier for the electronic prescription management system. Maximum penalty—80 penalty units.\n- (a) the person works for the entity; and\n- (b) the access given is limited to the extent required for the person to perform the person’s role or function for the entity; and\n- (c) the person has appropriate authorisation under the Act to use the system to perform the person’s role or function for the entity.\n- 1 A prescriber working for the entity is given access to view information and record prescriptions about the entity’s patients.\n- 2 A dispenser working for the entity is given access to retrieve prescriptions and record information when dispensing medicines for the entity’s patients.\n- 3 An information technology technician working for the entity is given access to perform administrative or technical tasks to maintain the security of the electronic prescription management system.","sortOrder":259},{"sectionNumber":"sec.189","sectionType":"section","heading":"Cancelling access to the system","content":"### sec.189 Cancelling access to the system\n\nThis section applies if a system administrator of an entity’s electronic prescription management system becomes aware that an approved user of the system has stopped performing the role or function for the entity for which the user was given access.\nThe system administrator must cancel the approved user’s access to the electronic prescription management system, unless the administrator has a reasonable excuse.\nMaximum penalty—80 penalty units.\n(sec.189-ssec.1) This section applies if a system administrator of an entity’s electronic prescription management system becomes aware that an approved user of the system has stopped performing the role or function for the entity for which the user was given access.\n(sec.189-ssec.2) The system administrator must cancel the approved user’s access to the electronic prescription management system, unless the administrator has a reasonable excuse. Maximum penalty—80 penalty units.","sortOrder":260},{"sectionNumber":"sec.190","sectionType":"section","heading":"Making and keeping records of users","content":"### sec.190 Making and keeping records of users\n\nThis section applies if a system administrator of an entity’s electronic prescription management system has given or cancelled a person’s access to the system.\nUnless the system administrator has a reasonable excuse, the administrator must make and keep a record of any information used in relation to giving or cancelling the access, including—\nthe name of the person and the person’s secure system identifier; and\nthe date on which the person was given access; and\nthe date on which the person’s access was cancelled, if applicable.\nMaximum penalty—40 penalty units.\nSee section 224 about keeping records.\n(sec.190-ssec.1) This section applies if a system administrator of an entity’s electronic prescription management system has given or cancelled a person’s access to the system.\n(sec.190-ssec.2) Unless the system administrator has a reasonable excuse, the administrator must make and keep a record of any information used in relation to giving or cancelling the access, including— the name of the person and the person’s secure system identifier; and the date on which the person was given access; and the date on which the person’s access was cancelled, if applicable. Maximum penalty—40 penalty units. See section 224 about keeping records.\n- (a) the name of the person and the person’s secure system identifier; and\n- (b) the date on which the person was given access; and\n- (c) the date on which the person’s access was cancelled, if applicable.","sortOrder":261},{"sectionNumber":"sec.191","sectionType":"section","heading":"Maintaining system","content":"### sec.191 Maintaining system\n\nEach system administrator of an entity’s electronic prescription management system must take all reasonable steps to maintain the security of the system and the records kept in the system.\nMaximum penalty—40 penalty units.\nregularly running virus protection programs, installing software updates","sortOrder":262},{"sectionNumber":"sec.192","sectionType":"section","heading":"Reporting system breaches for monitored medicines","content":"### sec.192 Reporting system breaches for monitored medicines\n\nThis section applies if the system manager, or a system administrator, of an entity’s electronic prescription management system becomes aware of an incident in which the system may have been unlawfully accessed or otherwise unlawfully used to obtain a monitored medicine.\nvirus software enters an electronic prescription management system to create false prescriptions\nWithin 5 business days after becoming aware of the incident, the system manager or system administrator must give notice to the chief executive about the incident in the approved form, unless the manager or administrator has a reasonable excuse.\nMaximum penalty—80 penalty units.\n(sec.192-ssec.1) This section applies if the system manager, or a system administrator, of an entity’s electronic prescription management system becomes aware of an incident in which the system may have been unlawfully accessed or otherwise unlawfully used to obtain a monitored medicine. virus software enters an electronic prescription management system to create false prescriptions\n(sec.192-ssec.2) Within 5 business days after becoming aware of the incident, the system manager or system administrator must give notice to the chief executive about the incident in the approved form, unless the manager or administrator has a reasonable excuse. Maximum penalty—80 penalty units.","sortOrder":263},{"sectionNumber":"ch.8-pt.1-div.5","sectionType":"division","heading":"Approved users","content":"## Approved users","sortOrder":264},{"sectionNumber":"sec.193","sectionType":"section","heading":"Protecting secure system identifiers","content":"### sec.193 Protecting secure system identifiers\n\nAn approved user of an entity’s electronic prescription management system must take all reasonable steps to prevent the user’s secure system identifier for the system being accessed by another person.\nMaximum penalty—20 penalty units.\nusing a strong password or locking a device on which a secure system identifier is stored","sortOrder":265},{"sectionNumber":"ch.8-pt.2","sectionType":"part","heading":"Secure storage systems","content":"# Secure storage systems","sortOrder":266},{"sectionNumber":"ch.8-pt.2-div.1","sectionType":"division","heading":"Preliminary","content":"## Preliminary","sortOrder":267},{"sectionNumber":"sec.194","sectionType":"section","heading":"Non-application of part to animal feed","content":"### sec.194 Non-application of part to animal feed\n\nThis part does not apply in relation to—\nan S4 medicine or medicated feed to be mixed with food for administration to a group of animals; or\na person who is the farmer of the animals—\npossessing the medicine or feed mentioned in paragraph (a) ; or\nadministering the medicine or feed to the animals.\n- (a) an S4 medicine or medicated feed to be mixed with food for administration to a group of animals; or\n- (b) a person who is the farmer of the animals— (i) possessing the medicine or feed mentioned in paragraph (a) ; or (ii) administering the medicine or feed to the animals.\n- (i) possessing the medicine or feed mentioned in paragraph (a) ; or\n- (ii) administering the medicine or feed to the animals.\n- (i) possessing the medicine or feed mentioned in paragraph (a) ; or\n- (ii) administering the medicine or feed to the animals.","sortOrder":268},{"sectionNumber":"sec.195","sectionType":"section","heading":"Definitions for part","content":"### sec.195 Definitions for part\n\nIn this part—\naccess , in relation to an S8 safe, means a device or electronic way to open the safe.\nassistant , for possessing a medicine, means a person who is authorised to possess the medicine only under the supervision of another person.\nauthorised user , of a medicine, means a person who is authorised to deal with the medicine, other than a person who is an assistant.\nmedicine store means any receptacle, structure or part of a vehicle used for the storage or preservation of medicines.\nchest, cupboard, refrigerator, room, vehicle cage\nmedicine store establisher , for a place, means—\nif the place is a shared clinic—the person appointed under section 196 (2) (b) for the clinic; or\notherwise—a person who possesses S2, S3 or S4 medicines at the place for independently practising a profession or performing a function.\nS8 safe means a lockable medicine store for S8 medicines or S8 waste.\nS8 safe establisher , for a place, means—\nif the place is a shared clinic—a person appointed under section 196 (2) (a) for the clinic; or\notherwise—a person who possesses S8 medicines at the place for independently practising a profession or performing a function.\nshared clinic means a place at which medicines are possessed for more than 1 person to use for supply or administration.\ns 195 def shared clinic amd 2022 SL No. 77 s 7\n- (a) if the place is a shared clinic—the person appointed under section 196 (2) (b) for the clinic; or\n- (b) otherwise—a person who possesses S2, S3 or S4 medicines at the place for independently practising a profession or performing a function.\n- (a) if the place is a shared clinic—a person appointed under section 196 (2) (a) for the clinic; or\n- (b) otherwise—a person who possesses S8 medicines at the place for independently practising a profession or performing a function.","sortOrder":269},{"sectionNumber":"ch.8-pt.2-div.2","sectionType":"division","heading":"Medicine stores and S8 safes","content":"## Medicine stores and S8 safes","sortOrder":270},{"sectionNumber":"sec.196","sectionType":"section","heading":"Appointing establishers and managers","content":"### sec.196 Appointing establishers and managers\n\nThis section applies in relation to a shared clinic.\nThe person in charge of the shared clinic must appoint, in writing, an appropriately qualified person to be responsible for establishing and maintaining—\nan S8 safe for S8 medicines possessed at the clinic; and\na medicine store for any other medicines possessed at the clinic.\nMaximum penalty—40 penalty units.\nThe person in charge of the shared clinic must also appoint, in writing, an appropriately qualified person to be a manager of the S8 safe or medicine store at the clinic.\nMaximum penalty—40 penalty units.\nThe person in charge of the shared clinic must take all reasonable steps to ensure that each person appointed under subsection (2) or (3) is advised, in writing, of the provisions applying to the person under this part.\nMaximum penalty—40 penalty units.\n(sec.196-ssec.1) This section applies in relation to a shared clinic.\n(sec.196-ssec.2) The person in charge of the shared clinic must appoint, in writing, an appropriately qualified person to be responsible for establishing and maintaining— an S8 safe for S8 medicines possessed at the clinic; and a medicine store for any other medicines possessed at the clinic. Maximum penalty—40 penalty units.\n(sec.196-ssec.3) The person in charge of the shared clinic must also appoint, in writing, an appropriately qualified person to be a manager of the S8 safe or medicine store at the clinic. Maximum penalty—40 penalty units.\n(sec.196-ssec.4) The person in charge of the shared clinic must take all reasonable steps to ensure that each person appointed under subsection (2) or (3) is advised, in writing, of the provisions applying to the person under this part. Maximum penalty—40 penalty units.\n- (a) an S8 safe for S8 medicines possessed at the clinic; and\n- (b) a medicine store for any other medicines possessed at the clinic.","sortOrder":271},{"sectionNumber":"sec.197","sectionType":"section","heading":"S8 safe must comply with standard","content":"### sec.197 S8 safe must comply with standard\n\nAn S8 safe establisher for a place must establish an S8 safe for S8 medicines at the place in a way that complies with the departmental standard called ‘Secure storage of S8 medicines’.\nMaximum penalty—40 penalty units.\nThe S8 safe establisher must take all reasonable steps to ensure the S8 safe is established and maintained in a way that keeps the medicines in the safe in accordance with the manufacturer’s conditions for the medicines.\nMaximum penalty—40 penalty units.\n(sec.197-ssec.1) An S8 safe establisher for a place must establish an S8 safe for S8 medicines at the place in a way that complies with the departmental standard called ‘Secure storage of S8 medicines’. Maximum penalty—40 penalty units.\n(sec.197-ssec.2) The S8 safe establisher must take all reasonable steps to ensure the S8 safe is established and maintained in a way that keeps the medicines in the safe in accordance with the manufacturer’s conditions for the medicines. Maximum penalty—40 penalty units.","sortOrder":272},{"sectionNumber":"sec.198","sectionType":"section","heading":"Storage for safety and quality of medicines","content":"### sec.198 Storage for safety and quality of medicines\n\nA medicine store establisher for a place must establish and maintain a medicine store for storing S2, S3 and S4 medicines at the place.\nMaximum penalty—40 penalty units.\nThe medicine store establisher must take all reasonable steps to ensure the medicine store is established and maintained in a way that keeps the medicines in the store in accordance with the manufacturer’s conditions for the medicines.\nMaximum penalty—40 penalty units.\nIf pentobarbital is possessed at the place, the medicine store establisher must ensure the medicine store for the pentobarbital is lockable.\nMaximum penalty—40 penalty units.\n(sec.198-ssec.1) A medicine store establisher for a place must establish and maintain a medicine store for storing S2, S3 and S4 medicines at the place. Maximum penalty—40 penalty units.\n(sec.198-ssec.2) The medicine store establisher must take all reasonable steps to ensure the medicine store is established and maintained in a way that keeps the medicines in the store in accordance with the manufacturer’s conditions for the medicines. Maximum penalty—40 penalty units.\n(sec.198-ssec.3) If pentobarbital is possessed at the place, the medicine store establisher must ensure the medicine store for the pentobarbital is lockable. Maximum penalty—40 penalty units.","sortOrder":273},{"sectionNumber":"sec.199","sectionType":"section","heading":"Preventing unauthorised access to medicines","content":"### sec.199 Preventing unauthorised access to medicines\n\nA medicine store establisher for a place must put each medicine store for the place in an area where the establisher reasonably believes a member of the public could not access the store without being seen by a worker at the place.\nMaximum penalty—40 penalty units.\nIf pseudoephedrine or therapeutic nicotine are possessed at the place, the medicine store must also be kept in an area that is out of sight from members of the public.\nMaximum penalty—40 penalty units.\ns 199 amd 2024 SL No. 230 s 4\n(sec.199-ssec.1) A medicine store establisher for a place must put each medicine store for the place in an area where the establisher reasonably believes a member of the public could not access the store without being seen by a worker at the place. Maximum penalty—40 penalty units.\n(sec.199-ssec.2) If pseudoephedrine or therapeutic nicotine are possessed at the place, the medicine store must also be kept in an area that is out of sight from members of the public. Maximum penalty—40 penalty units.","sortOrder":274},{"sectionNumber":"sec.200","sectionType":"section","heading":"S8 safe establisher giving access to S8 safe","content":"### sec.200 S8 safe establisher giving access to S8 safe\n\nAn S8 safe establisher may give a person access to an S8 safe at a place only if—\nthe person is an authorised user of the S8 medicines kept in the safe at the place; and\nif the safe is at a relevant institution or community pharmacy—the person is permitted to open the safe under the substance management plan for the institution or pharmacy.\ngiving a person a key or swipe card that opens the S8 safe\nproviding a person with a way to generate a code or password for an electronic keypad that opens the S8 safe\nentering a person’s biometric information into an electronic system that allows the person to open the safe\nMaximum penalty—40 penalty units.\nThe S8 safe establisher may give the access to the authorised user only if the user’s access is subject to any restrictions or controls required under—\nthe departmental standard called ‘Secure storage of S8 medicines’; and\nif the safe is at a relevant institution or community pharmacy—the substance management plan for the institution or pharmacy.\nMaximum penalty—40 penalty units.\na key or swipe card does not have any marking on it to identify it opens an S8 safe\na code or password is connected to a system that records when it is used\n(sec.200-ssec.1) An S8 safe establisher may give a person access to an S8 safe at a place only if— the person is an authorised user of the S8 medicines kept in the safe at the place; and if the safe is at a relevant institution or community pharmacy—the person is permitted to open the safe under the substance management plan for the institution or pharmacy. giving a person a key or swipe card that opens the S8 safe providing a person with a way to generate a code or password for an electronic keypad that opens the S8 safe entering a person’s biometric information into an electronic system that allows the person to open the safe Maximum penalty—40 penalty units.\n(sec.200-ssec.2) The S8 safe establisher may give the access to the authorised user only if the user’s access is subject to any restrictions or controls required under— the departmental standard called ‘Secure storage of S8 medicines’; and if the safe is at a relevant institution or community pharmacy—the substance management plan for the institution or pharmacy. Maximum penalty—40 penalty units. a key or swipe card does not have any marking on it to identify it opens an S8 safe a code or password is connected to a system that records when it is used\n- (a) the person is an authorised user of the S8 medicines kept in the safe at the place; and\n- (b) if the safe is at a relevant institution or community pharmacy—the person is permitted to open the safe under the substance management plan for the institution or pharmacy.\n- 1 giving a person a key or swipe card that opens the S8 safe\n- 2 providing a person with a way to generate a code or password for an electronic keypad that opens the S8 safe\n- 3 entering a person’s biometric information into an electronic system that allows the person to open the safe\n- (a) the departmental standard called ‘Secure storage of S8 medicines’; and\n- (b) if the safe is at a relevant institution or community pharmacy—the substance management plan for the institution or pharmacy.\n- 1 a key or swipe card does not have any marking on it to identify it opens an S8 safe\n- 2 a code or password is connected to a system that records when it is used","sortOrder":275},{"sectionNumber":"sec.201","sectionType":"section","heading":"Requirements for authorised user accessing S8 safe","content":"### sec.201 Requirements for authorised user accessing S8 safe\n\nThis section applies to an authorised user of an S8 medicine who has been given access to an S8 safe to obtain the medicine.\nThe authorised user must—\nkeep any device or information that allows the user to access the S8 safe secure; and\ncode, identification number, password\ncomply with any restrictions or controls on the access given in writing to the user by the safe establisher; and\nclose and lock the safe when the user is no longer using it.\nMaximum penalty—40 penalty units.\nHowever, subsection (4) applies if the authorised user is supervising an assistant possessing a medicine.\nThe authorised user may give the assistant the user’s device for accessing the S8 safe for the purpose for which the assistant is authorised only if—\nthe device operates solely as a key to open and close the S8 safe, without an additional code or password; and\nthe user gets the device back from the assistant immediately after the assistant uses it.\nSee also division 3 in relation to recording information in the medicine register kept with an S8 safe.\n(sec.201-ssec.1) This section applies to an authorised user of an S8 medicine who has been given access to an S8 safe to obtain the medicine.\n(sec.201-ssec.2) The authorised user must— keep any device or information that allows the user to access the S8 safe secure; and code, identification number, password comply with any restrictions or controls on the access given in writing to the user by the safe establisher; and close and lock the safe when the user is no longer using it. Maximum penalty—40 penalty units.\n(sec.201-ssec.3) However, subsection (4) applies if the authorised user is supervising an assistant possessing a medicine.\n(sec.201-ssec.4) The authorised user may give the assistant the user’s device for accessing the S8 safe for the purpose for which the assistant is authorised only if— the device operates solely as a key to open and close the S8 safe, without an additional code or password; and the user gets the device back from the assistant immediately after the assistant uses it.\n- (a) keep any device or information that allows the user to access the S8 safe secure; and Examples of information— code, identification number, password\n- (b) comply with any restrictions or controls on the access given in writing to the user by the safe establisher; and\n- (c) close and lock the safe when the user is no longer using it.\n- (a) the device operates solely as a key to open and close the S8 safe, without an additional code or password; and\n- (b) the user gets the device back from the assistant immediately after the assistant uses it.","sortOrder":276},{"sectionNumber":"sec.202","sectionType":"section","heading":"Taking medicine from S8 safe and medicine store","content":"### sec.202 Taking medicine from S8 safe and medicine store\n\nThis section applies to an authorised user of a medicine or an assistant possessing a medicine at a place.\nUnless the authorised user or assistant has a reasonable excuse, the user or assistant must not—\ntake the medicine from an S8 safe or a medicine store at the place unless the medicine is intended for supply or administration; or\nleave the medicine unattended in an area other than the S8 safe or medicine store at the place for the medicine.\nMaximum penalty—40 penalty units.\n(sec.202-ssec.1) This section applies to an authorised user of a medicine or an assistant possessing a medicine at a place.\n(sec.202-ssec.2) Unless the authorised user or assistant has a reasonable excuse, the user or assistant must not— take the medicine from an S8 safe or a medicine store at the place unless the medicine is intended for supply or administration; or leave the medicine unattended in an area other than the S8 safe or medicine store at the place for the medicine. Maximum penalty—40 penalty units.\n- (a) take the medicine from an S8 safe or a medicine store at the place unless the medicine is intended for supply or administration; or\n- (b) leave the medicine unattended in an area other than the S8 safe or medicine store at the place for the medicine.","sortOrder":277},{"sectionNumber":"ch.8-pt.2-div.3","sectionType":"division","heading":"Medicine registers","content":"## Medicine registers","sortOrder":278},{"sectionNumber":"sec.203","sectionType":"section","heading":"Application of division","content":"### sec.203 Application of division\n\nThis division applies in relation to medicines put in, or taken from, an S8 safe or approved store.\nHowever, this division does not apply in relation to an S8 medicine kept in an S8 safe that has been packed in a dose administration aid.\nTo remove any doubt, it is declared that this division applies in relation to medicines moved or distributed at or between workplaces.\nSee section 29 of the Act about the distribution or transfer of regulated substances at or between workplaces.\n(sec.203-ssec.1) This division applies in relation to medicines put in, or taken from, an S8 safe or approved store.\n(sec.203-ssec.2) However, this division does not apply in relation to an S8 medicine kept in an S8 safe that has been packed in a dose administration aid.\n(sec.203-ssec.3) To remove any doubt, it is declared that this division applies in relation to medicines moved or distributed at or between workplaces. See section 29 of the Act about the distribution or transfer of regulated substances at or between workplaces.","sortOrder":279},{"sectionNumber":"sec.204","sectionType":"section","heading":"Definitions for division","content":"### sec.204 Definitions for division\n\nIn this division—\napproved store means a medicine store established for dealing with medicines under any of the following general approvals—\na general approval (acute health conditions at isolated sites);\na general approval (emergency first aid);\na general approval (emergency management of animals).\nmanager , of an S8 safe or approved store, means—\na person appointed under section 196 (3) to be the manager of the safe or store; or\na person who keeps the safe or store for independently practising a profession or performing a function.\ntype , of a medicine, means each form and strength of a type of the medicine.\nmorphine sulfate pentahydrate 10mg tablet\nmorphine sulfate pentahydrate 10mg modified release tablet\noxycodone hydrochloride 10mg capsule\noxycodone hydrochloride 10mg modified release tablet\n- (a) a general approval (acute health conditions at isolated sites);\n- (b) a general approval (emergency first aid);\n- (c) a general approval (emergency management of animals).\n- (a) a person appointed under section 196 (3) to be the manager of the safe or store; or\n- (b) a person who keeps the safe or store for independently practising a profession or performing a function.\n- • morphine sulfate pentahydrate 10mg tablet\n- • morphine sulfate pentahydrate 10mg modified release tablet\n- • oxycodone hydrochloride 10mg capsule\n- • oxycodone hydrochloride 10mg modified release tablet","sortOrder":280},{"sectionNumber":"sec.205","sectionType":"section","heading":"Meaning of medicine register","content":"### sec.205 Meaning of medicine register\n\nA medicine register , for an S8 safe or approved store, is a document that states—\nwhen each type of medicine is put in, or taken from, the safe or store for a dealing; and\nthe amount of the type of medicine in the safe or store at any given time.\n- (a) when each type of medicine is put in, or taken from, the safe or store for a dealing; and\n- (b) the amount of the type of medicine in the safe or store at any given time.","sortOrder":281},{"sectionNumber":"sec.206","sectionType":"section","heading":"Manager must make and keep register with safe or store","content":"### sec.206 Manager must make and keep register with safe or store\n\nA manager of an S8 safe or approved store must take all reasonable steps to—\nmake and keep a medicine register for the safe or store; and\nkeep the medicine register with, or as close as practicable to, the safe or store.\nMaximum penalty—40 penalty units.\nSee section 224 about keeping records.\n- (a) make and keep a medicine register for the safe or store; and\n- (b) keep the medicine register with, or as close as practicable to, the safe or store.","sortOrder":282},{"sectionNumber":"sec.207","sectionType":"section","heading":"Layout of medicine register","content":"### sec.207 Layout of medicine register\n\nA manager of an S8 safe or approved store must organise the information in the medicine register for the safe or store in a way that shows—\nthe medicines stored in the safe or store at any given time; and\nthe dealings related to the medicines stored in the safe or store listed consecutively based on the time the dealings occurred, to the extent practicable; and\na separate record for each type of medicine.\nMaximum penalty—40 penalty units.\nDespite subsection (1) (c) , information about medicines disposed of by destruction may be shown in a single, combined record that is separate from the record for a particular type of medicine.\n(sec.207-ssec.1) A manager of an S8 safe or approved store must organise the information in the medicine register for the safe or store in a way that shows— the medicines stored in the safe or store at any given time; and the dealings related to the medicines stored in the safe or store listed consecutively based on the time the dealings occurred, to the extent practicable; and a separate record for each type of medicine. Maximum penalty—40 penalty units.\n(sec.207-ssec.2) Despite subsection (1) (c) , information about medicines disposed of by destruction may be shown in a single, combined record that is separate from the record for a particular type of medicine.\n- (a) the medicines stored in the safe or store at any given time; and\n- (b) the dealings related to the medicines stored in the safe or store listed consecutively based on the time the dealings occurred, to the extent practicable; and\n- (c) a separate record for each type of medicine.","sortOrder":283},{"sectionNumber":"sec.208","sectionType":"section","heading":"Electronic register","content":"### sec.208 Electronic register\n\nThis section applies to a manager of an S8 safe or approved store who keeps a medicine register for the safe or store in an electronic form (an electronic register ).\nThe manager must take all reasonable steps to ensure the electronic register has the following properties—\na person can not make entries in the register unless the person has a secure system identifier;\na secure system identifier is automatically recorded for every person making every entry in the register;\nan entry made by an assistant possessing a medicine is shown as pending in the register until—\nan authorised user who is supervising the assistant confirms the entry; or\nif the entry relates to disposal of waste from a diversion-risk medicine by destruction—a witness confirms the entry;\na unique reference number is recorded with the time and date of each entry that is confirmed;\nan entry that has been confirmed cannot be deleted from the register;\na hard copy report can be produced at any time from the register to show—\nthe balance of medicines to which the register applies at that time; or\nthe confirmed entries in the register for any particular period of time for which the register applies.\nMaximum penalty—40 penalty units.\nThe manager must not give a secure system identifier for the electronic register to a person unless—\nthe person is an authorised user of the medicines in the S8 safe or approved store; or\nif the person is an assistant dealing with a medicine from the S8 safe or approved store—the person is given a secure system identifier that only permits the person to make entries mentioned in subsection (2) (c) in the register.\nMaximum penalty—40 penalty units.\nThe manager must make and keep a record of each person’s secure system identifier for the electronic register.\nMaximum penalty—40 penalty units.\nSee section 224 about keeping records.\n(sec.208-ssec.1) This section applies to a manager of an S8 safe or approved store who keeps a medicine register for the safe or store in an electronic form (an electronic register ).\n(sec.208-ssec.2) The manager must take all reasonable steps to ensure the electronic register has the following properties— a person can not make entries in the register unless the person has a secure system identifier; a secure system identifier is automatically recorded for every person making every entry in the register; an entry made by an assistant possessing a medicine is shown as pending in the register until— an authorised user who is supervising the assistant confirms the entry; or if the entry relates to disposal of waste from a diversion-risk medicine by destruction—a witness confirms the entry; a unique reference number is recorded with the time and date of each entry that is confirmed; an entry that has been confirmed cannot be deleted from the register; a hard copy report can be produced at any time from the register to show— the balance of medicines to which the register applies at that time; or the confirmed entries in the register for any particular period of time for which the register applies. Maximum penalty—40 penalty units.\n(sec.208-ssec.3) The manager must not give a secure system identifier for the electronic register to a person unless— the person is an authorised user of the medicines in the S8 safe or approved store; or if the person is an assistant dealing with a medicine from the S8 safe or approved store—the person is given a secure system identifier that only permits the person to make entries mentioned in subsection (2) (c) in the register. Maximum penalty—40 penalty units.\n(sec.208-ssec.4) The manager must make and keep a record of each person’s secure system identifier for the electronic register. Maximum penalty—40 penalty units. See section 224 about keeping records.\n- (a) a person can not make entries in the register unless the person has a secure system identifier;\n- (b) a secure system identifier is automatically recorded for every person making every entry in the register;\n- (c) an entry made by an assistant possessing a medicine is shown as pending in the register until— (i) an authorised user who is supervising the assistant confirms the entry; or (ii) if the entry relates to disposal of waste from a diversion-risk medicine by destruction—a witness confirms the entry;\n- (i) an authorised user who is supervising the assistant confirms the entry; or\n- (ii) if the entry relates to disposal of waste from a diversion-risk medicine by destruction—a witness confirms the entry;\n- (d) a unique reference number is recorded with the time and date of each entry that is confirmed;\n- (e) an entry that has been confirmed cannot be deleted from the register;\n- (f) a hard copy report can be produced at any time from the register to show— (i) the balance of medicines to which the register applies at that time; or (ii) the confirmed entries in the register for any particular period of time for which the register applies.\n- (i) the balance of medicines to which the register applies at that time; or\n- (ii) the confirmed entries in the register for any particular period of time for which the register applies.\n- (i) an authorised user who is supervising the assistant confirms the entry; or\n- (ii) if the entry relates to disposal of waste from a diversion-risk medicine by destruction—a witness confirms the entry;\n- (i) the balance of medicines to which the register applies at that time; or\n- (ii) the confirmed entries in the register for any particular period of time for which the register applies.\n- (a) the person is an authorised user of the medicines in the S8 safe or approved store; or\n- (b) if the person is an assistant dealing with a medicine from the S8 safe or approved store—the person is given a secure system identifier that only permits the person to make entries mentioned in subsection (2) (c) in the register.","sortOrder":284},{"sectionNumber":"sec.209","sectionType":"section","heading":"Paper register","content":"### sec.209 Paper register\n\nThis section applies to a manager of an S8 safe or approved store who keeps a medicine register for the safe or store on paper.\nThe manager must take all reasonable steps to ensure the medicine register has the following properties—\na page can not be removed from the register without detection;\na bound book with consecutively numbered pages\na separate page is used for each type of medicine.\nMaximum penalty—40 penalty units.\n(sec.209-ssec.1) This section applies to a manager of an S8 safe or approved store who keeps a medicine register for the safe or store on paper.\n(sec.209-ssec.2) The manager must take all reasonable steps to ensure the medicine register has the following properties— a page can not be removed from the register without detection; a bound book with consecutively numbered pages a separate page is used for each type of medicine. Maximum penalty—40 penalty units.\n- (a) a page can not be removed from the register without detection; Example— a bound book with consecutively numbered pages\n- (b) a separate page is used for each type of medicine.","sortOrder":285},{"sectionNumber":"sec.210","sectionType":"section","heading":"Replacing paper register","content":"### sec.210 Replacing paper register\n\nThis section applies if—\na manager of an S8 safe or approved store who keeps a medicine register for the safe or store on paper (the original register ); and\nthe original register has no space or pages remaining to record entries.\nUnless the manager has a reasonable excuse, the manager must—\nreplace the original register with a new medicine register; and\nin the new register, record the amount of each type of medicine stated in the last entry of the original register; and\nreconcile the record with the amount of medicine physically held in the S8 safe or approved store; and\nkeep the original register.\nMaximum penalty—40 penalty units.\nSee section 224 about keeping records.\n(sec.210-ssec.1) This section applies if— a manager of an S8 safe or approved store who keeps a medicine register for the safe or store on paper (the original register ); and the original register has no space or pages remaining to record entries.\n(sec.210-ssec.2) Unless the manager has a reasonable excuse, the manager must— replace the original register with a new medicine register; and in the new register, record the amount of each type of medicine stated in the last entry of the original register; and reconcile the record with the amount of medicine physically held in the S8 safe or approved store; and keep the original register. Maximum penalty—40 penalty units. See section 224 about keeping records.\n- (a) a manager of an S8 safe or approved store who keeps a medicine register for the safe or store on paper (the original register ); and\n- (b) the original register has no space or pages remaining to record entries.\n- (a) replace the original register with a new medicine register; and\n- (b) in the new register, record the amount of each type of medicine stated in the last entry of the original register; and\n- (c) reconcile the record with the amount of medicine physically held in the S8 safe or approved store; and\n- (d) keep the original register.","sortOrder":286},{"sectionNumber":"sec.211","sectionType":"section","heading":"Information that must be recorded in register","content":"### sec.211 Information that must be recorded in register\n\nThis section applies if an authorised user or assistant accesses an S8 safe or approved store for a dealing with a type of medicine.\nAs soon as practicable, but no later than 24 hours, after the dealing, the authorised user or assistant must take all reasonable steps to ensure a record is made in the medicine register of the information mentioned in sections 212 and 213 for the dealing.\nMaximum penalty—40 penalty units.\n(sec.211-ssec.1) This section applies if an authorised user or assistant accesses an S8 safe or approved store for a dealing with a type of medicine.\n(sec.211-ssec.2) As soon as practicable, but no later than 24 hours, after the dealing, the authorised user or assistant must take all reasonable steps to ensure a record is made in the medicine register of the information mentioned in sections 212 and 213 for the dealing. Maximum penalty—40 penalty units.","sortOrder":287},{"sectionNumber":"sec.212","sectionType":"section","heading":"General information recorded in register","content":"### sec.212 General information recorded in register\n\nFor section 211 , the information for any dealing is—\nthe date of the dealing; and\nthe amount of the medicine; and\na description of the dealing; and\nfor an authorised user—the signature of the authorised user; and\nfor an assistant—\nthe name of the assistant; and\nthe signature of the authorised user supervising the assistant; and\nthe name and signature of any other person recording the information; and\nthe amount of medicine remaining after the dealing.\n- (a) the date of the dealing; and\n- (b) the amount of the medicine; and\n- (c) a description of the dealing; and\n- (d) for an authorised user—the signature of the authorised user; and\n- (e) for an assistant— (i) the name of the assistant; and (ii) the signature of the authorised user supervising the assistant; and\n- (i) the name of the assistant; and\n- (ii) the signature of the authorised user supervising the assistant; and\n- (f) the name and signature of any other person recording the information; and\n- (g) the amount of medicine remaining after the dealing.\n- (i) the name of the assistant; and\n- (ii) the signature of the authorised user supervising the assistant; and","sortOrder":288},{"sectionNumber":"sec.213","sectionType":"section","heading":"Specific information for particular dealings recorded in register","content":"### sec.213 Specific information for particular dealings recorded in register\n\nFor section 211 , the information for each of the following particular dealings is—\nfor stock of a medicine put in or taken from the S8 safe or approved store to which the register applies—\nthe name and address of the supplier of the stock; and\nthe unique identifier of the notice mentioned in section 61 (1) for the supply of the stock; and\nthe name and address of the person to whom the stock was supplied; and\nthe unique identifier (if any) of the purchase order for the supply;\nfor administration—\nif the administration is to a person—the name of the person; and\nif the administration is to an animal—the name of the owner or custodian of the animal; and\nif the administration happens at a specified place—the time of the administration;\nfor dispensing or giving a treatment dose on a prescription—\nthe name of the prescriber; and\nthe unique identifier (if any) of the prescription; and\nif the medicine is dispensed or given to a person—the name and address of the person; and\nif the medicine is dispensed or given to an animal—the name and address of the owner or custodian of the animal;\nfor a dealing under a general approval—the name of the person who authorised the dealing;\nfor possession by distribution—the name of the person to whom the medicine was given or the place where the medicine was moved;\nfor disposal of waste from a diversion-risk medicine by transfer—the name and signature of the person to whom the waste was transferred;\nSee also section 146 for the requirement for the transferee to sign the medicine register in particular circumstances.\nfor disposal of waste from a diversion-risk medicine by destruction—\nthe name and signature of the person who witnessed the destruction of the medicine; and\ninformation stating the person’s authority to witness the destruction.\nSee also section 147 in relation to destruction.\n- (a) for stock of a medicine put in or taken from the S8 safe or approved store to which the register applies— (i) the name and address of the supplier of the stock; and (ii) the unique identifier of the notice mentioned in section 61 (1) for the supply of the stock; and (iii) the name and address of the person to whom the stock was supplied; and (iv) the unique identifier (if any) of the purchase order for the supply;\n- (i) the name and address of the supplier of the stock; and\n- (ii) the unique identifier of the notice mentioned in section 61 (1) for the supply of the stock; and\n- (iii) the name and address of the person to whom the stock was supplied; and\n- (iv) the unique identifier (if any) of the purchase order for the supply;\n- (b) for administration— (i) if the administration is to a person—the name of the person; and (ii) if the administration is to an animal—the name of the owner or custodian of the animal; and (iii) if the administration happens at a specified place—the time of the administration;\n- (i) if the administration is to a person—the name of the person; and\n- (ii) if the administration is to an animal—the name of the owner or custodian of the animal; and\n- (iii) if the administration happens at a specified place—the time of the administration;\n- (c) for dispensing or giving a treatment dose on a prescription— (i) the name of the prescriber; and (ii) the unique identifier (if any) of the prescription; and (iii) if the medicine is dispensed or given to a person—the name and address of the person; and (iv) if the medicine is dispensed or given to an animal—the name and address of the owner or custodian of the animal;\n- (i) the name of the prescriber; and\n- (ii) the unique identifier (if any) of the prescription; and\n- (iii) if the medicine is dispensed or given to a person—the name and address of the person; and\n- (iv) if the medicine is dispensed or given to an animal—the name and address of the owner or custodian of the animal;\n- (d) for a dealing under a general approval—the name of the person who authorised the dealing;\n- (e) for possession by distribution—the name of the person to whom the medicine was given or the place where the medicine was moved;\n- (f) for disposal of waste from a diversion-risk medicine by transfer—the name and signature of the person to whom the waste was transferred; Note— See also section 146 for the requirement for the transferee to sign the medicine register in particular circumstances.\n- (g) for disposal of waste from a diversion-risk medicine by destruction— (i) the name and signature of the person who witnessed the destruction of the medicine; and (ii) information stating the person’s authority to witness the destruction. Note— See also section 147 in relation to destruction.\n- (i) the name and signature of the person who witnessed the destruction of the medicine; and\n- (ii) information stating the person’s authority to witness the destruction.\n- (i) the name and address of the supplier of the stock; and\n- (ii) the unique identifier of the notice mentioned in section 61 (1) for the supply of the stock; and\n- (iii) the name and address of the person to whom the stock was supplied; and\n- (iv) the unique identifier (if any) of the purchase order for the supply;\n- (i) if the administration is to a person—the name of the person; and\n- (ii) if the administration is to an animal—the name of the owner or custodian of the animal; and\n- (iii) if the administration happens at a specified place—the time of the administration;\n- (i) the name of the prescriber; and\n- (ii) the unique identifier (if any) of the prescription; and\n- (iii) if the medicine is dispensed or given to a person—the name and address of the person; and\n- (iv) if the medicine is dispensed or given to an animal—the name and address of the owner or custodian of the animal;\n- (i) the name and signature of the person who witnessed the destruction of the medicine; and\n- (ii) information stating the person’s authority to witness the destruction.","sortOrder":289},{"sectionNumber":"sec.214","sectionType":"section","heading":"Amending register","content":"### sec.214 Amending register\n\nA person must not amend the medicine register for an S8 safe or approved store unless the person is correcting the register in the way mentioned in subsection (2) and (3) or has a reasonable excuse.\nMaximum penalty—40 penalty units.\nThe person may correct an entry in the medicine register by making a record of the following information with the entry—\nthe date the correction is made;\nthe name and position of the person making the correction;\nthe reason for the correction;\nif the correction relates to the disposal of waste from a diversion-risk medicine by destruction—the name and position of the person who witnessed the destruction of the medicine.\nThe person must not cancel, delete or obscure an original entry when making the correction.\n(sec.214-ssec.1) A person must not amend the medicine register for an S8 safe or approved store unless the person is correcting the register in the way mentioned in subsection (2) and (3) or has a reasonable excuse. Maximum penalty—40 penalty units.\n(sec.214-ssec.2) The person may correct an entry in the medicine register by making a record of the following information with the entry— the date the correction is made; the name and position of the person making the correction; the reason for the correction; if the correction relates to the disposal of waste from a diversion-risk medicine by destruction—the name and position of the person who witnessed the destruction of the medicine.\n(sec.214-ssec.3) The person must not cancel, delete or obscure an original entry when making the correction.\n- (a) the date the correction is made;\n- (b) the name and position of the person making the correction;\n- (c) the reason for the correction;\n- (d) if the correction relates to the disposal of waste from a diversion-risk medicine by destruction—the name and position of the person who witnessed the destruction of the medicine.","sortOrder":290},{"sectionNumber":"sec.215","sectionType":"section","heading":"Keeping secure system identifier secure","content":"### sec.215 Keeping secure system identifier secure\n\nA person given a secure system identifier for a medicine register for an S8 safe or an approved store kept in an electronic form must take all reasonable steps to keep the identifier secure from access by another person.\nMaximum penalty—20 penalty units.\nusing a strong password or locking a device on which the secure system identifier is stored","sortOrder":291},{"sectionNumber":"sec.216","sectionType":"section","heading":"Making entries in paper register","content":"### sec.216 Making entries in paper register\n\nA person must not make an entry in a medicine register for an S8 safe or approved store kept on paper unless the person—\nis permitted to make the entry by a manager of the safe or store; and\nsigns the entry, including any corrections to the entry; and\ndoes not remove or tamper with pages in the register.\nMaximum penalty—40 penalty units.\n- (a) is permitted to make the entry by a manager of the safe or store; and\n- (b) signs the entry, including any corrections to the entry; and\n- (c) does not remove or tamper with pages in the register.","sortOrder":292},{"sectionNumber":"sec.217","sectionType":"section","heading":"Reconciling with medicines on hand","content":"### sec.217 Reconciling with medicines on hand\n\nA manager of an S8 safe or approved store must—\nreconcile the register for the safe or store at least monthly with the amount of medicines physically held in the safe or store; and\nrecord the date the reconciliation is done in the medicine register.\nMaximum penalty—40 penalty units.\nHowever, if a substance management plan applies to the place at which the S8 safe or approved store is located, the reconciliation must be done at the times stated in the substance management plan.\nSee section 210 about reconciling a replacement paper register.\n(sec.217-ssec.1) A manager of an S8 safe or approved store must— reconcile the register for the safe or store at least monthly with the amount of medicines physically held in the safe or store; and record the date the reconciliation is done in the medicine register. Maximum penalty—40 penalty units.\n(sec.217-ssec.2) However, if a substance management plan applies to the place at which the S8 safe or approved store is located, the reconciliation must be done at the times stated in the substance management plan.\n- (a) reconcile the register for the safe or store at least monthly with the amount of medicines physically held in the safe or store; and\n- (b) record the date the reconciliation is done in the medicine register.","sortOrder":293},{"sectionNumber":"sec.218","sectionType":"section","heading":"Reporting lost, stolen or destroyed register","content":"### sec.218 Reporting lost, stolen or destroyed register\n\nThis section applies if a medicine register for an S8 safe or approved store is lost, stolen or destroyed (each an incident ).\nA manager of the safe or store must give notice about the incident to the chief executive in the approved form as soon as practicable, but no later than the end of the next business day, after the incident.\nMaximum penalty—40 penalty units.\n(sec.218-ssec.1) This section applies if a medicine register for an S8 safe or approved store is lost, stolen or destroyed (each an incident ).\n(sec.218-ssec.2) A manager of the safe or store must give notice about the incident to the chief executive in the approved form as soon as practicable, but no later than the end of the next business day, after the incident. Maximum penalty—40 penalty units.","sortOrder":294},{"sectionNumber":"ch.8-pt.2-div.4","sectionType":"division","heading":"Carriers","content":"## Carriers","sortOrder":295},{"sectionNumber":"sec.219","sectionType":"section","heading":"Systems for tracking stock of medicines","content":"### sec.219 Systems for tracking stock of medicines\n\nSubsection (2) applies to a person (a carrier ) who operates a business for delivering stock of medicines.\nThe carrier must take all reasonable steps to establish a tracking system to track stock of any medicines being delivered by the carrier.\nMaximum penalty—40 penalty units.\nSubsection (4) applies to a person (an employee ) employed by the carrier to deliver stock of medicines.\nWhen delivering the stock, the employee must use any tracking system established by the carrier in the way advised to the employee, unless the employee has a reasonable excuse.\nMaximum penalty—40 penalty units.\nIn this section—\ntracking system , for stock of medicines, means a system designed to electronically track the location of the stock from time to time while the stock is in transit.\n(sec.219-ssec.1) Subsection (2) applies to a person (a carrier ) who operates a business for delivering stock of medicines.\n(sec.219-ssec.2) The carrier must take all reasonable steps to establish a tracking system to track stock of any medicines being delivered by the carrier. Maximum penalty—40 penalty units.\n(sec.219-ssec.3) Subsection (4) applies to a person (an employee ) employed by the carrier to deliver stock of medicines.\n(sec.219-ssec.4) When delivering the stock, the employee must use any tracking system established by the carrier in the way advised to the employee, unless the employee has a reasonable excuse. Maximum penalty—40 penalty units.\n(sec.219-ssec.5) In this section— tracking system , for stock of medicines, means a system designed to electronically track the location of the stock from time to time while the stock is in transit.","sortOrder":296},{"sectionNumber":"sec.220","sectionType":"section","heading":"Safe delivery of stock of S2 or S3 medicines","content":"### sec.220 Safe delivery of stock of S2 or S3 medicines\n\nThis section applies if a carrier is delivering stock of an S2 or S3 medicine.\nSee chapter 4 , part 5 in relation to requirements for persons who are authorised to possess stock of an S4 or S8 medicine for delivering the stock.\nThe carrier must take all reasonable steps to keep the stock within any temperature limits for the stock notified to the carrier by the person who engaged the carrier to deliver it.\nMaximum penalty—40 penalty units.\nThe carrier must not leave the stock unattended, other than in a secure area.\nMaximum penalty—40 penalty units.\nA carrier must deliver the stock to the street address stated on the packaging for the stock.\nMaximum penalty—40 penalty units.\nThe carrier must not leave the stock at the street address unless the carrier obtains a written receipt for the delivery of the stock from—\nthe person named on the package for the stock; or\nan adult at the address acting, or purportedly acting, on behalf of the person mentioned in paragraph (a) .\nMaximum penalty—40 penalty units.\n(sec.220-ssec.1) This section applies if a carrier is delivering stock of an S2 or S3 medicine. See chapter 4 , part 5 in relation to requirements for persons who are authorised to possess stock of an S4 or S8 medicine for delivering the stock.\n(sec.220-ssec.2) The carrier must take all reasonable steps to keep the stock within any temperature limits for the stock notified to the carrier by the person who engaged the carrier to deliver it. Maximum penalty—40 penalty units.\n(sec.220-ssec.3) The carrier must not leave the stock unattended, other than in a secure area. Maximum penalty—40 penalty units.\n(sec.220-ssec.4) A carrier must deliver the stock to the street address stated on the packaging for the stock. Maximum penalty—40 penalty units.\n(sec.220-ssec.5) The carrier must not leave the stock at the street address unless the carrier obtains a written receipt for the delivery of the stock from— the person named on the package for the stock; or an adult at the address acting, or purportedly acting, on behalf of the person mentioned in paragraph (a) . Maximum penalty—40 penalty units.\n- (a) the person named on the package for the stock; or\n- (b) an adult at the address acting, or purportedly acting, on behalf of the person mentioned in paragraph (a) .","sortOrder":297},{"sectionNumber":"ch.8-pt.3","sectionType":"part","heading":"Containers","content":"# Containers","sortOrder":298},{"sectionNumber":"sec.221","sectionType":"section","heading":"Restriction on used containers","content":"### sec.221 Restriction on used containers\n\nA person preparing a medicine for supply must not use an immediate container to package the medicine if the person knows the container has previously been used.\nMaximum penalty—20 penalty units.\nSee the Poisons Standard, section 6 for the definition immediate container .\ns 221 amd 2023 SL No. 170 s 6","sortOrder":299},{"sectionNumber":"ch.8-pt.4","sectionType":"part","heading":"Recording and keeping information","content":"# Recording and keeping information","sortOrder":300},{"sectionNumber":"sec.222","sectionType":"section","heading":"Writing paper documents","content":"### sec.222 Writing paper documents\n\nThis section applies to a person writing on paper to comply with a requirement mentioned in this regulation, including writing a prescription or purchase order.\nThe person must write—\nin ink; and\nlegibly, other than the person’s signature; and\nin English or use terms or symbols, including Latin terms, used in the ordinary practice of the person’s profession.\nMaximum penalty—40 penalty units.\n(sec.222-ssec.1) This section applies to a person writing on paper to comply with a requirement mentioned in this regulation, including writing a prescription or purchase order.\n(sec.222-ssec.2) The person must write— in ink; and legibly, other than the person’s signature; and in English or use terms or symbols, including Latin terms, used in the ordinary practice of the person’s profession. Maximum penalty—40 penalty units.\n- (a) in ink; and\n- (b) legibly, other than the person’s signature; and\n- (c) in English or use terms or symbols, including Latin terms, used in the ordinary practice of the person’s profession.","sortOrder":301},{"sectionNumber":"sec.223","sectionType":"section","heading":"Writing electronic documents","content":"### sec.223 Writing electronic documents\n\nThis section applies to a person writing an electronic document to comply with a requirement mentioned in this regulation, including writing an electronic prescription or electronic purchase order.\nThe person must—\nwrite in English or use terms or symbols, including Latin terms, used in the ordinary practice of the person’s profession; and\nif the entry relates to another document—link or attach the other document to the electronic document.\nMaximum penalty—40 penalty units.\nThis section does not apply if the person uses an electronic prescription management system to make the document.\n(sec.223-ssec.1) This section applies to a person writing an electronic document to comply with a requirement mentioned in this regulation, including writing an electronic prescription or electronic purchase order.\n(sec.223-ssec.2) The person must— write in English or use terms or symbols, including Latin terms, used in the ordinary practice of the person’s profession; and if the entry relates to another document—link or attach the other document to the electronic document. Maximum penalty—40 penalty units.\n(sec.223-ssec.3) This section does not apply if the person uses an electronic prescription management system to make the document.\n- (a) write in English or use terms or symbols, including Latin terms, used in the ordinary practice of the person’s profession; and\n- (b) if the entry relates to another document—link or attach the other document to the electronic document.","sortOrder":302},{"sectionNumber":"sec.224","sectionType":"section","heading":"Period and way of keeping records","content":"### sec.224 Period and way of keeping records\n\nThis section applies to a person if a provision of this regulation states the person is required to keep a record.\nHowever, this section does not apply to—\na pharmacist keeping a record under section 162 ; or\nthe chief executive keeping information in the monitored medicines database.\nThe person must keep the record for—\nif the record is the details of an appointment of a system administrator under section 185 —2 years after the appointment ends; or\nif the record is an entry in a medicine register kept on paper—2 years after the last entry in the register is made; or\notherwise—2 years after the record is made.\nMaximum penalty—40 penalty units.\nDuring the period for which the record must be kept, the person must take all reasonable steps to ensure the record is—\nkept in a retrievable form; and\nkept securely to ensure it can not be altered, obscured, deleted or removed without detection.\nMaximum penalty—40 penalty units.\nIf the record is kept electronically, the person must—\nensure any data stored in the record is secure and tamper-proof in accordance with acceptable industry standards; and\nbackup the record regularly during the period for which the record must be kept.\nMaximum penalty—40 penalty units.\nHowever, subsection (5) does not apply if the record is kept in an electronic prescription management system.\nSee chapter 8 , part 1 for requirements for electronic prescription management systems.\nIn this section—\nrecord includes a copy of a record or information contained in a record.\n(sec.224-ssec.1) This section applies to a person if a provision of this regulation states the person is required to keep a record.\n(sec.224-ssec.2) However, this section does not apply to— a pharmacist keeping a record under section 162 ; or the chief executive keeping information in the monitored medicines database.\n(sec.224-ssec.3) The person must keep the record for— if the record is the details of an appointment of a system administrator under section 185 —2 years after the appointment ends; or if the record is an entry in a medicine register kept on paper—2 years after the last entry in the register is made; or otherwise—2 years after the record is made. Maximum penalty—40 penalty units.\n(sec.224-ssec.4) During the period for which the record must be kept, the person must take all reasonable steps to ensure the record is— kept in a retrievable form; and kept securely to ensure it can not be altered, obscured, deleted or removed without detection. Maximum penalty—40 penalty units.\n(sec.224-ssec.5) If the record is kept electronically, the person must— ensure any data stored in the record is secure and tamper-proof in accordance with acceptable industry standards; and backup the record regularly during the period for which the record must be kept. Maximum penalty—40 penalty units.\n(sec.224-ssec.6) However, subsection (5) does not apply if the record is kept in an electronic prescription management system. See chapter 8 , part 1 for requirements for electronic prescription management systems.\n(sec.224-ssec.7) In this section— record includes a copy of a record or information contained in a record.\n- (a) a pharmacist keeping a record under section 162 ; or\n- (b) the chief executive keeping information in the monitored medicines database.\n- (a) if the record is the details of an appointment of a system administrator under section 185 —2 years after the appointment ends; or\n- (b) if the record is an entry in a medicine register kept on paper—2 years after the last entry in the register is made; or\n- (c) otherwise—2 years after the record is made.\n- (a) kept in a retrievable form; and\n- (b) kept securely to ensure it can not be altered, obscured, deleted or removed without detection.\n- (a) ensure any data stored in the record is secure and tamper-proof in accordance with acceptable industry standards; and\n- (b) backup the record regularly during the period for which the record must be kept.","sortOrder":303},{"sectionNumber":"sec.225","sectionType":"section","heading":"Securing prescription stationery","content":"### sec.225 Securing prescription stationery\n\nA prescriber must take all reasonable steps to keep secure any stationery used, or to be used, by the prescriber for prescribing.\nMaximum penalty—40 penalty units.","sortOrder":304},{"sectionNumber":"ch.8-pt.5","sectionType":"part","heading":"Reporting particular matters","content":"# Reporting particular matters","sortOrder":305},{"sectionNumber":"sec.226","sectionType":"section","heading":"Reporting lost or stolen medicine","content":"### sec.226 Reporting lost or stolen medicine\n\nThis section applies to each of the following persons in the following circumstances (each an incident )—\na person, in the course of acting as an approved person, reasonably suspects an S8 medicine has been lost or stolen;\na person, in the course of acting as an approved person, reasonably suspects pentobarbital has been lost or stolen;\na pharmacist, in the course of practising the pharmacist’s profession, reasonably suspects pseudoephedrine or therapeutic nicotine have been lost or stolen;\na person, dealing with a diversion-risk medicine under a general approval, reasonably suspects the medicine has been lost or stolen.\nAs soon as practicable, but no later than the end of the next business day, after the incident, the person must—\ngive notice about the incident to the chief executive in the approved form; and\nnotify the police service about the incident.\nMaximum penalty—40 penalty units.\nSubsection (2) does not apply if—\nthe medicine is lost or stolen from an RFDS medicine chest kept by the Royal Flying Doctor Service of Australia; and\na report about the incident is given to the senior medical officer of the Royal Flying Doctor Service of Australia.\ns 226 amd 2024 SL No. 230 s 5\n(sec.226-ssec.1) This section applies to each of the following persons in the following circumstances (each an incident )— a person, in the course of acting as an approved person, reasonably suspects an S8 medicine has been lost or stolen; a person, in the course of acting as an approved person, reasonably suspects pentobarbital has been lost or stolen; a pharmacist, in the course of practising the pharmacist’s profession, reasonably suspects pseudoephedrine or therapeutic nicotine have been lost or stolen; a person, dealing with a diversion-risk medicine under a general approval, reasonably suspects the medicine has been lost or stolen.\n(sec.226-ssec.2) As soon as practicable, but no later than the end of the next business day, after the incident, the person must— give notice about the incident to the chief executive in the approved form; and notify the police service about the incident. Maximum penalty—40 penalty units.\n(sec.226-ssec.3) Subsection (2) does not apply if— the medicine is lost or stolen from an RFDS medicine chest kept by the Royal Flying Doctor Service of Australia; and a report about the incident is given to the senior medical officer of the Royal Flying Doctor Service of Australia. s 226 amd 2024 SL No. 230 s 5\n- (a) a person, in the course of acting as an approved person, reasonably suspects an S8 medicine has been lost or stolen;\n- (b) a person, in the course of acting as an approved person, reasonably suspects pentobarbital has been lost or stolen;\n- (c) a pharmacist, in the course of practising the pharmacist’s profession, reasonably suspects pseudoephedrine or therapeutic nicotine have been lost or stolen;\n- (d) a person, dealing with a diversion-risk medicine under a general approval, reasonably suspects the medicine has been lost or stolen.\n- (a) give notice about the incident to the chief executive in the approved form; and\n- (b) notify the police service about the incident.\n- (a) the medicine is lost or stolen from an RFDS medicine chest kept by the Royal Flying Doctor Service of Australia; and\n- (b) a report about the incident is given to the senior medical officer of the Royal Flying Doctor Service of Australia.","sortOrder":306},{"sectionNumber":"sec.227","sectionType":"section","heading":"Reporting failure to give written prescription","content":"### sec.227 Reporting failure to give written prescription\n\nThis section applies if—\na prescriber fails to comply with a relevant provision relating to a prescription for a medicine; and\na person dispenses, gives or administers the medicine on the prescription; and\nthe person is not aware of a reasonable excuse for the prescriber’s failure to comply.\nThe person must give notice about the prescriber’s failure to comply with the relevant provision—\nif the person is employed by the same entity as the prescriber—to the relevant manager of the prescriber as soon as practicable;\notherwise—to the chief executive in the approved form within 48 hours after the end of the period for compliance mentioned in subsection (1) .\nMaximum penalty—20 penalty units.\nSubsection (4) applies if—\nthe person notifies the relevant manager of the prescriber of the prescriber’s failure to comply; and\nthe prescriber does not rectify the failure within 48 hours after the notification.\nThe relevant manager must give notice about the failure to the chief executive in the approved form as soon as practicable.\nMaximum penalty—20 penalty units.\nIn this section—\nrelevant manager , of a prescriber, means a person who is responsible for managing the prescriber’s compliance with a relevant provision.\nrelevant provision means section 84 (4) , 92 (3) or (4) , or 100 (2) or (3) .\n(sec.227-ssec.1) This section applies if— a prescriber fails to comply with a relevant provision relating to a prescription for a medicine; and a person dispenses, gives or administers the medicine on the prescription; and the person is not aware of a reasonable excuse for the prescriber’s failure to comply.\n(sec.227-ssec.2) The person must give notice about the prescriber’s failure to comply with the relevant provision— if the person is employed by the same entity as the prescriber—to the relevant manager of the prescriber as soon as practicable; otherwise—to the chief executive in the approved form within 48 hours after the end of the period for compliance mentioned in subsection (1) . Maximum penalty—20 penalty units.\n(sec.227-ssec.3) Subsection (4) applies if— the person notifies the relevant manager of the prescriber of the prescriber’s failure to comply; and the prescriber does not rectify the failure within 48 hours after the notification.\n(sec.227-ssec.4) The relevant manager must give notice about the failure to the chief executive in the approved form as soon as practicable. Maximum penalty—20 penalty units.\n(sec.227-ssec.5) In this section— relevant manager , of a prescriber, means a person who is responsible for managing the prescriber’s compliance with a relevant provision. relevant provision means section 84 (4) , 92 (3) or (4) , or 100 (2) or (3) .\n- (a) a prescriber fails to comply with a relevant provision relating to a prescription for a medicine; and\n- (b) a person dispenses, gives or administers the medicine on the prescription; and\n- (c) the person is not aware of a reasonable excuse for the prescriber’s failure to comply.\n- (a) if the person is employed by the same entity as the prescriber—to the relevant manager of the prescriber as soon as practicable;\n- (b) otherwise—to the chief executive in the approved form within 48 hours after the end of the period for compliance mentioned in subsection (1) .\n- (a) the person notifies the relevant manager of the prescriber of the prescriber’s failure to comply; and\n- (b) the prescriber does not rectify the failure within 48 hours after the notification.","sortOrder":307},{"sectionNumber":"sec.228","sectionType":"section","heading":"Reporting and preventing use of unlawful document","content":"### sec.228 Reporting and preventing use of unlawful document\n\nThis section applies if a person who is authorised to deal with a medicine receives any of the following documents—\na purchase order for stock of a medicine;\na prescription for dispensing a medicine;\na prescription for giving a treatment dose of a medicine.\nIf the person reasonably believes the document has been unlawfully obtained or made, the person must take the following action—\nrecord the name and address of whoever gave the person the document;\nnotify the police service as soon as practicable;\nif the document is for a diversion-risk medicine—give notice to the chief executive in the approved form as soon as practicable;\nfor a hard copy of a purchase order—keep the purchase order or a copy of the order;\nfor a purchase order given electronically—process the purchase order in the system in which it is kept to prevent stock of the medicine being supplied;\nfor a paper prescription—keep the prescription or a copy of the prescription;\nfor an electronic prescription—process the prescription in the system in which it is kept to prevent the medicine being dispensed or given.\nMaximum penalty—60 penalty units.\nThe person is required to comply with subsection (2) only to the extent it is safe for the person to comply.\n(sec.228-ssec.1) This section applies if a person who is authorised to deal with a medicine receives any of the following documents— a purchase order for stock of a medicine; a prescription for dispensing a medicine; a prescription for giving a treatment dose of a medicine.\n(sec.228-ssec.2) If the person reasonably believes the document has been unlawfully obtained or made, the person must take the following action— record the name and address of whoever gave the person the document; notify the police service as soon as practicable; if the document is for a diversion-risk medicine—give notice to the chief executive in the approved form as soon as practicable; for a hard copy of a purchase order—keep the purchase order or a copy of the order; for a purchase order given electronically—process the purchase order in the system in which it is kept to prevent stock of the medicine being supplied; for a paper prescription—keep the prescription or a copy of the prescription; for an electronic prescription—process the prescription in the system in which it is kept to prevent the medicine being dispensed or given. Maximum penalty—60 penalty units.\n(sec.228-ssec.3) The person is required to comply with subsection (2) only to the extent it is safe for the person to comply.\n- (a) a purchase order for stock of a medicine;\n- (b) a prescription for dispensing a medicine;\n- (c) a prescription for giving a treatment dose of a medicine.\n- (a) record the name and address of whoever gave the person the document;\n- (b) notify the police service as soon as practicable;\n- (c) if the document is for a diversion-risk medicine—give notice to the chief executive in the approved form as soon as practicable;\n- (d) for a hard copy of a purchase order—keep the purchase order or a copy of the order;\n- (e) for a purchase order given electronically—process the purchase order in the system in which it is kept to prevent stock of the medicine being supplied;\n- (f) for a paper prescription—keep the prescription or a copy of the prescription;\n- (g) for an electronic prescription—process the prescription in the system in which it is kept to prevent the medicine being dispensed or given.","sortOrder":308},{"sectionNumber":"sec.229","sectionType":"section","heading":"Marking non-compliant paper prescription","content":"### sec.229 Marking non-compliant paper prescription\n\nThis section applies if—\na person who is authorised to dispense a medicine, or give a treatment dose of a medicine, does not dispense or give the medicine on a paper prescription; and\nthe person did not take the action mentioned in paragraph (a) because the person reasonably suspects—\nthe prescription has been unlawfully obtained or made; or\nthe prescription has been given by a person who is not authorised under the Act , or permitted under a corresponding law or another law, to prescribe the medicine; or\nthe prescription does not otherwise comply with the Act .\nThe person must mark the prescription with—\na statement that the prescription is cancelled or not to be dispensed or given; and\nthe date of marking the prescription; and\nthe person’s name or signature; and\nthe address of the place where the prescription was presented.\nMaximum penalty—60 penalty units.\nThe person is required to comply with subsection (2) only to the extent it is safe for the person to comply.\n(sec.229-ssec.1) This section applies if— a person who is authorised to dispense a medicine, or give a treatment dose of a medicine, does not dispense or give the medicine on a paper prescription; and the person did not take the action mentioned in paragraph (a) because the person reasonably suspects— the prescription has been unlawfully obtained or made; or the prescription has been given by a person who is not authorised under the Act , or permitted under a corresponding law or another law, to prescribe the medicine; or the prescription does not otherwise comply with the Act .\n(sec.229-ssec.2) The person must mark the prescription with— a statement that the prescription is cancelled or not to be dispensed or given; and the date of marking the prescription; and the person’s name or signature; and the address of the place where the prescription was presented. Maximum penalty—60 penalty units.\n(sec.229-ssec.3) The person is required to comply with subsection (2) only to the extent it is safe for the person to comply.\n- (a) a person who is authorised to dispense a medicine, or give a treatment dose of a medicine, does not dispense or give the medicine on a paper prescription; and\n- (b) the person did not take the action mentioned in paragraph (a) because the person reasonably suspects— (i) the prescription has been unlawfully obtained or made; or (ii) the prescription has been given by a person who is not authorised under the Act , or permitted under a corresponding law or another law, to prescribe the medicine; or (iii) the prescription does not otherwise comply with the Act .\n- (i) the prescription has been unlawfully obtained or made; or\n- (ii) the prescription has been given by a person who is not authorised under the Act , or permitted under a corresponding law or another law, to prescribe the medicine; or\n- (iii) the prescription does not otherwise comply with the Act .\n- (i) the prescription has been unlawfully obtained or made; or\n- (ii) the prescription has been given by a person who is not authorised under the Act , or permitted under a corresponding law or another law, to prescribe the medicine; or\n- (iii) the prescription does not otherwise comply with the Act .\n- (a) a statement that the prescription is cancelled or not to be dispensed or given; and\n- (b) the date of marking the prescription; and\n- (c) the person’s name or signature; and\n- (d) the address of the place where the prescription was presented.","sortOrder":309},{"sectionNumber":"sec.230","sectionType":"section","heading":"Reporting supply on false prescription or purchase order for diversion-risk medicine","content":"### sec.230 Reporting supply on false prescription or purchase order for diversion-risk medicine\n\nThis section applies if, after supplying a diversion-risk medicine on a prescription or purchase order, the supplier of the medicine reasonably suspects any of the following incidents has happened—\nfalse information, material to the prescription or purchase order, was given to the person who prescribed the medicine or gave the purchase order;\nthe prescription or purchase order was changed by a person other than—\nfor a prescription—the prescriber of the prescription or the dispenser of the medicine for the prescription; or\nfor a purchase order—the person who gave the purchase order;\nthe prescription or purchase order was false in any material particular.\nThe supplier must give notice about the incident to the chief executive in the approved form and to the police service no later than 24 hours after becoming aware of the incident.\nMaximum penalty—60 penalty units.\nIn this section—\nsupplier , in relation to a medicine, means a person who is authorised to supply the medicine.\n(sec.230-ssec.1) This section applies if, after supplying a diversion-risk medicine on a prescription or purchase order, the supplier of the medicine reasonably suspects any of the following incidents has happened— false information, material to the prescription or purchase order, was given to the person who prescribed the medicine or gave the purchase order; the prescription or purchase order was changed by a person other than— for a prescription—the prescriber of the prescription or the dispenser of the medicine for the prescription; or for a purchase order—the person who gave the purchase order; the prescription or purchase order was false in any material particular.\n(sec.230-ssec.2) The supplier must give notice about the incident to the chief executive in the approved form and to the police service no later than 24 hours after becoming aware of the incident. Maximum penalty—60 penalty units.\n(sec.230-ssec.3) In this section— supplier , in relation to a medicine, means a person who is authorised to supply the medicine.\n- (a) false information, material to the prescription or purchase order, was given to the person who prescribed the medicine or gave the purchase order;\n- (b) the prescription or purchase order was changed by a person other than— (i) for a prescription—the prescriber of the prescription or the dispenser of the medicine for the prescription; or (ii) for a purchase order—the person who gave the purchase order;\n- (i) for a prescription—the prescriber of the prescription or the dispenser of the medicine for the prescription; or\n- (ii) for a purchase order—the person who gave the purchase order;\n- (c) the prescription or purchase order was false in any material particular.\n- (i) for a prescription—the prescriber of the prescription or the dispenser of the medicine for the prescription; or\n- (ii) for a purchase order—the person who gave the purchase order;","sortOrder":310},{"sectionNumber":"sec.231","sectionType":"section","heading":"Notification of loss or theft","content":"### sec.231 Notification of loss or theft\n\nThis section applies to a person (each the wholesaler ) who—\nis authorised to supply medicines by wholesale; or\nis a wholesale representative.\nThe wholesaler must report the loss or theft of a diversion-risk medicine that was in the possession of the wholesaler immediately before the loss or theft.\nMaximum penalty—40 penalty units.\nThe report must be made as soon as practicable, but no later than the end of the next business day, after the loss or theft—\nto the police service; and\nto the chief executive in the approved form.\nMaximum penalty—40 penalty units.\n(sec.231-ssec.1) This section applies to a person (each the wholesaler ) who— is authorised to supply medicines by wholesale; or is a wholesale representative.\n(sec.231-ssec.2) The wholesaler must report the loss or theft of a diversion-risk medicine that was in the possession of the wholesaler immediately before the loss or theft. Maximum penalty—40 penalty units.\n(sec.231-ssec.3) The report must be made as soon as practicable, but no later than the end of the next business day, after the loss or theft— to the police service; and to the chief executive in the approved form. Maximum penalty—40 penalty units.\n- (a) is authorised to supply medicines by wholesale; or\n- (b) is a wholesale representative.\n- (a) to the police service; and\n- (b) to the chief executive in the approved form.","sortOrder":311},{"sectionNumber":"sec.232","sectionType":"section","heading":"Return of transactions for wholesale representatives","content":"### sec.232 Return of transactions for wholesale representatives\n\nA wholesale representative must, periodically but at least every 3 months, give the representative’s employer a return complying with subsection (2) about the transactions carried out by the representative for the period.\nMaximum penalty—40 penalty units.\nThe return must state the following information—\nthe period of the return;\nthe total amount of each type of medicine in the representative’s possession at the start and end of the period;\nthe amount of each type of medicine received by the representative;\nthe amount of each type of medicine given as a sample, or returned, by the representative;\nthe invoice number for each medicine given as a sample or return.\nThe wholesale representative must keep a copy of each return sent to the representative’s employer.\nMaximum penalty—40 penalty units.\nSee section 224 about keeping records.\nThe wholesale representative’s employer must also keep a copy of each return received from the wholesale representative.\nMaximum penalty—40 penalty units.\nIn this section—\nemployer , of a wholesale representative, means the wholesaler that the representative acts as an agent or representative for.\n(sec.232-ssec.1) A wholesale representative must, periodically but at least every 3 months, give the representative’s employer a return complying with subsection (2) about the transactions carried out by the representative for the period. Maximum penalty—40 penalty units.\n(sec.232-ssec.2) The return must state the following information— the period of the return; the total amount of each type of medicine in the representative’s possession at the start and end of the period; the amount of each type of medicine received by the representative; the amount of each type of medicine given as a sample, or returned, by the representative; the invoice number for each medicine given as a sample or return.\n(sec.232-ssec.3) The wholesale representative must keep a copy of each return sent to the representative’s employer. Maximum penalty—40 penalty units. See section 224 about keeping records.\n(sec.232-ssec.4) The wholesale representative’s employer must also keep a copy of each return received from the wholesale representative. Maximum penalty—40 penalty units.\n(sec.232-ssec.5) In this section— employer , of a wholesale representative, means the wholesaler that the representative acts as an agent or representative for.\n- (a) the period of the return;\n- (b) the total amount of each type of medicine in the representative’s possession at the start and end of the period;\n- (c) the amount of each type of medicine received by the representative;\n- (d) the amount of each type of medicine given as a sample, or returned, by the representative;\n- (e) the invoice number for each medicine given as a sample or return.","sortOrder":312},{"sectionNumber":"sec.233","sectionType":"section","heading":"Giving chief executive information about particular diversion-risk medicines","content":"### sec.233 Giving chief executive information about particular diversion-risk medicines\n\nThis section applies if—\na person seeks a supply of a diversion-risk medicine from a pharmacist, other than a medicine that is also a monitored medicine; and\nthe pharmacist reasonably suspects the amount of the medicine sought exceeds the amount or frequency of doses that the person could reasonably be seeking for the therapeutic treatment of the person or the person’s animal.\nThe pharmacist must give notice to the chief executive in the approved form unless the pharmacist has a reasonable excuse.\nMaximum penalty—40 penalty units.\n(sec.233-ssec.1) This section applies if— a person seeks a supply of a diversion-risk medicine from a pharmacist, other than a medicine that is also a monitored medicine; and the pharmacist reasonably suspects the amount of the medicine sought exceeds the amount or frequency of doses that the person could reasonably be seeking for the therapeutic treatment of the person or the person’s animal.\n(sec.233-ssec.2) The pharmacist must give notice to the chief executive in the approved form unless the pharmacist has a reasonable excuse. Maximum penalty—40 penalty units.\n- (a) a person seeks a supply of a diversion-risk medicine from a pharmacist, other than a medicine that is also a monitored medicine; and\n- (b) the pharmacist reasonably suspects the amount of the medicine sought exceeds the amount or frequency of doses that the person could reasonably be seeking for the therapeutic treatment of the person or the person’s animal.","sortOrder":313},{"sectionNumber":"ch.8-pt.6","sectionType":"part","heading":"Advertising and vending machines","content":"# Advertising and vending machines","sortOrder":314},{"sectionNumber":"sec.234","sectionType":"section","heading":"Unlawful advertising of medicines","content":"### sec.234 Unlawful advertising of medicines\n\nA person must not advertise, or cause a person to advertise, an S3, S4 or S8 medicine.\nMaximum penalty—80 penalty units.\nHowever, subsection (1) does not apply in relation to—\nan advertisement of an S3, S4 or S8 medicine—\nin a journal, a price list or other promotional material that relates only to the therapeutic use of the medicine in the practise of a profession; or\nin accordance with the Therapeutic Goods Advertising Code under the Therapeutic Goods Act 1989 (Cwlth) ; or\nan advertisement of an S3 medicine listed in the Poisons Standard, Appendix H.\ns 234 amd 2025 SL No. 148 s 7\n(sec.234-ssec.1) A person must not advertise, or cause a person to advertise, an S3, S4 or S8 medicine. Maximum penalty—80 penalty units.\n(sec.234-ssec.2) However, subsection (1) does not apply in relation to— an advertisement of an S3, S4 or S8 medicine— in a journal, a price list or other promotional material that relates only to the therapeutic use of the medicine in the practise of a profession; or in accordance with the Therapeutic Goods Advertising Code under the Therapeutic Goods Act 1989 (Cwlth) ; or an advertisement of an S3 medicine listed in the Poisons Standard, Appendix H.\n- (a) an advertisement of an S3, S4 or S8 medicine— (i) in a journal, a price list or other promotional material that relates only to the therapeutic use of the medicine in the practise of a profession; or (ii) in accordance with the Therapeutic Goods Advertising Code under the Therapeutic Goods Act 1989 (Cwlth) ; or\n- (i) in a journal, a price list or other promotional material that relates only to the therapeutic use of the medicine in the practise of a profession; or\n- (ii) in accordance with the Therapeutic Goods Advertising Code under the Therapeutic Goods Act 1989 (Cwlth) ; or\n- (b) an advertisement of an S3 medicine listed in the Poisons Standard, Appendix H.\n- (i) in a journal, a price list or other promotional material that relates only to the therapeutic use of the medicine in the practise of a profession; or\n- (ii) in accordance with the Therapeutic Goods Advertising Code under the Therapeutic Goods Act 1989 (Cwlth) ; or","sortOrder":315},{"sectionNumber":"sec.235","sectionType":"section","heading":"Offence to install medicine vending machines","content":"### sec.235 Offence to install medicine vending machines\n\nA person who is the owner or occupier of premises must not install a medicine vending machine on the premises.\nMaximum penalty—30 penalty units.\nIn this section—\nmedicine vending machine means a machine or device that supplies a medicine to a person on the payment of money.\n(sec.235-ssec.1) A person who is the owner or occupier of premises must not install a medicine vending machine on the premises. Maximum penalty—30 penalty units.\n(sec.235-ssec.2) In this section— medicine vending machine means a machine or device that supplies a medicine to a person on the payment of money.","sortOrder":316},{"sectionNumber":"ch.9-pt.1","sectionType":"part","heading":"Administration by chief executive","content":"# Administration by chief executive","sortOrder":317},{"sectionNumber":"sec.236","sectionType":"section","heading":"Matters to be considered before making particular extended practice authorities— Act , s 232","content":"### sec.236 Matters to be considered before making particular extended practice authorities— Act , s 232\n\nFor section 232 (3) of the Act , the following matters are prescribed in relation to a dealing with a medicine—\nthe nature of the dealing;\nwhether there is a community need for any service to be facilitated by the extended practice authority;\nthe way in which any health risks associated with the dealing are to be managed under the authority;\nwhether there is a need for a review of the authority and the timing of any review needed;\nif the approved person is subject to the governance of an entity under the authority—the governance capability of the entity;\nif the medicine is a restricted medicine or unregistered medicine—whether it is in the public interest to make the authority, considering the particular health risks associated with restricted medicines and unregistered medicines.\nIn this section—\nunregistered medicine means a medicine that is not included in a product on the Australian Register of Therapeutic Goods.\ns 236 amd 2024 SL No. 102 s 5\n(sec.236-ssec.1) For section 232 (3) of the Act , the following matters are prescribed in relation to a dealing with a medicine— the nature of the dealing; whether there is a community need for any service to be facilitated by the extended practice authority; the way in which any health risks associated with the dealing are to be managed under the authority; whether there is a need for a review of the authority and the timing of any review needed; if the approved person is subject to the governance of an entity under the authority—the governance capability of the entity; if the medicine is a restricted medicine or unregistered medicine—whether it is in the public interest to make the authority, considering the particular health risks associated with restricted medicines and unregistered medicines.\n(sec.236-ssec.2) In this section— unregistered medicine means a medicine that is not included in a product on the Australian Register of Therapeutic Goods.\n- (a) the nature of the dealing;\n- (b) whether there is a community need for any service to be facilitated by the extended practice authority;\n- (c) the way in which any health risks associated with the dealing are to be managed under the authority;\n- (d) whether there is a need for a review of the authority and the timing of any review needed;\n- (e) if the approved person is subject to the governance of an entity under the authority—the governance capability of the entity;\n- (f) if the medicine is a restricted medicine or unregistered medicine—whether it is in the public interest to make the authority, considering the particular health risks associated with restricted medicines and unregistered medicines.","sortOrder":318},{"sectionNumber":"sec.237","sectionType":"section","heading":"Chief executive may approve alternative ways of labelling or packaging medicines","content":"### sec.237 Chief executive may approve alternative ways of labelling or packaging medicines\n\nThe chief executive may approve a way (an alternative way ) of labelling or packaging a medicine that is different to the Poisons Standard.\nHowever, the chief executive may approve the alternative way only if the chief executive is satisfied it is unlikely to adversely affect public safety, having regard to the nature of the medicine and the purpose for which it is to be used.\nThe chief executive must publish, on the department’s website, a notice stating—\nthe requirements of the alternative way; and\nthe day, no earlier than the day the notice is published, that the approval of the alternative way takes effect; and\nthe period, if any, for which the approval of the alternative way has effect.\nSubsection (5) applies if an appropriate authority, for a purpose or in another State, has authorised (whether by approval, exemption or some other way) another way to label or package a medicine for the purpose or other State.\nSee the Poisons Standard, section 6 for the definition appropriate authority .\nTo the extent authorised by the appropriate authority, the other way is taken to be an alternative way approved under this section, unless the chief executive publishes a notice on the department’s website stating the other way is not approved for Queensland.\ns 237 amd 2023 SL No. 170 s 7\n(sec.237-ssec.1) The chief executive may approve a way (an alternative way ) of labelling or packaging a medicine that is different to the Poisons Standard.\n(sec.237-ssec.2) However, the chief executive may approve the alternative way only if the chief executive is satisfied it is unlikely to adversely affect public safety, having regard to the nature of the medicine and the purpose for which it is to be used.\n(sec.237-ssec.3) The chief executive must publish, on the department’s website, a notice stating— the requirements of the alternative way; and the day, no earlier than the day the notice is published, that the approval of the alternative way takes effect; and the period, if any, for which the approval of the alternative way has effect.\n(sec.237-ssec.4) Subsection (5) applies if an appropriate authority, for a purpose or in another State, has authorised (whether by approval, exemption or some other way) another way to label or package a medicine for the purpose or other State. See the Poisons Standard, section 6 for the definition appropriate authority .\n(sec.237-ssec.5) To the extent authorised by the appropriate authority, the other way is taken to be an alternative way approved under this section, unless the chief executive publishes a notice on the department’s website stating the other way is not approved for Queensland.\n- (a) the requirements of the alternative way; and\n- (b) the day, no earlier than the day the notice is published, that the approval of the alternative way takes effect; and\n- (c) the period, if any, for which the approval of the alternative way has effect.","sortOrder":319},{"sectionNumber":"ch.9-pt.2","sectionType":"part","heading":"Fees","content":"# Fees","sortOrder":320},{"sectionNumber":"ch.9-pt.2-div.1","sectionType":"division","heading":"General","content":"## General","sortOrder":321},{"sectionNumber":"sec.238","sectionType":"section","heading":"Definitions for part and schedule 19","content":"### sec.238 Definitions for part and schedule 19\n\nIn this part and schedule 19 —\nlicensing fee means a fee for an application relating to a substance authority stated in schedule 19 , items 1 to 8.\nsite , for a substance authority, means a place at which a dealing with a medicine is, or is proposed to be, carried out under the authority.","sortOrder":322},{"sectionNumber":"sec.239","sectionType":"section","heading":"Fees payable generally","content":"### sec.239 Fees payable generally\n\nThe fees payable under the Act in relation to a substance authority for a dealing with a medicine are stated in schedule 19 .\nA licensing fee for a substance authority is payable for each site for the authority for each year of the term of the authority.\nHowever, for any part of the term of a substance authority that is not a full year, the licensing fee payable in relation to that part of the term is the proportion of the licensing fee attributable to the number of months, rounded up to whole months, of that year that are in the term.\n(sec.239-ssec.1) The fees payable under the Act in relation to a substance authority for a dealing with a medicine are stated in schedule 19 .\n(sec.239-ssec.2) A licensing fee for a substance authority is payable for each site for the authority for each year of the term of the authority.\n(sec.239-ssec.3) However, for any part of the term of a substance authority that is not a full year, the licensing fee payable in relation to that part of the term is the proportion of the licensing fee attributable to the number of months, rounded up to whole months, of that year that are in the term.","sortOrder":323},{"sectionNumber":"ch.9-pt.2-div.2","sectionType":"division","heading":"Exemptions","content":"## Exemptions","sortOrder":324},{"sectionNumber":"sec.240","sectionType":"section","heading":"Manufacturing licence for S2, S3 or S4 medicines","content":"### sec.240 Manufacturing licence for S2, S3 or S4 medicines\n\nNo licensing fee is payable for an initial application or renewal application for a manufacturing licence for an S2, S3 or S4 medicine (each a later application ) if—\nan initial application or renewal application for a manufacturing licence for an S7 poison (each a first application ) has been made, and not withdrawn or refused, under the Medicines and Poisons (Poisons and Prohibited Substances) Regulation 2021 ; and\nthe site the subject of the later application is the same as the site the subject of the first application; and\nthe term proposed for the later application ends no later than the last month of—\nthe term proposed for the first application; or\nif the chief executive has granted the first application—the term of the substance authority granted on the first application; and\nall fees payable under the Act for the first application have been paid.\n- (a) an initial application or renewal application for a manufacturing licence for an S7 poison (each a first application ) has been made, and not withdrawn or refused, under the Medicines and Poisons (Poisons and Prohibited Substances) Regulation 2021 ; and\n- (b) the site the subject of the later application is the same as the site the subject of the first application; and\n- (c) the term proposed for the later application ends no later than the last month of— (i) the term proposed for the first application; or (ii) if the chief executive has granted the first application—the term of the substance authority granted on the first application; and\n- (i) the term proposed for the first application; or\n- (ii) if the chief executive has granted the first application—the term of the substance authority granted on the first application; and\n- (d) all fees payable under the Act for the first application have been paid.\n- (i) the term proposed for the first application; or\n- (ii) if the chief executive has granted the first application—the term of the substance authority granted on the first application; and","sortOrder":325},{"sectionNumber":"sec.241","sectionType":"section","heading":"Wholesale licence for S2, S3 or S4 medicines","content":"### sec.241 Wholesale licence for S2, S3 or S4 medicines\n\nNo licensing fee is payable for an initial application or renewal application for a wholesale licence for an S2, S3 or S4 medicine (each a later application ) if—\nan initial application or renewal application for a manufacturing licence or wholesale licence for an S7 poison (each a first application ) has been made, and not withdrawn or refused, under the Medicines and Poisons (Poisons and Prohibited Substances) Regulation 2021 ; and\nthe site the subject of the later application is the same as the site the subject of the first application; and\nthe term proposed for the later application ends no later than the last month of—\nthe term proposed for the first application; or\nif the chief executive has granted the first application—the term of the substance authority granted on the first application; and\nall fees payable under the Act for the first application have been paid.\n- (a) an initial application or renewal application for a manufacturing licence or wholesale licence for an S7 poison (each a first application ) has been made, and not withdrawn or refused, under the Medicines and Poisons (Poisons and Prohibited Substances) Regulation 2021 ; and\n- (b) the site the subject of the later application is the same as the site the subject of the first application; and\n- (c) the term proposed for the later application ends no later than the last month of— (i) the term proposed for the first application; or (ii) if the chief executive has granted the first application—the term of the substance authority granted on the first application; and\n- (i) the term proposed for the first application; or\n- (ii) if the chief executive has granted the first application—the term of the substance authority granted on the first application; and\n- (d) all fees payable under the Act for the first application have been paid.\n- (i) the term proposed for the first application; or\n- (ii) if the chief executive has granted the first application—the term of the substance authority granted on the first application; and","sortOrder":326},{"sectionNumber":"ch.9-pt.2-div.3","sectionType":"division","heading":"Refunds","content":"## Refunds","sortOrder":327},{"sectionNumber":"sec.242","sectionType":"section","heading":"Rejected or withdrawn application","content":"### sec.242 Rejected or withdrawn application\n\nThis section applies if—\nan applicant has paid the licensing fee for an application for a substance authority for a medicine; and\nthe application is refused by the chief executive or withdrawn by the applicant.\nThe chief executive must refund the applicant the licensing fee for the application.\n(sec.242-ssec.1) This section applies if— an applicant has paid the licensing fee for an application for a substance authority for a medicine; and the application is refused by the chief executive or withdrawn by the applicant.\n(sec.242-ssec.2) The chief executive must refund the applicant the licensing fee for the application.\n- (a) an applicant has paid the licensing fee for an application for a substance authority for a medicine; and\n- (b) the application is refused by the chief executive or withdrawn by the applicant.","sortOrder":328},{"sectionNumber":"sec.243","sectionType":"section","heading":"Authority granted for shorter term","content":"### sec.243 Authority granted for shorter term\n\nThis section applies if—\nan applicant has paid the licensing fee for an application for a substance authority for a medicine for a particular term (the proposed term ); and\nthe application is granted for a period (the granted term ) that is shorter than the proposed term.\nThe chief executive must refund the applicant the amount that is the proportion of the paid licensing fee attributable to the number of months, rounded up to whole months, that is the difference between the proposed term and granted term.\nNo refund is payable if the amount under subsection (2) is zero or less than zero.\n(sec.243-ssec.1) This section applies if— an applicant has paid the licensing fee for an application for a substance authority for a medicine for a particular term (the proposed term ); and the application is granted for a period (the granted term ) that is shorter than the proposed term.\n(sec.243-ssec.2) The chief executive must refund the applicant the amount that is the proportion of the paid licensing fee attributable to the number of months, rounded up to whole months, that is the difference between the proposed term and granted term.\n(sec.243-ssec.3) No refund is payable if the amount under subsection (2) is zero or less than zero.\n- (a) an applicant has paid the licensing fee for an application for a substance authority for a medicine for a particular term (the proposed term ); and\n- (b) the application is granted for a period (the granted term ) that is shorter than the proposed term.","sortOrder":329},{"sectionNumber":"sec.244","sectionType":"section","heading":"Surrender of authority","content":"### sec.244 Surrender of authority\n\nThis section applies if—\nthe holder of a substance authority for a medicine paid the licensing fee for an application for the authority for a particular term (the granted term ); and\nthe substance authority is surrendered before the end of the granted term.\nThe chief executive must refund the applicant the amount that is the proportion of the paid licensing fee attributable to the number of months, rounded up to whole months, remaining in the granted term after the surrender.\nNo refund is payable if the amount under subsection (2) is zero or less than zero.\n(sec.244-ssec.1) This section applies if— the holder of a substance authority for a medicine paid the licensing fee for an application for the authority for a particular term (the granted term ); and the substance authority is surrendered before the end of the granted term.\n(sec.244-ssec.2) The chief executive must refund the applicant the amount that is the proportion of the paid licensing fee attributable to the number of months, rounded up to whole months, remaining in the granted term after the surrender.\n(sec.244-ssec.3) No refund is payable if the amount under subsection (2) is zero or less than zero.\n- (a) the holder of a substance authority for a medicine paid the licensing fee for an application for the authority for a particular term (the granted term ); and\n- (b) the substance authority is surrendered before the end of the granted term.","sortOrder":330},{"sectionNumber":"ch.10-pt.1","sectionType":"part","heading":"Repeal","content":"# Repeal","sortOrder":331},{"sectionNumber":"sec.245","sectionType":"section","heading":"Repeal","content":"### sec.245 Repeal\n\nThe Medicines and Poisons (Monitored Medicines Database Testing) Regulation 2020, SL No. 59 is repealed.","sortOrder":332},{"sectionNumber":"ch.10-pt.2","sectionType":"part","heading":"Transitional provisions for SL No. 140 of 2021","content":"# Transitional provisions for SL No. 140 of 2021","sortOrder":333},{"sectionNumber":"ch.10-pt.2-div.1","sectionType":"division","heading":"Monitored medicines database","content":"## Monitored medicines database","sortOrder":334},{"sectionNumber":"sec.246","sectionType":"section","heading":"Prescribed day when database is fully operational— Act , s 281","content":"### sec.246 Prescribed day when database is fully operational— Act , s 281\n\nFor section 281 (1) (b) of the Act , 27 October 2021 is prescribed to be the day that the monitored medicines database is fully operational.","sortOrder":335},{"sectionNumber":"sec.247","sectionType":"section","heading":"Information transitioned to database— Act , s 225","content":"### sec.247 Information transitioned to database— Act , s 225\n\nThis section applies in relation to information—\nrecorded in the monitored medicines database under the repealed Medicines and Poisons (Monitored Medicines Database Testing) Regulation 2020 immediately before the repeal of that regulation; and\ngiven to, or held by, the chief executive under section 281 of the Act relating to an approval in effect during the transition period under that section.\nThe information is prescribed for section 225 (1) of the Act .\n(sec.247-ssec.1) This section applies in relation to information— recorded in the monitored medicines database under the repealed Medicines and Poisons (Monitored Medicines Database Testing) Regulation 2020 immediately before the repeal of that regulation; and given to, or held by, the chief executive under section 281 of the Act relating to an approval in effect during the transition period under that section.\n(sec.247-ssec.2) The information is prescribed for section 225 (1) of the Act .\n- (a) recorded in the monitored medicines database under the repealed Medicines and Poisons (Monitored Medicines Database Testing) Regulation 2020 immediately before the repeal of that regulation; and\n- (b) given to, or held by, the chief executive under section 281 of the Act relating to an approval in effect during the transition period under that section.","sortOrder":336},{"sectionNumber":"ch.10-pt.2-div.2","sectionType":"division","heading":"Special arrangement period","content":"## Special arrangement period","sortOrder":337},{"sectionNumber":"sec.248","sectionType":"section","heading":"Sending and keeping particular prescriptions during special arrangement period","content":"### sec.248 Sending and keeping particular prescriptions during special arrangement period\n\nThis section applies if, during the special arrangement period, a prescriber gives a digital copy of a paper prescription for an S4 medicine, other than a diversion-risk medicine, to a dispenser.\nThe prescriber is taken to have complied with section 84(4) if the prescriber keeps the paper prescription for a period of 2 years after giving the dispenser a digital copy of the paper prescription.\nIn this section—\nspecial arrangement period means the period—\nstarting on the commencement of this section; and\nending at the end of the day the special arrangement the National Health (COVID-19 Supply of Pharmaceutical Benefits) Special Arrangement 2020 (Cwlth) is repealed or expires.\n(sec.248-ssec.1) This section applies if, during the special arrangement period, a prescriber gives a digital copy of a paper prescription for an S4 medicine, other than a diversion-risk medicine, to a dispenser.\n(sec.248-ssec.2) The prescriber is taken to have complied with section 84(4) if the prescriber keeps the paper prescription for a period of 2 years after giving the dispenser a digital copy of the paper prescription.\n(sec.248-ssec.3) In this section— special arrangement period means the period— starting on the commencement of this section; and ending at the end of the day the special arrangement the National Health (COVID-19 Supply of Pharmaceutical Benefits) Special Arrangement 2020 (Cwlth) is repealed or expires.\n- (a) starting on the commencement of this section; and\n- (b) ending at the end of the day the special arrangement the National Health (COVID-19 Supply of Pharmaceutical Benefits) Special Arrangement 2020 (Cwlth) is repealed or expires.","sortOrder":338},{"sectionNumber":"ch.10-pt.2-div.3","sectionType":"division","heading":"Transitioned approvals, documents and records","content":"## Transitioned approvals, documents and records","sortOrder":339},{"sectionNumber":"sec.249","sectionType":"section","heading":"Definitions for division","content":"### sec.249 Definitions for division\n\nIn this division—\nHDPR means the repealed Health (Drugs and Poisons) Regulation 1996 .\nnew clinical protocol means a clinical protocol made under chapter 4, part 7, division 3.","sortOrder":340},{"sectionNumber":"sec.250","sectionType":"section","heading":"Certified way of packaging","content":"### sec.250 Certified way of packaging\n\nThis section applies if—\nthe chief executive certified a container for packing a medicine under the HDPR, section 10(3); and\nthe certification was in effect immediately before the commencement.\nThe certification is taken to be an alternative way for packaging the medicine approved under section 237 until—\nif an expiry day is stated in the certification—the stated day; or\notherwise—the day that is 1 year after the commencement.\n(sec.250-ssec.1) This section applies if— the chief executive certified a container for packing a medicine under the HDPR, section 10(3); and the certification was in effect immediately before the commencement.\n(sec.250-ssec.2) The certification is taken to be an alternative way for packaging the medicine approved under section 237 until— if an expiry day is stated in the certification—the stated day; or otherwise—the day that is 1 year after the commencement.\n- (a) the chief executive certified a container for packing a medicine under the HDPR, section 10(3); and\n- (b) the certification was in effect immediately before the commencement.\n- (a) if an expiry day is stated in the certification—the stated day; or\n- (b) otherwise—the day that is 1 year after the commencement.","sortOrder":341},{"sectionNumber":"sec.251","sectionType":"section","heading":"Certified way of labelling","content":"### sec.251 Certified way of labelling\n\nThis section applies if—\nthe chief executive certified an alternative way of labelling a package for a medicine under the HDPR, section 11(3); and\nthe certification was in effect immediately before the commencement.\nThe certification is taken to be an alternative way of labelling a package for the medicine approved under section 237 until—\nif an expiry day is stated in the certification—the stated day; or\notherwise—the day that is 1 year after the commencement.\n(sec.251-ssec.1) This section applies if— the chief executive certified an alternative way of labelling a package for a medicine under the HDPR, section 11(3); and the certification was in effect immediately before the commencement.\n(sec.251-ssec.2) The certification is taken to be an alternative way of labelling a package for the medicine approved under section 237 until— if an expiry day is stated in the certification—the stated day; or otherwise—the day that is 1 year after the commencement.\n- (a) the chief executive certified an alternative way of labelling a package for a medicine under the HDPR, section 11(3); and\n- (b) the certification was in effect immediately before the commencement.\n- (a) if an expiry day is stated in the certification—the stated day; or\n- (b) otherwise—the day that is 1 year after the commencement.","sortOrder":342},{"sectionNumber":"sec.252","sectionType":"section","heading":"Controlled drugs registers","content":"### sec.252 Controlled drugs registers\n\nThis section applies if, immediately before the commencement, a person kept a controlled drugs register under the HDPR, section 50.\nThe controlled drugs register is taken to be a medicine register for S8 medicines.\n(sec.252-ssec.1) This section applies if, immediately before the commencement, a person kept a controlled drugs register under the HDPR, section 50.\n(sec.252-ssec.2) The controlled drugs register is taken to be a medicine register for S8 medicines.","sortOrder":343},{"sectionNumber":"sec.253","sectionType":"section","heading":"Clinical protocols","content":"### sec.253 Clinical protocols\n\nThis section applies if, immediately before the commencement, an existing clinical protocol was in effect for a person practising a profession at a place.\nThe existing clinical protocol is taken to be a new clinical protocol for the person practising the profession at the place until the earlier of—\nthe day the existing protocol is revoked; or\nthe day stated to be the expiry date in the existing clinical protocol.\nIn this section—\nexisting clinical protocol means a clinical protocol made under the HDPR.\n(sec.253-ssec.1) This section applies if, immediately before the commencement, an existing clinical protocol was in effect for a person practising a profession at a place.\n(sec.253-ssec.2) The existing clinical protocol is taken to be a new clinical protocol for the person practising the profession at the place until the earlier of— the day the existing protocol is revoked; or the day stated to be the expiry date in the existing clinical protocol.\n(sec.253-ssec.3) In this section— existing clinical protocol means a clinical protocol made under the HDPR.\n- (a) the day the existing protocol is revoked; or\n- (b) the day stated to be the expiry date in the existing clinical protocol.","sortOrder":344},{"sectionNumber":"sec.254","sectionType":"section","heading":"Orthoptist protocols","content":"### sec.254 Orthoptist protocols\n\nThis section applies if—\nimmediately before the commencement, a health management protocol was in effect for a person who was an orthoptist under the HDPR practising orthoptics; and\non the commencement, the person is an orthoptist mentioned in schedule 8, section 6.\nThe health management protocol is taken to be a new clinical protocol applying to the person for practising orthoptics until the earlier of—\nthe day the protocol is revoked; or\nthe day stated to be the expiry date in the health management protocol.\nIn this section—\nhealth management protocol means a document called a ‘health management protocol’ made under the orthoptist DTP.\northoptist DTP see the HDPR, appendix 9.\n(sec.254-ssec.1) This section applies if— immediately before the commencement, a health management protocol was in effect for a person who was an orthoptist under the HDPR practising orthoptics; and on the commencement, the person is an orthoptist mentioned in schedule 8, section 6.\n(sec.254-ssec.2) The health management protocol is taken to be a new clinical protocol applying to the person for practising orthoptics until the earlier of— the day the protocol is revoked; or the day stated to be the expiry date in the health management protocol.\n(sec.254-ssec.3) In this section— health management protocol means a document called a ‘health management protocol’ made under the orthoptist DTP. orthoptist DTP see the HDPR, appendix 9.\n- (a) immediately before the commencement, a health management protocol was in effect for a person who was an orthoptist under the HDPR practising orthoptics; and\n- (b) on the commencement, the person is an orthoptist mentioned in schedule 8, section 6.\n- (a) the day the protocol is revoked; or\n- (b) the day stated to be the expiry date in the health management protocol.","sortOrder":345},{"sectionNumber":"sec.255","sectionType":"section","heading":"Practice plans","content":"### sec.255 Practice plans\n\nThis section applies if, immediately before the commencement, a practice plan was in effect under the HDPR for either—\nan Aboriginal and Torres Strait Islander health practitioner; or\na physician’s assistant.\nThe practice plan is—\nif the practitioner is an Aboriginal and Torres Strait Islander health practitioner mentioned in schedule 3, part 1 on or after the commencement—taken to be a practice plan for the practitioner under that part; or\nif the practitioner is a physician assistant mentioned in schedule 6, part 3 on or after the commencement—taken to be a practice plan for the practitioner under that part.\n(sec.255-ssec.1) This section applies if, immediately before the commencement, a practice plan was in effect under the HDPR for either— an Aboriginal and Torres Strait Islander health practitioner; or a physician’s assistant.\n(sec.255-ssec.2) The practice plan is— if the practitioner is an Aboriginal and Torres Strait Islander health practitioner mentioned in schedule 3, part 1 on or after the commencement—taken to be a practice plan for the practitioner under that part; or if the practitioner is a physician assistant mentioned in schedule 6, part 3 on or after the commencement—taken to be a practice plan for the practitioner under that part.\n- (a) an Aboriginal and Torres Strait Islander health practitioner; or\n- (b) a physician’s assistant.\n- (a) if the practitioner is an Aboriginal and Torres Strait Islander health practitioner mentioned in schedule 3, part 1 on or after the commencement—taken to be a practice plan for the practitioner under that part; or\n- (b) if the practitioner is a physician assistant mentioned in schedule 6, part 3 on or after the commencement—taken to be a practice plan for the practitioner under that part.","sortOrder":346},{"sectionNumber":"sec.256","sectionType":"section","heading":"Chief executive’s approvals or certifications for bodies and facilities","content":"### sec.256 Chief executive’s approvals or certifications for bodies and facilities\n\nThis section applies if, immediately before the commencement, an approval or certification by the chief executive was in effect under the HDPR for—\na professional body; or\na facilities accreditation body; or\na laboratory; or\nanother facility.\nThe approval or certification continues in effect—\nto the extent the chief executive’s approval is required for the same purpose under this regulation for which the body or facility was approved or certified for; and\nuntil it is revoked by the chief executive.\n(sec.256-ssec.1) This section applies if, immediately before the commencement, an approval or certification by the chief executive was in effect under the HDPR for— a professional body; or a facilities accreditation body; or a laboratory; or another facility.\n(sec.256-ssec.2) The approval or certification continues in effect— to the extent the chief executive’s approval is required for the same purpose under this regulation for which the body or facility was approved or certified for; and until it is revoked by the chief executive.\n- (a) a professional body; or\n- (b) a facilities accreditation body; or\n- (c) a laboratory; or\n- (d) another facility.\n- (a) to the extent the chief executive’s approval is required for the same purpose under this regulation for which the body or facility was approved or certified for; and\n- (b) until it is revoked by the chief executive.","sortOrder":347},{"sectionNumber":"ch.10-pt.3","sectionType":"part","heading":"Transitional provision for Health Legislation Amendment Regulation (No. 2) 2025","content":"# Transitional provision for Health Legislation Amendment Regulation (No. 2) 2025","sortOrder":348},{"sectionNumber":"sec.257","sectionType":"section","heading":"Application of amended schedule 19, item 9 from 27 September 2021","content":"### sec.257 Application of amended schedule 19, item 9 from 27 September 2021\n\nAmended schedule 19, item 9 is taken to have applied from 27 September 2021.\nThis regulation commenced on 27 September 2021.\nIn this section—\namended schedule 19, item 9 means schedule 19, item 9 as amended by the Health Legislation Amendment Regulation (No. 2) 2025 .\ns 257 ins 2025 SL No. 151 s 6\n(sec.257-ssec.1) Amended schedule 19, item 9 is taken to have applied from 27 September 2021. This regulation commenced on 27 September 2021.\n(sec.257-ssec.2) In this section— amended schedule 19, item 9 means schedule 19, item 9 as amended by the Health Legislation Amendment Regulation (No. 2) 2025 .","sortOrder":349},{"sectionNumber":"ch.10-pt.4","sectionType":"part","heading":"Transitional provision for Medicines and Poisons (Medicines) Amendment Regulation 2026","content":"# Transitional provision for Medicines and Poisons (Medicines) Amendment Regulation 2026","sortOrder":350},{"sectionNumber":"sec.258","sectionType":"section","heading":"Particular qualifications or training taken to be immunisation training","content":"### sec.258 Particular qualifications or training taken to be immunisation training\n\nThis section applies if, immediately before the commencement—\na person was required, for practising a profession under a former extended practice authority, to hold a particular qualification or have completed particular training to deal with a medicine stated in the authority to carry out an immunisation program or service; and\nthe person held the qualification or had completed the training.\nFrom the commencement, for applying schedule 3 , 7 or 9 to the person practising the profession, the person is taken to have completed immunisation training to carry out the same type of dealing with any immunisation medicine.\nIn this section—\nformer extended practice authority means an extended practice authority in effect immediately before the commencement.\ns 258 ins 2026 SL No. 16 s 4\n(sec.258-ssec.1) This section applies if, immediately before the commencement— a person was required, for practising a profession under a former extended practice authority, to hold a particular qualification or have completed particular training to deal with a medicine stated in the authority to carry out an immunisation program or service; and the person held the qualification or had completed the training.\n(sec.258-ssec.2) From the commencement, for applying schedule 3 , 7 or 9 to the person practising the profession, the person is taken to have completed immunisation training to carry out the same type of dealing with any immunisation medicine.\n(sec.258-ssec.3) In this section— former extended practice authority means an extended practice authority in effect immediately before the commencement.\n- (a) a person was required, for practising a profession under a former extended practice authority, to hold a particular qualification or have completed particular training to deal with a medicine stated in the authority to carry out an immunisation program or service; and\n- (b) the person held the qualification or had completed the training.","sortOrder":351},{"sectionNumber":"sch.1-pt.1","sectionType":"part","heading":"Approved extended practice authorities","content":"# Approved extended practice authorities","sortOrder":352},{"sectionNumber":"sch.1-pt.2","sectionType":"part","heading":"Approved departmental standards","content":"# Approved departmental standards","sortOrder":353},{"sectionNumber":"sch.2-pt.1","sectionType":"part","heading":"Restricted medicines","content":"# Restricted medicines","sortOrder":354},{"sectionNumber":"sch.2-pt.1-div.1","sectionType":"division","heading":"Medicines for human use","content":"## Medicines for human use","sortOrder":355},{"sectionNumber":"sch.2-pt.1-div.2","sectionType":"division","heading":"Other medicines","content":"## Other medicines","sortOrder":356},{"sectionNumber":"sch.2-pt.2","sectionType":"part","heading":"High-risk medicines","content":"# High-risk medicines","sortOrder":357},{"sectionNumber":"sch.2-pt.3","sectionType":"part","heading":"Diversion-risk medicines","content":"# Diversion-risk medicines","sortOrder":358},{"sectionNumber":"sch.2-pt.4","sectionType":"part","heading":"Monitored medicines","content":"# Monitored medicines","sortOrder":359},{"sectionNumber":"sch.3-pt.1","sectionType":"part","heading":"Aboriginal and Torres Strait Islander health practitioners","content":"# Aboriginal and Torres Strait Islander health practitioners","sortOrder":360},{"sectionNumber":"sch.3-pt.1-div.1","sectionType":"division","heading":"Preliminary","content":"## Preliminary","sortOrder":361},{"sectionNumber":"sch.3-sec.1","sectionType":"section","heading":"Definitions for part","content":"### sch.3-sec.1 Definitions for part\n\nIn this part—\nAboriginal and Torres Strait Islander health practitioner means a person registered under the Health Practitioner Regulation National Law to practise in the Aboriginal and Torres Strait Islander health practice profession.\npractice plan , for an Aboriginal and Torres Strait Islander health practitioner, means a document in the approved form—\ndeveloped and signed by the health practitioner and the primary clinical supervisor for the practitioner; and\nstating the circumstances and conditions for the practitioner to administer or give a treatment dose of a medicine.\nprimary clinical supervisor , for an Aboriginal and Torres Strait Islander health practitioner, means the person who has primary responsibility for supervising the clinical work performed by the health practitioner for the practitioner’s employment in a relevant health service.\nrelevant health service ...\nsch 3 s 1 def relevant health service om 2023 SL No. 6 s 6 (2)\n- (a) developed and signed by the health practitioner and the primary clinical supervisor for the practitioner; and\n- (b) stating the circumstances and conditions for the practitioner to administer or give a treatment dose of a medicine.","sortOrder":362},{"sectionNumber":"sch.3-pt.1-div.2","sectionType":"division","heading":"Aboriginal and Torres Strait Islander health practitioners","content":"## Aboriginal and Torres Strait Islander health practitioners","sortOrder":363},{"sectionNumber":"sch.3-sec.2","sectionType":"section","heading":"Class of person","content":"### sch.3-sec.2 Class of person\n\nAn Aboriginal and Torres Strait Islander health practitioner who is employed by a relevant health service.\nsch 3 s 2 sub 2023 SL No. 6 s 6 (3)","sortOrder":364},{"sectionNumber":"sch.3-sec.3","sectionType":"section","heading":"Dealing authorised","content":"### sch.3-sec.3 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a treatment dose\na medicine mentioned in the extended practice authority called ‘Aboriginal and Torres Strait Islander health practitioners’\nthe medicine is given—\nunder the extended practice authority; and\nin accordance with a practice plan for the Aboriginal and Torres Strait Islander health practitioner\nan S2 medicine that is paracetamol\nthe medicine is given for the treatment of a side effect, or a potential side effect, of an immunisation medicine\n2\nrepackage\na medicine mentioned in the extended practice authority called ‘Aboriginal and Torres Strait Islander health practitioners’\nthe medicine is repackaged for giving a treatment dose under the extended practice authority\n3\nadminister\na medicine mentioned in the extended practice authority called ‘Aboriginal and Torres Strait Islander health practitioners’\nthe medicine is administered—\nunder the extended practice authority; and\nin accordance with a practice plan for the Aboriginal and Torres Strait Islander health practitioner\nan S4 medicine that is an immunisation medicine\nthe Aboriginal and Torres Strait Islander health practitioner has completed immunisation training\nadrenaline (epinephrine)\nthe medicine is administered to treat anaphylaxis\nan S2 medicine that is paracetamol\nthe medicine is administered for the treatment of a side effect, or a potential side effect, of an immunisation medicine\n4\ngive a purchase order\nstock of a medicine mentioned in the extended practice authority called ‘Aboriginal and Torres Strait Islander health practitioners’\nthe purchase order—\nis given under the extended practice authority; and\nis for stock for the relevant health service to be used in a place in an isolated practice area\nstock of an S4 medicine that is an immunisation medicine\nthe Aboriginal and Torres Strait Islander health practitioner has completed immunisation training\n5\npossess\nan S4 or S8 medicine mentioned in this column\nthe medicine is possessed for a purpose mentioned in this column\n6\ndispose\nwaste from a diversion-risk medicine mentioned in this column\nsch 3 s 3 amd 2023 SL No. 6 s 6 (4) ; 2026 SL No. 16 s 6","sortOrder":365},{"sectionNumber":"sch.3-pt.1A","sectionType":"part","heading":"Aboriginal and Torres Strait Islander health workers","content":"# Aboriginal and Torres Strait Islander health workers","sortOrder":366},{"sectionNumber":"sch.3-pt.1A-div.1","sectionType":"division","heading":"Preliminary","content":"## Preliminary","sortOrder":367},{"sectionNumber":"sch.3-sec.3A","sectionType":"section","heading":"Definitions for part","content":"### sch.3-sec.3A Definitions for part\n\nIn this part—\nAboriginal and Torres Strait Islander health worker means a person who holds—\na Certificate III in Aboriginal and Torres Strait Islander Primary Health Care; or\na qualification in Aboriginal and Torres Strait Islander primary health that is higher than the qualification mentioned in paragraph (a) .\npractice plan , for an Aboriginal and Torres Strait Islander health worker, means a document in the approved form—\ndeveloped and signed by the worker and the primary clinical supervisor for the worker; and\nstating the circumstances and conditions for the worker to administer a medicine.\nprimary clinical supervisor , for an Aboriginal and Torres Strait Islander health worker, means the person who has primary responsibility for supervising the clinical work performed by the worker for the worker’s employment in a relevant health service.\nsch 3 s 3A ins 2023 SL No. 6 s 6 (5)\n- (a) a Certificate III in Aboriginal and Torres Strait Islander Primary Health Care; or\n- (b) a qualification in Aboriginal and Torres Strait Islander primary health that is higher than the qualification mentioned in paragraph (a) .\n- (a) developed and signed by the worker and the primary clinical supervisor for the worker; and\n- (b) stating the circumstances and conditions for the worker to administer a medicine.","sortOrder":368},{"sectionNumber":"sch.3-pt.1A-div.2","sectionType":"division","heading":"Aboriginal and Torres Strait Islander health workers","content":"## Aboriginal and Torres Strait Islander health workers","sortOrder":369},{"sectionNumber":"sch.3-sec.3B","sectionType":"section","heading":"Class of person","content":"### sch.3-sec.3B Class of person\n\nAn Aboriginal and Torres Strait Islander health worker who is employed by a relevant health service.\nsch 3 s 3B ins 2023 SL No. 6 s 6 (5)","sortOrder":370},{"sectionNumber":"sch.3-sec.3C","sectionType":"section","heading":"Dealing authorised","content":"### sch.3-sec.3C Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\na medicine mentioned in the extended practice authority called ‘Aboriginal and Torres Strait Islander health workers’\nthe medicine is administered—\nunder the extended practice authority; and\nin accordance with a practice plan for the Aboriginal and Torres Strait Islander health worker\n2\npossess\nan S4 medicine mentioned in the extended practice authority called ‘Aboriginal and Torres Strait Islander health workers’\nthe medicine is possessed under the extended practice authority\nsch 3 s 3C ins 2023 SL No. 6 s 6 (5)","sortOrder":371},{"sectionNumber":"sch.3-pt.2","sectionType":"part","heading":"Indigenous health workers in remote areas","content":"# Indigenous health workers in remote areas","sortOrder":372},{"sectionNumber":"sch.3-pt.2-div.1","sectionType":"division","heading":"Preliminary","content":"## Preliminary","sortOrder":373},{"sectionNumber":"sch.3-sec.4","sectionType":"section","heading":"Definition for part","content":"### sch.3-sec.4 Definition for part\n\nIn this part—\nIndigenous health worker means a person who—\nholds a Diploma of Health Science ATSI Primary Health Care (Generalist) ASF 5 from a college of technical and further education or an equivalent qualification approved by the chief executive; and\nhas successfully completed the North Queensland Rural Health Training Unit Isolated Practice Course, or an equivalent course of training approved by the chief executive, for the accreditation of registered nurses for practice in an isolated practice area.\n- (a) holds a Diploma of Health Science ATSI Primary Health Care (Generalist) ASF 5 from a college of technical and further education or an equivalent qualification approved by the chief executive; and\n- (b) has successfully completed the North Queensland Rural Health Training Unit Isolated Practice Course, or an equivalent course of training approved by the chief executive, for the accreditation of registered nurses for practice in an isolated practice area.","sortOrder":374},{"sectionNumber":"sch.3-pt.2-div.2","sectionType":"division","heading":"Indigenous health workers in remote areas","content":"## Indigenous health workers in remote areas","sortOrder":375},{"sectionNumber":"sch.3-sec.5","sectionType":"section","heading":"Class of person","content":"### sch.3-sec.5 Class of person\n\nAn Indigenous health worker who—\nis practising in an isolated practice area; and\nis employed by any of the following Hospital and Health Services—\nCairns and Hinterland Hospital and Health Service;\nNorth West Hospital and Health Service;\nTorres and Cape Hospital and Health Service.\n- (a) is practising in an isolated practice area; and\n- (b) is employed by any of the following Hospital and Health Services— (i) Cairns and Hinterland Hospital and Health Service; (ii) North West Hospital and Health Service; (iii) Torres and Cape Hospital and Health Service.\n- (i) Cairns and Hinterland Hospital and Health Service;\n- (ii) North West Hospital and Health Service;\n- (iii) Torres and Cape Hospital and Health Service.\n- (i) Cairns and Hinterland Hospital and Health Service;\n- (ii) North West Hospital and Health Service;\n- (iii) Torres and Cape Hospital and Health Service.","sortOrder":376},{"sectionNumber":"sch.3-sec.6","sectionType":"section","heading":"Dealing authorised","content":"### sch.3-sec.6 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a treatment dose\na medicine mentioned in the extended practice authority called ‘Indigenous health workers’\nthe medicine is given for a patient under the extended practice authority\n2\nrepackage\na medicine mentioned in the extended practice authority called ‘Indigenous health workers’\nthe medicine is repackaged for giving a treatment dose under the extended practice authority\n3\nadminister\na medicine mentioned in the extended practice authority called ‘Indigenous health workers’\nthe medicine is administered under the extended practice authority\n4\npossess\nan S4 or S8 medicine mentioned in this column\nthe medicine is possessed for a purpose mentioned in this column\n5\ndispose\nwaste from a diversion-risk medicine mentioned in this column","sortOrder":377},{"sectionNumber":"sch.3-pt.3","sectionType":"part","heading":"Practitioners employed by approved Aboriginal health services","content":"# Practitioners employed by approved Aboriginal health services","sortOrder":378},{"sectionNumber":"sch.3-sec.7","sectionType":"section","heading":"Class of person","content":"### sch.3-sec.7 Class of person\n\nA person who is employed by an approved Aboriginal health service under the National Health (Remote Area Aboriginal Health Services Program) Special Arrangement 2017 (PB 107 of 2017) (Cwlth) .","sortOrder":379},{"sectionNumber":"sch.3-sec.8","sectionType":"section","heading":"Dealing authorised","content":"### sch.3-sec.8 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a purchase order\nstock of an S4 or S8 medicine\nthe stock is for the approved Aboriginal health service\n2\npossess\nstock of an S4 or S8 medicine\nthe stock is possessed for the approved Aboriginal health service\n3\ndispose\nwaste from a diversion-risk medicine mentioned in this column","sortOrder":380},{"sectionNumber":"sch.4-pt.1","sectionType":"part","heading":"Dentists","content":"# Dentists","sortOrder":381},{"sectionNumber":"sch.4-pt.1-div.1","sectionType":"division","heading":"Dentists generally","content":"## Dentists generally","sortOrder":382},{"sectionNumber":"sch.4-sec.1","sectionType":"section","heading":"Definition for division","content":"### sch.4-sec.1 Definition for division\n\nIn this division—\nimmediate release formulation , of a medicine, means a formulation of the medicine in which the rate of release and absorption of the medicine is not appreciably or intentionally modified by the way in which it is formulated.","sortOrder":383},{"sectionNumber":"sch.4-sec.2","sectionType":"section","heading":"Class of person","content":"### sch.4-sec.2 Class of person\n\nA person (a dentist ) who is registered under the Health Practitioner Regulation National Law to practise in the dentists division of the dental profession.","sortOrder":384},{"sectionNumber":"sch.4-sec.3","sectionType":"section","heading":"Dealing authorised","content":"### sch.4-sec.3 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\nan S2, S3 or S4 medicine, other than a restricted medicine\nany of the following S8 medicines—\ncodeine;\nhydromorphone;\nmorphine;\noxycodone\nthe medicine is in an immediate release formulation—\nfor which a repeat prescription is not given; and\nthat is no more than 3 days supply\n2\ngive a treatment dose\nan S2, S3 or S4 medicine, other than a restricted medicine\n3\nrepackage\nan S2, S3 or S4 medicine, other than a restricted medicine\nthe medicine is repackaged for giving a treatment dose for a patient\n4\nadminister\nan S2, S3 or S4 medicine, other than a restricted medicine\nany of the following S8 medicines—\ncodeine;\nhydromorphone;\nmorphine;\noxycodone\nthe medicine is in an immediate release formulation\n5\ngive a purchase order\nstock of an S4 or S8 medicine mentioned in this column\nthe stock is not for a specified place\n6\npossess\nan S4 or S8 medicine mentioned in this column\nthe medicine is possessed for a purpose mentioned in this column\n7\ndispose\nwaste from a diversion-risk medicine mentioned in this column","sortOrder":385},{"sectionNumber":"sch.4-pt.1-div.2","sectionType":"division","heading":"Endorsed conscious sedation dentists","content":"## Endorsed conscious sedation dentists","sortOrder":386},{"sectionNumber":"sch.4-sec.4","sectionType":"section","heading":"Class of person","content":"### sch.4-sec.4 Class of person\n\nA dentist who is endorsed for conscious sedation.","sortOrder":387},{"sectionNumber":"sch.4-sec.5","sectionType":"section","heading":"Dealing authorised","content":"### sch.4-sec.5 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nfentanyl or pethidine\n2\ngive a purchase order\nstock of fentanyl or pethidine\nthe stock is not for a specified place\n3\npossess\nfentanyl or pethidine","sortOrder":388},{"sectionNumber":"sch.4-pt.1-div.3","sectionType":"division","heading":null,"content":"","sortOrder":389},{"sectionNumber":"sch.4-sec.6","sectionType":"section","heading":null,"content":"### Section sch.4-sec.6\n\nsch 4 s 6 om 2025 SL No. 148 s 10","sortOrder":390},{"sectionNumber":"sch.4-sec.7","sectionType":"section","heading":null,"content":"### Section sch.4-sec.7\n\nsch 4 s 7 om 2025 SL No. 148 s 10","sortOrder":391},{"sectionNumber":"sch.4-pt.2","sectionType":"part","heading":"Dental hygienists","content":"# Dental hygienists","sortOrder":392},{"sectionNumber":"sch.4-sec.8","sectionType":"section","heading":"Class of person","content":"### sch.4-sec.8 Class of person\n\nA person (a dental hygienist ) who is registered under the Health Practitioner Regulation National Law to practise in the dental hygienists division of the dental profession.","sortOrder":393},{"sectionNumber":"sch.4-sec.9","sectionType":"section","heading":"Dealing authorised","content":"### sch.4-sec.9 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nany of the following S2 or S3 medicines—\nan adrenaline (epinephrine) device;\nlocal anaesthetics in preparations for topical human therapeutic use (other than eye drops);\nfluorides in preparations for topical human therapeutic use;\nsilver salts\nlocal anaesthetics, whether alone or in combination with adrenaline (epinephrine) or felypressin\n2\ngive a purchase order\nan S4 medicine that is a local anaesthetic\nthe stock is not for a specified place\n3\npossess\nan S4 medicine that is a local anaesthetic\nsch 4 s 9 amd 2025 SL No. 148 s 11","sortOrder":394},{"sectionNumber":"sch.4-pt.3","sectionType":"part","heading":"Dental therapists","content":"# Dental therapists","sortOrder":395},{"sectionNumber":"sch.4-sec.10","sectionType":"section","heading":"Class of person","content":"### sch.4-sec.10 Class of person\n\nA person (a dental therapist ) who is registered under the Health Practitioner Regulation National Law to practise in the dental therapists division of the dental profession.","sortOrder":396},{"sectionNumber":"sch.4-sec.11","sectionType":"section","heading":"Dealing authorised","content":"### sch.4-sec.11 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nany of the following S2 or S3 medicines—\nan adrenaline (epinephrine) device;\nlocal anaesthetics in preparations for topical human therapeutic use (other than eye drops);\nether;\nferric sulphate;\nfluorides in preparations for topical human therapeutic use;\nphenol;\nsilver salts\nany of the following S4 medicines—\nlocal anaesthetics, whether alone or in combination with adrenaline (epinephrine) or felypressin;\nantibiotics and corticosteroids in combination for topical endodontic use;\nmercury for human therapeutic use\n2\ngive a purchase order\nan S4 medicine mentioned in this column\nthe stock is not for a specified place\n3\npossess\nan S4 medicine mentioned in this column\nsch 4 s 11 amd 2025 SL No. 148 s 12","sortOrder":397},{"sectionNumber":"sch.4-pt.4","sectionType":"part","heading":"Oral health therapists","content":"# Oral health therapists","sortOrder":398},{"sectionNumber":"sch.4-sec.12","sectionType":"section","heading":"Class of person","content":"### sch.4-sec.12 Class of person\n\nA person (an oral health therapist ) who is registered under the Health Practitioner Regulation National Law to practise in the oral health therapists division of the dental profession.","sortOrder":399},{"sectionNumber":"sch.4-sec.13","sectionType":"section","heading":"Dealing authorised","content":"### sch.4-sec.13 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nany of the following S2 or S3 medicines—\nan adrenaline (epinephrine) device;\nlocal anaesthetics in preparations for topical human therapeutic use (other than eye drops);\nether;\nferric sulphate;\nfluorides in preparations for topical human therapeutic use;\nphenol;\nsilver salts\nany of the following S4 medicines—\nlocal anaesthetics, whether alone or in combination with adrenaline (epinephrine) or felypressin;\nantibiotics and corticosteroids in combination for topical endodontic use;\nmercury for human therapeutic use\n2\ngive a purchase order\nan S4 medicine mentioned in this column\nthe stock is not for a specified place\n3\npossess\nan S4 medicine mentioned in this column\nsch 4 s 13 amd 2025 SL No. 148 s 13","sortOrder":400},{"sectionNumber":"sch.4-pt.5","sectionType":"part","heading":"Hospital and health service dental assistants","content":"# Hospital and health service dental assistants","sortOrder":401},{"sectionNumber":"sch.4-pt.5-div.1","sectionType":"division","heading":"Preliminary","content":"## Preliminary","sortOrder":402},{"sectionNumber":"sch.4-sec.14","sectionType":"section","heading":"Definitions for part","content":"### sch.4-sec.14 Definitions for part\n\nIn this part—\ndental hygienist see section 8 of this schedule.\ndental practitioner means a dentist, dental hygienist, dental therapist or oral health therapist.\ndental therapist see section 10 of this schedule.\noral health therapist see section 12 of this schedule.\ns 14 ins 2025 SL No. 60 s 14","sortOrder":403},{"sectionNumber":"sch.4-pt.5-div.2","sectionType":"division","heading":"Hospital and health service dental assistants","content":"## Hospital and health service dental assistants","sortOrder":404},{"sectionNumber":"sch.4-sec.15","sectionType":"section","heading":"Class of person","content":"### sch.4-sec.15 Class of person\n\nA person who is employed as a dental assistant by a Hospital and Health Service.\ns 15 ins 2025 SL No. 60 s 14","sortOrder":405},{"sectionNumber":"sch.4-sec.16","sectionType":"section","heading":"Dealing authorised","content":"### sch.4-sec.16 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nan S4 medicine that is fluoride in a preparation for human use\nthe medicine is administered under the supervision of a dental practitioner\n2\npossess\nan S4 medicine that is fluoride in a preparation for human use\nthe medicine is possessed under the supervision of a dental practitioner\ns 16 ins 2025 SL No. 60 s 14","sortOrder":406},{"sectionNumber":"sch.5-pt.1","sectionType":"part","heading":"Queensland Ambulance Service officers","content":"# Queensland Ambulance Service officers","sortOrder":407},{"sectionNumber":"sch.5-pt.1-div.1","sectionType":"division","heading":"Commissioner or delegates","content":"## Commissioner or delegates","sortOrder":408},{"sectionNumber":"sch.5-sec.1","sectionType":"section","heading":"Class of person","content":"### sch.5-sec.1 Class of person\n\nA person who is the commissioner of the Queensland Ambulance Service under the Ambulance Service Act 1991 or is exercising a power under that Act as the commissioner’s delegate.","sortOrder":409},{"sectionNumber":"sch.5-sec.2","sectionType":"section","heading":"Dealing authorised","content":"### sch.5-sec.2 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a purchase order\nstock of an S4 or S8 medicine\nthe purchase order is given for the Queensland Ambulance Service\n2\npossess\nstock of an S4 or S8 medicine\nthe stock is possessed for the Queensland Ambulance Service\n3\ndispose\nwaste from a diversion-risk medicine that is an S4 or S8 medicine","sortOrder":410},{"sectionNumber":"sch.5-pt.1-div.2","sectionType":"division","heading":"Ambulance officers","content":"## Ambulance officers","sortOrder":411},{"sectionNumber":"sch.5-sec.3","sectionType":"section","heading":"Class of person","content":"### sch.5-sec.3 Class of person\n\nA person who is an ambulance officer under the Ambulance Service Act 1991 .","sortOrder":412},{"sectionNumber":"sch.5-sec.4","sectionType":"section","heading":"Dealing authorised","content":"### sch.5-sec.4 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a treatment dose\na medicine mentioned in the extended practice authority called ‘Queensland Ambulance Service’\nthe medicine is given under the extended practice authority\n2\nadminister\na medicine mentioned in the extended practice authority called ‘Queensland Ambulance Service’\nthe medicine is administered under the extended practice authority\n3\npossess\nan S4 or S8 medicine mentioned in the extended practice authority called ‘Queensland Ambulance Service’\nthe medicine is possessed under the extended practice authority\n4\ndispose\nwaste from a diversion-risk medicine mentioned in this column","sortOrder":413},{"sectionNumber":"sch.5-pt.2","sectionType":"part","heading":"First aid providers","content":"# First aid providers","sortOrder":414},{"sectionNumber":"sch.5-sec.5","sectionType":"section","heading":"Class of person","content":"### sch.5-sec.5 Class of person\n\nA person (a first aid provider ) who has a current certificate granted by a registered training organisation for the provision of first aid.","sortOrder":415},{"sectionNumber":"sch.5-sec.6","sectionType":"section","heading":"Dealing authorised","content":"### sch.5-sec.6 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nmethoxyflurane\nthe medicine is administered on a prescription\nthe first aid provider has completed methoxyflurane training\nan adrenaline (epinephrine) device\nthe first aid provider has completed anaphylaxis training\nnaloxone\nthe first aid provider has completed naloxone training\ninhaled asthma reliever, other than an S4 medicine\nthe first aid provider has completed asthma training\n2\npossess\nan S4 medicine mentioned in this column\nthe medicine is possessed for a purpose mentioned in this column\nsch 5 s 6 amd 2025 SL No. 148 s 14","sortOrder":416},{"sectionNumber":"sch.5-pt.3","sectionType":"part","heading":"Royal Flying Doctor Service workers","content":"# Royal Flying Doctor Service workers","sortOrder":417},{"sectionNumber":"sch.5-sec.7","sectionType":"section","heading":"Definition for part","content":"### sch.5-sec.7 Definition for part\n\nIn this part—\nRFDS medicine chest means a medicine chest kept at a place for the Royal Flying Doctor Service of Australia if the medicine chest is approved by a medical practitioner who is—\nemployed by the Royal Flying Doctor Service of Australia; and\nauthorised in writing by the Royal Flying Doctor Service of Australia to approve the keeping of medicine chests.\n- (a) employed by the Royal Flying Doctor Service of Australia; and\n- (b) authorised in writing by the Royal Flying Doctor Service of Australia to approve the keeping of medicine chests.","sortOrder":418},{"sectionNumber":"sch.5-sec.8","sectionType":"section","heading":"Class of person","content":"### sch.5-sec.8 Class of person\n\nA person who—\nis a worker for the Royal Flying Doctor Service of Australia; and\nis in charge of an RFDS medicine chest.\n- (a) is a worker for the Royal Flying Doctor Service of Australia; and\n- (b) is in charge of an RFDS medicine chest.","sortOrder":419},{"sectionNumber":"sch.5-sec.9","sectionType":"section","heading":"Dealing authorised","content":"### sch.5-sec.9 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a treatment dose\na medicine from the RFDS medicine chest\nthe medicine is given on a prescription\n2\nadminister\na medicine from the RFDS medicine chest\nthe medicine is administered on a prescription\n3\npossess\nan S4 or S8 medicine from the RFDS medicine chest\nthe medicine is possessed for a purpose mentioned in this column","sortOrder":420},{"sectionNumber":"sch.6-pt.1","sectionType":"part","heading":"Medical practitioners generally","content":"# Medical practitioners generally","sortOrder":421},{"sectionNumber":"sch.6-pt.1-div.1","sectionType":"division","heading":"Dealing with non-restricted medicines and waste from diversion-risk medicines","content":"## Dealing with non-restricted medicines and waste from diversion-risk medicines","sortOrder":422},{"sectionNumber":"sch.6-sec.1","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.1 Class of person\n\nA person (a medical practitioner ) who is registered under the Health Practitioner Regulation National Law to practise in the medical profession.","sortOrder":423},{"sectionNumber":"sch.6-sec.2","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.2 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\na non-restricted medicine\n2\nmake a standing order\na non-restricted medicine\n3\ndispense\na non-restricted medicine\n4\ngive a treatment dose\na non-restricted medicine\n5\nadminister\na non-restricted medicine\n6\nrepackage\na non-restricted medicine\n7\ngive a purchase order\nstock of an S4 or S8 medicine that is a non-restricted medicine\nthe stock is not for a specified place\n8\npossess\nan S4 or S8 medicine that is a non-restricted medicine\n9\ndispose\nwaste from a diversion-risk medicine","sortOrder":424},{"sectionNumber":"sch.6-pt.1-div.2","sectionType":"division","heading":"Dispensing restricted medicines prescribed by other practitioners","content":"## Dispensing restricted medicines prescribed by other practitioners","sortOrder":425},{"sectionNumber":"sch.6-sec.3","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.3 Class of person\n\nA medical practitioner.","sortOrder":426},{"sectionNumber":"sch.6-sec.4","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.4 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ndispense\na restricted medicine\nthe medicine is dispensed on a prescription from another medical practitioner\n2\nrepackage\na restricted medicine\nthe medicine is repackaged for a patient to dispense a prescription from another medical practitioner\n3\ngive a purchase order\nstock of a restricted medicine\nthe stock—\nis required for dispensing prescriptions from other medical practitioners; and\nis not for a specified place\n4\npossess\na restricted medicine\nthe medicine is possessed for a purpose mentioned in this column","sortOrder":427},{"sectionNumber":"sch.6-pt.1-div.3","sectionType":"division","heading":"Continuing treatment with restricted medicines at particular institutions","content":"## Continuing treatment with restricted medicines at particular institutions","sortOrder":428},{"sectionNumber":"sch.6-sec.5","sectionType":"section","heading":"Definitions for division","content":"### sch.6-sec.5 Definitions for division\n\nIn this division—\ncontinuing institutional treatment , by a medical practitioner of a patient, means—\nthe practitioner is treating the patient in a hospital or custodial facility; and\nthe patient was being treated with the medicine within a reasonable period before—\nbeing admitted to the hospital or being taken into custody at the custodial facility; or\nbeing treated by the practitioner.\nsch 6 s 5 def continuing institutional treatment amd 2025 SL No. 90 s 4 (3)\ncontinuing opioid dependence treatment , by a medical practitioner of a patient, means—\nthe practitioner is treating the patient with an approved opioid in a hospital or custodial facility; and\nthe patient was being treated with the approved opioid under an opioid treatment program within a reasonable period before—\nbeing admitted to the hospital or being taken into custody at the custodial facility; or\nbeing treated by the practitioner.\nsch 6 s 5 def continuing opioid dependence treatment ins 2025 SL No. 90 s 4 (2)\nsch 6 s 5 amd 2025 SL No. 90 s 4 (1)\n- (a) the practitioner is treating the patient in a hospital or custodial facility; and\n- (b) the patient was being treated with the medicine within a reasonable period before— (i) being admitted to the hospital or being taken into custody at the custodial facility; or (ii) being treated by the practitioner.\n- (i) being admitted to the hospital or being taken into custody at the custodial facility; or\n- (ii) being treated by the practitioner.\n- (i) being admitted to the hospital or being taken into custody at the custodial facility; or\n- (ii) being treated by the practitioner.\n- (a) the practitioner is treating the patient with an approved opioid in a hospital or custodial facility; and\n- (b) the patient was being treated with the approved opioid under an opioid treatment program within a reasonable period before— (i) being admitted to the hospital or being taken into custody at the custodial facility; or (ii) being treated by the practitioner.\n- (i) being admitted to the hospital or being taken into custody at the custodial facility; or\n- (ii) being treated by the practitioner.\n- (i) being admitted to the hospital or being taken into custody at the custodial facility; or\n- (ii) being treated by the practitioner.","sortOrder":429},{"sectionNumber":"sch.6-sec.6","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.6 Class of person\n\nA medical practitioner.","sortOrder":430},{"sectionNumber":"sch.6-sec.7","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.7 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\na restricted medicine, other than an approved opioid\nthe medicine is prescribed for administration by a health practitioner—\nfor the continuing institutional treatment of a patient; and\nunder the supervision of a registrar or specialist medical practitioner authorised to prescribe the medicine\nan approved opioid\nthe medicine is prescribed for administration by a health practitioner for the continuing opioid dependence treatment of a patient\n2\nadminister\na restricted medicine, other than an approved opioid\nthe medicine is administered—\nfor the continuing institutional treatment of a patient; and\nunder the supervision of a registrar or specialist medical practitioner authorised to administer the medicine\nan approved opioid\nthe medicine is administered for the continuing opioid dependence treatment of a patient\n3\npossess\na restricted medicine, other than an approved opioid\nthe medicine is possessed—\nfor the continuing institutional treatment of a patient; and\nunder the supervision of a registrar or specialist medical practitioner authorised to possess the medicine\nan approved opioid\nthe medicine is possessed for the continuing opioid dependence treatment of a patient\nsch 6 s 7 amd 2025 SL No. 90 s 4 (4)","sortOrder":431},{"sectionNumber":"sch.6-pt.1-div.4","sectionType":"division","heading":null,"content":"","sortOrder":432},{"sectionNumber":"sch.6-sec.8","sectionType":"section","heading":null,"content":"### Section sch.6-sec.8\n\nsch 6 s 8 om 2025 SL No. 148 s 15","sortOrder":433},{"sectionNumber":"sch.6-sec.9","sectionType":"section","heading":null,"content":"### Section sch.6-sec.9\n\nsch 6 s 9 om 2025 SL No. 148 s 15","sortOrder":434},{"sectionNumber":"sch.6-sec.10","sectionType":"section","heading":null,"content":"### Section sch.6-sec.10\n\nsch 6 s 10 om 2025 SL No. 148 s 15","sortOrder":435},{"sectionNumber":"sch.6-pt.1-div.5","sectionType":"division","heading":"Dealing with psychostimulant medicines","content":"## Dealing with psychostimulant medicines","sortOrder":436},{"sectionNumber":"sch.6-sec.11","sectionType":"section","heading":"Definition for division","content":"### sch.6-sec.11 Definition for division\n\nIn this division—\nrelevant condition means—\nnarcolepsy; or\nADHD, or brain injury, of a child patient who is 4 years or more.\nsch 6 s 11 sub 2025 SL No. 148 s 16\n- (a) narcolepsy; or\n- (b) ADHD, or brain injury, of a child patient who is 4 years or more.","sortOrder":437},{"sectionNumber":"sch.6-sec.12","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.12 Class of person\n\nA medical practitioner.\nsch 6 s 12 sub 2025 SL No. 148 s 16","sortOrder":438},{"sectionNumber":"sch.6-sec.13","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.13 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\na psychostimulant medicine\nthe medicine is prescribed for the treatment of a relevant condition\n2\ngive a treatment dose\na psychostimulant medicine\nthe medicine is given for the treatment of a relevant condition\n3\ndispense\na psychostimulant medicine\nthe medicine is dispensed for the treatment of a relevant condition\n4\nadminister\na psychostimulant medicine\nthe medicine is administered for the treatment of a relevant condition\n5\ngive a purchase order\nstock of a psychostimulant medicine\nthe stock is for the treatment of relevant conditions, other than at a specified place\n6\npossess\na psychostimulant medicine\nthe medicine is possessed for a purpose mentioned in this column\nsch 6 s 13 sub 2025 SL No. 148 s 16","sortOrder":439},{"sectionNumber":"sch.6-pt.1-div.6","sectionType":"division","heading":"Giving purchase orders at relevant institutions","content":"## Giving purchase orders at relevant institutions","sortOrder":440},{"sectionNumber":"sch.6-sec.14","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.14 Class of person\n\nA medical practitioner who is in charge of clinical or medical services at a relevant institution.","sortOrder":441},{"sectionNumber":"sch.6-sec.15","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.15 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a purchase order\nstock of an S4 or S8 medicine\nthe purchase order is given for the relevant institution; and\nthe purchase order is given for the therapeutic treatment of patients at the relevant institution\n2\npossess\nstock of an S4 or S8 medicine\nthe stock is possessed at the relevant institution","sortOrder":442},{"sectionNumber":"sch.6-pt.2","sectionType":"part","heading":"Specialist medical practitioners and registrars","content":"# Specialist medical practitioners and registrars","sortOrder":443},{"sectionNumber":"sch.6-pt.2-div.1","sectionType":"division","heading":"Registrars","content":"## Registrars","sortOrder":444},{"sectionNumber":"sch.6-sec.16","sectionType":"section","heading":"Definition for division","content":"### sch.6-sec.16 Definition for division\n\nIn this division—\nrelevant restricted medicine , for a registrar, means a restricted medicine relating to the specialty area of practice in which the registrar is working.","sortOrder":445},{"sectionNumber":"sch.6-sec.17","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.17 Class of person\n\nA medical practitioner (a registrar ) employed as a registrar in a hospital working under the supervision of a medical practitioner who is a specialist in the specialty area of practice in which the registrar is working.","sortOrder":446},{"sectionNumber":"sch.6-sec.18","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.18 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\na relevant restricted medicine\n2\ngive a treatment dose\na relevant restricted medicine\n3\ndispense\na relevant restricted medicine\n4\nadminister\na relevant restricted medicine\n5\ngive a purchase order\nstock of a relevant restricted medicine\nthe stock is not for a specified place\n6\npossess\na relevant restricted medicine","sortOrder":447},{"sectionNumber":"sch.6-pt.2-div.2","sectionType":"division","heading":"Cardiologists","content":"## Cardiologists","sortOrder":448},{"sectionNumber":"sch.6-sec.19","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.19 Class of person\n\nA medical practitioner who is a specialist registrant in cardiology.","sortOrder":449},{"sectionNumber":"sch.6-sec.20","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.20 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\nambrisentan, bosentan, macitentan, riociguat or sitaxentan\n2\ngive a treatment dose\nambrisentan, bosentan, macitentan, riociguat or sitaxentan\n3\ndispense\nambrisentan, bosentan, macitentan, riociguat or sitaxentan\n4\nadminister\nambrisentan, bosentan, macitentan, riociguat or sitaxentan\n5\ngive a purchase order\nstock of a medicine mentioned in this column\nthe stock is not for a specified place\n6\npossess\na medicine mentioned in this column\nsch 6 s 20 amd 2023 SL No. 51 s 8 (1)","sortOrder":450},{"sectionNumber":"sch.6-pt.2-div.3","sectionType":"division","heading":"Dermatologists","content":"## Dermatologists","sortOrder":451},{"sectionNumber":"sch.6-sec.21","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.21 Class of person\n\nA medical practitioner who is a specialist registrant in dermatology.","sortOrder":452},{"sectionNumber":"sch.6-sec.22","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.22 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\nacitretin, alefacept, bexarotene, etretinate, isotretinoin for oral use, thalidomide or tretinoin for oral use\n2\ngive a treatment dose\nacitretin, alefacept, bexarotene, etretinate, isotretinoin for oral use, thalidomide or tretinoin for oral use\n3\ndispense\nacitretin, alefacept, bexarotene, etretinate, isotretinoin for oral use, thalidomide or tretinoin for oral use\n4\nadminister\nacitretin, alefacept, bexarotene, etretinate, isotretinoin for oral use, thalidomide or tretinoin for oral use\n5\ngive a purchase order\nstock of a medicine mentioned in this column\nthe stock is not for a specified place\n6\npossess\na medicine mentioned in this column\nsch 6 s 22 amd 2022 SL No. 77 s 10 (1) – (2) ; 2023 SL No. 51 s 8 (2) ; 2023 SL No. 170 s 10(1) ; 2025 SL No. 148 s 18","sortOrder":453},{"sectionNumber":"sch.6-pt.2-div.4","sectionType":"division","heading":null,"content":"","sortOrder":454},{"sectionNumber":"sch.6-sec.23","sectionType":"section","heading":null,"content":"### Section sch.6-sec.23\n\nsch 6 s 23 om 2025 SL No. 148 s 19","sortOrder":455},{"sectionNumber":"sch.6-sec.24","sectionType":"section","heading":null,"content":"### Section sch.6-sec.24\n\nsch 6 s 24 om 2025 SL No. 148 s 19","sortOrder":456},{"sectionNumber":"sch.6-pt.2-div.5","sectionType":"division","heading":"Endocrinologists","content":"## Endocrinologists","sortOrder":457},{"sectionNumber":"sch.6-sec.25","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.25 Class of person\n\nA medical practitioner who is a specialist registrant in endocrinology.","sortOrder":458},{"sectionNumber":"sch.6-sec.26","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.26 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\nclomifene, corifollitropin alfa, cyclofenil, dinoprost, dinoprostone, follitropin alpha, follitropin beta, follitropin delta, luteinising hormone, teriparatide or urofollitropin (human follicle stimulating hormone)\n2\ngive a treatment dose\nclomifene, corifollitropin alfa, cyclofenil, dinoprost, dinoprostone, follitropin alpha, follitropin beta, follitropin delta, luteinising hormone, teriparatide or urofollitropin (human follicle stimulating hormone)\n3\ndispense\nclomifene, corifollitropin alfa, cyclofenil, dinoprost, dinoprostone, follitropin alpha, follitropin beta, follitropin delta, luteinising hormone, teriparatide or urofollitropin (human follicle stimulating hormone)\n4\nadminister\nclomifene, corifollitropin alfa, cyclofenil, dinoprost, dinoprostone, follitropin alpha, follitropin beta, follitropin delta, luteinising hormone, teriparatide or urofollitropin (human follicle stimulating hormone)\n5\ngive a purchase order\nstock of a medicine mentioned in this column\nthe stock is not for a specified place\n6\npossess\na medicine mentioned in this column\nsch 6 s 26 amd 2023 SL No. 51 s 8 (3)","sortOrder":459},{"sectionNumber":"sch.6-pt.2-div.5A","sectionType":"division","heading":"General practitioners","content":"## General practitioners","sortOrder":460},{"sectionNumber":"sch.6-sec.26A","sectionType":"section","heading":"Definition for division","content":"### sch.6-sec.26A Definition for division\n\nIn this division—\nadult ADHD means ADHD of an adult patient.\nsch 6 s 26A prev sch 6 s 26A ins 2022 SL No. 77 s 10 (3)\nom 2023 SL No. 170 s 10 (2)\npres sch 6 s 26A ins 2025 SL No. 148 s 20","sortOrder":461},{"sectionNumber":"sch.6-sec.26B","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.26B Class of person\n\nA medical practitioner who is a specialist registrant in general practice.\nsch 6 s 26B prev sch 6 s 26B ins 2022 SL No. 77 s 10 (3)\nom 2023 SL No. 170 s 10 (2)\npres sch 6 s 26B ins 2025 SL No. 148 s 20","sortOrder":462},{"sectionNumber":"sch.6-sec.26C","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.26C Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\na psychostimulant medicine\nthe medicine is prescribed for the treatment of adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine\n2\ngive a treatment dose\na psychostimulant medicine\nthe medicine is given for the treatment of adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine\n3\ndispense\na psychostimulant medicine\nthe medicine is dispensed for the treatment of adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine\n4\nadminister\na psychostimulant medicine\nthe medicine is administered for the treatment of adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine\n5\ngive a purchase order\nstock of a psychostimulant medicine\nthe stock is for the treatment of adult ADHD, other than at a specified place\n6\npossess\na psychostimulant medicine\nthe medicine is possessed for a purpose mentioned in this column\nsch 6 s 26C ins 2025 SL No. 148 s 20","sortOrder":463},{"sectionNumber":"sch.6-pt.2-div.6","sectionType":"division","heading":"Geriatricians","content":"## Geriatricians","sortOrder":464},{"sectionNumber":"sch.6-sec.27","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.27 Class of person\n\nA medical practitioner who is a specialist registrant in geriatrics.","sortOrder":465},{"sectionNumber":"sch.6-sec.28","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.28 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\nteriparatide\n2\ngive a treatment dose\nteriparatide\n3\ndispense\nteriparatide\n4\nadminister\nteriparatide\n5\ngive a purchase order\nstock of teriparatide\nthe stock is not for a specified place\n6\npossess\nteriparatide","sortOrder":466},{"sectionNumber":"sch.6-pt.2-div.7","sectionType":"division","heading":"Gynaecologists and obstetricians","content":"## Gynaecologists and obstetricians","sortOrder":467},{"sectionNumber":"sch.6-sec.29","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.29 Class of person\n\nA medical practitioner who is a specialist registrant in gynaecology or obstetrics.","sortOrder":468},{"sectionNumber":"sch.6-sec.30","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.30 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\nclomifene, corifollitropin alfa, cyclofenil, dinoprost, dinoprostone, follitropin alpha, follitropin beta, follitropin delta, luteinising hormone or urofollitropin (human follicle stimulating hormone)\n2\ngive a treatment dose\nclomifene, corifollitropin alfa, cyclofenil, dinoprost, dinoprostone, follitropin alpha, follitropin beta, follitropin delta, luteinising hormone or urofollitropin (human follicle stimulating hormone)\n3\ndispense\nclomifene, corifollitropin alfa, cyclofenil, dinoprost, dinoprostone, follitropin alpha, follitropin beta, follitropin delta, luteinising hormone or urofollitropin (human follicle stimulating hormone)\n4\nadminister\nclomifene, corifollitropin alfa, cyclofenil, dinoprost, dinoprostone, follitropin alpha, follitropin beta, follitropin delta, luteinising hormone or urofollitropin (human follicle stimulating hormone)\n5\ngive a purchase order\nstock of a medicine mentioned in this column\nthe stock is not for a specified place\n6\npossess\na medicine mentioned in this column\nsch 6 s 30 amd 2023 SL No. 51 s 8 (4)","sortOrder":469},{"sectionNumber":"sch.6-pt.2-div.8","sectionType":"division","heading":"Haematologists","content":"## Haematologists","sortOrder":470},{"sectionNumber":"sch.6-sec.31","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.31 Class of person\n\nA medical practitioner who is a specialist registrant in haematology.","sortOrder":471},{"sectionNumber":"sch.6-sec.32","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.32 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\nbexarotene, lenalidomide, pomalidomide, thalidomide or tretinoin for oral use\n2\ngive a treatment dose\nbexarotene, lenalidomide, pomalidomide, thalidomide or tretinoin for oral use\n3\ndispense\nbexarotene, lenalidomide, pomalidomide, thalidomide or tretinoin for oral use\n4\nadminister\nbexarotene, lenalidomide, pomalidomide, thalidomide or tretinoin for oral use\n5\ngive a purchase order\nstock of a medicine mentioned in this column\nthe stock is not for a specified place\n6\npossess\na medicine mentioned in this column\nsch 6 s 32 amd 2022 SL No. 77 s 10 (1) ; 2025 SL No. 148 s 21","sortOrder":472},{"sectionNumber":"sch.6-pt.2-div.9","sectionType":"division","heading":null,"content":"","sortOrder":473},{"sectionNumber":"sch.6-sec.33","sectionType":"section","heading":null,"content":"### Section sch.6-sec.33\n\nsch 6 s 33 om 2025 SL No. 148 s 22","sortOrder":474},{"sectionNumber":"sch.6-sec.34","sectionType":"section","heading":null,"content":"### Section sch.6-sec.34\n\nsch 6 s 34 om 2025 SL No. 148 s 22","sortOrder":475},{"sectionNumber":"sch.6-pt.2-div.10","sectionType":"division","heading":"Infectious diseases specialists","content":"## Infectious diseases specialists","sortOrder":476},{"sectionNumber":"sch.6-sec.35","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.35 Class of person\n\nA medical practitioner who is a specialist registrant in infectious diseases.","sortOrder":477},{"sectionNumber":"sch.6-sec.36","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.36 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\nthalidomide\n2\ngive a treatment dose\nthalidomide\n3\ndispense\nthalidomide\n4\nadminister\nthalidomide\n5\ngive a purchase order\nstock of thalidomide\nthe stock is not for a specified place\n6\npossess\nthalidomide\nsch 6 s 36 amd 2022 SL No. 77 s 10 (4) ; 2023 SL No. 170 s 10 (3) ; 2025 SL No. 148 s 23","sortOrder":478},{"sectionNumber":"sch.6-pt.2-div.11","sectionType":"division","heading":null,"content":"","sortOrder":479},{"sectionNumber":"sch.6-sec.37","sectionType":"section","heading":null,"content":"### Section sch.6-sec.37\n\nsch 6 s 37 om 2025 SL No. 148 s 24","sortOrder":480},{"sectionNumber":"sch.6-sec.38","sectionType":"section","heading":null,"content":"### Section sch.6-sec.38\n\nsch 6 s 38 om 2025 SL No. 148 s 24","sortOrder":481},{"sectionNumber":"sch.6-pt.2-div.12","sectionType":"division","heading":"Medical oncologists","content":"## Medical oncologists","sortOrder":482},{"sectionNumber":"sch.6-sec.39","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.39 Class of person\n\nA medical practitioner who is a specialist registrant in medical oncology.","sortOrder":483},{"sectionNumber":"sch.6-sec.40","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.40 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\nbexarotene, enzalutamide, lenalidomide, pomalidomide, thalidomide\n2\ngive a treatment dose\nbexarotene, enzalutamide, lenalidomide, pomalidomide, thalidomide\n3\ndispense\nbexarotene, enzalutamide, lenalidomide, pomalidomide, thalidomide\n4\nadminister\nbexarotene, enzalutamide, lenalidomide, pomalidomide, thalidomide\n5\ngive a purchase order\nstock of a medicine mentioned in this column\nthe stock is not for a specified place\n6\npossess\na medicine mentioned in this column","sortOrder":484},{"sectionNumber":"sch.6-pt.2-div.13","sectionType":"division","heading":null,"content":"","sortOrder":485},{"sectionNumber":"sch.6-sec.41","sectionType":"section","heading":null,"content":"### Section sch.6-sec.41\n\nsch 6 s 41 om 2025 SL No. 148 s 25","sortOrder":486},{"sectionNumber":"sch.6-sec.42","sectionType":"section","heading":null,"content":"### Section sch.6-sec.42\n\nsch 6 s 42 om 2025 SL No. 148 s 25","sortOrder":487},{"sectionNumber":"sch.6-pt.2-div.14","sectionType":"division","heading":"Neurologists","content":"## Neurologists","sortOrder":488},{"sectionNumber":"sch.6-sec.43","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.43 Class of person\n\nA medical practitioner who is a specialist registrant in neurology.","sortOrder":489},{"sectionNumber":"sch.6-sec.44","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.44 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\nsodium oxybate\n2\ngive a treatment dose\nsodium oxybate\n3\ndispense\nsodium oxybate\n4\nadminister\nsodium oxybate\n5\ngive a purchase order\nstock of sodium oxybate\nthe stock is not for a specified place\n6\npossess\nsodium oxybate","sortOrder":490},{"sectionNumber":"sch.6-pt.2-div.15","sectionType":"division","heading":"Paediatricians","content":"## Paediatricians","sortOrder":491},{"sectionNumber":"sch.6-sec.45","sectionType":"section","heading":"Definitions for division","content":"### sch.6-sec.45 Definitions for division\n\nIn this division—\nrelevant child condition means ADHD, or brain injury, of a child patient.\nyoung adult ADHD means ADHD of an adult patient who is under 25 years.\nsch 6 s 45 sub 2025 SL No. 148 s 26 (1)","sortOrder":492},{"sectionNumber":"sch.6-sec.46","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.46 Class of person\n\nA medical practitioner who is a specialist registrant in paediatrics.","sortOrder":493},{"sectionNumber":"sch.6-sec.47","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.47 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\na psychostimulant medicine\nthe medicine is prescribed—\nfor the treatment of young adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or\nfor the treatment of a relevant child condition\nsodium oxybate\n2\ngive a treatment dose\na psychostimulant medicine\nthe medicine is given—\nfor the treatment of young adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or\nfor the treatment of a relevant child condition\nsodium oxybate\n3\ndispense\na psychostimulant medicine\nthe medicine is dispensed—\nfor the treatment of young adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or\nfor the treatment of a relevant child condition\nsodium oxybate\n4\nadminister\na psychostimulant medicine\nthe medicine is administered—\nfor the treatment of young adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or\nfor the treatment of a relevant child condition\nsodium oxybate\n5\ngive a purchase order\na psychostimulant medicine\nthe stock is for the treatment of young adult ADHD or relevant child conditions, other than at a specified place\nsodium oxybate\nthe stock is not for a specified place\n6\npossess\na psychostimulant medicine\nthe medicine is possessed for a purpose mentioned in this column\nsodium oxybate\nsch 6 s 47 amd 2022 SL No. 77 s 10 (5) ; 2023 SL No. 170 s 10 (4)\nsub 2025 SL No. 148 s 26 (2)","sortOrder":494},{"sectionNumber":"sch.6-pt.2-div.16","sectionType":"division","heading":"Psychiatrists","content":"## Psychiatrists","sortOrder":495},{"sectionNumber":"sch.6-sec.48","sectionType":"section","heading":"Definitions for division","content":"### sch.6-sec.48 Definitions for division\n\nIn this division—\nadult ADHD means ADHD of an adult patient.\nsch 6 s 48 def adult ADHD ins 2025 SL No. 148 s 27 (2)\nmaximum dosage ...\nsch 6 s 48 def maximum dosage om 2025 SL No. 148 s 27 (1)\nrelevant adult condition ...\nsch 6 s 48 def relevant adult condition om 2025 SL No. 148 s 27 (1)\nrelevant child condition means ADHD, or brain injury, of a child patient.\nsch 6 s 48 def relevant child condition sub 2025 SL No. 148 s 27 (1) – (2)","sortOrder":496},{"sectionNumber":"sch.6-sec.49","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.49 Class of person\n\nA medical practitioner who is a specialist registrant in psychiatry.","sortOrder":497},{"sectionNumber":"sch.6-sec.50","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.50 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\nclozapine, MDMA or psilocybine\na psychostimulant medicine\nthe medicine is prescribed—\nfor the treatment of adult ADHD up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or\nfor the treatment of a relevant child condition\n2\ngive a treatment dose\nclozapine\na psychostimulant medicine\nthe medicine is given—\nfor the treatment of adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or\nfor the treatment of a relevant child condition\n3\ndispense\nclozapine\na psychostimulant medicine\nthe medicine is dispensed—\nfor the treatment of adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or\nthe treatment of a relevant child condition\n4\nadminister\nclozapine, MDMA or psilocybine\na psychostimulant medicine\nthe medicine is administered—\nfor the treatment of adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or\nfor the treatment of a relevant child condition\n5\ngive a purchase order\nstock of clozapine, MDMA or psilocybine\nthe stock is not for a specified place\nstock of a psychostimulant medicine\nthe stock is for the treatment of adult ADHD or relevant child conditions, other than at a specified place\n6\npossess\nclozapine, MDMA or psilocybine\na psychostimulant medicine\nthe medicine is possessed for a purpose mentioned in this column\nsch 6 s 50 amd 2023 SL No. 51 s 8 (5) – (6)\nsub 2025 SL No. 148 s 27 (3)","sortOrder":498},{"sectionNumber":"sch.6-pt.2-div.17","sectionType":"division","heading":"Respiratory and sleep medicine specialists","content":"## Respiratory and sleep medicine specialists","sortOrder":499},{"sectionNumber":"sch.6-sec.51","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.51 Class of person\n\nA medical practitioner who is a specialist registrant in respiratory medicine or sleep medicine.","sortOrder":500},{"sectionNumber":"sch.6-sec.52","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.52 Dealing authorised\n\n1\nprescribe\nambrisentan, bosentan, macitentan, riociguat, sitaxentan or sodium oxybate\n2\ngive a treatment dose\nambrisentan, bosentan, macitentan, riociguat, sitaxentan or sodium oxybate\n3\ndispense\nambrisentan, bosentan, macitentan, riociguat, sitaxentan or sodium oxybate\n4\nadminister\nambrisentan, bosentan, macitentan, riociguat, sitaxentan or sodium oxybate\n5\ngive a purchase order\nstock of a medicine mentioned in this column\nthe stock is not for a specified place\n6\npossess\na medicine mentioned in this column\nsch 6 s 52 sub 2022 SL No. 77 s 10 (6)\namd 2023 SL No. 51 s 8 (7)","sortOrder":501},{"sectionNumber":"sch.6-pt.2-div.18","sectionType":"division","heading":"Rheumatologists","content":"## Rheumatologists","sortOrder":502},{"sectionNumber":"sch.6-sec.53","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.53 Class of person\n\nA medical practitioner who is a specialist registrant in rheumatology.","sortOrder":503},{"sectionNumber":"sch.6-sec.54","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.54 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\nambrisentan, bosentan, macitentan, riociguat, sitaxentan or teriparatide\n2\ngive a treatment dose\nambrisentan, bosentan, macitentan, riociguat, sitaxentan or teriparatide\n3\ndispense\nambrisentan, bosentan, macitentan, riociguat, sitaxentan or teriparatide\n4\nadminister\nambrisentan, bosentan, macitentan, riociguat, sitaxentan or teriparatide\n5\ngive a purchase order\nstock of a medicine mentioned in this column\nthe stock is not for a specified place\n6\npossess\na medicine mentioned in this column\nsch 6 s 54 amd 2023 SL No. 51 s 8 (8) ; 2025 SL No. 148 s 28","sortOrder":504},{"sectionNumber":"sch.6-pt.2-div.19","sectionType":"division","heading":"Specialist gynaecology practitioners","content":"## Specialist gynaecology practitioners","sortOrder":505},{"sectionNumber":"sch.6-sec.55","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.55 Class of person\n\nA medical practitioner who, under the Health Practitioner Regulation National Law —\nis a specialist general practitioner; and\nhas advanced skills in gynaecology.\n- (a) is a specialist general practitioner; and\n- (b) has advanced skills in gynaecology.","sortOrder":506},{"sectionNumber":"sch.6-sec.56","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.56 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\ndinoprost or dinoprostone\n2\ngive a treatment dose\ndinoprost or dinoprostone\n3\ndispense\ndinoprost or dinoprostone\n4\nadminister\ndinoprost or dinoprostone\n5\ngive a purchase order\nstock of dinoprost or dinoprostone\nthe stock is not for a specified place\n6\npossess\ndinoprost or dinoprostone","sortOrder":507},{"sectionNumber":"sch.6-pt.2-div.20","sectionType":"division","heading":"Specialist physicians","content":"## Specialist physicians","sortOrder":508},{"sectionNumber":"sch.6-sec.57","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.57 Class of person\n\nA medical practitioner who is a specialist registrant in general medicine.","sortOrder":509},{"sectionNumber":"sch.6-sec.58","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.58 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\nacitretin, ambrisentan, bexarotene, bosentan, enzalutamide, etretinate, isotretinoin for oral use, lenalidomide, macitentan, pomalidimide, riociguat, sitaxentan, teriparatide, thalidomide or tretinoin for oral use\n2\ngive a treatment dose\nacitretin, ambrisentan, bexarotene, bosentan, enzalutamide, etretinate, isotretinoin for oral use, lenalidomide, macitentan, pomalidimide, riociguat, sitaxentan, teriparatide, thalidomide or tretinoin for oral use\n3\ndispense\nacitretin, ambrisentan, bexarotene, bosentan, enzalutamide, etretinate, isotretinoin for oral use, lenalidomide, macitentan, pomalidimide, riociguat, sitaxentan, teriparatide, thalidomide or tretinoin for oral use\n4\nadminister\nacitretin, ambrisentan, bexarotene, bosentan, enzalutamide, etretinate, isotretinoin for oral use, lenalidomide, macitentan, pomalidimide, riociguat, sitaxentan, teriparatide, thalidomide or tretinoin for oral use\n5\ngive a purchase order\nstock of a medicine mentioned in this column\nthe stock is not for a specified place\n6\npossess\na medicine mentioned in this column\nsch 6 s 58 amd 2022 SL No. 77 s 10 (1) ; 2023 SL No. 51 s 8 (9) ; 2025 SL No. 148 s 29","sortOrder":510},{"sectionNumber":"sch.6-pt.2-div.21","sectionType":"division","heading":"Urologists","content":"## Urologists","sortOrder":511},{"sectionNumber":"sch.6-sec.59","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.59 Class of person\n\nA medical practitioner who is a specialist registrant in urology.","sortOrder":512},{"sectionNumber":"sch.6-sec.60","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.60 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\nenzalutamide\n2\ngive a treatment dose\nenzalutamide\n3\ndispense\nenzalutamide\n4\nadminister\nenzalutamide\n5\ngive a purchase order\nstock of enzalutamide\nthe stock is not for a specified place\n6\npossess\nenzalutamide","sortOrder":513},{"sectionNumber":"sch.6-pt.3","sectionType":"part","heading":"Physician assistants","content":"# Physician assistants","sortOrder":514},{"sectionNumber":"sch.6-sec.61","sectionType":"section","heading":"Definition for part","content":"### sch.6-sec.61 Definition for part\n\nIn this part—\npractice plan , for a physician assistant, means a document in the approved form—\ndeveloped and signed by the physician assistant and the medical practitioner supervising the assistant; and\nstating the circumstances and conditions for the physician assistant to prescribe, administer, or give a treatment dose, of a medicine.\n- (a) developed and signed by the physician assistant and the medical practitioner supervising the assistant; and\n- (b) stating the circumstances and conditions for the physician assistant to prescribe, administer, or give a treatment dose, of a medicine.","sortOrder":515},{"sectionNumber":"sch.6-sec.62","sectionType":"section","heading":"Class of person","content":"### sch.6-sec.62 Class of person\n\nA person (a physician assistant ) appointed and employed as a physician assistant by a Hospital and Health Service or the chief executive.","sortOrder":516},{"sectionNumber":"sch.6-sec.63","sectionType":"section","heading":"Dealing authorised","content":"### sch.6-sec.63 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\na non-restricted medicine\nthe medicine is prescribed under—\nthe supervision of a medical practitioner; and\na practice plan for the physician assistant\n2\ngive a treatment dose\na non-restricted medicine\nthe medicine is given under—\nthe supervision of a medical practitioner; and\na practice plan for the physician assistant\n3\nadminister\na non-restricted medicine\nthe medicine is administered under—\nthe supervision of a medical practitioner; and\na practice plan for the physician assistant\n4\npossess\nan S4 or S8 non-restricted medicine\nthe medicine is possessed for a purpose mentioned in this column","sortOrder":517},{"sectionNumber":"sch.7-pt.1","sectionType":"part","heading":"Nurse practitioners","content":"# Nurse practitioners","sortOrder":518},{"sectionNumber":"sch.7-sec.1","sectionType":"section","heading":"Definitions for part","content":"### sch.7-sec.1 Definitions for part\n\nIn this part—\ncontinuing hydroxychloroquine treatment ...\nsch 7 s 1 def continuing hydroxchloroquine treatment om 2025 SL No. 148 30(1)\ncontinuing institutional treatment , by a nurse practitioner of a patient, means—\nthe practitioner is treating the patient in a hospital or custodial facility; and\nthe patient was being treated with the medicine within a reasonable period before—\nbeing admitted to the hospital or being taken into custody at the custodial facility; or\nbeing treated by the practitioner.\nsch 7 s 1 def continuing institutional treatment amd 2025 SL No. 90 s 5 (2)\ncontinuing opioid dependence treatment , by a nurse practitioner of a patient, means—\nthe practitioner is treating the patient with an approved opioid in a hospital or custodial facility; and\nthe patient was being treated with the approved opioid under an opioid treatment program within a reasonable period before—\nbeing admitted to the hospital or being taken into custody at the custodial facility; or\nbeing treated by the practitioner.\nsch 7 s 1 def continuing opioid dependence treatment ins 2025 SL No. 90 s 5 (1)\n- (a) the practitioner is treating the patient in a hospital or custodial facility; and\n- (b) the patient was being treated with the medicine within a reasonable period before— (i) being admitted to the hospital or being taken into custody at the custodial facility; or (ii) being treated by the practitioner.\n- (i) being admitted to the hospital or being taken into custody at the custodial facility; or\n- (ii) being treated by the practitioner.\n- (i) being admitted to the hospital or being taken into custody at the custodial facility; or\n- (ii) being treated by the practitioner.\n- (a) the practitioner is treating the patient with an approved opioid in a hospital or custodial facility; and\n- (b) the patient was being treated with the approved opioid under an opioid treatment program within a reasonable period before— (i) being admitted to the hospital or being taken into custody at the custodial facility; or (ii) being treated by the practitioner.\n- (i) being admitted to the hospital or being taken into custody at the custodial facility; or\n- (ii) being treated by the practitioner.\n- (i) being admitted to the hospital or being taken into custody at the custodial facility; or\n- (ii) being treated by the practitioner.","sortOrder":519},{"sectionNumber":"sch.7-sec.2","sectionType":"section","heading":"Class of person","content":"### sch.7-sec.2 Class of person\n\nA person (a nurse practitioner ) who is a registered nurse and endorsed under the Health Practitioner Regulation National Law as being qualified to practise as a nurse practitioner.","sortOrder":520},{"sectionNumber":"sch.7-sec.3","sectionType":"section","heading":"Dealing authorised","content":"### sch.7-sec.3 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\na medicine, other than a restricted medicine\na restricted medicine, other than an approved opioid\nthe medicine is prescribed for administration by a health practitioner—\nfor the continuing institutional treatment of a patient; and\nunder the supervision of a registrar or specialist medical practitioner authorised to prescribe the medicine\nan approved opioid\nthe medicine is prescribed for administration for the continuing opioid dependence treatment of a patient\n2\nmake a standing order, other than a clinical protocol\nan S2, S3 or S4 medicine, other than an S4 diversion-risk medicine or restricted medicine\n3\ngive a treatment dose\na medicine, other than a restricted medicine\na restricted medicine, other than an approved opioid\nthe medicine is given—\nfor the continuing institutional treatment of a patient; and\nunder the supervision of a registrar or specialist medical practitioner authorised to give the medicine\n4\nadminister\na medicine, other than a restricted medicine\na restricted medicine, other than an approved opioid\nthe medicine is administered—\nfor the continuing institutional treatment of a patient; and\nunder the supervision of a registrar or specialist medical practitioner authorised to give the medicine\nan approved opioid\nthe medicine is administered for the continuing opioid dependence treatment of a patient\nany medicine, including a restricted medicine\nthe medicine is administered on a prescription\n5\nrepackage\nany medicine\nthe medicine is repackaged for giving a treatment dose for a patient\n6\ngive a purchase order\nstock of an S4 or S8 medicine\nthe stock is not for a specified place\n7\npossess\nan S4 or S8 medicine mentioned in this column\nthe medicine is possessed for a purpose mentioned in this column\n8\ndispose\nwaste from a diversion-risk medicine mentioned in this column\nsch 7 s 3 amd 2024 SL No. 102 s 7 ; 2025 SL No. 90 s 5 (3) – (4) ; 2025 SL No. 148 s 30 (2)","sortOrder":521},{"sectionNumber":"sch.7-pt.2","sectionType":"part","heading":"Midwives","content":"# Midwives","sortOrder":522},{"sectionNumber":"sch.7-pt.2-div.1","sectionType":"division","heading":"Preliminary","content":"## Preliminary","sortOrder":523},{"sectionNumber":"sch.7-sec.4","sectionType":"section","heading":"Definition for part","content":"### sch.7-sec.4 Definition for part\n\nIn this part—\nchildbirth means the process of labour and delivery beginning with uterine contractions and ending with the expulsion of the placenta and membranes from the woman giving birth.","sortOrder":524},{"sectionNumber":"sch.7-pt.2-div.2","sectionType":"division","heading":"Midwives","content":"## Midwives","sortOrder":525},{"sectionNumber":"sch.7-sec.5","sectionType":"section","heading":"Class of person","content":"### sch.7-sec.5 Class of person\n\nA person (a midwife ) who is registered under the Health Practitioner Regulation National Law to practise in the midwifery profession as a midwife.","sortOrder":526},{"sectionNumber":"sch.7-sec.6","sectionType":"section","heading":"Dealing authorised","content":"### sch.7-sec.6 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a treatment dose\nan S2 or S3 medicine\nthe medicine is given at a rural hospital or in an isolated practice area\nany medicine\nthe medicine is given on a standing order\nan S4 or S8 medicine\nthe medicine is given on a prescription\nan S4 or S8 medicine mentioned in the extended practice authority called ‘Midwives’\nthe medicine is given under the extended practice authority\nan S2 medicine that is paracetamol\nthe medicine is given for the treatment of a side effect, or a potential side effect, of an immunisation medicine\n2\nadminister\nan S2 or S3 medicine\na nitrous oxide mixture\nthe medicine is administered as an analgesic to treat a woman during childbirth\nany medicine\nthe medicine is administered on a standing order\nan S4 or S8 medicine\nthe medicine is administered on a prescription\nan S4 or S8 medicine\nthe medicine is administered in accordance with the medicine’s approved label\nan S4 or S8 medicine mentioned in the extended practice authority called ‘Midwives’\nthe medicine is administered under the extended practice authority\nan S4 medicine that is an immunisation medicine\nthe midwife has completed immunisation training\n3\nrepackage\nany medicine\nthe medicine is repackaged for giving a treatment dose for a patient on a prescription\n4\ngive a purchase order\nstock of a medicine mentioned in the extended practice authority called ‘Midwives’\nthe purchase order is given under the extended practice authority\nstock of an S4 medicine that is an immunisation medicine\nthe midwife has completed immunisation training\n5\npossess\nan S4 or S8 medicine mentioned in this column\nthe medicine is possessed for a purpose mentioned in this column\n6\ndispose\nwaste from a diversion-risk medicine mentioned in this column\nsch 7 s 6 amd 2026 SL No. 16 s 7","sortOrder":527},{"sectionNumber":"sch.7-pt.2-div.3","sectionType":"division","heading":"Endorsed midwives","content":"## Endorsed midwives","sortOrder":528},{"sectionNumber":"sch.7-sec.7","sectionType":"section","heading":"Class of person","content":"### sch.7-sec.7 Class of person\n\nA midwife who is endorsed.","sortOrder":529},{"sectionNumber":"sch.7-sec.8","sectionType":"section","heading":"Dealing authorised","content":"### sch.7-sec.8 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\na medicine, other than a restricted medicine\n2\ngive a treatment dose\na medicine, other than a restricted medicine\n3\nadminister\na medicine, other than a restricted medicine\n4\nrepackage\na medicine\nthe medicine is repackaged for giving a treatment dose for a patient\n5\ngive a purchase order\nstock of an S4 or S8 medicine mentioned in this column\nthe stock is not for a specified place\n6\npossess\nan S4 or S8 medicine mentioned in this column\nthe medicine is possessed for a purpose mentioned in this column\n7\ndispose\nwaste from a diversion-risk medicine mentioned in this column","sortOrder":530},{"sectionNumber":"sch.7-pt.3","sectionType":"part","heading":"Registered nurses","content":"# Registered nurses","sortOrder":531},{"sectionNumber":"sch.7-pt.3-div.1","sectionType":"division","heading":"Preliminary","content":"## Preliminary","sortOrder":532},{"sectionNumber":"sch.7-sec.9","sectionType":"section","heading":"Definitions for part","content":"### sch.7-sec.9 Definitions for part\n\nIn this part—\ncustodial patient means—\na patient in custody at a custodial facility; or\na patient being released from a custodial facility into the custody of a court; or\na patient being transferred from 1 custodial facility to another custodial facility; or\na patient being released from a custodial facility into the community.\nsch 7 s 9 def custodial patient ins 2025 SL No. 19 s 6 (2)\ndose administration aid repackaging guidelines means the document called ‘Repackaging medicines into a dose administration aid: Guidelines for registered nurses’, version 1, made by the chief executive and published on the department’s website.\nprison patient ...\nsch 7 s 9 def prison patient om 2025 SL No. 19 s 6 (1)\nrural discharge circumstances , in relation to a patient at a rural hospital or a hospital in an isolated practice area, means—\nthe patient is being discharged from, or is an outpatient of, the hospital; and\nthe hospital does not employ a pharmacist or the pharmacist is absent from the hospital when it is necessary to give a treatment dose of a medicine.\n- (a) a patient in custody at a custodial facility; or\n- (b) a patient being released from a custodial facility into the custody of a court; or\n- (c) a patient being transferred from 1 custodial facility to another custodial facility; or\n- (d) a patient being released from a custodial facility into the community.\n- (a) the patient is being discharged from, or is an outpatient of, the hospital; and\n- (b) the hospital does not employ a pharmacist or the pharmacist is absent from the hospital when it is necessary to give a treatment dose of a medicine.","sortOrder":533},{"sectionNumber":"sch.7-pt.3-div.2","sectionType":"division","heading":"Nurses generally","content":"## Nurses generally","sortOrder":534},{"sectionNumber":"sch.7-sec.10","sectionType":"section","heading":"Class of person","content":"### sch.7-sec.10 Class of person\n\nA person (a registered nurse ) who is registered under the Health Practitioner Regulation National Law to practise in the registered nurses division of the nursing profession.","sortOrder":535},{"sectionNumber":"sch.7-sec.11","sectionType":"section","heading":"Dealing authorised","content":"### sch.7-sec.11 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a treatment dose\na medicine mentioned in the extended practice authority called ‘Registered nurses’\nthe medicine is given under the extended practice authority\nan S2 medicine that is paracetamol\nthe medicine is given for the treatment of a side effect, or a potential side effect, of an immunisation medicine\n2\nadminister\nan S2 or S3 medicine\nany medicine\nthe medicine is administered on a standing order\nan S4 or S8 medicine\nthe medicine is administered on a prescription\nan S4 or S8 medicine\nthe medicine is administered in accordance with the medicine’s approved label\nan S4 or S8 medicine mentioned in the extended practice authority called ‘Registered nurses’\nthe medicine is administered under the extended practice authority\nan S4 medicine that is an immunisation medicine\nthe registered nurse has completed immunisation training\n3\ngive a purchase order\nstock of a medicine mentioned in the extended practice authority called ‘Registered nurses’\nthe purchase order is given under the extended practice authority\nstock of an S4 medicine that is an immunisation medicine\nthe registered nurse has completed immunisation training\n4\npossess\nan S4 or S8 medicine mentioned in this column\nthe medicine is possessed for a purpose mentioned in this column\n5\ndispose\nwaste from a diversion-risk medicine mentioned in this column\nsch 7 s 11 amd 2026 SL No. 16 s 8","sortOrder":536},{"sectionNumber":"sch.7-pt.3-div.3","sectionType":"division","heading":"Nurses giving purchase orders at relevant institutions","content":"## Nurses giving purchase orders at relevant institutions","sortOrder":537},{"sectionNumber":"sch.7-sec.12","sectionType":"section","heading":"Class of person","content":"### sch.7-sec.12 Class of person\n\nA registered nurse who is a nurse manager at a relevant institution.","sortOrder":538},{"sectionNumber":"sch.7-sec.13","sectionType":"section","heading":"Dealing authorised","content":"### sch.7-sec.13 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a purchase order\nstock of an S4 or S8 medicine\nthe purchase order is given for the relevant institution; and\nthe purchase order is given for the therapeutic treatment of patients at the relevant institution\n2\npossess\nstock of an S4 or S8 medicine\nthe stock is possessed at the relevant institution","sortOrder":539},{"sectionNumber":"sch.7-pt.3-div.4","sectionType":"division","heading":"Rural and isolated hospital nurses","content":"## Rural and isolated hospital nurses","sortOrder":540},{"sectionNumber":"sch.7-sec.14","sectionType":"section","heading":"Class of person","content":"### sch.7-sec.14 Class of person\n\nA registered nurse who—\nis employed at a rural hospital or at a hospital in an isolated practice area; and\nis the hospital’s nurse manager.\n- (a) is employed at a rural hospital or at a hospital in an isolated practice area; and\n- (b) is the hospital’s nurse manager.","sortOrder":541},{"sectionNumber":"sch.7-sec.15","sectionType":"section","heading":"Dealing authorised","content":"### sch.7-sec.15 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a treatment dose\nany medicine\nthe medicine is given on a prescription in rural discharge circumstances\n2\nrepackage\nany medicine\nthe medicine is repackaged—\nfor giving a treatment dose for a patient on a prescription; and\nif repackaged in a dose administration aid—under the dose administration aid repackaging guidelines\n3\npossess\nan S4 or S8 medicine\nthe medicine is possessed for a purpose mentioned in this column","sortOrder":542},{"sectionNumber":"sch.7-pt.3-div.5","sectionType":"division","heading":"Custodial nurses","content":"## Custodial nurses","sortOrder":543},{"sectionNumber":"sch.7-sec.16","sectionType":"section","heading":"Class of person","content":"### sch.7-sec.16 Class of person\n\nA registered nurse who is employed at a custodial facility.\nsch 7 s 16 sub 2025 SL No. 19 s 6 (3)","sortOrder":544},{"sectionNumber":"sch.7-sec.17","sectionType":"section","heading":"Dealing authorised","content":"### sch.7-sec.17 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a treatment dose\nan S2, S3 or S4 medicine\nthe medicine is given for a custodial patient on a prescription\nan S8 medicine, other than a psychostimulant medicine or an approved opioid\nthe medicine is given for a custodial patient—\non a prescription; and\nin an amount that is not more than 1 day’s supply\na psychostimulant medicine\nthe medicine is given for a patient in custody at, or being released from or transferred to or from, a detention centre or prison—\non a prescription; and\nin an amount that is not more than 7 days’ supply\n2\nrepackage\nany medicine\nthe medicine is repackaged—\nfor giving a treatment dose for a custodial patient on a prescription; and\nif repackaged in a dose administration aid—under the dose administration aid repackaging guidelines\n3\npossess\nan S4 or S8 medicine\nthe medicine is possessed for a purpose mentioned in this column\nsch 7 s 17 sub 2025 SL No. 19 s 6 (3)\namd 2025 SL No. 148 s 31","sortOrder":545},{"sectionNumber":"sch.7-pt.3-div.6","sectionType":"division","heading":"Hospital and health service nurses","content":"## Hospital and health service nurses","sortOrder":546},{"sectionNumber":"sch.7-sec.17A","sectionType":"section","heading":"Class of person","content":"### sch.7-sec.17A Class of person\n\nA registered nurse employed by, or for, a Hospital and Health Service.\nsch 7 s 17A ins 2025 SL No. 148 s 32","sortOrder":547},{"sectionNumber":"sch.7-sec.17B","sectionType":"section","heading":"Dealing authorised","content":"### sch.7-sec.17B Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a treatment dose\nan S2, S3 or S4 medicine, other than a restricted medicine\nthe medicine is given—\nfor preparation of the bowel for a procedure; and\non a prescription or a standing order\n2\npossess\nan S4 medicine\nthe medicine is possessed for a purpose mentioned in this column\nsch 7 s 17B ins 2025 SL No. 148 s 32","sortOrder":548},{"sectionNumber":"sch.7-pt.4","sectionType":"part","heading":"Enrolled nurses","content":"# Enrolled nurses","sortOrder":549},{"sectionNumber":"sch.7-sec.18","sectionType":"section","heading":"Class of person","content":"### sch.7-sec.18 Class of person\n\nA person (an enrolled nurse ) who is registered under the Health Practitioner Regulation National Law to practise in the enrolled nurses division of the nursing profession—\nincluding a person with provisional registration or limited registration; but\nnot including a person—\nwho is registered to practise in the profession only as a student or for training purposes; or\nwhose registration contains a notation indicating the enrolled nurse is not qualified to administer medicines.\n- (a) including a person with provisional registration or limited registration; but\n- (b) not including a person— (i) who is registered to practise in the profession only as a student or for training purposes; or (ii) whose registration contains a notation indicating the enrolled nurse is not qualified to administer medicines.\n- (i) who is registered to practise in the profession only as a student or for training purposes; or\n- (ii) whose registration contains a notation indicating the enrolled nurse is not qualified to administer medicines.\n- (i) who is registered to practise in the profession only as a student or for training purposes; or\n- (ii) whose registration contains a notation indicating the enrolled nurse is not qualified to administer medicines.","sortOrder":550},{"sectionNumber":"sch.7-sec.19","sectionType":"section","heading":"Dealing authorised","content":"### sch.7-sec.19 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nany medicine\nthe medicine is administered—\nunder the direct supervision of a medical practitioner administering anaesthesia; and\nbefore or during the patient’s anaesthetic procedure at a hospital\nany medicine\nthe medicine is administered—\nunder the supervision of a dentist, medical practitioner, midwife or registered nurse; and\nin accordance with the medicine’s approved label or on a prescription or a standing order\n2\npossess\nan S4 or S8 medicine\nthe medicine is possessed under the supervision of a dentist, medical practitioner, midwife or registered nurse\n3\ndispose\nwaste from a diversion-risk medicine that is an S4 or S8 medicine\nsch 7 s 19 amd 2023 SL No. 170 s 11","sortOrder":551},{"sectionNumber":"sch.7-pt.5","sectionType":"part","heading":"Restricted enrolled nurses","content":"# Restricted enrolled nurses","sortOrder":552},{"sectionNumber":"sch.7-sec.20","sectionType":"section","heading":"Class of person","content":"### sch.7-sec.20 Class of person\n\nA person who is registered in the enrolled nurses division of the nursing provision but whose registration contains a notation indicating the enrolled nurse is not qualified to administer S4 or S8 medicines.","sortOrder":553},{"sectionNumber":"sch.7-sec.21","sectionType":"section","heading":"Dealing authorised","content":"### sch.7-sec.21 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nan S2 or S3 medicine\nthe medicine is administered—\nunder the supervision of a dentist, medical practitioner, midwife or registered nurse; and\nin accordance with the medicine’s approved label or on a prescription or a standing order","sortOrder":554},{"sectionNumber":"sch.7-pt.6","sectionType":"part","heading":"Trainee enrolled nurses","content":"# Trainee enrolled nurses","sortOrder":555},{"sectionNumber":"sch.7-sec.22","sectionType":"section","heading":"Class of person","content":"### sch.7-sec.22 Class of person\n\nA person who is undertaking training to obtain a qualification required to be registered under the Health Practitioner Regulation National Law to practise in the enrolled nurses division of the nursing profession.","sortOrder":556},{"sectionNumber":"sch.7-sec.23","sectionType":"section","heading":"Dealing authorised","content":"### sch.7-sec.23 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nany medicine\nthe medicine is administered to the extent authorised for an enrolled nurse—\nunder the direct supervision of a dentist, medical practitioner, midwife or registered nurse; and\nin accordance with the medicine’s approved label or on a prescription or a standing order\n2\npossess\nan S4 or S8 medicine\nthe medicine is possessed to the extent authorised for an enrolled nurse under the direct supervision of a registered nurse at the place where the registered nurse is practising","sortOrder":557},{"sectionNumber":"sch.8-pt.1","sectionType":"part","heading":"Preliminary","content":"# Preliminary","sortOrder":558},{"sectionNumber":"sch.8-sec.1","sectionType":"section","heading":"Definitions for schedule","content":"### sch.8-sec.1 Definitions for schedule\n\nIn this schedule—\nophthalmologist means a person who is registered under the Health Practitioner Regulation National Law to practise in the specialty of ophthalmology.\nOptometry Board means the Optometry Board of Australia established under the Health Practitioner Regulation National Law .\noptometry guidelines means the document called ‘Guidelines for use of scheduled medicines’ made by the Optometry Board and stated to have effect from 10 December 2021.\nsch 8 s 1 def optometry guidelines amd 2022 SL No. 77 s 11 (1)","sortOrder":559},{"sectionNumber":"sch.8-pt.2","sectionType":"part","heading":"Optometrists","content":"# Optometrists","sortOrder":560},{"sectionNumber":"sch.8-sec.2","sectionType":"section","heading":"Class of person","content":"### sch.8-sec.2 Class of person\n\nA person (an optometrist ) who is registered under the Health Practitioner Regulation National Law to practise in the optometry profession.","sortOrder":561},{"sectionNumber":"sch.8-sec.3","sectionType":"section","heading":"Dealing authorised","content":"### sch.8-sec.3 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\na topical S2, S3 or S4 medicine mentioned in appendix A of the optometry guidelines\nthe medicine is administered under the guidelines\n2\ngive a purchase order\nstock of an S4 medicine mentioned in this column\nthe stock is not for a specified place\n3\npossess\nan S4 medicine mentioned in this column\nthe medicine is possessed for a purpose mentioned in this column\nsch 8 s 3 amd 2022 SL No. 77 s 11 (2)","sortOrder":562},{"sectionNumber":"sch.8-pt.3","sectionType":"part","heading":"Endorsed optometrists","content":"# Endorsed optometrists","sortOrder":563},{"sectionNumber":"sch.8-sec.4","sectionType":"section","heading":"Class of person","content":"### sch.8-sec.4 Class of person\n\nAn endorsed optometrist.","sortOrder":564},{"sectionNumber":"sch.8-sec.5","sectionType":"section","heading":"Dealing authorised","content":"### sch.8-sec.5 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\nan S2, S3 or S4 medicine mentioned in appendix B or appendix C of the optometry guidelines\nthe medicine is prescribed under the guidelines\n2\ngive a treatment dose\nan S2, S3 or S4 medicine mentioned in appendix B or appendix C of the optometry guidelines\nthe medicine is given under the guidelines\n3\nadminister\nan S2, S3 or S4 medicine mentioned in appendix B or appendix C of the optometry guidelines\nthe medicine is administered under the guidelines\n4\ngive a purchase order\nstock of an S4 medicine mentioned in this column\nthe stock is not for a specified place\n5\npossess\nan S4 medicine mentioned in this column\nthe medicine is possessed for a purpose mentioned in this column","sortOrder":565},{"sectionNumber":"sch.8-pt.4","sectionType":"part","heading":"Orthoptists","content":"# Orthoptists","sortOrder":566},{"sectionNumber":"sch.8-sec.6","sectionType":"section","heading":"Class of person","content":"### sch.8-sec.6 Class of person\n\nA person (an orthoptist ) whose name is recorded in the register of orthoptists kept by the Australian Orthoptists Registration Body Pty Ltd ACN 095 117 678.","sortOrder":567},{"sectionNumber":"sch.8-sec.7","sectionType":"section","heading":"Dealing authorised","content":"### sch.8-sec.7 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\na topical ophthalmic preparation\nthe medicine is administered on a prescription from an ophthalmologist\nany of the following S4 medicines—\nthe medicine is administered on a clinical protocol made by an ophthalmologist\nproxymetacaine hydrochloride of a strength of 0.5% or less\noxybuprocaine hydrochloride of a strength of 0.4% or less\namethocaine hydrochloride of a strength of 0.5% or less\nlidocaine (lignocaine) of a strength of 4% or less combined with fluorescein of a strength of 0.25%\ncyclopentolate hydrochloride of a strength of 1% or less\nhomatropine hydrobromide of a strength of 2% or less\natropine of a strength of 1% or less\ntropicamide of a strength of 1% or less\npilocarpine hydrochloride nitrate of a strength of 4% or less\nphenylephrine of a strength of 2.5% or less in eye drops\n2\ngive a purchase order\nstock of an S4 medicine mentioned in this column\nthe stock is not for a specified place\n3\npossess\nan S4 medicine mentioned in this column\nthe medicine is possessed for a purpose mentioned in this column","sortOrder":568},{"sectionNumber":"sch.9-pt.1","sectionType":"part","heading":"Pharmacists","content":"# Pharmacists","sortOrder":569},{"sectionNumber":"sch.9-pt.1-div.1","sectionType":"division","heading":"Pharmacists generally","content":"## Pharmacists generally","sortOrder":570},{"sectionNumber":"sch.9-sec.1","sectionType":"section","heading":"Class of person","content":"### sch.9-sec.1 Class of person\n\nA person (a pharmacist ) who is registered under the Health Practitioner Regulation National Law to practise in the pharmacy profession but not including an intern pharmacist or a trainee pharmacist.\nSee division 3 in relation to intern pharmacists and division 4 in relation to trainee pharmacists.","sortOrder":571},{"sectionNumber":"sch.9-sec.2","sectionType":"section","heading":"Dealing authorised","content":"### sch.9-sec.2 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1AA\nprescribe\nan S4 medicine, other than a restricted medicine or diversion-risk medicine, mentioned in the extended practice authority called ‘Pharmacists’\nthe medicine is prescribed under the extended practice authority\n1\ndispense\nany medicine\n2\nsupply\nstock of any medicine\nthe stock is supplied on a compliant purchase order to a person under the National Health (Pharmaceutical Benefits) Regulations 2017 (Cwlth) , section 33\nstock of any medicine\nthe stock is supplied to another pharmacist—\nto urgently fill a shortage of stock held by the other pharmacist; or\nas part of an arrangement with the pharmacist to prevent the stock from expiring; or\nfor satisfying an order made by a client of the other pharmacist\nstock of any medicine\nthe stock is supplied from a pharmacy to an approved person, other than a pharmacist, who is authorised to give a purchase order for the medicine or administer the medicine\n3\nsell, other than on a prescription\nan S2, S3 or S4 medicine, other than therapeutic nicotine\nthe medicine is sold at a pharmacy\ntherapeutic nicotine\nthe medicine is sold at a community pharmacy\na medicine that is mentioned as a pharmaceutical benefit in a Continued Dispensing Determination\nthe medicine is sold in the circumstances mentioned in the Continued Dispensing Determination\na medicine mentioned in the extended practice authority called ‘Pharmacists’\nthe medicine is sold under the extended practice authority\n4\ngive a treatment dose\nany medicine\nthe medicine is given on a standing order at a public hospital\nan S2 medicine that is paracetamol\nthe medicine is given for the treatment of a side effect, or a potential side effect, of an immunisation medicine\n5\nadminister\na medicine mentioned in the extended practice authority called ‘Pharmacists’\nthe medicine is administered under the extended practice authority\nan approved opioid\nthe medicine is administered on a prescription\nan S4 medicine that is an immunisation medicine\nthe pharmacist has completed immunisation training\nadrenaline (epinephrine)\nthe medicine is administered to treat anaphylaxis\nan S2 medicine that is paracetamol\nthe medicine is administered for the treatment of a side effect, or a potential side effect, of an immunisation medicine\n6\nrepackage\nany medicine\nthe medicine is repackaged for—\nselling to a patient; or\nsupply to an approved person, other than another pharmacist; or\nsupply to, or possession of stock at, a clinical area of a hospital\n7\ncompound\nan S2 or S3 medicine\nthe medicine is compounded for the treatment of a patient\nan S4 or S8 medicine\nthe medicine is compounded to fulfil a prescription from a prescriber for a patient\n8\ngive a purchase order\nstock of an S4 or S8 medicine, including an S4 medicine that is an immunisation medicine\nthe stock is not for a specified place\nstock of an S4 medicine that is an immunisation medicine\nthe stock is for a specified place and—\nthe pharmacist has completed immunisation training; or\nthe pharmacist is otherwise authorised to give a purchase order for the specified place\n9\npossess\nan S4 or S8 medicine\nthe medicine is possessed for a purpose mentioned in this column\n10\ndispose\nwaste from a diversion-risk medicine that is an S4 or S8 medicine\nsch 9 s 2 amd 2024 SL No. 102 s 8 ; 2024 SL No. 230 s 7 ; 2026 SL No. 16 s 9","sortOrder":572},{"sectionNumber":"sch.9-pt.1-div.1A","sectionType":"division","heading":"Pharmacists employed at particular places","content":"## Pharmacists employed at particular places","sortOrder":573},{"sectionNumber":"sch.9-sec.2A","sectionType":"section","heading":"Class of person","content":"### sch.9-sec.2A Class of person\n\nA pharmacist who—\nis employed at a community pharmacy or private health facility; or\nis a health service employee.\nsch 9 s 2A ins 2023 SL No. 152 s 5\n- (a) is employed at a community pharmacy or private health facility; or\n- (b) is a health service employee.","sortOrder":574},{"sectionNumber":"sch.9-sec.2B","sectionType":"section","heading":"Dealing authorised","content":"### sch.9-sec.2B Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nan S2 or S3 medicine\nany medicine\nthe medicine is administered on a standing order\nan S4 or S8 medicine\nthe medicine is administered—\non a prescription; or\nin accordance with the medicine’s approved label\n2\npossess\nan S4 or S8 medicine\nthe medicine is possessed for a purpose mentioned in this column\nsch 9 s 2B ins 2023 SL No. 152 s 5","sortOrder":575},{"sectionNumber":"sch.9-pt.1-div.2","sectionType":"division","heading":"Pharmacists giving purchase orders at relevant institutions","content":"## Pharmacists giving purchase orders at relevant institutions","sortOrder":576},{"sectionNumber":"sch.9-sec.3","sectionType":"section","heading":"Class of person","content":"### sch.9-sec.3 Class of person\n\nA pharmacist who is in charge of a dispensary at a relevant institution.","sortOrder":577},{"sectionNumber":"sch.9-sec.4","sectionType":"section","heading":"Dealing authorised","content":"### sch.9-sec.4 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a purchase order\nstock of an S4 or S8 medicine\nthe purchase order is given for the relevant institution; and\nthe purchase order is given for the therapeutic treatment of patients at the relevant institution\n2\npossess\nstock of an S4 or S8 medicine\nthe stock is possessed at the relevant institution","sortOrder":578},{"sectionNumber":"sch.9-pt.1-div.2A","sectionType":"division","heading":"Participating pharmacists practising at participating pharmacies","content":"## Participating pharmacists practising at participating pharmacies","sortOrder":579},{"sectionNumber":"sch.9-sec.4A","sectionType":"section","heading":"Definitions for division","content":"### sch.9-sec.4A Definitions for division\n\nIn this division—\ncommunity pharmacy chronic conditions management pilot means the program set up by the department known as the ‘community pharmacy chronic conditions management pilot’.\nsch 9 s 4A def community pharmacy chronic conditions management pilot ins 2025 SL No. 60 s 15 (1)\ncommunity pharmacy scope of practice pilot ...\nsch 9 s 4A def community pharmacy scope of practice pilot om 2025 SL No. 60 s 15 (1)\nparticipating pharmacist means a pharmacist approved by the chief executive to participate in the community pharmacy chronic conditions management pilot.\nsch 9 s 4A def participating pharmacist amd 2025 SL No. 60 s 15 (2)\nparticipating pharmacy means a community pharmacy approved by the chief executive as a place to which the community pharmacy chronic conditions management pilot applies.\nsch 9 s 4A def participating pharmacy amd 2025 SL No. 60 s 15 (2)\nsch 9 s 4A ins 2023 SL No. 170 s 18","sortOrder":580},{"sectionNumber":"sch.9-sec.4B","sectionType":"section","heading":"Class of person","content":"### sch.9-sec.4B Class of person\n\nA participating pharmacist who is practising at a participating pharmacy.\nsch 9 s 4B ins 2023 SL No. 170 s 18","sortOrder":581},{"sectionNumber":"sch.9-sec.4C","sectionType":"section","heading":"Dealing authorised","content":"### sch.9-sec.4C Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\nan S4 medicine, other than a restricted medicine or diversion-risk medicine, mentioned in the extended practice authority called Pharmacists—community pharmacy chronic conditions management pilot\nthe medicine is prescribed under the extended practice authority\nsch 9 s 4C ins 2023 SL No. 170 s 18\namd 2025 SL No. 60 s 15 (3) – (4)","sortOrder":582},{"sectionNumber":"sch.9-pt.1-div.2B","sectionType":"division","heading":"Pharmacists employed at public sector health service facilities and private health facilities","content":"## Pharmacists employed at public sector health service facilities and private health facilities","sortOrder":583},{"sectionNumber":"sch.9-sec.4D","sectionType":"section","heading":"Definitions for division","content":"### sch.9-sec.4D Definitions for division\n\nIn this division—\ncollaborative prescribing protocol , for a public sector health service facility or a private health facility, means a document that—\napplies to any pharmacist, or a stated class of pharmacist, employed at the facility; and\nstates the circumstances in which any pharmacist or the stated class of pharmacist may prescribe any medicine, or a stated medicine, at the facility; and\nstates the process for any pharmacist or the stated class of pharmacist to prescribe any medicine, or the stated medicine, in collaboration with a medical practitioner or nurse practitioner employed at the facility; and\nis approved by—\nif a medicines and therapeutics committee mentioned in section 103 (2) is established for the facility—the committee; or\notherwise—the person responsible for the day-to-day management of the facility; and\nis available for inspection by—\na health practitioner employed at the facility; and\nthe chief executive; and\nan inspector; and\na health ombudsman official.\npublic sector health service facility see the Hospital and Health Boards Act 2011 , schedule 2 .\nsch 9 s 4D ins 2025 SL No. 19 s 7\n- (a) applies to any pharmacist, or a stated class of pharmacist, employed at the facility; and\n- (b) states the circumstances in which any pharmacist or the stated class of pharmacist may prescribe any medicine, or a stated medicine, at the facility; and\n- (c) states the process for any pharmacist or the stated class of pharmacist to prescribe any medicine, or the stated medicine, in collaboration with a medical practitioner or nurse practitioner employed at the facility; and\n- (d) is approved by— (i) if a medicines and therapeutics committee mentioned in section 103 (2) is established for the facility—the committee; or (ii) otherwise—the person responsible for the day-to-day management of the facility; and\n- (i) if a medicines and therapeutics committee mentioned in section 103 (2) is established for the facility—the committee; or\n- (ii) otherwise—the person responsible for the day-to-day management of the facility; and\n- (e) is available for inspection by— (i) a health practitioner employed at the facility; and (ii) the chief executive; and (iii) an inspector; and (iv) a health ombudsman official.\n- (i) a health practitioner employed at the facility; and\n- (ii) the chief executive; and\n- (iii) an inspector; and\n- (iv) a health ombudsman official.\n- (i) if a medicines and therapeutics committee mentioned in section 103 (2) is established for the facility—the committee; or\n- (ii) otherwise—the person responsible for the day-to-day management of the facility; and\n- (i) a health practitioner employed at the facility; and\n- (ii) the chief executive; and\n- (iii) an inspector; and\n- (iv) a health ombudsman official.","sortOrder":584},{"sectionNumber":"sch.9-sec.4E","sectionType":"section","heading":"Class of person","content":"### sch.9-sec.4E Class of person\n\nA pharmacist—\nwho is employed at a public sector health service facility or a private health facility; and\nto whom a collaborative prescribing protocol applies for prescribing at the facility.\nsch 9 s 4E ins 2025 SL No. 19 s 7\n- (a) who is employed at a public sector health service facility or a private health facility; and\n- (b) to whom a collaborative prescribing protocol applies for prescribing at the facility.","sortOrder":585},{"sectionNumber":"sch.9-sec.4F","sectionType":"section","heading":"Dealing authorised","content":"### sch.9-sec.4F Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\na medicine mentioned in a collaborative prescribing protocol for a public sector health service facility or a private health facility\nthe medicine is prescribed in the circumstances and in accordance with the process mentioned in the collaborative prescribing protocol for the facility\n2\npossess\nan S4 or S8 medicine\nthe medicine is possessed for a purpose mentioned in this column\nsch 9 s 4F ins 2025 SL No. 19 s 7","sortOrder":586},{"sectionNumber":"sch.9-pt.1-div.3","sectionType":"division","heading":"Intern pharmacists","content":"## Intern pharmacists","sortOrder":587},{"sectionNumber":"sch.9-sec.5","sectionType":"section","heading":"Class of person","content":"### sch.9-sec.5 Class of person\n\nA person (an intern pharmacist ) who is—\nregistered under the Health Practitioner Regulation National Law to practise in the pharmacy profession with provisional registration; and\nemployed as an intern undertaking supervised practice.\n- (a) registered under the Health Practitioner Regulation National Law to practise in the pharmacy profession with provisional registration; and\n- (b) employed as an intern undertaking supervised practice.","sortOrder":588},{"sectionNumber":"sch.9-sec.6","sectionType":"section","heading":"Dealing authorised","content":"### sch.9-sec.6 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\na dealing mentioned in the table in division 1\na medicine mentioned in the table in division 1\nthe dealing with the medicine is carried out to the extent authorised for a pharmacist under the supervision of a pharmacist\n2\na dealing mentioned in the table in division 1A\na medicine mentioned in the table in division 1A\nthe dealing with the medicine is carried out to the extent authorised for a pharmacist under the supervision of a pharmacist\nsch 9 s 6 amd 2025 SL No. 60 s 15 (5)","sortOrder":589},{"sectionNumber":"sch.9-pt.1-div.4","sectionType":"division","heading":"Trainee pharmacists","content":"## Trainee pharmacists","sortOrder":590},{"sectionNumber":"sch.9-sec.7","sectionType":"section","heading":"Class of person","content":"### sch.9-sec.7 Class of person\n\nA person (a trainee pharmacist ) who is registered under the Health Practitioner Regulation National Law to practise in the pharmacy profession as a student or for training purposes.","sortOrder":591},{"sectionNumber":"sch.9-sec.8","sectionType":"section","heading":"Dealing authorised","content":"### sch.9-sec.8 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nsell by retail\na medicine mentioned in the table in division 1\nthe sale is carried out to the extent authorised for a pharmacist under the direct supervision of a pharmacist\n2\nadminister\na medicine mentioned in the table in division 1\nthe medicine is administered to the extent authorised for a pharmacist under the direct supervision of a pharmacist\na medicine mentioned in the table in division 1A\nthe medicine is administered to the extent authorised for a pharmacist under the direct supervision of a pharmacist\n3\ncompound\na medicine mentioned in the table in division 1\nthe medicine is compounded to the extent authorised for a pharmacist under the direct supervision of a pharmacist\n4\npossess\na medicine mentioned in the table in division 1\nthe medicine is possessed to the extent authorised for a pharmacist under the direct supervision of a pharmacist\na medicine mentioned in the table in division 1A\nthe medicine is possessed to the extent authorised for a pharmacist under the direct supervision of a pharmacist\nsch 9 s 8 amd 2025 SL No. 60 s 15 (6) – (7)","sortOrder":592},{"sectionNumber":"sch.9-pt.2","sectionType":"part","heading":"Pharmacy assistants","content":"# Pharmacy assistants","sortOrder":593},{"sectionNumber":"sch.9-pt.2-div.1","sectionType":"division","heading":"Hospital pharmaceutical technicians","content":"## Hospital pharmaceutical technicians","sortOrder":594},{"sectionNumber":"sch.9-sec.9","sectionType":"section","heading":"Definitions for part","content":"### sch.9-sec.9 Definitions for part\n\nIn this part—\npharmaceutical imprest duties means duties related to keeping an inventory of stock of medicines possessed for a specific health service or supplied for treatment of patients of the service.\nspecific health service means a Hospital and Health Service or private health facility.","sortOrder":595},{"sectionNumber":"sch.9-sec.10","sectionType":"section","heading":"Class of person","content":"### sch.9-sec.10 Class of person\n\nA person (a hospital pharmaceutical technician ) who—\nhas a qualification, or statement of attainment, recognising the person has the skills and knowledge required to carry out pharmaceutical imprest duties for a specific health service; and\ncarries out pharmaceutical imprest duties for a specific health service.\n- (a) has a qualification, or statement of attainment, recognising the person has the skills and knowledge required to carry out pharmaceutical imprest duties for a specific health service; and\n- (b) carries out pharmaceutical imprest duties for a specific health service.","sortOrder":596},{"sectionNumber":"sch.9-sec.11","sectionType":"section","heading":"Dealing authorised","content":"### sch.9-sec.11 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a purchase order\nstock of an S4 or S8 medicine\nthe purchase order is given under the supervision of a pharmacist in charge of a dispensary for a specific health service; and\nthe purchase order is given for the therapeutic treatment of patients of the specific health service\n2\npossess\nan S4 or S8 medicine\nthe medicine is possessed under the supervision of a pharmacist","sortOrder":597},{"sectionNumber":"sch.9-pt.2-div.2","sectionType":"division","heading":"Dispensary pharmacy assistants","content":"## Dispensary pharmacy assistants","sortOrder":598},{"sectionNumber":"sch.9-sec.12","sectionType":"section","heading":"Class of person","content":"### sch.9-sec.12 Class of person\n\nA person who—\nis 16 years or more and employed at a pharmacy; and\nis appropriately qualified to assist with compounding at the pharmacy.\n- (a) is 16 years or more and employed at a pharmacy; and\n- (b) is appropriately qualified to assist with compounding at the pharmacy.","sortOrder":599},{"sectionNumber":"sch.9-sec.13","sectionType":"section","heading":"Dealing authorised","content":"### sch.9-sec.13 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ncompound\na medicine\nthe medicine is compounded under the direct supervision of a pharmacist","sortOrder":600},{"sectionNumber":"sch.9-pt.2-div.3","sectionType":"division","heading":"General pharmacy assistants","content":"## General pharmacy assistants","sortOrder":601},{"sectionNumber":"sch.9-sec.14","sectionType":"section","heading":"Class of person","content":"### sch.9-sec.14 Class of person\n\nA person (a general pharmacy assistant ) who is 16 years or more and employed at a pharmacy.","sortOrder":602},{"sectionNumber":"sch.9-sec.15","sectionType":"section","heading":"Dealing authorised","content":"### sch.9-sec.15 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nsell by retail\nan S2 medicine\nthe medicine is sold under the direct supervision of a pharmacist\n2\ngive a purchase order\nstock of an S4 or S8 medicine\nthe purchase order is given, under the direct supervision of a pharmacist, for stock of medicines for the pharmacy to be delivered to the pharmacy\n3\npossess\nan S4 or S8 medicine\nthe medicine is possessed under the direct supervision of a pharmacist","sortOrder":603},{"sectionNumber":"sch.10-pt.1","sectionType":"part","heading":"Preliminary","content":"# Preliminary","sortOrder":604},{"sectionNumber":"sch.10-sec.1","sectionType":"section","heading":"Definitions for schedule","content":"### sch.10-sec.1 Definitions for schedule\n\nIn this schedule—\nendorsed podiatrist standard means the document called ‘Registration standard: endorsement for scheduled medicines’, made by the Podiatry Board on 1 August 2018.\npodiatric surgeon means a person who is a specialist registrant in the specialty of podiatric surgery.\nPodiatry Board means the Podiatry Board of Australia established under the Health Practitioner Regulation National Law .","sortOrder":605},{"sectionNumber":"sch.10-pt.2","sectionType":"part","heading":"Podiatrists","content":"# Podiatrists","sortOrder":606},{"sectionNumber":"sch.10-sec.2","sectionType":"section","heading":"Class of person","content":"### sch.10-sec.2 Class of person\n\nA person (a podiatrist ) who is registered under the Health Practitioner Regulation National Law to practise in the podiatry profession.","sortOrder":607},{"sectionNumber":"sch.10-sec.3","sectionType":"section","heading":"Dealing authorised","content":"### sch.10-sec.3 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nan S2 medicine\nan adrenaline (epinephrine) device\nany of the following medicines, other than when combined with adrenaline (epinephrine) or another vasoconstrictor medicine—\nbupivacaine of a strength of 0.5% or less\nlevobupivacaine of a strength of 0.5% or less\nlidocaine (lignocaine) of a strength of 2% or less\nprilocaine of a strength of 2% or less\n2\ngive a purchase order\nstock of an S4 medicine mentioned in this column\nthe stock is not for a specified place\n3\npossess\nan S4 medicine mentioned in this column\nsch 10 s 3 amd 2025 SL No. 148 s 33","sortOrder":608},{"sectionNumber":"sch.10-pt.3","sectionType":"part","heading":"Endorsed podiatrists","content":"# Endorsed podiatrists","sortOrder":609},{"sectionNumber":"sch.10-sec.4","sectionType":"section","heading":"Class of person","content":"### sch.10-sec.4 Class of person\n\nAn endorsed podiatrist, whether or not the podiatrist is also a podiatric surgeon.","sortOrder":610},{"sectionNumber":"sch.10-sec.5","sectionType":"section","heading":"Dealing authorised","content":"### sch.10-sec.5 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\na medicine mentioned in attachment A of the endorsed podiatrist standard\nthe medicine is prescribed under the standard\n2\ngive a treatment dose\na medicine mentioned in attachment A of the endorsed podiatrist standard\nthe medicine is given under the standard\n3\nadminister\na medicine mentioned in attachment A of the endorsed podiatrist standard\nthe medicine is administered under the standard\n4\ngive a purchase order\nstock of an S4 or S8 medicine mentioned in this column\nthe stock is not for a specified place\n5\npossess\nan S4 or S8 medicine mentioned in this column\nthe medicine is possessed for a purpose mentioned in this column\n6\ndispose\nwaste from a diversion-risk medicine mentioned in this column","sortOrder":611},{"sectionNumber":"sch.10-pt.4","sectionType":"part","heading":"Podiatric surgeons","content":"# Podiatric surgeons","sortOrder":612},{"sectionNumber":"sch.10-sec.6","sectionType":"section","heading":"Class of person","content":"### sch.10-sec.6 Class of person\n\nA podiatric surgeon who is not endorsed.","sortOrder":613},{"sectionNumber":"sch.10-sec.7","sectionType":"section","heading":"Dealing","content":"### sch.10-sec.7 Dealing\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\ndiclofenac, fexofenadine, ibuprofen, loratadine, naproxen, promethazine\nthe medicine is prescribed as an oral preparation for no more than a 10 day course of treatment\nhydrocortisone\nthe medicine is prescribed as a topical preparation for no more than a 10 day course of treatment with each dose being of a strength of 1% or less\namoxycillin or amoxycillin with clavulanic acid, cephalexin, dicloxacillin, doxycycline, erythromycin, metronidazole, roxithromycin\nthe medicine is prescribed as an oral preparation for no more than a 10 day course of treatment\ncodeine\nthe medicine is prescribed as an oral preparation of no more than 20 doses with each dose being not more than 30mg in combination with each 500mg of paracetamol\ndiazepam\nthe medicine is prescribed as an oral preparation of no more than 10 doses of 5mg each\nmupirocin\nthe medicine is prescribed as a topical preparation for no more than a 10 day course of treatment\ntemazepam\nthe medicine is prescribed as an oral preparation of no more than 2 doses of 10mg each\noxycodone\nthe medicine is prescribed as an oral preparation in a short acting form of no more than 10 doses of 5mg each\n2\nadminister\nany of the following S4 medicines—\ndexamethasone as a local injection\nropivacaine of a strength of 1% or less\nepinephrine (adrenaline) when combined with lidocaine (lignocaine), bupivacaine or prilocaine\n3\ngive a purchase order\nstock of an S4 medicine the podiatric surgeon may administer\nthe stock is not for a specified place\n4\npossess\nan S4 or S8 medicine mentioned in this column\nthe medicine is possessed for a purpose mentioned in this column\n5\ndispose\nwaste from a diversion-risk medicine mentioned in this column","sortOrder":614},{"sectionNumber":"sch.11-pt.1","sectionType":"part","heading":"Veterinary surgeons","content":"# Veterinary surgeons","sortOrder":615},{"sectionNumber":"sch.11-sec.1","sectionType":"section","heading":"Class of person","content":"### sch.11-sec.1 Class of person\n\nA veterinary surgeon.","sortOrder":616},{"sectionNumber":"sch.11-sec.2","sectionType":"section","heading":"Dealing authorised","content":"### sch.11-sec.2 Dealing authorised\n\nColumn 1 Dealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\na non-restricted medicine, other than a diversion-risk medicine\na diversion-risk medicine\nthe medicine prescribed is no more than the amount necessary for treating an animal for 6 months\n2\ndispense\na non-restricted medicine, other than a diversion-risk medicine\na non-restricted diversion-risk medicine\nthe medicine dispensed is no more than the amount necessary for treating an animal for 6 months\n3\ngive a treatment dose\na non-restricted medicine, other than a diversion-risk medicine\na diversion-risk medicine\nthe medicine given is no more than the amount necessary for treating an animal for 6 months\n4\nsupply\nan S4 medicine or medicated feed\nthe medicine or feed is to be mixed with food for administration to a group of animals by the farmer of the animals\n5\nadminister\nany medicine\n6\ncompound\na non-restricted medicine\nthe medicine is compounded for the treatment of an animal\n7\nrepackage\na non-restricted medicine\nthe medicine is repackaged for an animal\n8\ngive a purchase order\nstock of an S4 or S8 medicine that is a non-restricted medicine\nthe stock is not for a specified place\n9\npossess\nan S4 or S8 medicine\nthe medicine is possessed for a purpose mentioned in this column\n10\ndispose\nwaste from a diversion-risk medicine","sortOrder":617},{"sectionNumber":"sch.11-pt.2","sectionType":"part","heading":"Veterinary nurses","content":"# Veterinary nurses","sortOrder":618},{"sectionNumber":"sch.11-sec.3","sectionType":"section","heading":"Class of person","content":"### sch.11-sec.3 Class of person\n\nA person (a veterinary nurse ) who—\nis employed to practise veterinary nursing; and\nholds a qualification that makes the person eligible for full membership of the Veterinary Nurses Council of Australia Inc.\n- (a) is employed to practise veterinary nursing; and\n- (b) holds a qualification that makes the person eligible for full membership of the Veterinary Nurses Council of Australia Inc.","sortOrder":619},{"sectionNumber":"sch.11-sec.4","sectionType":"section","heading":"Dealing authorised","content":"### sch.11-sec.4 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nan S8 medicine\nthe medicine is administered at veterinary premises—\nwhen a veterinary surgeon is not able to be physically present but is available to be contacted using technology to communicate with a veterinary nurse in real time; and\nthe medicine has been pre-prepared into a treatment dose by a veterinary surgeon or a pharmacist; and\nthe medicine is administered on a prescription or in accordance with the medicine’s approved label\nan S2, S3 or S4 medicine\nthe medicine is administered at veterinary premises—\nunder the supervision of a veterinary surgeon; and\non a prescription or in accordance with the medicine’s approved label\nan S2, S3 or S4 medicine\nthe medicine is administered—\nunder the direct supervision of a veterinary surgeon; and\non a prescription or in accordance with the medicine’s approved label\n2\npossess\nan S4 or S8 medicine\nthe medicine is possessed for a purpose mentioned in this column","sortOrder":620},{"sectionNumber":"sch.11-pt.3","sectionType":"part","heading":"Trainees","content":"# Trainees","sortOrder":621},{"sectionNumber":"sch.11-pt.3-div.1","sectionType":"division","heading":"Trainee veterinary surgeons","content":"## Trainee veterinary surgeons","sortOrder":622},{"sectionNumber":"sch.11-sec.5","sectionType":"section","heading":"Class of person","content":"### sch.11-sec.5 Class of person\n\nA person undertaking training to obtain a qualification required to be a veterinary surgeon.","sortOrder":623},{"sectionNumber":"sch.11-sec.6","sectionType":"section","heading":"Dealing authorised","content":"### sch.11-sec.6 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\na medicine mentioned in the table in part 1\nthe medicine is administered—\nto the extent authorised for a veterinary surgeon; and\nunder the direct supervision of a veterinary surgeon\n2\npossess\na medicine mentioned in the table in part 1\nthe medicine is possessed—\nto the extent authorised for a veterinary surgeon; and\nunder the direct supervision of a veterinary surgeon","sortOrder":624},{"sectionNumber":"sch.11-pt.3-div.2","sectionType":"division","heading":"Trainee veterinary nurses","content":"## Trainee veterinary nurses","sortOrder":625},{"sectionNumber":"sch.11-sec.7","sectionType":"section","heading":"Class of person","content":"### sch.11-sec.7 Class of person\n\nA person undertaking training to obtain a qualification required to be a veterinary nurse.","sortOrder":626},{"sectionNumber":"sch.11-sec.8","sectionType":"section","heading":"Dealing authorised","content":"### sch.11-sec.8 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\na medicine mentioned in the table in part 2\nthe medicine is administered under the direct supervision of a veterinary surgeon\n2\npossess\na medicine mentioned in the table in part 2\nthe medicine is possessed under the direct supervision of a veterinary surgeon at the place where the veterinary surgeon is practising","sortOrder":627},{"sectionNumber":"sch.11-pt.4","sectionType":"part","heading":"Veterinary assistants","content":"# Veterinary assistants","sortOrder":628},{"sectionNumber":"sch.11-sec.9","sectionType":"section","heading":"Class of person","content":"### sch.11-sec.9 Class of person\n\nA person (a veterinary assistant ) assisting a veterinary surgeon to manage stock of medicines at veterinary premises.","sortOrder":629},{"sectionNumber":"sch.11-sec.10","sectionType":"section","heading":"Dealing authorised","content":"### sch.11-sec.10 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\npossess\nan S4 medicine, other than pentobarbital\nthe medicine is possessed under the direct supervision of a veterinary surgeon","sortOrder":630},{"sectionNumber":"sch.12-pt.1","sectionType":"part","heading":"Anaesthetic technicians","content":"# Anaesthetic technicians","sortOrder":631},{"sectionNumber":"sch.12-sec.1","sectionType":"section","heading":"Class of person","content":"### sch.12-sec.1 Class of person\n\nA person (an anaesthetic technician ) who holds a qualification acceptable to the Australian and New Zealand College of Anaesthetists to be an anaesthetic technician.","sortOrder":632},{"sectionNumber":"sch.12-sec.2","sectionType":"section","heading":"Dealing authorised","content":"### sch.12-sec.2 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nany medicine\nthe medicine is administered to a patient at a hospital—\nunder the direct supervision of a medical practitioner; and\nfor the patient’s anaesthetic procedure\n2\npossess\nan S4 or S8 medicine\nthe medicine is possessed under the supervision of a dentist, medical practitioner, midwife or registered nurse\n3\ndispose\nwaste from a diversion-risk medicine mentioned in this column\nsch 12 s 2 sub 2023 SL No. 170 s 12","sortOrder":633},{"sectionNumber":"sch.12-pt.2","sectionType":"part","heading":"Clinical perfusionists","content":"# Clinical perfusionists","sortOrder":634},{"sectionNumber":"sch.12-sec.3","sectionType":"section","heading":"Class of person","content":"### sch.12-sec.3 Class of person\n\nA person (a clinical perfusionist ) who is—\nemployed as a clinical perfusionist for a Hospital and Health Service, private health facility or approved health facility; or\naccredited or certified to work as a clinical perfusionist by a professional body approved by the chief executive.\nsch 12 s 3 amd 2025 SL No. 148 s 34\n- (a) employed as a clinical perfusionist for a Hospital and Health Service, private health facility or approved health facility; or\n- (b) accredited or certified to work as a clinical perfusionist by a professional body approved by the chief executive.","sortOrder":635},{"sectionNumber":"sch.12-sec.4","sectionType":"section","heading":"Dealing authorised","content":"### sch.12-sec.4 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nany medicine\nthe medicine is administered into extracorporeal circulation equipment to prepare for an anaesthetic, intensive care or surgical procedure for a patient—\nunder the supervision of an anaesthetist, cardiothoracic surgeon or another intensive care physician; or\non a clinical protocol applying to the clinical perfusionist\n2\npossess\nan S4 or S8 medicine\nthe medicine is possessed for administration to the extent mentioned in this column\n3\ndispose\nwaste from a diversion-risk medicine mentioned in this column","sortOrder":636},{"sectionNumber":"sch.12-pt.3","sectionType":"part","heading":"Nuclear medicine technologists","content":"# Nuclear medicine technologists","sortOrder":637},{"sectionNumber":"sch.12-sec.5","sectionType":"section","heading":"Class of person","content":"### sch.12-sec.5 Class of person\n\nA person (a nuclear medicine technologist ) who is registered under the Health Practitioner Regulation National Law to practise in the nuclear medicine technology division of the medical radiation practice profession.","sortOrder":638},{"sectionNumber":"sch.12-sec.6","sectionType":"section","heading":"Dealing authorised","content":"### sch.12-sec.6 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\na medicine, other than an adrenaline (epinephrine) device\nthe medicine is administered—\non a clinical protocol applying to the nuclear medicine technologist; or\non a written prescription\nan adrenaline (epinephrine) device\nthe nuclear medicine technologist has completed anaphylaxis training and the medicine is administered to treat anaphylaxis—\non a clinical protocol applying to the technologist; or\non a written prescription\n2\npossess\nan S4 or S8 medicine\nthe medicine is possessed for administration to the extent mentioned in this column\n3\ndispose\nwaste from a diversion-risk medicine mentioned in this column\nsch 12 s 6 amd 2025 SL No. 90 s 6 ; 2025 SL No. 148 s 35","sortOrder":639},{"sectionNumber":"sch.12-pt.4","sectionType":"part","heading":"Physiotherapists","content":"# Physiotherapists","sortOrder":640},{"sectionNumber":"sch.12-sec.7","sectionType":"section","heading":"Class of person","content":"### sch.12-sec.7 Class of person\n\nA person (a physiotherapist ) who is registered with the Physiotherapy Board of Australia, established under the Health Practitioner Regulation National Law, to practise in the physiotherapy profession.","sortOrder":641},{"sectionNumber":"sch.12-sec.8","sectionType":"section","heading":"Dealing authorised","content":"### sch.12-sec.8 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nprescribe\na medicine mentioned in the extended practice authority called ‘Physiotherapists’\nthe medicine is prescribed under the extended practice authority\n2\nadminister\nan S2 medicine\na nitrous oxide mixture\nthe medicine is administered in a hospital on a written prescription\nan S3 medicine for pain relief\nthe medicine—\nis administered on a written prescription; or\nhas been lawfully supplied to the patient being treated with the medicine\nan S3 or S4 medicine for the physiotherapy treatment of a respiratory condition\nthe medicine—\nis administered on a written prescription; or\nhas been lawfully supplied to the patient being treated with the medicine\na medicine mentioned in the extended practice authority called ‘Physiotherapists’\nthe medicine is administered under the extended practice authority\n3\npossess\nan S4 or S8 medicine mentioned in this column\nthe medicine is possessed for a purpose mentioned in this column\n4\ndispose\nwaste from a diversion-risk medicine mentioned in this column\nsch 12 s 8 amd 2025 SL No. 148 s 36","sortOrder":642},{"sectionNumber":"sch.12-pt.5","sectionType":"part","heading":"Respiratory scientists","content":"# Respiratory scientists","sortOrder":643},{"sectionNumber":"sch.12-sec.9","sectionType":"section","heading":"Class of person","content":"### sch.12-sec.9 Class of person\n\nA person (a respiratory scientist ) who—\nis employed as a respiratory scientist for a Hospital and Health Service, private health facility or approved health facility; or\nis accredited or certified to work as a respiratory scientist by a professional body approved by the chief executive.\nsch 12 s 9 amd 2025 SL No. 148 s 37 (1)\n- (a) is employed as a respiratory scientist for a Hospital and Health Service, private health facility or approved health facility; or\n- (b) is accredited or certified to work as a respiratory scientist by a professional body approved by the chief executive.","sortOrder":644},{"sectionNumber":"sch.12-sec.10","sectionType":"section","heading":"Dealing authorised","content":"### sch.12-sec.10 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nan S2 or S3 medicine, other than an adrenaline (epinephrine) device\nthe medicine is administered—\non a clinical protocol applying to the respiratory scientist; or\non a written prescription\nan adrenaline (epinephrine) device\nthe respiratory scientist has completed anaphylaxis training and the medicine is administered to treat anaphylaxis—\non a clinical protocol applying to the scientist; or\non a written prescription\nan S4 medicine that is an anti-histamine for systemic use or a broncho-constrictor agent or bronchodilator agent\nthe medicine is administered—\non a clinical protocol applying to the respiratory scientist; or\non a written prescription\n2\npossess\nan S4 medicine mentioned in this column\nthe medicine is possessed for a purpose mentioned in this column\nsch 12 s 10 amd 2025 SL No. 148 s 37 (2)","sortOrder":645},{"sectionNumber":"sch.12-pt.6","sectionType":"part","heading":"Speech pathologists","content":"# Speech pathologists","sortOrder":646},{"sectionNumber":"sch.12-sec.11","sectionType":"section","heading":"Definition for part","content":"### sch.12-sec.11 Definition for part\n\nIn this part—\nmedication safety course means the online course called ‘Medication safety’ provided by NPS MedicineWise ABN 61 082 034 393.","sortOrder":647},{"sectionNumber":"sch.12-sec.12","sectionType":"section","heading":"Class of person","content":"### sch.12-sec.12 Class of person\n\nA person (a speech pathologist ) who has completed the medication safety course and is—\nemployed as a speech pathologist for a Hospital and Health Service, private health facility or in another government entity under the Public Sector Act 2022 , section 276 ; or\naccredited or certified to work as a speech pathologist by a professional body approved by the chief executive.\nsch 12 s 12 amd 2023 SL No. 51 s 9 ; 2025 SL No. 148 s 38 (1)\n- (a) employed as a speech pathologist for a Hospital and Health Service, private health facility or in another government entity under the Public Sector Act 2022 , section 276 ; or\n- (b) accredited or certified to work as a speech pathologist by a professional body approved by the chief executive.","sortOrder":648},{"sectionNumber":"sch.12-sec.13","sectionType":"section","heading":"Dealing authorised","content":"### sch.12-sec.13 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nan S2 or S3 medicine, other than an adrenaline (epinephrine) device\nthe medicine is administered—\non a clinical protocol applying to the speech pathologist; or\non a written prescription\nan adrenaline (epinephrine) device\nthe speech pathologist has completed anaphylaxis training and the medicine is administered to treat anaphylaxis—\non a clinical protocol applying to the pathologist; or\non a written prescription\nan S4 medicine that is a topical antibiotic or a topical corticosteroid\nthe medicine is administered—\non a clinical protocol applying to the speech pathologist; or\non a written prescription\n2\npossess\nan S4 medicine mentioned in this column\nthe medicine is possessed for a purpose mentioned in this column\nsch 12 s 13 amd 2025 SL No. 148 s 38 (2)","sortOrder":649},{"sectionNumber":"sch.12-pt.7","sectionType":"part","heading":"Trainee health practitioners in other professions","content":"# Trainee health practitioners in other professions","sortOrder":650},{"sectionNumber":"sch.12-sec.14","sectionType":"section","heading":"Definitions for part","content":"### sch.12-sec.14 Definitions for part\n\nIn this part—\nhealth trainee means a person undertaking training to obtain a qualification required to become a member of a relevant class of health practitioner mentioned in schedules 3 to 11 , 13 or 15 , other than an enrolled nurse or pharmacist.\nrelevant class , in relation to a health trainee, means the class of health practitioner for which the trainee is undertaking training to become.","sortOrder":651},{"sectionNumber":"sch.12-sec.15","sectionType":"section","heading":"Class of person","content":"### sch.12-sec.15 Class of person\n\nA health trainee.","sortOrder":652},{"sectionNumber":"sch.12-sec.16","sectionType":"section","heading":"Dealing authorised","content":"### sch.12-sec.16 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\na medicine mentioned in the table for the relevant class in relation to the health trainee\nthe medicine is administered to the extent authorised for the relevant class under the direct supervision of a person authorised to administer the medicine, other than a person who is—\nanother health trainee; or\nauthorised to administer the medicine only under the supervision of someone else\n2\npossess\na medicine mentioned in the table for the relevant class in relation to the health trainee\nthe medicine is possessed to the extent authorised for the relevant class under the direct supervision of a person authorised to possess the medicine, other than a person who is—\nanother health trainee; or\nauthorised to possess the medicine only under the supervision of someone else","sortOrder":653},{"sectionNumber":"sch.13-pt.1","sectionType":"part","heading":"Detention institution workers","content":"# Detention institution workers","sortOrder":654},{"sectionNumber":"sch.13-pt.1-div.1","sectionType":"division","heading":"Executive directors of detention centres","content":"## Executive directors of detention centres","sortOrder":655},{"sectionNumber":"sch.13-sec.1","sectionType":"section","heading":"Class of person","content":"### sch.13-sec.1 Class of person\n\nA person who is the executive director of a detention centre.","sortOrder":656},{"sectionNumber":"sch.13-sec.2","sectionType":"section","heading":"Dealing authorised","content":"### sch.13-sec.2 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a purchase order\nstock of an S4 or S8 medicine\nthe purchase order is given for medicines for the therapeutic treatment of children detained at the detention centre\n2\npossess\nstock of an S4 or S8 medicine\nthe stock is possessed at the detention centre","sortOrder":657},{"sectionNumber":"sch.13-pt.1-div.2","sectionType":"division","heading":"General managers of prisons","content":"## General managers of prisons","sortOrder":658},{"sectionNumber":"sch.13-sec.3","sectionType":"section","heading":"Class of person","content":"### sch.13-sec.3 Class of person\n\nA person who is the general manager of a prison.","sortOrder":659},{"sectionNumber":"sch.13-sec.4","sectionType":"section","heading":"Dealing authorised","content":"### sch.13-sec.4 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a purchase order\nstock of an S4 or S8 medicine\nthe purchase order is given for medicines for the therapeutic treatment of persons detained at the prison or children accommodated with the person detained\n2\npossess\nstock of an S4 or S8 medicine\nthe stock is possessed at the prison","sortOrder":660},{"sectionNumber":"sch.13-pt.1-div.3","sectionType":"division","heading":"Custodial officers","content":"## Custodial officers","sortOrder":661},{"sectionNumber":"sch.13-sec.5","sectionType":"section","heading":"Definitions for division","content":"### sch.13-sec.5 Definitions for division\n\nIn this division—\ncorrective services officer see the Corrective Services Act 2006 , schedule 4 .\ncourt see the Corrective Services Act 2006 , schedule 4 .\nproper officer , of a court, see the Corrective Services Act 2006 , schedule 4 .","sortOrder":662},{"sectionNumber":"sch.13-sec.6","sectionType":"section","heading":"Class of person","content":"### sch.13-sec.6 Class of person\n\nA person (a custodial officer ) who is—\na proper officer of a court; or\na corrective services officer.\n- (a) a proper officer of a court; or\n- (b) a corrective services officer.","sortOrder":663},{"sectionNumber":"sch.13-sec.7","sectionType":"section","heading":"Dealing authorised","content":"### sch.13-sec.7 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nsupply\nany medicine\nthe medicine—\nis supplied by giving it to a police officer or another custodial officer to possess for the therapeutic treatment of a person in custody; and\nwas lawfully supplied to the person in custody for the therapeutic treatment of the person","sortOrder":664},{"sectionNumber":"sch.13-pt.2","sectionType":"part","heading":"School workers","content":"# School workers","sortOrder":665},{"sectionNumber":"sch.13-pt.2-div.1","sectionType":"division","heading":"Principals or delegates","content":"## Principals or delegates","sortOrder":666},{"sectionNumber":"sch.13-sec.8","sectionType":"section","heading":"Class of person","content":"### sch.13-sec.8 Class of person\n\nA person who is the principal of a school or the principal’s delegate.","sortOrder":667},{"sectionNumber":"sch.13-sec.9","sectionType":"section","heading":"Dealing authorised","content":"### sch.13-sec.9 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nany medicine\nthe medicine—\nwas dispensed for a child attending the school or supplied for the child by the child’s parent or guardian; and\nis administered in accordance with the medicine’s approval label or on a written instruction from the prescriber of the medicine\n2\npossess\nan S4 or S8 medicine\nthe medicine is possessed for administration to the extent mentioned in this column","sortOrder":668},{"sectionNumber":"sch.13-pt.2-div.2","sectionType":"division","heading":"Trained staff","content":"## Trained staff","sortOrder":669},{"sectionNumber":"sch.13-sec.10","sectionType":"section","heading":"Class of person","content":"### sch.13-sec.10 Class of person\n\nA person who is employed at a school.","sortOrder":670},{"sectionNumber":"sch.13-sec.11","sectionType":"section","heading":"Dealing authorised","content":"### sch.13-sec.11 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nan adrenaline (epinephrine) device\nthe medicine is administered to a child attending the school and the person has completed anaphylaxis training\nan inhaled asthma reliever, other than an S4 medicine\nthe medicine is administered to a child attending the school and the person has completed asthma training\n2\npossess\na medicine mentioned in this column\nthe medicine is possessed for administration to the extent mentioned in this column\nsch 13 s 11 amd 2025 SL No. 148 s 39","sortOrder":671},{"sectionNumber":"sch.13-pt.3","sectionType":"part","heading":"Child care workers","content":"# Child care workers","sortOrder":672},{"sectionNumber":"sch.13-pt.3-div.1","sectionType":"division","heading":"Heads or delegates","content":"## Heads or delegates","sortOrder":673},{"sectionNumber":"sch.13-sec.12","sectionType":"section","heading":"Definition for division","content":"### sch.13-sec.12 Definition for division\n\nIn this division—\nhead , of a child care facility, means—\nif the facility provides an education and care service under the Education and Care Services National Law (Queensland) —an approved provider or nominated supervisor for the service within the meaning of the Education and Care Services National Law (Queensland) , section 5 (1) ; or\nif the facility provides a Queensland education and care service under the Education and Care Services Act 2013 —an approved provider or supervisor within the meaning of the Education and Care Services Act 2013 , schedule 1 .\n- (a) if the facility provides an education and care service under the Education and Care Services National Law (Queensland) —an approved provider or nominated supervisor for the service within the meaning of the Education and Care Services National Law (Queensland) , section 5 (1) ; or\n- (b) if the facility provides a Queensland education and care service under the Education and Care Services Act 2013 —an approved provider or supervisor within the meaning of the Education and Care Services Act 2013 , schedule 1 .","sortOrder":674},{"sectionNumber":"sch.13-sec.13","sectionType":"section","heading":"Class of person","content":"### sch.13-sec.13 Class of person\n\nA person who is the head of a child care facility or the head’s delegate.","sortOrder":675},{"sectionNumber":"sch.13-sec.14","sectionType":"section","heading":"Dealing authorised","content":"### sch.13-sec.14 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nany medicine\nthe medicine—\nwas dispensed for a child attending the child care facility or supplied for the child by the child’s parent or guardian; and\nis administered in accordance with the medicine’s approval label or on a written instruction from the prescriber of the medicine\n2\npossess\nan S4 or S8 medicine\nthe medicine is possessed for administration to the extent mentioned in this column","sortOrder":676},{"sectionNumber":"sch.13-pt.3-div.2","sectionType":"division","heading":"Trained staff","content":"## Trained staff","sortOrder":677},{"sectionNumber":"sch.13-sec.15","sectionType":"section","heading":"Class of person","content":"### sch.13-sec.15 Class of person\n\nA person who is employed at a child care facility.","sortOrder":678},{"sectionNumber":"sch.13-sec.16","sectionType":"section","heading":"Dealing authorised","content":"### sch.13-sec.16 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nan adrenaline (epinephrine) device\nthe medicine is administered to a child attending the child care facility and the person has completed anaphylaxis training\nan inhaled asthma reliever, other than an S4 medicine\nthe medicine is administered to a child attending the child care facility and the person has completed asthma training\n2\npossess\na medicine mentioned in this column\nthe medicine is possessed for administration to the extent mentioned in this column\nsch 13 s 16 amd 2025 SL No. 148 s 40 (2)","sortOrder":679},{"sectionNumber":"sch.13-pt.4","sectionType":"part","heading":"Hospital employees","content":"# Hospital employees","sortOrder":680},{"sectionNumber":"sch.13-sec.17","sectionType":"section","heading":"Class of person","content":"### sch.13-sec.17 Class of person\n\nA person who is an adult employed at a hospital whose duties include storing and distributing medical gas at the hospital.","sortOrder":681},{"sectionNumber":"sch.13-sec.18","sectionType":"section","heading":"Dealing authorised","content":"### sch.13-sec.18 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\npossess\nan S4 medical gas\nthe medicine is possessed in accordance with any procedures in place at the hospital for the possession of the medicine","sortOrder":682},{"sectionNumber":"sch.13-pt.5","sectionType":"part","heading":"Ship employees","content":"# Ship employees","sortOrder":683},{"sectionNumber":"sch.13-pt.5-div.1","sectionType":"division","heading":"Preliminary","content":"## Preliminary","sortOrder":684},{"sectionNumber":"sch.13-sec.19","sectionType":"section","heading":"Definitions for part","content":"### sch.13-sec.19 Definitions for part\n\nIn this part—\nmaster , of a ship, means the person having command or charge of the ship.\nship see the Transport Operations (Marine Safety) Act 1994 , section 10 .","sortOrder":685},{"sectionNumber":"sch.13-pt.5-div.2","sectionType":"division","heading":"Ship’s master","content":"## Ship’s master","sortOrder":686},{"sectionNumber":"sch.13-sec.20","sectionType":"section","heading":"Class of person","content":"### sch.13-sec.20 Class of person\n\nA person who is the master of a ship.","sortOrder":687},{"sectionNumber":"sch.13-sec.21","sectionType":"section","heading":"Dealing authorised","content":"### sch.13-sec.21 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nany medicine\nthe medicine is administered—\nto a person on the ship who it is necessary to treat; and\nin accordance with the medicine’s approved label\n2\ngive a purchase order\nstock of an S4 or S8 medicine\nthe purchase order is given for medicines for ensuring the health or safety of persons on the ship\n3\npossess\nstock of an S4 or S8 medicine\nthe stock is possessed on the ship","sortOrder":688},{"sectionNumber":"sch.13-pt.5-div.3","sectionType":"division","heading":"Ship’s staff","content":"## Ship’s staff","sortOrder":689},{"sectionNumber":"sch.13-sec.22","sectionType":"section","heading":"Definition for division","content":"### sch.13-sec.22 Definition for division\n\nIn this division—\nship’s medicine means an S2 or S3 medicine kept on a ship under any of the following laws—\nthe Transport Operations (Marine Safety) Act 1994 ;\nthe Marine Safety (Domestic Commercial Vessel) National Law Act 2012 (Cwlth) ;\nthe Navigation Act 2012 (Cwlth) .\n- (a) the Transport Operations (Marine Safety) Act 1994 ;\n- (b) the Marine Safety (Domestic Commercial Vessel) National Law Act 2012 (Cwlth) ;\n- (c) the Navigation Act 2012 (Cwlth) .","sortOrder":690},{"sectionNumber":"sch.13-sec.23","sectionType":"section","heading":"Class of person","content":"### sch.13-sec.23 Class of person\n\nA person who is employed on a ship.","sortOrder":691},{"sectionNumber":"sch.13-sec.24","sectionType":"section","heading":"Dealing authorised","content":"### sch.13-sec.24 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\na ship’s medicine\nthe medicine is administered—\nto a person on the ship who it is necessary to treat; and\nin accordance with the medicine’s approved label\n2\npossess\na ship’s medicine\nthe medicine is possessed for administration to a person on the ship","sortOrder":692},{"sectionNumber":"sch.13-pt.6","sectionType":"part","heading":"Mine employees","content":"# Mine employees","sortOrder":693},{"sectionNumber":"sch.13-pt.6-div.1","sectionType":"division","heading":"Preliminary","content":"## Preliminary","sortOrder":694},{"sectionNumber":"sch.13-sec.25","sectionType":"section","heading":"Definition for part","content":"### sch.13-sec.25 Definition for part\n\nIn this part—\nS4 inhaled analgesic means an S4 medicine analgesic that is administered by inhalation.","sortOrder":695},{"sectionNumber":"sch.13-pt.6-div.2","sectionType":"division","heading":"Mine manager","content":"## Mine manager","sortOrder":696},{"sectionNumber":"sch.13-sec.26","sectionType":"section","heading":"Class of person","content":"### sch.13-sec.26 Class of person\n\nA person who is in charge of a mine.","sortOrder":697},{"sectionNumber":"sch.13-sec.27","sectionType":"section","heading":"Dealing authorised","content":"### sch.13-sec.27 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a purchase order\nstock of an S4 inhaled analgesic\nthe purchase order is given for the medicines for the first aid treatment of persons at the mine\n2\npossess\nstock of an S4 inhaled analgesic\nthe stock is possessed at the mine","sortOrder":698},{"sectionNumber":"sch.13-pt.6-div.3","sectionType":"division","heading":"Mine’s first aid provider","content":"## Mine’s first aid provider","sortOrder":699},{"sectionNumber":"sch.13-sec.28","sectionType":"section","heading":"Class of person","content":"### sch.13-sec.28 Class of person\n\nA first aid provider employed at a mine who has completed training from a registered training organisation about using an S4 inhaled analgesic.","sortOrder":700},{"sectionNumber":"sch.13-sec.29","sectionType":"section","heading":"Dealing authorised","content":"### sch.13-sec.29 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nan S4 inhaled analgesic that does not include methoxyflurane\nthe medicine is administered for the first aid treatment of a person at the mine\nan S4 inhaled analgesic that includes methoxyflurane\nthe medicine is administered—\nfor the first aid treatment of a person at the mine; and\nin 1 dose of no greater than 3 millilitres unless the medicine is administered on a prescription\n2\npossess\na medicine mentioned in this column\nthe medicine is possessed for administration to a person at the mine","sortOrder":701},{"sectionNumber":"sch.13-pt.7","sectionType":"part","heading":"Health department employees","content":"# Health department employees","sortOrder":702},{"sectionNumber":"sch.13-sec.30","sectionType":"section","heading":null,"content":"### Section sch.13-sec.30\n\nregistered vaccine service provider ...\nsch 13 s 30 def registered vaccine service provider om 2025 SL No. 19 s 8 (1)\ns 30 om 2025 SL No. 19 s 8 (1)","sortOrder":703},{"sectionNumber":"sch.13-sec.31","sectionType":"section","heading":"Class of person","content":"### sch.13-sec.31 Class of person\n\nA person who is—\nemployed in the department; and\napproved by the chief executive to deal with immunisation medicines for an immunisation program.\nsch 13 s 31 amd 2025 SL No. 19 s 8 (2)\n- (a) employed in the department; and\n- (b) approved by the chief executive to deal with immunisation medicines for an immunisation program.","sortOrder":704},{"sectionNumber":"sch.13-sec.32","sectionType":"section","heading":"Dealing authorised","content":"### sch.13-sec.32 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nsupply\nstock of an immunisation medicine\nthe stock is supplied to a registered immunisation service provider\n2\ngive a purchase order\nstock of an immunisation medicine\nthe stock is to supply a registered immunisation service provider\n3\npossess\nstock of an immunisation medicine\nthe stock is possessed for an immunisation program\nsch 13 s 32 amd 2025 SL No. 19 s 8 (3) – (4)","sortOrder":705},{"sectionNumber":"sch.13-pt.8","sectionType":"part","heading":"Local government environmental health officers","content":"# Local government environmental health officers","sortOrder":706},{"sectionNumber":"sch.13-sec.33","sectionType":"section","heading":"Class of person","content":"### sch.13-sec.33 Class of person\n\nA person who is employed as an environmental health officer for a local government.","sortOrder":707},{"sectionNumber":"sch.13-sec.34","sectionType":"section","heading":"Dealing authorised","content":"### sch.13-sec.34 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\ngive a purchase order\nstock of an S4 medicine that is an immunisation medicine for human therapeutic use\nthe purchase order is given for medicines for an immunisation program carried out by the department, the local government or a Hospital and Health Service\n2\npossess\nstock of an S4 medicine that is an immunisation medicine for human therapeutic use\nthe stock is possessed for the immunisation program\nsch 13 s 34 amd 2025 SL No. 19 s 9","sortOrder":708},{"sectionNumber":"sch.14-pt.1","sectionType":"part","heading":"Commonwealth law manufacturers","content":"# Commonwealth law manufacturers","sortOrder":709},{"sectionNumber":"sch.14-sec.1","sectionType":"section","heading":"Class of person","content":"### sch.14-sec.1 Class of person\n\nA person who is permitted under a Commonwealth law to manufacture a medicine.","sortOrder":710},{"sectionNumber":"sch.14-sec.2","sectionType":"section","heading":"Dealing authorised","content":"### sch.14-sec.2 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nsupply\nstock of any medicine\nthe stock is supplied in compliance with any conditions of the person’s permission under the Commonwealth law; and\nthe stock is supplied from a place where the person is permitted to manufacture the medicine under the Commonwealth law; and\nthe supply is not otherwise authorised under section 50 of the Act\n2\ngive a purchase order\nstock of an S4 or S8 medicine\nthe purchase order is given for stock required for an activity permitted in the person’s permission under the Commonwealth law, to the extent not otherwise authorised under section 50 of the Act\n3\ndispose\nwaste from a diversion-risk medicine mentioned in this column","sortOrder":711},{"sectionNumber":"sch.14-pt.2","sectionType":"part","heading":"Corresponding law wholesalers","content":"# Corresponding law wholesalers","sortOrder":712},{"sectionNumber":"sch.14-sec.3","sectionType":"section","heading":"Class of person","content":"### sch.14-sec.3 Class of person\n\nA person permitted under a corresponding law to supply a medicine by wholesale.","sortOrder":713},{"sectionNumber":"sch.14-sec.4","sectionType":"section","heading":"Dealing authorised","content":"### sch.14-sec.4 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nsupply\nstock of any medicine\nthe stock is supplied in compliance with any conditions of the entity’s permission under the corresponding law; and\nthe person arranges the delivery of the medicine only to someone within Queensland who is authorised, or for whom it is not unlawful, to buy the medicine; and\nthe person does not—\npossess the medicine by storing it at a place in Queensland; or\narrange for the medicine to be collected from a storage facility located in Queensland; and\nthe supply is not otherwise authorised under section 50 of the Act\nsch 14 s 4 amd 2025 SL No. 90 s 7 (1)","sortOrder":714},{"sectionNumber":"sch.14-pt.3","sectionType":"part","heading":"Corresponding law retailers","content":"# Corresponding law retailers","sortOrder":715},{"sectionNumber":"sch.14-sec.5","sectionType":"section","heading":"Class of person","content":"### sch.14-sec.5 Class of person\n\nA person permitted under a corresponding law to supply a medicine by retail.","sortOrder":716},{"sectionNumber":"sch.14-sec.6","sectionType":"section","heading":"Dealing authorised","content":"### sch.14-sec.6 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nsupply by retail\nstock of any medicine\nthe stock is supplied in compliance with any conditions of the entity’s permission under the corresponding law; and\nthe person arranges the delivery of the medicine only to someone within Queensland who is authorised to buy the medicine; and\nthe person does not—\npossess the medicine by storing it at a place in Queensland; or\narrange for the medicine to be collected from a storage facility located in Queensland; and\nthe supply is not otherwise authorised under section 50 of the Act\nsch 14 s 6 amd 2025 SL No. 90 s 7 (2)","sortOrder":717},{"sectionNumber":"sch.14-pt.4","sectionType":"part","heading":"Wholesale representatives","content":"# Wholesale representatives","sortOrder":718},{"sectionNumber":"sch.14-sec.7","sectionType":"section","heading":"Definition for part","content":"### sch.14-sec.7 Definition for part\n\nIn this part—\nauthorised practitioner , for a medicine, means a health practitioner or veterinary surgeon who is authorised to prescribe the medicine or supply the medicine without a prescription from another practitioner.","sortOrder":719},{"sectionNumber":"sch.14-sec.8","sectionType":"section","heading":"Class of person","content":"### sch.14-sec.8 Class of person\n\nA person (a wholesale representative ) employed to display or give starter packs of medicines for—\nan entity, other than a pharmacist, authorised to supply a medicine by wholesale under the Act ; or\na person otherwise permitted under a corresponding law to supply a medicine by wholesale.\n- (a) an entity, other than a pharmacist, authorised to supply a medicine by wholesale under the Act ; or\n- (b) a person otherwise permitted under a corresponding law to supply a medicine by wholesale.","sortOrder":720},{"sectionNumber":"sch.14-sec.9","sectionType":"section","heading":"Dealing authorised","content":"### sch.14-sec.9 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nsupply\nstock of an S2, S3 or S4 medicine in a starter pack, other than a monitored medicine\nthe stock is supplied—\nto an authorised practitioner for the medicine; and\nto the extent stated in the purchase order for the medicine from the practitioner\n2\npossess\nan S4 medicine in a starter pack, other than a monitored medicine\nthe medicine possessed is not more than is reasonably necessary to meet the business needs of the representative for a 6-month period","sortOrder":721},{"sectionNumber":"sch.15-pt.1","sectionType":"part","heading":"Carriers","content":"# Carriers","sortOrder":722},{"sectionNumber":"sch.15-sec.1","sectionType":"section","heading":"Class of person","content":"### sch.15-sec.1 Class of person\n\nA person engaged to deliver a medicine from place to place.","sortOrder":723},{"sectionNumber":"sch.15-sec.2","sectionType":"section","heading":"Dealing authorised","content":"### sch.15-sec.2 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\npossess\nan S4 or S8 medicine\nthe medicine is possessed for the purposes of delivery of the medicine","sortOrder":724},{"sectionNumber":"sch.15-pt.2","sectionType":"part","heading":"Health practitioner assistants","content":"# Health practitioner assistants","sortOrder":725},{"sectionNumber":"sch.15-sec.3","sectionType":"section","heading":"Class of person","content":"### sch.15-sec.3 Class of person\n\nA person assisting a health practitioner to manage stock of medicines as part of the person’s employment at a place.","sortOrder":726},{"sectionNumber":"sch.15-sec.4","sectionType":"section","heading":"Dealing authorised","content":"### sch.15-sec.4 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\npossess\nan S4 medicine\nthe medicine is possessed at the place under the direct supervision of the health practitioner","sortOrder":727},{"sectionNumber":"sch.15-pt.3","sectionType":"part","heading":"Farmers of animals","content":"# Farmers of animals","sortOrder":728},{"sectionNumber":"sch.15-sec.5","sectionType":"section","heading":"Class of person","content":"### sch.15-sec.5 Class of person\n\nA farmer of a group of animals who has a prescription for an S4 medicine or medicated feed to be mixed with food for administering to the animals.","sortOrder":729},{"sectionNumber":"sch.15-sec.6","sectionType":"section","heading":"Dealing authorised","content":"### sch.15-sec.6 Dealing authorised\n\nColumn 1\nDealing\nColumn 2\nMedicine\nColumn 3\nScope of dealing\n1\nadminister\nan S4 medicine or medicated feed\nthe medicine or feed is administered to the group of animals on the prescription\n2\npossess\nan S4 medicine or medicated feed\nthe medicine or feed is possessed for administering to the group of animals","sortOrder":730},{"sectionNumber":"sch.16-pt.1","sectionType":"part","heading":"Acute health conditions at isolated sites","content":"# Acute health conditions at isolated sites","sortOrder":731},{"sectionNumber":"sch.16-sec.1","sectionType":"section","heading":"Definitions for part","content":"### sch.16-sec.1 Definitions for part\n\nIn this part—\nisolated site means a remote site for which limited medical and pharmaceutical services are available.\nmine sites, island resorts\nsenior person , at an isolated site, means a person who is responsible for daily operations at the site.","sortOrder":732},{"sectionNumber":"sch.16-sec.2","sectionType":"section","heading":"Classes of persons and dealings","content":"### sch.16-sec.2 Classes of persons and dealings\n\nColumn 1\nClass of person\nColumn 2\nDealing with medicine\n1\na medical practitioner employed by the holder of an approval\ngive a purchase order for stock of medicines for an isolated site stated in the approval\n2\na nurse practitioner employed by the holder of an approval\ngive a purchase order for stock of medicines for an isolated site stated in the approval\n3\na senior person at an isolated site stated in an approval who is employed by the holder of the approval\npossess stock of medicines for the isolated site\n4\na registered nurse employed by the holder of an approval\npossess stock of medicines for an isolated site stated in the approval\ngive a treatment dose of an S2, S3 or S4 medicine stated in the approval on a prescription from a medical practitioner or nurse practitioner","sortOrder":733},{"sectionNumber":"sch.16-pt.2","sectionType":"part","heading":"Emergency first aid","content":"# Emergency first aid","sortOrder":734},{"sectionNumber":"sch.16-sec.3","sectionType":"section","heading":"Definitions for part","content":"### sch.16-sec.3 Definitions for part\n\nIn this part—\nemergency medicine , in relation to a general approval (emergency first aid), means—\neach of the following medicines—\nadrenaline (epinephrine);\natropine;\nbenzatropine;\nceftriaxone;\nfurosemide (frusemide);\nglucagon;\nglyceryl trinitrate;\nhydrocortisone;\nipratropium bromide monohydrate;\nlidocaine (lignocaine);\nmethoxyflurane;\nmetoclopramide;\nmidazolam;\nmorphine;\nnaloxone;\nnitrous oxide;\npromethazine;\nsalbutamol; or\nanother medicine for emergencies stated in the approval.\nfirst aid provider means a person who has a current certificate granted by a registered training organisation for the provision of first aid.\nparamedic means a person registered under the Health Practitioner Regulation National Law as being qualified to practise as a paramedic.\nsenior person , in relation to a general approval (emergency first aid), means a person who is responsible for daily operations at a site stated in the approval.\nsite , in relation to an approval, means—\na place at which an event, notified to the chief executive by the holder of the approval under section 35 , takes place; or\na place stated in the approval.\n- (a) each of the following medicines— • adrenaline (epinephrine); • atropine; • benzatropine; • ceftriaxone; • furosemide (frusemide); • glucagon; • glyceryl trinitrate; • hydrocortisone; • ipratropium bromide monohydrate; • lidocaine (lignocaine); • methoxyflurane; • metoclopramide; • midazolam; • morphine; • naloxone; • nitrous oxide; • promethazine; • salbutamol; or\n- • adrenaline (epinephrine);\n- • atropine;\n- • benzatropine;\n- • ceftriaxone;\n- • furosemide (frusemide);\n- • glucagon;\n- • glyceryl trinitrate;\n- • hydrocortisone;\n- • ipratropium bromide monohydrate;\n- • lidocaine (lignocaine);\n- • methoxyflurane;\n- • metoclopramide;\n- • midazolam;\n- • morphine;\n- • naloxone;\n- • nitrous oxide;\n- • promethazine;\n- • salbutamol; or\n- (b) another medicine for emergencies stated in the approval.\n- • adrenaline (epinephrine);\n- • atropine;\n- • benzatropine;\n- • ceftriaxone;\n- • furosemide (frusemide);\n- • glucagon;\n- • glyceryl trinitrate;\n- • hydrocortisone;\n- • ipratropium bromide monohydrate;\n- • lidocaine (lignocaine);\n- • methoxyflurane;\n- • metoclopramide;\n- • midazolam;\n- • morphine;\n- • naloxone;\n- • nitrous oxide;\n- • promethazine;\n- • salbutamol; or\n- (a) a place at which an event, notified to the chief executive by the holder of the approval under section 35 , takes place; or\n- (b) a place stated in the approval.","sortOrder":735},{"sectionNumber":"sch.16-sec.4","sectionType":"section","heading":"Classes of person and dealings","content":"### sch.16-sec.4 Classes of person and dealings\n\nColumn 1\nClass of person\nColumn 2\nDealing with medicine\n1\na medical practitioner working for the holder of an approval\ngive a purchase order for stock of medicines for a site for the approval\n2\na nurse practitioner working for the holder of an approval\ngive a purchase order for stock of medicines for a site for the approval\n3\na senior person at a site for an approval, working for the holder of the approval\npossess stock of medicines at the site\n4\na paramedic working at a site for an approval\nadminister an emergency medicine on an oral prescription or a standing order made under the approval\npossess an emergency medicine under the approval\ndispose of waste from an emergency medicine that is a diversion-risk medicine under the approval\n5\na registered nurse working at a site for an approval\nadminister an emergency medicine on an oral prescription or a standing order made under the approval\npossess an emergency medicine under the approval\n6\na first aid provider working at a site for an approval\nadminister glyceryl trinitrate on a prescription from a medical practitioner or nurse practitioner made under the approval\npossess glyceryl trinitrate under the approval","sortOrder":736},{"sectionNumber":"sch.16-pt.3","sectionType":"part","heading":"Emergency management of animals","content":"# Emergency management of animals","sortOrder":737},{"sectionNumber":"sch.16-sec.5","sectionType":"section","heading":"Definitions for part","content":"### sch.16-sec.5 Definitions for part\n\nIn this part—\nqualified person means a person who has—\ncompleted a training course approved by the chief executive about the safe administration of medicines to animals; or\nskills and knowledge equivalent to the competency the person would achieve by completing the training course mentioned in paragraph (a) , as stated in writing by a veterinary surgeon.\nsenior person , at a location stated in a general approval (emergency management of animals), means a person who is responsible for daily operations at the location.\n- (a) completed a training course approved by the chief executive about the safe administration of medicines to animals; or\n- (b) skills and knowledge equivalent to the competency the person would achieve by completing the training course mentioned in paragraph (a) , as stated in writing by a veterinary surgeon.","sortOrder":738},{"sectionNumber":"sch.16-sec.6","sectionType":"section","heading":"Classes of persons and dealings","content":"### sch.16-sec.6 Classes of persons and dealings\n\nColumn 1\nClass of person\nColumn 2\nDealing with medicine\n1\na veterinary surgeon working for the holder of an approval\ngive a purchase order for stock of medicines for a location stated in the approval\nmake a standing order under the approval\n2\na senior person at a location stated in the approval, working for the holder of an approval\npossess stock of medicines at the location\n3\na qualified person working for the holder of an approval\npossess stock of medicines\nadminister a medicine on an oral prescription or a standing order from a veterinary surgeon working under the approval\n4\na person training to become a qualified person for the holder of an approval\nadminister or possess a medicine under the direct supervision of a veterinary surgeon working under the approval\n5\na person working for the holder of an approval\npossess stock of medicines for working under the approval","sortOrder":739},{"sectionNumber":"sch.18-pt.1","sectionType":"part","heading":"Relevant practitioners required to check database","content":"# Relevant practitioners required to check database","sortOrder":740},{"sectionNumber":"sch.18-pt.1A","sectionType":"part","heading":"Exempt circumstances","content":"# Exempt circumstances","sortOrder":741},{"sectionNumber":"sch.18-pt.2","sectionType":"part","heading":"Information providers and relevant information","content":"# Information providers and relevant information","sortOrder":742},{"sectionNumber":"sch.18-pt.3","sectionType":"part","heading":"Users and purposes for disclosure","content":"# Users and purposes for disclosure","sortOrder":743}],"analysis":{"kimi_summary":{"_metrics":{"completionTokens":993},"content_quality":"ok","complexity_score":9,"scope_assessment":{"changed":true,"description":"The regulation has expanded significantly beyond a simple medicines control scheme. Originally likely focused on basic prescription and supply controls, it now incorporates: a comprehensive monitored medicines database with real-time tracking; electronic prescription management systems with technical security standards; extended practice authorities enabling non-medical practitioners to prescribe/administer; naloxone treatment programs for opioid overdose; national blood supply and emergency stockpile arrangements; and complex transitional arrangements preserving old approvals. The scope now encompasses public health surveillance, digital health infrastructure, harm reduction programs, and national health security coordination."},"complexity_factors":["Extensive cross-referencing between the Act, multiple other regulations, and numerous schedules (22 schedules referenced)","Nested conditional logic with multiple exceptions and exceptions-to-exceptions (e.g., section 5 has multiple layers of inclusion/exclusion for registration types)","Highly granular categorisation system (S2/S3/S4/S8, plus restricted/high-risk/diversion-risk/monitored medicines with overlapping definitions)","Version-controlled documents (extended practice authorities and departmental standards with specific version numbers)","Multiple parallel regulatory schemes operating simultaneously (general approvals, extended practice authorities, standing orders, clinical protocols)","Detailed procedural requirements with specific timeframes (e.g., 24 hours, 5 business days, 6 months, 1 year, 2 years)","Extensive record-keeping obligations with specific data fields required for different transaction types","Electronic system requirements with technical specifications (secure system identifiers, tamper-proof records, backup requirements)","Geographic restrictions (25km rule for S2 retail, isolated practice areas)","Transitional provisions preserving old approvals and grandfathering arrangements from repealed regulations"],"plain_english_summary":"This is a **Queensland regulation** that sets out detailed rules for how medicines can be manufactured, supplied, prescribed, dispensed, administered, and disposed of throughout the state. It works alongside the main Medicines and Poisons Act 2019.\n\n**Who it affects:**\n- **Health professionals** — doctors, nurses, pharmacists, dentists, paramedics, veterinary surgeons, and many others\n- **Businesses** — medicine manufacturers, wholesalers, and retailers\n- **Patients** — anyone receiving prescription or over-the-counter medicines\n\n**What it does:**\n\n**1. Categorises medicines by risk level**\n- **S2** (pharmacy-only) and **S3** (pharmacist-only) — lower risk medicines\n- **S4** (prescription-only) — medicines needing a prescription\n- **S8** (controlled drugs) — high-risk medicines like strong painkillers and stimulants with strict controls\n- Special categories: **restricted medicines**, **high-risk medicines**, **diversion-risk medicines** (at risk of misuse), and **monitored medicines** (tracked in a database)\n\n**2. Sets licensing and approval requirements**\n- Manufacturers, wholesalers, and retailers need licences with conditions about quality control, record-keeping, and security\n- Health professionals need specific approvals to prescribe or handle certain medicines\n\n**3. Controls how medicines move through the system**\n- **Purchase orders** must be secure and traceable for S4 and S8 medicines\n- **Prescriptions** must contain specific information, with extra requirements for high-risk medicines\n- **Electronic prescriptions** are allowed through approved systems\n- **Delivery** must be secure, with tracking and temperature controls\n\n**4. Creates special access arrangements**\n- **Extended practice authorities** let non-doctors (like nurses or Aboriginal health workers) give certain medicines in specific circumstances\n- **General approvals** for emergency situations — first aid at events, isolated sites, or animal emergencies\n- **Standing orders** allow pre-approved treatment protocols\n\n**5. Establishes the monitored medicines database**\n- Tracks prescriptions of high-risk medicines across Queensland\n- Health practitioners must check it before prescribing certain medicines\n- Helps prevent \"doctor shopping\" and medicine misuse\n\n**6. Sets security and record-keeping rules**\n- **S8 safes** with strict access controls for controlled drugs\n- **Medicine registers** tracking every movement of high-risk medicines\n- **Electronic prescription management systems** with security requirements\n- Records must be kept for 2+ years\n\n**7. Includes emergency provisions**\n- Pharmacists can sell small amounts of some prescription medicines without a prescription in urgent situations\n- Naloxone programs for opioid overdose reversal\n- National blood supply and stockpile arrangements\n\n**Why it matters:**\nThis regulation balances **access to medicines** with **preventing harm** — from ensuring quality manufacturing to stopping misuse of addictive drugs. It affects everyday experiences like getting a prescription filled, buying painkillers, or receiving emergency medication."},"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"},"flash_summary":{"complexity_score":9,"scope_assessment":{"changed":true,"description":"The regulation has expanded beyond a narrow ‘‘storage and safe‑use’’ rulebook into an operational, IT‑enabled public health instrument. Compared with the core purpose of regulating safe possession and supply of medicines, later inserts and parts broaden the scope to: (1) enable large‑scale public health and emergency programs through carve‑outs and national tracking systems (national blood tracking, national stockpile, naloxone programs, immunisation stock transfers — secs 6, 6A, 6B, 6C); (2) mandate and prescribe detailed electronic prescription management systems and reporting obligations (chapter 8 and monitored medicines database chapters); and (3) expand delegated and extended practice roles across many health and allied professions via extensive schedules and extended practice authorities (schedules 3–15, secs 7–8, 236). Those additions move the instrument from purely safety and control of medicines towards enabling and governing program delivery, digital infrastructure and delegated clinical practice, increasing administrative and compliance reach compared with a more limited original regulatory intent."},"complexity_factors":["Length and scope: over 250 numbered provisions (sections) plus extensive schedules (at least 19 schedules) covering many professions and activities","Numerous defined terms and cross‑references: repeated references to the Act, Poisons Standard, Health Practitioner Regulation National Law, and Commonwealth instruments (multiple cross‑references throughout)","Many conditional and nested rules: multiple ‘‘only to the extent’’ qualifications, exceptions for emergency programs, transitional provisions and special arrangements (e.g. secs 6, 6A, 6B, 6C; transitional Part 10)","Large schedule matrix of authorised classes: schedules 3–15 list dozens of professional classes with bespoke scopes of dealing (prescribe/possess/administer/order) creating many role‑specific conditions","Detailed electronic system governance and security requirements with criminal/penalty provisions (chapter 8, secs 184–192, 185–191)","Extensive record‑keeping and register rules with precise formatting, reconciliation and retention rules (secs 203–224)","Multiple penalty levels and enforcement triggers (penalty units up to 80 for system/administrative breaches)","Interplay of state and federal regimes: permitted interactions with Commonwealth regulations and corresponding laws (e.g. National Health instruments, Therapeutic Goods legislation), increasing legal complexity","Transitional and amendment history embedded in the text (many insertions and temporal clauses), increasing interpretive complexity"],"plain_english_summary":"**What this regulation does (mechanics)\n\n- Establishes detailed rules for any dealing with a medicine: classification, who may do what, how medicines are manufactured, supplied, delivered, stored, prescribed, dispensed, administered, repackaged, recorded and destroyed. (See e.g. parts on manufacturing licences, supplying stock, prescribing, dispensing, storage and medicine registers.)\n\n- Creates categories of medicines that attract special controls: restricted, high‑risk, diversion‑risk and monitored medicines (see chapter 1, sections 9–12 and schedule 2). Monitored medicines feed into a central monitored medicines database and trigger mandatory checks for certain practitioners (chapter 7). \n\n- Specifies classes of people authorised to deal with particular medicines (schedules 3–15). Those schedules list dozens of professions and roles (doctors, nurses, pharmacists, dentists, allied health, ambulance/first aid workers, veterinary professions, school staff, carriers, wholesale representatives, farmers, etc.) and the precise scope each class has (prescribe, possess, administer, give purchase orders, etc.).\n\n- Sets operational requirements for supply chains and logistics: how purchase orders must be made and transmitted securely (secs 50–53), invoicing and marking on supply (secs 61–62), packaging and labelling rules and permitted alternatives (secs 64–66, 72–73, 237), secure delivery and carrier duties (chs 4 & 8), and special constraints for S8 (Schedule 8 / high‑control) medicines (e.g. packaging, separate handling, signed receipts) (secs 65, 68–69, Parts on S8 safes and medicine registers).\n\n- Describes record‑keeping, inspection and reporting obligations: what records must be kept, for how long, how to secure electronic records, and mandatory event reporting (lost/stolen medicines, supply on suspicious prescriptions, system breaches) (secs 224, 226–233, ch.8). Medicine registers and S8 safes have detailed layout, reconciliation and audit rules (secs 203–218).\n\n- Regulates electronic prescription systems: who must manage them, required security and audit functionality, user management, breach reporting and system standards (chapter 8, parts 1–2; secs 184–193, 185–192, 186–191).\n\n- Provides exemptions and special arrangements for public health or emergency activities: national blood supply tracking (s 6), S3 naloxone treatment programs (s 6A), national stockpile medicines during health emergencies (s 6B), and restricted transfers of immunisation stock between registered immunisation service providers (s 6C).\n\n- Authorises the chief executive of the health department to approve alternative labelling/packaging and to make or approve extended practice authorities and departmental standards (secs 7–8, 237). It also prescribes fees and refund rules for licences (chapter 9).\n\nWho is affected\n\n- Businesses in the medicine supply chain: manufacturers, wholesalers, pharmacies, repackagers, carriers and wholesale representatives. They face compliance duties on orders, packaging, delivery, safes/registers, and reporting.\n\n- Health practitioners: doctors, nurse practitioners, pharmacists, dentists, allied health (optometrists, physiotherapists, speech pathologists, etc.), and many specified auxiliary workers. For each role the regulation lists exactly which medicines can be prescribed, possessed, administered or ordered and under which conditions (see schedules 3–15).\n\n- Institutions and public bodies: hospitals, clinics, schools, detention centres, RFDS, ambulance services and government entities that run immunisation, stockpile or emergency programs.\n\n- Patients and the public: via limits on advertising (s 234), vending machines (s 235), restrictions on retail selling near pharmacies (s 27), and enhanced tracking of monitored medicines.\n\nWhy it matters (intended purposes and the trade-offs)\n\n- Safety, traceability and control: the regulation implements a system of classification, supervised dealing rights, mandatory records and a monitored medicines database to reduce diversion, ensure correct therapeutic use and enable audits and recalls (see chs 7–8, s 179–186, ss 203–218). That is the primary mechanism for preventing misuse of controlled medicines.\n\n- Enabling public health responses: special exemptions and transfer rules (secs 6, 6A, 6B, 6C) allow nationally coordinated blood product handling, naloxone programs, stockpile distribution, and immunisation program logistics without triggering ordinary licence barriers. Mechanism: carve‑outs tied to specific systems (e.g. national blood tracking) and to responsible government entities.\n\n- Digital transition and operational modernisation: mandatory use of secure electronic prescription management systems and detailed system governance aims to make prescribing and supply more efficient and traceable (secs 83–85, 114, ch.8). This shifts implementation risk into IT security, availability and inter‑operability.\n\nCosts, incentives and trade‑offs to watch (mechanisms, not judgments)\n\n- Compliance costs are concentrated on private suppliers and health employers: secure packaging, specialised safes, medicine registers, IT for electronic prescription systems, staff training and increased record‑keeping (many provisions in chapters 4, 8 and 224). These are recurring and may raise operating costs (see secs 197–208, 224, 185–192). \n\n- Competitive effects and constraints on private choice: a 25 km restriction on S2 sales near pharmacies (s 27) and the requirement that many medicines be sold only in manufacturer’s packs (secs 28, 72) limit non‑pharmacy retail options. Advertising bans (s 234) constrain commercial promotion of S3–S8 medicines.\n\n- Discretion and central control: the chief executive has power to approve alternative labelling/packaging, to publish departmental standards and to grant extended practice authorities (secs 7–8, 237, 236). These create administrative gates that can speed or block private initiatives depending on approvals processes and resourcing.\n\n- Implementation risk from technology: mandated electronic systems require robust access control, secure identifiers, breach monitoring and reporting (secs 186–192, 188–192). A failure or security breach creates operational and legal exposure (breach reporting and penalties are specified).\n\n- Enforcement and behavioural incentives: mandatory reporting duties, medicine register reconciliations and substantial penalties (up to 80 penalty units for some breaches) give regulators enforcement leverage; this creates incentives to invest in compliance but also risks conservative practice (e.g. refusals to supply when in doubt) that could affect timely patient care (see reporting and prohibition sections throughout chs 4–8).\n\nConcentrated benefits and diffuse costs\n\n- Concentrated benefits accrue to entities running authorised programs (e.g. National Blood Authority, immunisation services, ambulance services) through tailored exemptions and operational rules (secs 6, 6C, 6B). \n\n- Costs and administrative burdens are dispersed across pharmacies, wholesalers, carriers, health facilities and many practitioners who must implement the record, security and IT measures.\n\nKey behavioural changes the regulation requires\n\n- Suppliers and buyers must use secure, auditable written or electronic purchase orders for S4/S8 stock and keep records (secs 50–53, 61–62).\n\n- Dispensers and prescribers must follow strict prescription content, transmission and retention rules for S4/S8 and other controlled medicines (secs 83–92, 86–89, 95–100, 116–124).\n\n- Pharmacies and institutions must install and manage secure S8 safes, maintain medicine registers and reconcile stock regularly (secs 196–217).\n\n- Electronic prescription systems must be governed, secured, and audited; users are tightly managed and breaches reported (ch.8, secs 184–193).\n\nPractical implementation risks and opportunity costs\n\n- Time and money spent on IT upgrades, staff training and physical infrastructure (safes, tamper‑evident packaging) is diverted from other services.\n\n- The chief executive’s approval processes (alternative labelling, extended practice authorities) centralise decision making; their timeliness and consistency will determine how quickly legitimate practice innovations can scale.\n\n- Tight procedural rules (e.g. secure transmission, signature rules, prescription form constraints) can slow down urgent care unless exceptions (e.g. emergency orders, RFDS medicine chests) are properly used and understood (see sections on oral prescriptions, RFDS exemptions and emergency approvals).\n\nOverall: the regulation is a comprehensive operational rulebook that rebalances clinical delegation, supply‑chain controls and digital systems towards traceability and prevention of misuse while also providing targeted exceptions for national programs and emergency needs. It imposes significant compliance and governance obligations on private and public providers, and gives the chief executive structured discretion to approve alternatives or extended practices (see secs 236–237)."},"issue_detection":{"absurdities":[],"contradictions":[]},"summary":{"complexity_score":9,"scope_assessment":{"changed":true,"description":"The regulation began as a framework for controlling medicines dealings in Queensland, but subsequent amendments (2022–2025) have meaningfully expanded its scope. Notable additions include: a new exemption for S3 naloxone distribution programs (2023) reflecting public health policy to expand opioid overdose reversal access; an exemption for national stockpile medicine distribution during health emergencies (2024); and an exemption for immunisation medicine transfers between registered providers (2025). These additions extend the regulation beyond its original pharmaceutical supply chain focus into broader public health emergency and harm-reduction territory."},"complexity_factors":["Extremely large scope — covers the entire lifecycle of medicines from manufacture through to administration","Multiple overlapping regulatory frameworks — references Commonwealth laws (National Health Act, National Blood Authority Act, Health Practitioner Regulation National Law), state Acts, and the Poisons Standard simultaneously","Highly differentiated rules based on medicine schedule (S2, S3, S4, S8) requiring readers to understand which category applies in each situation","Extensive use of cross-references between sections, schedules (22 schedules referenced), parts and divisions making linear reading impossible","Different rules for different professional classes — doctors, nurses, enrolled nurses, pharmacists, veterinary surgeons, paramedics, first aid providers, midwives, school principals — each with different permissions","Multiple types of authority instruments (manufacturing licences, retail licences, prescribing approvals, general approvals, extended practice authorities, departmental standards) each with distinct conditions","Conditional exemptions that layer multiple requirements — exemptions apply only when several conditions are simultaneously satisfied","Technical pharmaceutical and legal terminology throughout (S-schedules, Poisons Standard, diversion-risk, compounding, medication chart prescription, national medication chart prescription)","Frequent amendments since commencement (2022, 2023, 2024, 2025) creating version complexity","Content truncated — the full regulation is significantly longer than what was provided, suggesting even greater complexity in the omitted sections"],"plain_english_summary":"The Medicines and Poisons (Medicines) Regulation 2021 is Queensland’s framework for who may possess, prescribe, dispense, transport and supply medicines, under what conditions, and how those activities must be recorded and inspected. It affects health professionals, pharmacies, manufacturers, carriers, hospitals and government programs—setting licensing, prescribing, supply and delivery safeguards (including stricter controls for high‑risk medicines) and exemptions for certain public health programs. It matters because it underpins medicine safety, access and legal compliance across the state."}},"importantCases":[],"_links":{"self":"/api/acts/medicines-and-poisons-medicines-regulation-2021","history":"/api/acts/medicines-and-poisons-medicines-regulation-2021/history","analysis":"/api/acts/medicines-and-poisons-medicines-regulation-2021/analysis","conflicts":"/api/acts/medicines-and-poisons-medicines-regulation-2021/conflicts","importantCases":"/api/acts/medicines-and-poisons-medicines-regulation-2021/important-cases","documents":"/api/acts/medicines-and-poisons-medicines-regulation-2021/documents"}}